{
  "results": [
    {
      "question": "Causes of thickened gallbladder wall on ultrasound examination are all except: A. Postprandial state | B. Cholecystitis | C. Congestive cardiac failure | D. Kawasaki disease",
      "answer": "The correct answer is **A. Postprandial state**.\n\nHere's why:\n\n*   **Thickened gallbladder wall** on ultrasound is a sign that the gallbladder is inflamed or experiencing some form of stress.\n*   **B. Cholecystitis:** This is inflammation of the gallbladder and is a very common cause of a thickened gallbladder wall.\n*   **C. Congestive cardiac failure:** In severe heart failure, fluid can back up in the body, including the liver and gallbladder, leading to edema and a thickened gallbladder wall.\n*   **D. Kawasaki disease:** This is a childhood illness that can cause inflammation in blood vessels throughout the body, including those supplying the gallbladder, leading to wall thickening.\n*   **A. Postprandial state:** After eating, the gallbladder contracts to release bile. This contraction can temporarily make the gallbladder wall appear slightly thicker than when it is relaxed, but it is a normal physiological change and not indicative of pathology. The thickening seen in the other conditions is usually more pronounced and persistent.",
      "ground_truth": "Kawasaki disease || Ans: D (Kawasaki disease) Ref: Manual of Emergency Critical Care Ultrasound Vicke E Noble. 2nd ed. Pg 156Explanation:Kawasaki disease is associated with hydrops of gallbladder.Gallbladder Wall Thickening A gallbladder wall that is thickened is a sign of inflammation. This is a non-specific finding, and many other pathologic processes, as well as a postprandial gallbladder, can give you falsely elevated measurements.It is important to measure the wall of the anterior gallbladder surface because of the acoustic enhancement artifact mentioned.Because sound waves travel through a fluid-filled structure, no attenuation occurs. Thus, when those sound weaves hit the back of the gallbladder, they will be so strong that they will obscure an accurate picture of the wall thickness.For gallbladder wall thickness, greater than 3 mm is abnormal.Differential for Thickened Gallbladder WallPostprandialRenal failureAscitesHepatitisHypoalbuminemiaHIV/AIDSAdenomyomatosisMultiple myelomaCholecystitisCongestive heart failure",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "An ill 16 days old baby girl is brought to the emergency. On examination pallor and dyspnoea present with a respiratory rate of 85 per minute. Her HR is 200 bpm, hea sounds are distant and a gallop is heard. X-ray showed cardiomegaly. An echocardiogram shows dilated ventricles and dilation of the left atrium. An ECG shows ventricular depolarization complexes that have low voltage. Which of the following is the most likely diagnosis? A. CHF | B. Glycogen storage disease | C. Pericarditis | D. Aberrant left coronary aery arising from pulmonary aery",
      "answer": "The most likely diagnosis for this 16-day-old infant is **A. CHF (Congestive Heart Failure)**.\n\nHere's why:\n\n*   **Pallor and Dyspnea:** These are classic signs of poor oxygenation and circulation, often seen in infants with heart problems.\n*   **High Respiratory Rate (85/min) and Heart Rate (200 bpm):** These are compensatory mechanisms in infants with heart failure. The body is trying to deliver more oxygen by breathing faster and pumping blood faster.\n*   **Distant Heart Sounds and Gallop Rhythm:** Distant heart sounds can indicate fluid around the heart (though less likely with the other findings) or a very enlarged heart. A gallop rhythm (S3 or S4 sound) is a hallmark of ventricular dysfunction and volume overload, common in heart failure.\n*   **Cardiomegaly on X-ray:** An enlarged heart is a direct indicator of cardiac strain or disease.\n*   **Dilated Ventricles and Left Atrium on Echocardiogram:** These findings strongly suggest that the heart chambers are enlarged due to increased workload and impaired pumping function, consistent with heart failure.\n*   **Low Voltage Ventricular Depolarization Complexes on ECG:** While not specific to CHF, low voltage can be seen in conditions where the heart muscle is weakened or there's increased fluid around the heart, which can be associated with severe heart failure.\n\nLet's consider why the other options are less likely:\n\n*   **B. Glycogen storage disease:** While some glycogen storage diseases can affect the heart (e.g., Pompe disease), they typically present with hypertrophied (thickened) ventricles, not dilated ones, and often have other systemic symptoms.\n*   **C. Pericarditis:** Pericarditis (inflammation of the sac around the heart) can cause distant heart sounds and dyspnea, but it typically leads to a pericardial effusion (fluid buildup), which might cause muffled heart sounds and a friction rub, not necessarily dilated ventricles and atria. The ECG findings in pericarditis are usually characteristic ST-segment changes.\n*   **D. Aberrant left coronary artery arising from the pulmonary artery (ALCAPA):** This is a serious congenital heart defect that can lead to myocardial ischemia and heart failure in infancy. However, ALCAPA typically presents with *dilated left ventricle and left atrium* due to the left ventricle receiving deoxygenated blood and the right ventricle working harder. While it can cause CHF, the description of \"dilated ventricles\" without specifying which one, and the overall picture of severe distress with compensatory tachycardia and tachypnea, points more broadly to CHF as the immediate clinical syndrome. If the question were more specific about the *cause* of the CHF, ALCAPA would be a strong contender, but CHF itself is the overarching clinical presentation.\n\nGiven the constellation of symptoms and findings, **Congestive Heart Failure (CHF)** is the most encompassing and likely diagnosis describing the infant's current critical state. The underlying cause of the CHF would then be investigated further.",
      "ground_truth": "CHF || In CHF pallor, dyspnoea, tachypnoea, tachycardia and cardiomegaly are common regardless of the cause.The most common causes of CHF in children include myocarditis caused by adenovirus and coxsackievirus B.The echocardiogram shows ventricular and left atrial dilatation as well as poor ventricular function. With glycogen storage disease of the hea muscle thickening would be expected. With pericarditis- pericardial effusion is seen. On ECG, the voltages of the ventricular complexes seen with aberrant origin of the left coronary aery are not diminished, and a pattern of myocardial infarction can be seen. *",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Congestive hea failure in an infant is characterized by all except A. Pedal edema | B. Tachypnea | C. Sweating | D. Poor weight gain",
      "answer": "The correct answer is **A. Pedal edema**.\n\nHere's why:\n\n*   **Congestive heart failure (CHF) in infants** is a condition where the heart cannot pump blood effectively to meet the body's needs.\n*   **Tachypnea (rapid breathing)** is a common sign as the infant tries to get more oxygen.\n*   **Sweating**, especially during feeding, is also a sign of increased work of breathing and cardiac effort.\n*   **Poor weight gain** occurs because the infant expends a lot of energy on breathing and feeding is difficult due to fatigue and rapid breathing.\n\n**Pedal edema (swelling in the feet and ankles)** is **rarely seen in infants with CHF**. This is because infants have different fluid distribution and their venous pressure is generally not high enough to cause significant peripheral edema. In adults, pedal edema is a hallmark sign of CHF, but this is not the case for infants.",
      "ground_truth": "Pedal edema || Congestive Cardiac Failure in InfantsSymptomsSignsuFeeding difficultyuTakes less volume per feeduDiaphoretic while suckinguForehead sweating.uSuck-rest-suck cycle.uPoor weight gainuPeriorbital edema uClothes no longer fituIncreasing cloth sizeuRapid breathing/nasal flaring/cyanosis/chest retractions.uTachycardia.uHepatomegaly.uOccasionally Splenomegaly.uPeriorbital edemauEdema in flanks. uDependent edema (Refer: Nelson's Textbook of Paediatrics, 19thedition, pg no:1530)",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Autosomal recessive polycystic kidney disease features include: A. Can be diagnosed intrauterine | B. Proceeds to renal failure till children reaches school going age | C. Can be palpated abdominally | D. Hypertension doesn't develop until late stages of the disease",
      "answer": "The correct answer is **A. Can be diagnosed intrauterine**.\n\nHere's why:\n\n*   **A. Can be diagnosed intrauterine:** Autosomal recessive polycystic kidney disease (ARPKD) is a severe genetic disorder that can often be detected during prenatal ultrasounds. The characteristic enlarged, echogenic kidneys are visible.\n*   **B. Proceeds to renal failure till children reaches school going age:** While ARPKD is a progressive disease, the timeline to renal failure can vary significantly. Many children with ARPKD develop severe kidney disease and may require dialysis or transplantation much earlier than school age, or in some cases, may not survive infancy.\n*   **C. Can be palpated abdominally:** The kidneys in ARPKD are significantly enlarged due to the numerous cysts. This enlargement can indeed lead to palpable masses in the abdomen, especially in infants and young children. However, this is a *feature* and not the *defining* diagnostic characteristic that is always present or the most crucial aspect of diagnosis.\n*   **D. Hypertension doesn't develop until late stages of the disease:** Hypertension is a common and often early complication of ARPKD, even in the presence of relatively preserved kidney function. It's related to the impaired kidney function and hormonal imbalances.\n\n**Explanation:**\n\nARPKD is a serious genetic condition affecting the kidneys and liver. The hallmark of the disease is the development of numerous cysts in the kidneys, leading to their enlargement and impaired function. This can manifest in various ways, including:\n\n*   **Prenatal diagnosis:** As mentioned, ultrasounds can detect the enlarged kidneys before birth.\n*   **Early onset of symptoms:** Many infants with ARPKD present with severe symptoms shortly after birth, including respiratory distress (due to lung hypoplasia, often associated with ARPKD), abdominal distension, and poor feeding.\n*   **Progressive kidney disease:** The cysts grow and multiply, leading to progressive loss of kidney function and eventual renal failure. This can occur in infancy, childhood, or adolescence, but often progresses rapidly.\n*   **Hypertension:** High blood pressure is a very common complication and can be present early in the disease course.\n*   **Liver involvement:** The liver is also affected, with the development of congenital hepatic fibrosis and portal hypertension, which can lead to complications like bleeding from esophageal varices.\n\nTherefore, the ability to diagnose ARPKD *intrauterine* is a significant and well-established feature of the disease.",
      "ground_truth": "Can be diagnosed intrauterine || Ans. A. Can be diagnosed intrauterineExplanationClinical features of ARPKD (Autosomal recessive polycystic kidney disease) are:Classic ARPKD is generally diagnosed in utero or within the neonatal period and characterized by greatly enlarged echogenic kidneys in diseased fetuses. (Option a)Reduced fetal urine production may contribute to oligohydramnios and pulmonary hypoplasia.About 30% of affected neonates die shortly after birth due to respiratory insufficiency. Close to 60% of mortality occurs within the first month of life.In the classic group, most patients are bom with renal insufficiency and ESRD (End stage renal disease). (Option b)However, infants often have a transient improvement in their GFR; death from renal insufficiency at this stage is rare.Some patients are diagnosed after the neonatal stage and form the older group. Morbidity and mortality in this group often involve systemic hypertension, progressive renal insufficiency, and liver manifestations.The hallmarks of ARPKD liver disease are biliary dysgenesis due to a primary ductal plate malformation with associated periportal fibrosis, namely congenital hepatic fibrosis (CHF) and dilatation of intrahepatic bile ducts (Caroli's disease). CHF and Caroli's disease can then lead to portal hypertension exhibiting hepatosplenomegaly, variceal bleeding, and cholangitis.Some patients with the diagnosis of ARPKD at 1 year of age with nephromegaly exhibit slowly declining renal function over 20 years with only minimally enlarged kidneys at ESRD (Option c and e) and markedly atrophic kidneys following renal transplantation.The slow progression of renal disease is likely due to increasing fibrosis rather than the development of cysts.Systemic hypertension is common in all ARPKD patients, even those with normal renal function. (option d)",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following is false about Takotsubo Cardiomyopathy A. Due to major catecholamine discharge | B. Lv Contractile dysfunction | C. Presents with acute chest pain | D. Echo never reverts back to normal",
      "answer": "The correct answer is **D. Echo never reverts back to normal**.\n\nHere's why:\n\n*   **A. Due to major catecholamine discharge:** This is **true**. Takotsubo cardiomyopathy is often triggered by a surge of stress hormones like adrenaline (catecholamines), which can stun the heart muscle.\n*   **B. Lv Contractile dysfunction:** This is **true**. The left ventricle (LV) in Takotsubo cardiomyopathy exhibits a characteristic ballooning or weakening of its contractile function, particularly in the apex.\n*   **C. Presents with acute chest pain:** This is **true**. The symptoms of Takotsubo cardiomyopathy are very similar to a heart attack, including acute chest pain, shortness of breath, and sometimes palpitations.\n*   **D. Echo never reverts back to normal:** This is **false**. A hallmark of Takotsubo cardiomyopathy is its transient nature. While the contractile dysfunction can be severe, the heart muscle typically recovers its normal function over weeks to months, and echocardiograms will show this improvement.",
      "ground_truth": "Echo never reverts back to normal || Echo comes back to normal in two weeks.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "True about primary peritonitis A. Mostly monobacterial | B. It is chemical peritonitis proceeds secondary peritonitis | C. Needs peritoneal lavage | D. Occurs with Cirrhosis of liver",
      "answer": "The correct answer is **D. Occurs with Cirrhosis of liver**.\n\nHere's why:\n\n*   **Primary peritonitis** (also known as spontaneous bacterial peritonitis or SBP) is an infection of the peritoneum that occurs in the absence of a perforated viscus or an intra-abdominal source of infection. It most commonly occurs in patients with ascites, particularly those with **cirrhosis of the liver**.\n\nLet's look at why the other options are incorrect:\n\n*   **A. Mostly monobacterial:** While primary peritonitis is often monobacterial, this is a characteristic, not the defining feature that makes it true in comparison to other options. Secondary peritonitis is typically polymicrobial.\n*   **B. It is chemical peritonitis proceeds secondary peritonitis:** This statement is incorrect. Chemical peritonitis is caused by non-infectious agents (like bile or pancreatic enzymes) and can lead to secondary peritonitis, but primary peritonitis is an infection itself, not a precursor to secondary peritonitis.\n*   **C. Needs peritoneal lavage:** Peritoneal lavage (washing out the abdominal cavity) is a treatment for **secondary peritonitis**, especially when there's a perforation or abscess. Primary peritonitis is typically treated with antibiotics.",
      "ground_truth": "Occurs with Cirrhosis of liver || (D) Occurs with Cirrhosis of liver # # PRIMARY (SPONTANEOUS) BACTERIAL PERITONITIS> Peritonitis is either primary (without an apparent source of contamination) or secondary.> The types of organisms found and the clinical presentations of these two processes are different. In adults, primary bacterial peritonitis (PBP) occurs most commonly in conjunction with cirrhosis of the liver (frequently the result of alcoholism).> However, the disease has been reported in adults with metastatic malignant disease, postnecrotic cirrhosis, chronic active hepatitis, acute viral hepatitis, congestive heart failure, systemic lupus erythematosus, and lymphedema as well as in patients with no underlying disease. PBP virtually always develops in patients with ascites.> While enteric gram-negative bacilli such as Escherichia coli are most commonly encountered, gram-positive organisms such as streptococci, enterococci, or even pneumococci are sometimes found.> In PBP, a single organism is typically isolated; anaerobes are found less frequently in PBP than in secondary peritonitis, in which a mixed flora including anaerobes is the rule. In fact, if PBP is suspected and multiple organisms including anaerobes are recovered from the peritoneal fluid, the diagnosis must be reconsidered and a source of secondary peritonitis sought.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following is non-competitive inhibitor of intestinal alkaline phosphatase? A. L-Alanine | B. L-Tyrosine | C. L-Tryptophan | D. L-Phenylalanine",
      "answer": "The correct answer is **C. L-Tryptophan**.\n\n**Explanation:**\n\n*   **Intestinal alkaline phosphatase (IAP)** is an enzyme that plays a role in various physiological processes, including lipid absorption and bone mineralization.\n*   **Inhibitors** are substances that can decrease or block the activity of an enzyme.\n*   **Non-competitive inhibitors** bind to the enzyme at a site different from the active site, altering the enzyme's conformation and reducing its catalytic efficiency. This type of inhibition cannot be overcome by increasing the substrate concentration.\n\nWhile L-alanine, L-tyrosine, and L-phenylalanine are amino acids that can interact with alkaline phosphatases, **L-tryptophan** is specifically known to be a non-competitive inhibitor of intestinal alkaline phosphatase. It binds to a regulatory site on the enzyme, distinct from the active site where the substrate binds, thereby reducing enzyme activity.",
      "ground_truth": "L-Phenylalanine || Ans. d (L-Phenylalanine) (Ref. Biochemistry by Vasudevan, 4th ed., 57; 5th ed., 55-56)ALKALINE PHOSPHATASE# The pH optimum for the enzyme reaction is between 9 and 10.# It is activated by magnesium and manganese.# Zinc is a constituent ion of ALR# It is produced by osteoblasts of bone, and is associated with the calcification process.# It is localised in cell membranes (ecto-enzyme), and is associated with transport mechanisms in liver, kidney and intestinal mucosa.# For estimation, sodium phenyl phosphate is used as the substrate, pH is adjusted to 9.9, serum sample is added as the source of ALP and incubated.# Normal serum value of ALP is 40-125 U/L.# Raised Levels:Mild increasepregnancy.Moderate (2-3 times) increaseIn infective hepatitis, alcoholic hepatitis or hepatocellular carcinoma, Hodgkin's lymphoma, congestive cardiac failure or ulcerative colitis.Very high levels of ALP (10-12 times)In extrahepatic obstruction (obstructive jaundice) or cholestasis.Drastically high levels of ALP (10-25 times)Bone diseases where osteoblastic activity is enhanced such as Paget's disease, rickets, osteomalacia, osteoblastoma, metastatic carcinoma of bone, and hyperparathyroidism.Iso-enzymes of Alkaline Phosphatase# Alpha-1 ALP moves in alpha-1 position, it is synthesized by epithelial cells of biliary canaliculi. It is about 10% of total activity and is increased in obstructive jaundice and to some extent in metastatic carcinoma of liver.# Alpha-2 heat labile ALP is stable at 56degC; but loses its activity when kept at 65degC for 30 minutes. It is produced by hepatic cells. Therefore, exaggerated alpha-2 band suggests hepatitis. This liver iso-enzyme forms about 25% of total ALP.# Alpha-2 heat stable ALP will not be destroyed at 65degC, but is inhibited by phenylalanine. It is of placental origin, which is found in blood in normal pregnancy. An iso-enzyme closely resembling the placental form is characteristically seen in circulation in about 15% cases of carcinoma of lung, liver and gut and named as Regan iso-enzyme (after the first patient in whom it was detected) or carcinoplacental iso-enzyme. Chronic heavy smoking also increases Regan iso-enzyme level in blood. Normal level is only 1% of the total ALP.# Pre-beta ALP is of bone origin and elevated levels are seen in bone diseases. This is most heat labile (destroyed at 56degC, 10 min). Wheat germ lectin will precipitate bone isoenzyme. This constitutes about 50% of normal ALP activity.# Gamma-ALP is inhibited by phenylalanine and originates from intestinal cells. It is increased in ulcerative colitis. About 10% of plasma ALP are of intestinal variety.# Leucocyte alkaline phosphatase (LAP) is significantly decreased in chronic myeloid leukemia. It is increased in lymphomas and leukemoid reactions.ALANINE AMINO TRANSFERASE (ALT)# It is also called as serum glutamate pyruvate transaminase (SGPT).# The enzyme needs pyridoxal phosphate as co-enzyme.# Normal serum level of AL T for male is 13^4-0 U/L and for female is 10-28 U/L.# Very high values (100 to 1000 U/L) are seen in acute hepatitis, either toxic or viral in origin.# Both ALT and AST levels are increased in liver disease, but ALT > AST.# Moderate increase (25 to 100 U/L) may be seen in chronic liver diseases such as cirrhosis, Hepatoma.# A sudden fall in ALT level in cases of hepatitis is very bad prognostic sign.NUCLEOTIDE PHOSPHATASE# It is also known as 5' nucleotidase.# It is a marker enzyme for plasma membranes and is seen as an ecto-enzyme (enzyme present on the cell membrane).# Serum samples contain both ALP and NTP.# These are distinguished by Nickel ions which inhibit NTP but not ALP.- Normal NTP level in serum is 2-10 IU/L. It is moderately increased in hepatitis and highly elevated in biliary obstruction.# Unlike ALP, the level is unrelated with osteoblastic activity and therefore unaffected by bone disease.GAMMA GLUTAMYL TRANSFERASE (GGT)# The old name was gamma glutamyl transpeptidase.# It can transfer gamma glutamyl residues to substrate.# In the body it is used in the synthesis of glutathione.# It is seen in liver, kidney, pancreas, intestinal cells and prostate gland.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Causes of restrictive cardiomyopathy are - A. Amyloid | B. Sarcoidosis | C. Storage disease | D. All of the above",
      "answer": "The correct answer is **D. All of the above**.\n\n**Explanation:**\n\nRestrictive cardiomyopathy (RCM) is a condition where the heart muscle becomes stiff and less flexible, making it difficult for the ventricles to fill with blood. This stiffness can be caused by a variety of infiltrative or storage diseases that affect the heart muscle.\n\n*   **A. Amyloid:** Amyloidosis is a condition where abnormal proteins (amyloid) build up in organs, including the heart. This infiltration can stiffen the heart muscle, leading to RCM.\n*   **B. Sarcoidosis:** Sarcoidosis is an inflammatory disease that can affect various organs, including the heart. When it affects the heart, it can cause granulomas (inflammatory cell clusters) to form, leading to scarring and stiffness of the heart muscle, characteristic of RCM.\n*   **C. Storage disease:** Certain genetic disorders that cause the abnormal accumulation of substances within cells can also affect the heart. Examples include hemochromatosis (iron overload) and Fabry disease (glycosphingolipid accumulation), which can lead to RCM.\n\nTherefore, amyloidosis, sarcoidosis, and storage diseases are all recognized causes of restrictive cardiomyopathy.",
      "ground_truth": "All of the above || Restrictive cardiomyopathy is characterised by a primary decrease in ventricular compliance , resulting in impaired ventricular filling during diastole. Restrictive cardiomyopathy can be idiopathic or associated with systemic disease that also happen to affect the myocardium for example radiation fibrosis, amyloidosis, sarcoidosis, or products of inborn errors of metabolism Robbins 9 th edition page no. 401",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following induction agent produce cardiac stability- A. Ketamine | B. Etomidate | C. Propofol | D. Midazolam",
      "answer": "The correct answer is **B. Etomidate**.\n\nHere's why:\n\n*   **Etomidate** is known for its **cardiac stability**. It generally causes minimal changes in heart rate, blood pressure, and cardiac output. This makes it a preferred choice for induction in patients who are hemodynamically unstable or at risk of cardiovascular compromise.\n\nLet's look at the other options:\n\n*   **A. Ketamine:** While ketamine can increase heart rate and blood pressure, it can also cause sympathetic blockade, leading to hypotension in some individuals, especially those with depleted catecholamines. It's not considered as reliably \"cardiac stable\" as etomidate.\n*   **C. Propofol:** Propofol is a potent anesthetic that commonly causes dose-dependent hypotension due to vasodilation and myocardial depression. It can also lead to bradycardia.\n*   **D. Midazolam:** Midazolam is a benzodiazepine and is primarily used for sedation and anxiolysis. While it can cause some respiratory depression and mild hypotension, its cardiovascular effects are generally less pronounced than propofol or ketamine, but it's not as reliably cardiac stable as etomidate.",
      "ground_truth": "Etomidate || Ans. is 'b' i.e., Etomidate Effects of Etomidate on cardiovascular systemEtomidate has minimal effects on the cardiovascular system.It causes mild reduction in peripheral vascular resistance which may cause a slight decline in arterial blood pressure.Myocardial contractility and cardiac output are usually unchanged. Etomidate does not release histamine. Cardiovascular effect of Propofol:The major cardiovascular effect of propofol is a decrease in arterial blood pressure due to a drop in systemic vascular resistance (inhibition of sympathetic vasoconstrictor activity, cardiac contractility and preload).Propofol markedly impairs the normal arterial baroreflex response to hypotension. Sometimes there may be a marked drop in preload.Cardiovascular effect of barbiturates (Thiopental)The cardiovascular effect of barbiturates vary markedly depending on the volume status, bas line autonomic tone and preexisting cardiovascular disease.Normally, intravenously administered barbiturates cause a fall in blood pressure.Cardiac output is maintained due to increase in heart rate and increased myocardial contractility from compensatory baroreceptor reflexes.However, in the absence of adequate baroreceptor response (e.g., hypovolemia, congestive heart failure, b adrenergic blockade) cardiac output and arterial blood pressure may fall dramatically due to uncompensated pooling and unmasked direct myocardial depression.Effect of ketamine on cardiovascular systemKetamine causes central stimulation of sympathetic system which causes increased arterial blood pressure, heart rate and cardiac output. There is also increase in pulmonary artery pressure and myocardial work.Because of these effects, ketamine should be avoided in patients with coronary artery disease, uncontrolled hypertension, congestive heart failure and arterial aneurysms.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "which is not a radiographic finding of CHF A. Kerley B lines | B. Kerley A lines | C. Cardiomegaly | D. Oligemia",
      "answer": "The correct answer is **D. Oligemia**.\n\nHere's why:\n\n*   **CHF (Congestive Heart Failure)** is a condition where the heart can't pump blood effectively. This leads to fluid buildup in the lungs and other parts of the body.\n*   **Radiographic findings** are what we see on X-rays.\n\nLet's break down the options:\n\n*   **A. Kerley B lines:** These are short, horizontal lines seen on chest X-rays, typically at the lung bases. They represent thickened interlobular septa due to interstitial edema, a common finding in CHF.\n*   **B. Kerley A lines:** These are longer, more oblique lines that extend from the hilum towards the periphery. They also indicate interstitial edema, though they are less common than Kerley B lines and can be seen in other conditions. However, they are still considered a radiographic finding associated with fluid overload, which can occur in CHF.\n*   **C. Cardiomegaly:** This refers to an enlarged heart. In CHF, the heart often has to work harder, leading to hypertrophy (thickening of the heart muscle) and/or dilation (enlargement of the heart chambers), both of which can result in cardiomegaly visible on an X-ray.\n*   **D. Oligemia:** This term refers to a **decrease in blood flow or blood volume**. In the context of the lungs, it would mean reduced vascularity. CHF, on the other hand, is characterized by **fluid overload and increased pulmonary vascular congestion**, not decreased vascularity. Therefore, oligemia is not a radiographic finding of CHF.",
      "ground_truth": "Oligemia || ref : harrisons 21st ed",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following is associated with cough? A. Lisinopril | B. Propranolol | C. Verapamil | D. Sodium nitroprusside",
      "answer": "The correct answer is **A. Lisinopril**.\n\n**Explanation:**\n\n*   **Lisinopril** is an ACE (angiotensin-converting enzyme) inhibitor. A common side effect of ACE inhibitors is a dry, persistent cough. This is thought to be due to the accumulation of bradykinin, which can irritate the airways.\n\nLet's look at why the other options are less likely to be associated with cough:\n\n*   **B. Propranolol:** This is a beta-blocker. While beta-blockers can sometimes cause bronchospasm in individuals with asthma or COPD, a general cough is not a primary or common side effect.\n*   **C. Verapamil:** This is a calcium channel blocker. Cough is not a typical side effect of verapamil.\n*   **D. Sodium nitroprusside:** This is a potent vasodilator used intravenously for severe hypertension. While it can cause side effects like nausea, vomiting, and dizziness, cough is not a commonly reported adverse effect.",
      "ground_truth": "Lisinopril || Ans: a (Lisinopril) Ref: KDT, 6th ed, p. 484* Cough is a side effect of ACE-1.* Bradykinin and substance P seem to be responsible for the cough. Thromboxane antagonism, aspirin, and iron supplementation reduce cough induced by ACE inhibitors. Once ACE inhibitors are stopped, the cough disappears, usually within 4 days.Important points on ACE inhibitorsEnalapril, fosinopril, perindopril, and ramipril are prodrags.Captopril & lisinopril does not require hydrolysis to become active ACE inhibitorEnalapril is converted in the body into enalaprilat. Enalaprilat differs from captopril in that it is an analog of a tripeptide rather than a dipeptide.Adverse effects of ACE inhibitors are cough; hypotension; hyperkalaemia; acute renal failure in patients with bilateral renal artery stenosis, stenosis of the artery to a single remaining kidney, heart failure, or volume depletion owing to diarrhea or diuretics; teratogenicity; skin rash; proteinuria, angioedema and dysguesia.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "ACE inhibitor contraindicated in which of the following condition: A. Bilateral renal artery stenosis | B. Chronic kidney disease | C. Post myocardial infarction | D. Diabetes mellitus",
      "answer": "The correct answer is **A. Bilateral renal artery stenosis**.\n\n**Explanation:**\n\nACE inhibitors (Angiotensin-Converting Enzyme inhibitors) work by blocking the production of angiotensin II, a hormone that constricts blood vessels. This leads to lower blood pressure.\n\nIn individuals with **bilateral renal artery stenosis** (narrowing of the arteries supplying both kidneys), the kidneys rely heavily on angiotensin II to maintain blood flow. Administering an ACE inhibitor in this situation can significantly reduce blood flow to the kidneys, potentially leading to acute kidney injury or even kidney failure.\n\nLet's look at why the other options are generally not contraindications:\n\n*   **B. Chronic kidney disease (CKD):** ACE inhibitors are often *used* in patients with CKD, especially those with proteinuria (protein in the urine), as they can help slow the progression of kidney disease.\n*   **C. Post myocardial infarction (MI):** ACE inhibitors are a cornerstone of treatment after a heart attack. They help reduce the workload on the heart, prevent remodeling of the heart muscle, and improve survival.\n*   **D. Diabetes mellitus:** ACE inhibitors are frequently prescribed for patients with diabetes, particularly those with diabetic nephropathy (kidney damage due to diabetes) or hypertension, as they can protect the kidneys and help control blood pressure.",
      "ground_truth": "Bilateral renal artery stenosis || Ans. (a) Bilateral renal artery stenosisRef. Katzung's pharmacology 10th ed. Ch 11* ACEI inhibits the converting enzyme peptidyl dipeptidase that hydrolyzes angiotensin I to angiotensin II and (under the name plasma kininase) inactivates bradykinin, a potent vasodilator, which works at least in part by stimulating release of nitric oxide and prostacyclin.* Drugs under this class are: Captopril, Enalapril, Lisinopril, Benazepril, fosinopril, moexipril, perindopril, quinapril, ramipril, and trandolapril.* ACE inhibitors have a particularly useful role in treating patients with chronic kidney disease because they diminish proteinuria and stabilize renal function (even in the absence of lowering of blood pressure).* ACE inhibitors have also proved to be extremely useful in the treatment of heart failure, and after myocardial infarction, and* There is recent evidence that ACE inhibitors reduce the incidence of diabetes in patients with high cardiovascular risk.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Congo red staining of abdominal fat has confirmed a diagnosis of Amyloidosis in a 28-year-old man. Which is the most common cause of death in primary AL Amylodosis? A. Respiratory failure | B. Cardiac failure | C. Renal failure | D. Septicemia",
      "answer": "The most common cause of death in primary AL Amyloidosis is **B. Cardiac failure**.\n\n**Explanation:**\n\nPrimary AL amyloidosis is a systemic disease where abnormal proteins (light chains produced by plasma cells) deposit in various organs. While amyloid can affect multiple organs, the heart is a frequent and critically involved site. The amyloid deposits in the heart muscle lead to:\n\n*   **Cardiomyopathy:** The heart muscle becomes stiff and thickened, impairing its ability to pump blood effectively.\n*   **Heart failure:** This stiffness and reduced pumping function can lead to congestive heart failure, characterized by symptoms like shortness of breath, fatigue, and swelling.\n*   **Arrhythmias:** The amyloid deposits can disrupt the electrical pathways of the heart, leading to irregular heartbeats.\n\nThese cardiac complications are the leading cause of mortality in patients with primary AL amyloidosis. While respiratory failure, renal failure, and septicemia can occur and contribute to morbidity, cardiac failure is statistically the most common direct cause of death.",
      "ground_truth": "Cardiac failure || Cardiac failure is the most common cause of death in primary or AL amyloidosis. Cardiac involvement is seen in 40% of patients with AL amyloidosis. Amyloid involvement of myocardium, intramural coronary aeries and conduction system may cause congestive hea failure, ischemic syndrome and rythm disturbances. Diagnosis of amyloidosis should be considered in patients with unexplained nephropathy, cardiomyopathy (diastolic dysfunction), neuropathy, enteropathy, or pathognomonic soft tissue findings of macroglossia or periorbital ecchymoses. Pathologic diagnosis of amyloid fibrils can be made by congo red staining of aspirated abdominal fat or of an involved organ biopsy specimen.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Most common cause of death in primary amyloidosis is? A. Respiratory failure | B. Cardiac failure | C. Renal failure | D. Septicemia",
      "answer": "The most common cause of death in primary amyloidosis is **B. Cardiac failure**.\n\n**Explanation:**\n\nPrimary amyloidosis, also known as AL amyloidosis, is characterized by the abnormal deposition of amyloid fibrils, which are misfolded proteins, in various organs. While amyloid can affect multiple organ systems, the heart is a frequent and critically involved site.\n\n*   **Cardiac involvement:** Amyloid deposits in the heart muscle (myocardium) lead to thickening and stiffening of the heart walls. This impairs the heart's ability to pump blood effectively, leading to diastolic dysfunction (difficulty relaxing and filling) and eventually systolic dysfunction (difficulty contracting). This progressive cardiac dysfunction can result in heart failure, arrhythmias, and ultimately death.\n\nWhile other complications can occur and contribute to mortality, cardiac failure is the most prevalent and often the terminal event in primary amyloidosis.\n\n*   **A. Respiratory failure:** While lung involvement can occur in amyloidosis, it is less common as the primary cause of death compared to cardiac issues.\n*   **C. Renal failure:** Kidney involvement is also common in primary amyloidosis and can lead to significant morbidity. However, cardiac failure is generally considered the more frequent cause of death.\n*   **D. Septicemia:** Sepsis can be a complication, especially in patients with compromised organ function or undergoing certain treatments, but it is not the primary underlying cause of death in most cases of primary amyloidosis.",
      "ground_truth": "Cardiac failure || ANSWER: (B) Cardiac failureREF: Harrison's Internal Medicine 17th edition chapter 324. AmyloidosisThe kidneys are the most frequently affected organ (80%), Renal amyloidosis is usually manifested by proteinuria, which is often in the nephrotic range and associated with significant hypoalbuminemia and edema or anasarca; rarely, tubular rather than glomerular deposition of amyloid can produce azotemia without significant proteinuria. Cardiac symptoms are the second most common presentation (40%), but cardiac dysfunction is associated with death in 75% of patients.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 3-day-old newborn was born with ectopia cordis. Despite the efforts of doctors at the pediatric intensive care unit the infant died from cardiac failure and hypoxemia. Which of the following embryologic events is most likely responsible for the development of such conditions? A. Faulty development of the sternum and pericardium, secondary to incomplete fusion of the lateral folds | B. Interruption of third pharyngeal arch development | C. Interruption of fourth pharyngeal arch development | D. Interruption of fifth pharyngeal arch development",
      "answer": "The correct answer is **A. Faulty development of the sternum and pericardium, secondary to incomplete fusion of the lateral folds**.\n\nHere's why:\n\n*   **Ectopia cordis** is a congenital condition where the heart is abnormally located outside the chest cavity. This often involves defects in the sternum and pericardium.\n*   **Lateral folds** are crucial in the formation of the ventral body wall, including the sternum and pericardium. During embryonic development, these folds fuse in the midline.\n*   **Incomplete fusion of the lateral folds** leads to a failure of the sternum and pericardium to form properly, creating an opening through which the heart can protrude.\n\nLet's look at why the other options are less likely:\n\n*   **B, C, and D. Interruption of pharyngeal arch development:** The pharyngeal arches are primarily involved in the development of structures in the head and neck, including the face, jaw, and parts of the aortic arch and great vessels. While abnormalities in great vessel development can occur with ectopia cordis, the primary defect leading to the heart being outside the chest is related to the ventral body wall closure.",
      "ground_truth": "Faulty development of the sternum and pericardium, secondary to incomplete fusion of the lateral folds || Ectopia cordis is a condition in which the heart is located abnormally outside the thoracic cavity, commonly resulting from a failure of fusion of the lateral folds in forming the thoracic wall. This is incompatible with life because of the occurrence of infection, cardiac failure, or hypoxemia. Faulty development of the sinus venosus is related to atrial septal defects that result from deficient absorption of the sinus venosus into the right atrium and/or unusual development of the septum secundum.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All the following are radiological features of Chronic Cor pulmonale except- A. Kerley B lines | B. Prominent lower lobe vessels | C. Pleural effusion | D. Cardiomegaly",
      "answer": "The correct answer is **B. Prominent lower lobe vessels**.\n\nHere's why:\n\n*   **Chronic Cor Pulmonale** is a condition where the right side of the heart enlarges and thickens due to lung disease. The primary problem is in the lungs, leading to increased pressure in the pulmonary arteries, which then strains the right ventricle.\n\nLet's look at the options:\n\n*   **A. Kerley B lines:** These are short, horizontal lines seen on chest X-rays, indicating interstitial edema or thickening of the interlobular septa. This can be a sign of pulmonary venous hypertension, which can be associated with chronic lung disease and cor pulmonale.\n*   **B. Prominent lower lobe vessels:** In chronic cor pulmonale, the increased pressure in the pulmonary arteries often leads to **pruning or attenuation of peripheral pulmonary vessels**, particularly in the upper lobes, as the blood flow is shunted to the lower lobes. Prominent lower lobe vessels are *not* a typical feature of chronic cor pulmonale; rather, the opposite is often seen.\n*   **C. Pleural effusion:** While not always present, pleural effusions can occur in chronic cor pulmonale, especially if there is significant right heart failure.\n*   **D. Cardiomegaly:** Enlargement of the heart, particularly the right ventricle and atrium, is a hallmark of chronic cor pulmonale. This is often visible on a chest X-ray as an enlarged cardiac silhouette.\n\nTherefore, prominent lower lobe vessels are the exception among the given radiological features of chronic cor pulmonale.",
      "ground_truth": "Prominent lower lobe vessels || Answer is B (Prominent lower lobe vessels) : Chronic Cor Palmonale is associated with prominence of upper lobe and not lower lobe veins. Features of Congestive Cardiac Failure(CCF / CHF) include : 1. Enlarged cardiac silhouette / Cardiac shadow on chest X-rayQ 2. Ground glass appearance of pulmonary edema Q 3. 'Kerley B' linesQ 4. Prominence of upper lobe blood vessels Q (not lower lobe veins) 5. Pleural effusion, usually bilateral Q 'Kerley B' lines', also known as 'Septa' lines', represent dilated lymphatics and distended interlobular septa. They occur most commonly in pulmonary edema as a result of chronic pulmonary venous hypeension (in CCF). Kerley 'A' lines stand for Apex, 'B' for Base, and 'C' for Central region. B lines are most commonly seen Q.Infact they have a relation with left atrial pressure Q :They are invariably present if LA pressure goes above 20 mmHg. Q Small bilateral pleural effusions are frequently seen in acute LVF. Large effusion may be present in long standing cases of congestive hea failure.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following is a BNP analogue? A. Eplerenone | B. Nesiritide | C. Levosimendan | D. Coenzyme Q",
      "answer": "The correct answer is **B. Nesiritide**.\n\nHere's why:\n\n*   **BNP (B-type natriuretic peptide)** is a hormone produced by the heart in response to stretching, often seen in heart failure. It helps to regulate blood pressure and fluid balance.\n*   **Nesiritide** is a synthetic form of human BNP. It is used to treat acute decompensated heart failure.\n\nLet's look at why the other options are incorrect:\n\n*   **A. Eplerenone:** This is a mineralocorticoid receptor antagonist, used to treat heart failure and high blood pressure. It works by blocking the effects of aldosterone.\n*   **C. Levosimendan:** This is a calcium sensitizer and phosphodiesterase inhibitor, also used in the treatment of acutely decompensated heart failure. It works by increasing the heart's contractility and dilating blood vessels.\n*   **D. Coenzyme Q:** Also known as ubiquinone, this is a vitamin-like substance involved in cellular energy production. It is sometimes used as a supplement for heart health, but it is not a BNP analogue.",
      "ground_truth": "Nesiritide || Ans. B. NesiritideBNP (Brain natriuretic peptide) is peptide which is secreted & formed in right atrium of the heart. This is responsible for vasodilation & hence used in CHF. Nesiritide is BNP analogue",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "The recipient twin in monochorionic twin gestation effected by twin-twin transfusion syndrome is characterised by all except A. Thrombosis | B. Hypovolemia | C. Kernicterus | D. Heart failure",
      "answer": "The correct answer is **C. Kernicterus**.\n\nHere's why:\n\n*   **Monochorionic twin gestation** means the twins share a placenta.\n*   **Twin-twin transfusion syndrome (TTTS)** occurs when there's an unequal sharing of blood flow between the twins through shared placental vessels. One twin (the donor) gives too much blood to the other (the recipient).\n\nLet's break down the options:\n\n*   **A. Thrombosis:** While not a direct characteristic of the recipient twin itself, complications arising from TTTS, such as placental vascular abnormalities, can sometimes lead to thrombosis. However, it's not a primary defining feature of the recipient twin's condition.\n*   **B. Hypovolemia:** The recipient twin receives an excess of blood, leading to **hypervolemia** (too much blood volume), not hypovolemia. The donor twin is typically hypovolemic.\n*   **C. Kernicterus:** Kernicterus is a severe form of jaundice caused by high levels of bilirubin in the brain. This is typically associated with conditions like hemolytic disease of the newborn or prematurity, and is **not** a direct consequence of TTTS in the recipient twin.\n*   **D. Heart failure:** The recipient twin's heart is working overtime to pump the excess blood volume, which can lead to **high-output heart failure**. This is a common and serious complication.\n\nTherefore, the recipient twin is characterized by hypervolemia and potential heart failure, not hypovolemia or kernicterus. Thrombosis is a less direct association.",
      "ground_truth": "Hypovolemia || In TTTS, recipient twin has circulatory overload, hyper volemia and heart failure.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Intracardiac defibrillator (ICD) is useful in which of the following ? A. Person with Brugada | B. Person with Arrhythmogenic RV dysplasia | C. Person after acute MI with CAD | D. All of the above",
      "answer": "The correct answer is **D. All of the above**.\n\nHere's why:\n\n*   **A. Person with Brugada Syndrome:** Brugada syndrome is a genetic disorder that can cause dangerous ventricular arrhythmias. ICDs are a primary treatment for individuals with Brugada syndrome who have experienced syncope (fainting) or documented ventricular arrhythmias, as they can prevent sudden cardiac death.\n\n*   **B. Person with Arrhythmogenic RV Dysplasia (ARVD):** ARVD is a condition where the muscle tissue of the right ventricle is replaced by fatty and fibrous tissue, leading to life-threatening arrhythmias. ICDs are recommended for patients with ARVD who have a history of ventricular tachycardia or fibrillation, or who are at high risk for these events.\n\n*   **C. Person after acute MI with CAD:** In individuals who have had an acute myocardial infarction (MI) and have coronary artery disease (CAD), an ICD may be indicated if they develop a significantly reduced left ventricular ejection fraction (LVEF) and/or have experienced sustained ventricular arrhythmias. This is because the damaged heart muscle after an MI is more prone to developing life-threatening electrical instability.\n\nTherefore, an ICD is useful in all the listed scenarios.",
      "ground_truth": "All of the above || Ref. AHA guidelines <NL> <NL> ICD Indications (AHA Guidelines) <NL> Class I indications (ie, the benefit greatly outweighs the risk, and the treatment should be administered) are as follows: <NL> <NL> Structural heart disease, sustained VT <NL> Syncope of undetermined origin, inducible VT or VF at electrophysiologic study (EPS) <NL> Left ventricular ejection fraction (LVEF) 35% due to prior MI, at least 40 days post-MI, NYHA class II or III <NL> LVEF 35%, NYHA class II or III <NL> LVEF 30% due to prior MI, at least 40 days post-MI <NL> LVEF 40% due to prior MI, inducible VT or VF at EPS <NL> <NL> <NL> Class IIa indications (ie, the benefit outweighs the risk and it is reasonable to administer the treatment) are as follows: <NL> <NL> Unexplained syncope, significant LV dysfunction, nonischemic cardiomyopathy <NL> Sustained VT, normal or near-normal ventricular function <NL> Hypertrophic cardiomyopathy with 1 or more major risk factors <NL> Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) with 1 or more risk factors for sudden cardiac death (SCD) <NL> Long QT syndrome, syncope or VT while receiving beta-blockers <NL> Nonhospitalized patients awaiting heart transplant <NL> Brugada syndrome, syncope or VT <NL> Catecholaminergic polymorphic VT, syncope or VT while receiving beta-blockers <NL> Cardiac sarcoidosis, giant cell myocarditis, or Chagas disease",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Alcohol causes - A. Dilated cardiomyopathy | B. HOCM | C. Restrictive cardiomyopathy | D. None",
      "answer": "The correct answer is **A. Dilated cardiomyopathy**.\n\n**Explanation:**\n\nAlcohol is a well-established cardiotoxin. Chronic and excessive alcohol consumption can lead to a weakening and enlargement of the heart muscle, a condition known as **alcoholic cardiomyopathy**, which is a form of dilated cardiomyopathy. The heart chambers become enlarged and the pumping function of the heart is impaired.\n\nLet's briefly explain why the other options are less likely or incorrect in this context:\n\n*   **B. HOCM (Hypertrophic Obstructive Cardiomyopathy):** This is a genetic condition characterized by thickening of the heart muscle, particularly the septum. While it can lead to heart problems, alcohol is not a primary cause of HOCM.\n*   **C. Restrictive Cardiomyopathy:** This condition involves stiffening of the heart muscle, making it difficult for the ventricles to fill with blood. While certain infiltrative diseases or amyloidosis can cause restrictive cardiomyopathy, alcohol is not a direct cause.\n*   **D. None:** This is incorrect because alcohol is a known cause of a specific type of cardiomyopathy.",
      "ground_truth": "Dilated cardiomyopathy || o Chronic Alcohol consumption is the most common cause of Toxic Dilated Cardiomyopathy. <NL> Alcohol is the most common toxin implicated in chronic dilated cardiomyopathy.' - Harrison 18th/e p. 1961",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Fatty liver is caused by all except A. DM | B. Tetracycline | C. Starvation | D. Excess iron intake",
      "answer": "The correct answer is **D. Excess iron intake**.\n\nHere's why:\n\n*   **Fatty liver disease (hepatic steatosis)** is characterized by the accumulation of excess fat in the liver.\n*   **A. DM (Diabetes Mellitus):** Insulin resistance, a hallmark of type 2 diabetes, is a major contributor to fatty liver disease. High blood sugar levels can lead to increased fat synthesis and decreased fat breakdown in the liver.\n*   **B. Tetracycline:** Certain medications, including some tetracycline antibiotics, can cause drug-induced liver injury, which can manifest as fatty liver.\n*   **C. Starvation:** Paradoxically, severe malnutrition and starvation can also lead to fatty liver. During starvation, the body mobilizes fat from peripheral tissues to the liver for energy, leading to fat accumulation.\n*   **D. Excess iron intake:** While iron overload (hemochromatosis) can damage the liver, it typically leads to fibrosis and cirrhosis rather than simple fatty infiltration as the primary mechanism. In some cases, iron overload can coexist with fatty liver, but excess iron intake itself is not a direct cause of fatty liver in the same way as the other options.\n\nTherefore, excess iron intake is the exception among the given options that directly causes fatty liver.",
      "ground_truth": "Excess iron intake || Fatty change in the liver may result from one of the two types of causes: 1.Conditions with excess fat: i) Obesity ii)Diabetes mellitus iii)Congenital hyperlipidaemia 2.Liver cell damage: i) Alcoholic liver disease (most common) ii)Starvation iii)Protein calorie malnutrition iv)Chronic illnesses (e.g. tuberculosis) v) Acute fatty liver in late pregnancy vi)Hypoxia (e.g. anaemia, cardiac failure) vii)Hepatotoxins (e.g. carbon tetrachloride, chloroform, ether, aflatoxins and other poisons) viii)Drug-induced liver cell injury (e.g. administration of methotrexate, steroids, CCl4, halothane anaesthetic, tetracycline etc) ix) Reye's syndrome. TEXTBOOK OF PATHOLOGY HARSH MOHAN 6TH EDITION PAGE NO:38",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 45-year old male presented with severe respiratory distress. O/E he had pedal edema, bilateral crepitation on auscultation. He was admitted to emergency department and expired 2 days of admission. Lung biopsy done suggested the following. What is your diagnosis? A. CMV pneumonitis | B. Small cell Ca lung | C. Tuberculosis | D. Heart failure cells",
      "answer": "The provided information is insufficient to definitively make a diagnosis. However, based on the limited clinical presentation and the options given, I can explain why certain options are more or less likely and what additional information would be crucial.\n\nHere's a breakdown of the options and why a definitive answer cannot be given without the lung biopsy findings:\n\n*   **A. CMV pneumonitis:** Cytomegalovirus (CMV) pneumonitis is an infection of the lungs caused by the CMV virus. It is more common in immunocompromised individuals. While it can cause severe respiratory distress, the presence of pedal edema and bilateral crepitations are not specific to CMV pneumonitis. The lung biopsy would be crucial to identify CMV inclusions within the lung tissue.\n\n*   **B. Small cell Ca lung:** Small cell carcinoma of the lung is a type of lung cancer that grows and spreads quickly. It can cause severe respiratory distress, but pedal edema and bilateral crepitations are not its primary or most common presenting features unless there are complications like a superior vena cava syndrome or metastatic disease affecting the heart. The lung biopsy would show characteristic small, hyperchromatic cells with scant cytoplasm.\n\n*   **C. Tuberculosis:** Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. It typically affects the lungs and can cause severe respiratory distress, cough, and sometimes hemoptysis. While TB can lead to diffuse lung involvement and respiratory failure, pedal edema and bilateral crepitations are not typical direct symptoms of pulmonary TB itself, but could be indicative of a co-existing condition or a severe systemic response. The lung biopsy would show granulomas with caseous necrosis and acid-fast bacilli.\n\n*   **D. Heart failure cells:** \"Heart failure cells\" are not a diagnosis in themselves, but rather a histological finding. They are macrophages in the lungs that have phagocytosed (engulfed) red blood cells that have leaked from damaged capillaries due to pulmonary edema. Pulmonary edema is a hallmark of **heart failure**. The clinical presentation of severe respiratory distress, pedal edema, and bilateral crepitations on auscultation are highly suggestive of **acute decompensated heart failure** leading to pulmonary edema.\n\n**Therefore, based on the clinical presentation alone, heart failure is the most likely underlying cause of the patient's symptoms.** The lung biopsy findings are essential to confirm this. If the biopsy reveals \"heart failure cells\" (hemosiderin-laden macrophages), it would strongly support a diagnosis of pulmonary edema secondary to heart failure.\n\n**To provide a definitive answer, the results of the lung biopsy are absolutely necessary.** The biopsy would describe the microscopic appearance of the lung tissue, which would either confirm or refute the presence of CMV inclusions, characteristic cancer cells, or granulomas of TB. If the biopsy shows findings consistent with pulmonary edema, such as alveolar spaces filled with proteinaceous fluid and the presence of hemosiderin-laden macrophages (heart failure cells), then option D would be the most appropriate interpretation of the biopsy findings in the context of the clinical picture.\n\n**Without the actual lung biopsy findings, I cannot definitively select an answer.** However, the clinical presentation strongly points towards a cardiac etiology.",
      "ground_truth": "Heart failure cells || Ans. (d) Heart failure cellsThe lung biopsy shows intra-alveolar transudate granular pale pink material along with alveolar micro-hemorrhages & hemosiderin-laden macrophages (\"heart failure\" cells) seen in left-sided congestive heart failure.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "An 6 cm simple ovarian cyst was identified in late pregnancy, what would be the best management ?: A. Emergency laparotomy | B. Removal after after 6 weeks of puerperium | C. Removal early in the puerperium | D. Conservative as most tumors would subside",
      "answer": "The best management for a 6 cm simple ovarian cyst identified in late pregnancy is **B. Removal after 6 weeks of puerperium**.\n\nHere's why:\n\n*   **Simple ovarian cysts** are generally benign and often resolve on their own.\n*   **Late pregnancy** is a critical period, and surgery carries increased risks for both the mother and the fetus.\n*   **Emergency laparotomy (A)** is reserved for situations with acute complications like torsion or rupture, which are not indicated by the description of a \"simple\" cyst.\n*   **Removal early in the puerperium (C)** might be considered if there are symptoms or concerns about complications, but waiting allows for natural resolution and minimizes surgical risks in the immediate postpartum period.\n*   **Conservative management (D)** is appropriate for smaller cysts, but a 6 cm cyst warrants closer monitoring and a planned approach due to its size and potential for complications, though most simple cysts do regress.\n\n**Explanation:**\n\nA 6 cm simple ovarian cyst in late pregnancy is a common finding. The primary goal is to ensure the safety of both the mother and the fetus.\n\n*   **Why not immediate surgery?** Surgery during late pregnancy carries significant risks, including preterm labor, miscarriage, and complications related to anesthesia and the surgical procedure itself.\n*   **Why wait until after the puerperium?** Many simple ovarian cysts, especially those that are functional (like follicular or corpus luteum cysts), will regress and disappear on their own after delivery. Waiting for 6 weeks postpartum allows for this natural resolution. It also provides a window to re-evaluate the cyst with imaging after the hormonal changes of pregnancy have subsided.\n*   **When would intervention be considered sooner?** If the cyst were causing significant pain, showing signs of torsion (twisting of the ovary), or if there were any suspicion of malignancy, a more urgent approach might be necessary. However, for a *simple* cyst without these complications, a delayed surgical approach is preferred.\n\nTherefore, the most prudent and evidence-based management for a 6 cm simple ovarian cyst identified in late pregnancy is to monitor it and plan for potential removal after the puerperium, typically around 6 weeks postpartum, if it has not resolved or if there are other concerns.",
      "ground_truth": "Removal early in the puerperium || Treatment of ovarian tumour in pregnancy depending on time of pregnancy: During pregnancy In an uncomplicated case, the best time of elective operation is b/w 14-18wks as chances of aboion are less and access to the pedicle is easy. But if the tumour is diagnosed beyond 36 weeks, tumour is removed early in puerperium. During labour If the tumour is above the presenting pa watchful expectancy is followed but if its impacted in pelvis, caesarian section should be done followed by removal of tumour in same setting. During puerperium The tumour should be removed as early in puerperium as possible because the longer is the wait for the surgery, there is more chance of having the tumor undergo a torsion",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Nitrates are not used in - A. CCF | B. Esophageal spasm | C. Renal colic | D. Cyanide poisoning",
      "answer": "The correct answer is **C. Renal colic**.\n\nHere's why:\n\n*   **Nitrates** are primarily vasodilators, meaning they widen blood vessels. This action is beneficial in conditions where blood flow is restricted or where the heart is under strain.\n\nLet's look at each option:\n\n*   **A. CCF (Congestive Cardiac Failure):** Nitrates can be used in CCF to reduce the workload on the heart by dilating blood vessels, which decreases the pressure the heart has to pump against.\n*   **B. Esophageal spasm:** Nitrates are effective in relieving esophageal spasms by relaxing the smooth muscles of the esophagus.\n*   **C. Renal colic:** Renal colic is caused by kidney stones obstructing the urinary tract. The pain is often severe and is related to the blockage and the body's attempt to pass the stone. Nitrates do not directly address the cause of renal colic (the stone) and are not a standard treatment for this condition. Pain management for renal colic typically involves analgesics and sometimes alpha-blockers to help relax the ureter.\n*   **D. Cyanide poisoning:** In cyanide poisoning, nitrates (specifically amyl nitrite or sodium nitrite) are used as part of the antidote. They work by converting hemoglobin to methemoglobin, which has a higher affinity for cyanide than cytochrome oxidase, thus sequestering the cyanide and preventing it from binding to and inhibiting cellular respiration.",
      "ground_truth": "Renal colic || Ans. is 'c' i.e., Renal colic Uses of nitrates Angina pectoris MI CHF and acute LVF --> nitroglycerine i.v. can be used Act by decreasing preload (LV filling pressure). Biliary colic and esophageal spasm (achalasia cardia) Acute coronary syndrome (unstable angina and non-ST segment elevation Ml). Cyanide poisoning",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All of the following may occur in Noonan syndrome except: A. Hypertrophic cardiomyopathy | B. Cryptorchidism | C. Infertility in females | D. Autosomal dominant transmission",
      "answer": "The correct answer is **D. Autosomal dominant transmission**.\n\nHere's why:\n\n*   **Noonan syndrome is indeed inherited in an autosomal dominant pattern.** This means that a person only needs to inherit one copy of the altered gene from one parent to have the condition. Therefore, autosomal dominant transmission is a characteristic of Noonan syndrome, not something that *excepts* it.\n\nLet's look at why the other options *can* occur in Noonan syndrome:\n\n*   **A. Hypertrophic cardiomyopathy:** This is a common cardiac abnormality seen in Noonan syndrome, characterized by thickening of the heart muscle.\n*   **B. Cryptorchidism:** This refers to undescended testes and is a frequent feature in males with Noonan syndrome.\n*   **C. Infertility in females:** While not universal, infertility can be a consequence of some of the reproductive tract abnormalities that can occur in females with Noonan syndrome.\n\n**Therefore, the statement that is *not* true for Noonan syndrome is that autosomal dominant transmission is an exception.** It is a defining characteristic of how the syndrome is inherited.",
      "ground_truth": "Infertility in females || c. Infertility in females(Ref: Nelson's 20/e p 2744-2746, Ghai 8/e p 640-641)Turner syndromeNoonan syndromeKaryotype 45, XOKaryotype normalInfertileFertile but delayed pubertySeen only in femalesMay be seen in males or femalesIntelligence normalIntellectual disability present",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "For anesthesiology mild systemic disease included in ASA grade- A. 1 | B. 2 | C. 3 | D. 4",
      "answer": "The correct answer is **B. 2**.\n\n**Explanation:**\n\nThe American Society of Anesthesiologists (ASA) Physical Status Classification System is used to assess a patient's overall health and risk before surgery.\n\n*   **ASA Class 1:** A normal healthy patient.\n*   **ASA Class 2:** A patient with mild systemic disease. This includes conditions that are well-controlled and do not cause significant functional limitations. Examples include mild hypertension, well-controlled diabetes, mild asthma, or a previous myocardial infarction without residual dysfunction.\n*   **ASA Class 3:** A patient with severe systemic disease that limits activity but is not incapacitating.\n*   **ASA Class 4:** A patient with severe systemic disease that is a constant threat to life.\n\nTherefore, mild systemic disease falls under ASA grade 2.",
      "ground_truth": "2 || Ans. is 'b' i.e., 2 ASA GradePatient conditionASA 1Normal healthy patient (no physical or mental illness)ASA 2Mild systemic disease not limiting functional activity(mild heart disease, DM, Mild hypertension, Anemia, Old age, obesity, mild chronic bronchitis)ASA 3Severe systemic disease that limits activity but not incapaciating (Angina, Severe DM, cardiac failure)ASA 4Severe systemic disease that is life-threatening(Marked cardiac insufficiency; presistent angina; severe renal, respiratory or hepatic insufficiency)ASA 5Moribund patient who is not expected to survive without operationASA 6Brain dead patient (for organ donation).",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A male patient 56 year old complains of swelling in legs. He is a known case of hypertension and is under treatment. On general physical examination pitting oedema is seen on legs and TSH level 3mU/L. Which of the following is not a cause of this condition? A. Increase in hydrostatic pressure | B. Decreased colloid osmotic pressure | C. Due to lymphatic obstruction | D. Myxedema",
      "answer": "The correct answer is **D. Myxedema**.\n\nHere's why:\n\n*   **The patient's presentation:** The patient has pitting edema in his legs, which is a sign of fluid accumulation in the interstitial space. He has hypertension, which can contribute to increased hydrostatic pressure. His TSH level of 3 mU/L is within the normal range, indicating that his thyroid function is likely normal.\n\nLet's break down the options:\n\n*   **A. Increase in hydrostatic pressure:** This is a common cause of edema. Conditions like heart failure, kidney disease, and venous insufficiency can lead to increased pressure in blood vessels, forcing fluid out into the surrounding tissues. Hypertension itself can contribute to this.\n*   **B. Decreased colloid osmotic pressure:** Colloid osmotic pressure is largely determined by proteins (like albumin) in the blood. If protein levels are low (e.g., due to liver disease or kidney disease causing protein loss), the blood's ability to hold fluid within the vessels is reduced, leading to edema.\n*   **C. Due to lymphatic obstruction:** The lymphatic system drains excess fluid from tissues. If the lymphatic vessels are blocked (e.g., by infection, surgery, or malignancy), fluid can accumulate, causing lymphedema.\n*   **D. Myxedema:** Myxedema is a severe form of hypothyroidism, characterized by a non-pitting edema (due to deposition of mucopolysaccharides in the dermis, not just excess fluid). The patient's TSH level is normal, making hypothyroidism and therefore myxedema unlikely.\n\n**In summary:** While increased hydrostatic pressure, decreased colloid osmotic pressure, and lymphatic obstruction are all valid causes of edema, myxedema is characterized by a specific type of non-pitting edema and is associated with hypothyroidism, which is not indicated by the patient's normal TSH level.",
      "ground_truth": "Myxedema || Most leg swelling is caused by oedema, the accumulation of uid within the interstitial space. Unilateral swelling usually indicates a localised pathology in either the venous or the lymphatic system, while bilateral oedema often represents generalised uid overload combined with the effects of gravity. However, all causes of unilateral leg swelling may present bilaterally, and generalised uid overload may present with asymmetrical (and therefore apparently unilateral) oedema. Fluid overload may be the result of cardiac failure, pulmonary hypertension (even in the absence of right ventricular failure), renal failure, hypoalbuminaemia or drugs (calcium channel blockers, glucocorticoids, mineralocorticoids, non-steroidal anti-inammatory drugs (NSAIDs) and others). <NL> Approximately 60% of lean body weight is water, two-thirds of which is intracellular. Most of the remaining water is found in extracellular compartments in the form of interstitial fluid; only 5% of the bodys water is in blood plasma. As noted earlier, edema is an accumulation of interstitial fluid within tissues. <NL> <NL> Increase in hydrostatic pressure are mainly caused by disorders that impair venous return. Local increases in intravascular pressure caused, for example, by deep venous thrombosis in the lower extremity can cause edema restricted to the distal portion of the affected leg. <NL> Reduction of plasma albumin concentrations leads to decreased colloidal osmotic pressure of the blood and loss of fluid from the circulation. <NL> Edema may result from lymphatic obstruction that compromises resorption of fluid from interstitial spaces. <NL> <NL> <NL> Reference:Davidsons Internal Medicine 23rd edition, page no.186",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Drug of choice for hypertension in pregnancy- A. Hydralazine | B. Methyldopa | C. Labetalol | D. Nifedipine",
      "answer": "The answer is **B. Methyldopa**.\n\n**Explanation:**\n\nWhile all the listed medications can be used to treat hypertension in pregnancy, **methyldopa** is generally considered the drug of choice due to its long history of use, established safety profile for both mother and fetus, and effectiveness in managing chronic hypertension in pregnancy.\n\nHere's a brief overview of why the others are also used but might not be the absolute first choice in all situations:\n\n*   **A. Hydralazine:** Often used for acute, severe hypertension (hypertensive emergencies) in pregnancy, but not typically the first-line for chronic management due to potential side effects like reflex tachycardia.\n*   **C. Labetalol:** A very effective and commonly used option, particularly for acute severe hypertension and chronic hypertension. It's a good alternative to methyldopa and is often considered a first-line agent as well. However, methyldopa has a slightly longer track record of safety in pregnancy.\n*   **D. Nifedipine:** A calcium channel blocker that is also effective and safe for hypertension in pregnancy. It's often used when methyldopa or labetalol are not tolerated or are ineffective.\n\n**In summary:** Methyldopa is the most widely recommended and historically preferred medication for chronic hypertension in pregnancy.",
      "ground_truth": "Methyldopa || (B) (Methyldopa) (506 Dutta 7th)* Intravenous labetalol or hydralazine are drugs most commonly used to manage preeclampsia (56-H 8th).* Antihypertensive drugs are essential when the BP is 160/110 mm Hg to protect the mother from eclampsia, cerebral hemorrhage, cardiac failure and placental abruption.* First line therapy is either methyldopa or labetalol second line drug is nifedipine. DrugsMechanism of actionSide effectsContraindication and precautionsMethyldopa* Drug of the first choice* Central and peripheral antiadrenergic action* Effective and safe for both the mother and the fetusMaternal - Postural hypotension, hemolytic anemia, sodium retention, excessive sedation, Coomb's test may be positive.Fetal - Intestinal ileusHepatic disorder psychic patients congestive heart failure.Postpartum (risk of depression)HydralazineActs by peripheral vasodilatation as it relaxes the arterial smooth muscle. Orally it is weak and shouldbe combined with methyldopa or b blocker.It increases the cardiac output and renal blood flow* Maternal hypotension, tachycardia arrhythmia, palpitation, lupus-like syndrome, fluid retention.* Fetal - reasonably safe.* Neonatal - ThrombocytopeniaBecause of variable sodium retention diuretics should be used. To control arrhythmias propanol may be administered intravenously.LabetalolCombined a and b adrenergic blocking agents* Tremors, headache asthma, CHF.* Efficacy and safety with short-term use appear equal to methyldopa* Hepatic disorders* Asthma, CHF",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Best investigation for pericardial effusion is - A. MRI | B. CT | C. X ray | D. Echocardiography",
      "answer": "The best investigation for pericardial effusion is **D. Echocardiography**.\n\n**Explanation:**\n\n*   **Echocardiography (ultrasound of the heart)** is the gold standard for diagnosing pericardial effusion. It can accurately detect the presence, size, and location of fluid in the pericardial sac. It also provides crucial information about the function of the heart and the impact of the effusion on cardiac structures.\n\nLet's look at why the other options are less ideal:\n\n*   **A. MRI (Magnetic Resonance Imaging):** While MRI can detect pericardial effusion and provide detailed anatomical information, it is more expensive, time-consuming, and less readily available than echocardiography. It is often used when the diagnosis is unclear or to assess for underlying causes of effusion.\n*   **B. CT (Computed Tomography):** CT can also detect pericardial effusion, but it involves radiation exposure and is generally less sensitive than echocardiography for quantifying the amount of fluid. It's more useful for evaluating the pericardium itself for thickening or calcification, or for identifying associated mediastinal abnormalities.\n*   **C. X-ray (Chest X-ray):** A chest X-ray can sometimes suggest a pericardial effusion if the cardiac silhouette is enlarged and has a characteristic \"water bottle\" shape. However, it is not sensitive enough to reliably detect small effusions and cannot quantify the amount of fluid or assess cardiac function.",
      "ground_truth": "Echocardiography || Ans. is 'd' i.e., Echocardiography Investigations o Investiation of choice to identify individual cardiac chamber enlargement - 2D-echocardiography. o Inv estigation of choice for pericardial effusion - 2D-echocardiography. o Investigation of choice for valvular heart disease - 2D-echocardiography. o Investigation of choice for cardiomyopathy -2D-echocardiography. o Investigation of choice for cardiac temponade - 2D-echocardiography. o Investigation of choice for aortic dissection in stable patient - MRl. o Investigation of choice for aortic dissection in unstable patient - TEE. o Investigation of choice for ventricular function and size - Echocardiography o Investigation of choice for congenital heart disease - Echocardiography, o Investigation of choice for pericardial defect - MRI. o Investigation of choice for radiotherapy/chemotherapy induced myocardial damage - Endomyocardial biopsy o Investigation of choice for myocardial perfusion and viability (reversible ischemia) - Nuclear cardiac imaging (thallium scan or Technetium scan) o Most sensitive investigation for air embolism - Trans-esophageal echocardiography. o Second most sensitive investigation for air embolism - PrecordiaJ Doppler o Best x-ray view for right atrial enlargement - Left anterior oblique view, o Best x-ray view for left atrial enlargement - Right anterior oblique view with barium swallow",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which one of the following congenital hea diseases has cyanosis without cardiomeglay and/ or congestive hea failure - A. Transposition of great aeries | B. Fallot's tetralogy | C. Congenital mitral regurgitaion | D. Congenital pulmonary stenosis",
      "answer": "The correct answer is **D. Congenital pulmonary stenosis**.\n\nHere's why:\n\n*   **Cyanosis** in congenital heart disease typically indicates that deoxygenated blood is mixing with oxygenated blood, leading to a lower than normal oxygen saturation in the blood.\n*   **Cardiomegaly** (enlarged heart) and **congestive heart failure** are often signs of the heart working harder to pump blood, which can occur when there's a significant volume or pressure overload.\n\nLet's analyze each option:\n\n*   **A. Transposition of great arteries:** This condition involves the aorta and pulmonary artery being switched. It almost always leads to cyanosis and often presents with cardiomegaly and/or heart failure, especially as the infant's pulmonary vascular resistance decreases.\n*   **B. Fallot's tetralogy:** This is a complex congenital heart defect that includes four abnormalities. It is characterized by cyanosis, and while not always immediately present, cardiomegaly and heart failure can develop over time due to the shunting of blood and increased workload.\n*   **C. Congenital mitral regurgitation:** This involves a leaky mitral valve. Significant regurgitation can lead to volume overload on the left ventricle, causing cardiomegaly and eventually congestive heart failure. Cyanosis is not a primary feature unless there is severe pulmonary hypertension secondary to heart failure.\n*   **D. Congenital pulmonary stenosis:** This is a narrowing of the pulmonary valve or artery.\n    *   **Cyanosis:** If the stenosis is severe, it can lead to a right-to-left shunt (blood bypassing the lungs), causing cyanosis.\n    *   **Cardiomegaly/Congestive Heart Failure:** In isolated pulmonary stenosis, the right ventricle has to work harder to pump blood through the narrowed valve. This can lead to right ventricular hypertrophy (thickening of the right ventricle wall), which is a form of cardiomegaly. However, significant congestive heart failure and widespread cardiomegaly are less common in *isolated* pulmonary stenosis compared to the other conditions listed, especially in the absence of a significant shunt. The heart may be enlarged due to right ventricular hypertrophy, but the overall picture can be cyanosis without overt signs of failure or a globally enlarged heart in all cases.\n\nTherefore, congenital pulmonary stenosis is the most likely condition among the choices to present with cyanosis without significant cardiomegaly and/or congestive heart failure, especially in its milder to moderate forms where the primary issue is obstruction rather than a large shunt causing immediate failure.",
      "ground_truth": "Fallot's tetralogy || Ans. is 'b' i.e., Fallot's Tetralogy Cardiomegaly and CHF do not occur in Fallot's tetrology. No Cardiomegaly o First you should know the following facts : ? i) Pressure overload to ventricles causes concentric hyperophy without dilatation. ii) Volume overload to ventricles causes hyperophy with dilatation --> Eccentric hyperophy. o Due to pulmonary stenosis, there is pressure overload to right ventricle --> Concentric hyperophy of right ventricle without dilatation - No Cardiomegaly. No CHF o The VSD of TOF is always large enough to allow free exit to the right to left shunt. Since the right ventricle is effectively decompressed by the VSD, CHF never occurs in TOF.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 63-year-old woman fell while crossing the street after her Thursday afternoon bridge game. Attempts at resuscitation for cardiac arrest by the emergency medical service (EMS) team were unsuccessful. The woman had previously been diagnosed as having aortic stenosis and left ventricular hypertrophy. In addition to these factors, which of the following predisposes to sudden cardiac death? A. Split first heart sound | B. Hypokalemia | C. Soft murmur at left of sternum that varies with inspiration | D. Failure of the central venous pressure (CVP) to rise more than 1 cm H2O with 30-second pressure on the liver (hepato-jugular reflux)",
      "answer": "The correct answer is **B. Hypokalemia**.\n\nHere's why:\n\n*   **Sudden Cardiac Death (SCD):** SCD is typically caused by a sudden, unexpected loss of heart function, often due to a life-threatening arrhythmia like ventricular fibrillation.\n*   **Hypokalemia (Low Potassium):** Potassium is crucial for maintaining the electrical stability of heart cells. Low potassium levels can disrupt the normal electrical activity of the heart, making it more prone to dangerous arrhythmias and thus increasing the risk of SCD.\n*   **Aortic Stenosis and Left Ventricular Hypertrophy (LVH):** The patient's pre-existing conditions of aortic stenosis (narrowing of the aortic valve) and LVH (thickening of the left ventricle) are significant risk factors for SCD. Aortic stenosis can lead to increased workload on the left ventricle, causing it to hypertrophy. This thickened muscle can be electrically unstable and prone to arrhythmias.\n\nLet's look at why the other options are less likely to predispose to sudden cardiac death in this context:\n\n*   **A. Split first heart sound:** A split first heart sound (S1) is often a normal finding, especially during inspiration. While certain pathological conditions can cause an abnormal split, it's not a direct or strong predisposing factor for sudden cardiac death.\n*   **C. Soft murmur at left of sternum that varies with inspiration:** This description is highly suggestive of a **tricuspid regurgitation murmur**. Tricuspid regurgitation is a condition where the tricuspid valve doesn't close properly, allowing blood to flow backward into the right atrium during ventricular contraction. While significant tricuspid regurgitation can lead to right-sided heart failure, it's not a primary cause of sudden cardiac death in the same way that ventricular arrhythmias are.\n*   **D. Failure of the central venous pressure (CVP) to rise more than 1 cm H2O with 30-second pressure on the liver (hepato-jugular reflux):** A normal hepato-jugular reflux involves a rise in CVP of at least 3-4 cm H2O when sustained pressure is applied to the abdomen over the liver. A *failure* of the CVP to rise significantly with hepato-jugular reflux suggests that the right ventricle has a reduced ability to pump blood forward, indicating **impaired right ventricular function or low circulating volume**. While this can be a sign of heart failure, it's not as direct a predisposing factor to sudden cardiac death as an electrolyte imbalance like hypokalemia, especially in the context of pre-existing structural heart disease.\n\nTherefore, among the given options, **hypokalemia** is the most significant independent predisposing factor to sudden cardiac death, especially when combined with the patient's known cardiac conditions.",
      "ground_truth": "Hypokalemia || Sudden cardiac death is defined as an unexpected death occurring within 1 hour after the beginning of symptoms in a patient who was previously hemodynamically stable. In asymptomatic patients presenting initially with cardiac disease, 20% will die within the first hour of symptoms. Electrolyte imbalance, hypoxia, and conduction system defect are additional factors that increase the risk of sudden death syndrome. Split first heart sound accentuated on inspiration occurs in normal individuals. In CHF, the CVP changes more than 1 cm when pressure is applied below the right costal margin to the liver (hepatojugular reflex) for a 30-second period.New York Classification of Functional changes in Heart DiseaseClassLimitation of Physical ActivityINoneIISlightIIIMarkedIVComplete (even at rest)",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following conditions cause congestive hea failure in neonates ? A. Bicuspid aoic valve | B. Tetralogy of Fallot | C. ASD | D. Total anomalous pulmonary venous return",
      "answer": "The correct answer is **D. Total anomalous pulmonary venous return**.\n\nHere's why:\n\n*   **Congestive Heart Failure (CHF) in Neonates:** CHF in newborns occurs when the heart cannot pump enough blood to meet the body's needs. This can lead to fluid buildup in the lungs and other tissues.\n*   **Total Anomalous Pulmonary Venous Return (TAPVR):** In TAPVR, the pulmonary veins (which carry oxygenated blood from the lungs to the left atrium) do not connect to the left atrium. Instead, they connect to the right atrium or a systemic vein. This results in oxygenated blood mixing with deoxygenated blood in the right side of the heart, leading to increased blood flow to the lungs and the heart working harder, which can cause CHF.\n*   **Bicuspid Aortic Valve:** While a bicuspid aortic valve can lead to aortic stenosis or regurgitation, these issues typically manifest later in life or cause symptoms related to reduced blood flow to the body, not necessarily immediate CHF in neonates.\n*   **Tetralogy of Fallot (TOF):** TOF is a complex congenital heart defect that causes cyanosis (bluish skin) due to insufficient oxygenated blood reaching the body. While it's a serious condition, CHF is not the primary or most common presentation in neonates with TOF.\n*   **Atrial Septal Defect (ASD):** A small ASD may not cause significant symptoms. Larger ASDs can lead to increased blood flow to the lungs, but typically do not cause severe CHF in the neonatal period unless there are other associated anomalies or significant shunting.\n\nTherefore, **Total anomalous pulmonary venous return** is the condition among the choices that most commonly causes congestive heart failure in neonates.",
      "ground_truth": "Total anomalous pulmonary venous return || In TAPVR can produce CHF in neonate. Ghai essential of pediatrics, eighth edition, p.no:397",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A liver biopsy reveals following findings. What is true about this condition A. Nodular regenerative hyperplasia of liver induced due to OCP | B. Nutmeg liver with dark areas of perivenular dead hepatocytes and gray areas of periportal viable hepatocytes | C. Nutmeg liver with pale areas of necrosis and dark congested areas of perivenular viable hepatocytes | D. Cirrhotic liver with fibrotic nodules.",
      "answer": "Let's break down the options and the likely findings of a liver biopsy to determine the correct answer.\n\n*   **Nodular Regenerative Hyperplasia (NRH):** This condition is characterized by nodules of regenerating hepatocytes without significant fibrosis. While oral contraceptive pills (OCPs) can be a risk factor for certain liver lesions, NRH itself doesn't typically present with the specific histological pattern described in the other options.\n\n*   **Nutmeg Liver:** This is a classic description of the gross appearance of a liver affected by **chronic passive congestion**, most commonly due to right-sided heart failure. Histologically, it refers to alternating areas of congestion and hepatocellular damage.\n\n    *   **Dark areas:** These represent **congested sinusoids** and often contain **perivenular hepatocytes** that are dying or dead due to lack of oxygen.\n    *   **Pale areas:** These represent areas with less congestion, often in the **periportal regions**, where hepatocytes may be viable or show less severe damage.\n\n*   **Cirrhotic Liver:** Cirrhosis is defined by diffuse fibrosis and the formation of regenerative nodules. While chronic passive congestion can eventually lead to cirrhosis, the description in the question points to a more acute or subacute process of congestion and necrosis.\n\nNow let's evaluate the options based on this understanding:\n\n*   **A. Nodular regenerative hyperplasia of liver induced due to OCP:** While OCPs can cause liver issues, NRH doesn't fit the typical \"nutmeg\" description.\n*   **B. Nutmeg liver with dark areas of perivenular dead hepatocytes and gray areas of periportal viable hepatocytes:** This option accurately describes the histological hallmarks of nutmeg liver due to chronic passive congestion. The dark areas are congested and show perivenular necrosis, while the paler periportal areas are less affected.\n*   **C. Nutmeg liver with pale areas of necrosis and dark congested areas of perivenular viable hepatocytes:** This is the opposite of what is typically seen. The dark areas are congested and show necrosis, and the pale areas are less congested and may have viable hepatocytes.\n*   **D. Cirrhotic liver with fibrotic nodules:** While congestion can lead to cirrhosis, the description of \"nutmeg liver\" with specific perivenular and periportal changes points away from established cirrhosis as the primary finding.\n\nTherefore, the most accurate description based on the likely findings of a liver biopsy revealing a \"nutmeg liver\" pattern is:\n\nThe final answer is $\\boxed{B}$.",
      "ground_truth": "Nutmeg liver with dark areas of perivenular dead hepatocytes and gray areas of periportal viable hepatocytes || This is a classical picture of nutmeg liver seen in chronic passive venous congestion on the liver. <NL> The dark congested areas consist of necrotic hepatocytes while the surrounding paler and brownish appearing regions are viable hepatocytes. <NL> <NL> \"The combination of hypoperfusion and retrograde congestion acts synergistically to cause centrilobular hemorrhagic necrosis. <NL> The liver takes on a variegated mottled appearance, reflecting haemorrhage and necrosis in the centrilobular regions. <NL> This finding is known as nutmeg liver due to its resemblance to the cut surface of a nutmeg.  <NL>  Robbins 9/e p864 <NL> <NL> Passive Congestion and Centrilobular Necrosis Hepatic manifestations of systemic circulatory compromise-passive congestion & centrilobular necrosis can be seen in both left & right-sided heart failure. <NL> Pathology <NL> Right-sided cardiac decompensation leads to passive congestion of the liver. <NL> The liver is slightly enlarged, tense, and cyanotic, with rounded edges. <NL> Microscopically there is congestion of centrilobular sinusoids. <NL> With time, centrilobular hepatocytes become atrophic, resulting in markedly attenuated liver cell plates. <NL> Left-sided cardiac failure or shock may lead to hepatic hypoperfusion & hypoxia, causing ischemic coagulative necrosis of hepatocytes in the central region of the lobule (centrilobular necrosis). Combination of hypoperfusion & retrograde congestion acts synergistically to cause centrilobular hemorrhagic necrosis. <NL> The liver takes on a variegated mottled appearance, reflecting hemorrhage & necrosis in the centrilobular regions. <NL> This finding is known as nutmeg liver due to its resemblance to the cut surface of a nutmeg.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "'Bull-neck' is seen in severe cases of which of the following? A. Diphtheria | B. Tubercular lymphadenitis | C. Mumps | D. Goitre",
      "answer": "The correct answer is **A. Diphtheria**.\n\n**Explanation:**\n\n*   **Diphtheria** is an infectious disease caused by the bacterium *Corynebacterium diphtheriae*. In severe cases, it can lead to the formation of a thick, gray membrane in the throat and tonsils. This membrane, along with swelling of the lymph nodes in the neck, can cause significant enlargement of the neck, giving it a \"bull-neck\" appearance.\n\nLet's look at why the other options are less likely:\n\n*   **B. Tubercular lymphadenitis:** While tuberculosis can affect lymph nodes in the neck (scrofula), it typically causes enlarged, sometimes matted lymph nodes, but not the characteristic \"bull-neck\" appearance associated with diphtheria's pseudomembrane and severe swelling.\n*   **C. Mumps:** Mumps is a viral infection that causes swelling of the salivary glands, particularly the parotid glands, located in front of the ears. This results in a puffy face, not a thickened neck.\n*   **D. Goitre:** A goitre is an enlargement of the thyroid gland in the neck. While a very large goitre can make the neck appear swollen, it doesn't have the specific \"bull-neck\" characteristic that is a hallmark of severe diphtheria.",
      "ground_truth": "Diphtheria || Ans. a. Diphtheria (Ref: Harrison 19/e p978, 18/e p1189-1190)Bull-neck is seen in severe cases of diphtheria.Respiratory DiphtheriaClinical Features:The clinical diagnosis of diphtheria is based on:Constellation of sore throatQAdherent tonsillar, pharyngeal, or nasal pseudomembranous lesionsQLow-grade feverQOccasionally, weakness, dysphagia, headache, and voice change are the initial manifestationsQ.Neck edema and difficulty breathing are seen in more advanced cases and carry a poor prognosisQ.The systemic manifestations of diphtheria stem from the effects of diphtheria toxin and include weakness as a result of neurotoxicity and cardiac arrhythmias or congestive heart failure due to myocarditisQ.The pseudomembranous lesion is most often located in the tonsiilopharyngeal regionQ.The diphtheritic pseudomembrane is gray or whitish and sharply demarcatedQ.Pseudomembrane in diphtheria is tightly adherent to the underlying tissuesQ.Less commonly, the lesions are detected in the larynx, nares. and trachea or bronchial passages.Large pseudomembranes are associated with severe disease and a poor prognosisQ.A few patients develop swelling of the tonsils and present with \"bull-neck\" diphtheria, which results from massive edema of the submandibular and paratracheal region and is further characterized by foul breath, thick speech, and stridorous breathingQ.Unlike the exudative lesion associated with streptococcal pharyngitis, the pseudomembrane in diphtheria is tightly adherent to the underlying tissuesQ.Diagnosis:Attempts to dislodge the membrane may cause bleeding.Hoarsensess suggests laryngeal diphtheria, in which laryngoscopy may be diagnostically helpful.In addition, diagnosis requires the isolation of C. diphtheria or the histopathologic isolation of compatible grampositive organismsQ.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Baby born to DM have following except : A. Hypercalcemia | B. Hypokalemia | C. Hypoglycemia | D. Obesity",
      "answer": "The correct answer is **A. Hypercalcemia**.\n\nHere's why:\n\n*   **Hypoglycemia (C):** This is a very common complication in babies born to mothers with diabetes. High maternal blood glucose leads to increased fetal insulin production. After birth, when the maternal glucose supply is cut off, the baby's high insulin levels continue to be produced, leading to a rapid drop in blood glucose.\n*   **Hypokalemia (B):** Babies born to diabetic mothers can experience hypokalemia (low potassium levels). This is often related to the increased insulin levels, which can drive potassium into cells.\n*   **Obesity (D):** Maternal diabetes can lead to macrosomia (being born significantly larger than average) and a predisposition to obesity later in life due to altered metabolic programming.\n*   **Hypercalcemia (A):** Hypercalcemia (high calcium levels) is **not** a typical complication of being born to a mother with diabetes. In fact, some studies suggest a potential for hypocalcemia (low calcium levels) in these infants, though it's less common than hypoglycemia.\n\nTherefore, hypercalcemia is the exception among the listed conditions.",
      "ground_truth": "Hypercalcemia || Ans. is a i.e. Hypercalcemia Neonatal complications of Maternal diabetes : Respiratory distress syndrome (RDS) Hypoglycaemiadeg Hypocalcemiadeg Hypomagnesemia Polycythemia Hyperbilirubinaemia Hyperviscosity syndrome Hyperophic cardiomyopathy Bih trauma - Erb's and Klumpke's paralysis and fractures of the clavicle and humerus due to large size Feeding problems. Late effects : Increased risk of diabetes in children if : If mother is diabetic Risk 1-3% If father is diabetic Risk 6% If both are diabetic - Risk 20% - Self Assessment & Review Obstetrics As far as Hypokalemia is concerned - It is not given anywhere that hypokalemia is seen in neonate of diabetic mother, but we all know that in neonate of diabetic mother hyperinsulinemia is seen. \"Insulin causes potassium to shift in to the cells by Na' antipoer and Na' ATPase pump thereby lowers plasma potassium concentration\".",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Kamli Rani, 75-years -old woman present with post myocardial infarction after 6 weeks mild CHF. There was past H/O neck surgery for parathyroid adenoma 5 years ago, ECG shows slow atrial fibrillation. Serum Ca2+ 13.0 mg/L and urinary Ca2+ is 300 mg/24 hr. On examination there is small mass in the Para tracheal position behind the right clavicle. Appropriate management at this time is: A. Repeat neck surgery | B. Treatment with technetium-99 | C. Observation and repeat serum Ca2+ in two months | D. Ultrasound-guided alcohol injection of the mass",
      "answer": "Here's a breakdown of the case and the reasoning behind the appropriate management:\n\n**Understanding the Key Findings:**\n\n*   **Post-MI with mild CHF:** This indicates a recent heart attack and ongoing heart failure, which needs careful management.\n*   **History of parathyroid adenoma surgery:** This is a crucial piece of information, suggesting a potential recurrence or a new parathyroid issue.\n*   **Slow atrial fibrillation:** This can be a symptom of hypercalcemia.\n*   **Elevated serum Ca2+ (13.0 mg/L):** This is significantly high and indicative of hypercalcemia. Normal serum calcium is typically around 8.5-10.5 mg/dL.\n*   **Elevated urinary Ca2+ (300 mg/24 hr):** This further supports hypercalcemia and suggests the kidneys are trying to excrete excess calcium.\n*   **Small mass in the paratracheal position behind the right clavicle:** This location is highly suggestive of a parathyroid adenoma, especially given the history.\n\n**Connecting the Dots:**\n\nThe combination of a history of parathyroid surgery, elevated calcium levels, and a palpable mass in a typical parathyroid location strongly points towards **recurrent or ectopic parathyroid adenoma** causing **hypercalcemia**. Hypercalcemia can contribute to atrial fibrillation and can worsen cardiac function.\n\n**Evaluating the Options:**\n\n*   **A. Repeat neck surgery:** While surgery is the definitive treatment for symptomatic parathyroid adenomas, it's not the *immediate* appropriate management in this scenario. The patient is post-MI with CHF, making immediate surgery a higher risk. Furthermore, the mass is described as \"small\" and in the paratracheal position, which might be an ectopic (out of place) parathyroid gland, making surgical localization and removal more complex.\n*   **B. Treatment with technetium-99:** Technetium-99m sestamibi scanning is a *diagnostic* tool used to locate parathyroid adenomas, not a treatment.\n*   **C. Observation and repeat serum Ca2+ in two months:** This is **inappropriate**. The patient has symptomatic hypercalcemia (contributing to atrial fibrillation and potentially worsening CHF). Waiting two months for a repeat calcium level is too long and risks further complications from prolonged hypercalcemia.\n*   **D. Ultrasound-guided alcohol injection of the mass:** This is a less invasive procedure that can be used to treat hypercalcemia caused by small parathyroid adenomas, especially when surgery is contraindicated or high-risk. Ultrasound can accurately guide the injection of ethanol into the adenoma, causing it to shrink and reduce hormone production. Given the patient's recent MI and CHF, a less invasive approach is preferable initially.\n\n**The Most Appropriate Management:**\n\nThe most appropriate management at this time is to address the hypercalcemia in a way that minimizes risk to the patient's cardiac status. While surgery is the ultimate goal for a symptomatic adenoma, a less invasive approach is warranted first.\n\n**Therefore, the most appropriate management at this time is likely to involve initial medical management of hypercalcemia and then planning for definitive treatment.** However, among the given options, we need to select the best immediate step.\n\nLet's re-evaluate the options with the understanding that definitive treatment might be surgery, but immediate management is key.\n\n*   **A. Repeat neck surgery:** This is a definitive treatment but carries risks given the patient's cardiac status. It's not the *first* step.\n*   **B. Treatment with technetium-99:** Diagnostic, not treatment.\n*   **C. Observation and repeat serum Ca2+ in two months:** Too passive for symptomatic hypercalcemia.\n*   **D. Ultrasound-guided alcohol injection of the mass:** This is a less invasive treatment option for hypercalcemia from parathyroid adenomas. It directly addresses the source of the problem with lower immediate risk than surgery.\n\n**Considering the options provided, and the need to address symptomatic hypercalcemia in a patient with cardiac compromise, the most appropriate *initial* management strategy would be to stabilize the patient and then consider definitive treatment. However, the question asks for \"appropriate management at this time,\" implying an action to be taken.**\n\nLet's assume the question is looking for the *next best step* to manage the hypercalcemia and the potential parathyroid issue.\n\nGiven the options, and the fact that the mass is identified and likely the cause of hypercalcemia, **ultrasound-guided alcohol injection (D)** is a reasonable less invasive option to attempt to control the hypercalcemia before considering more aggressive surgical intervention, especially in a patient with recent MI and CHF.\n\nHowever, it's important to note that in many clinical scenarios, the *very first* step for symptomatic hypercalcemia would be medical management (hydration, loop diuretics if appropriate, calcitonin, bisphosphonates) to rapidly lower calcium levels before definitive treatment of the underlying cause. Since medical management isn't an option, we must choose from the provided choices.\n\nLet's reconsider the possibility of the question implying a diagnostic step before treatment. Technetium-99 is diagnostic. However, the mass is already identified.\n\nLet's assume the question is asking for the *definitive management* of the identified mass causing hypercalcemia. In that case, surgery would be the gold standard. But the patient's cardiac status makes immediate surgery risky.\n\nLet's re-examine the options with a focus on addressing the hypercalcemia and the likely parathyroid issue.\n\n*   **A. Repeat neck surgery:** This is a definitive treatment for parathyroid adenoma. Given the history and the mass, it's a strong contender for definitive management. The \"repeat\" implies it's a recurrence.\n*   **D. Ultrasound-guided alcohol injection of the mass:** This is a less invasive treatment for parathyroid adenomas.\n\nThe question asks for \"appropriate management *at this time*.\" This suggests an immediate action.\n\nIn a patient with symptomatic hypercalcemia and a palpable mass suggestive of a parathyroid adenoma, the primary goal is to lower the calcium. While surgery is definitive, it's not always the immediate first step in a compromised patient.\n\nLet's consider the possibility that the question is flawed or that there's a specific protocol being tested.\n\nIf we consider the most direct way to address the *cause* of the hypercalcemia, it's the mass.\n\nLet's assume the question is asking for the *most appropriate intervention to manage the hypercalcemia and the identified mass, considering the patient's overall condition.*\n\n*   **A. Repeat neck surgery:** This is a definitive treatment for parathyroid adenoma. The patient has a history of neck surgery for parathyroid adenoma, and a mass in a parathyroid location with hypercalcemia. This strongly suggests a recurrent or ectopic parathyroid adenoma. Surgery is the definitive treatment for symptomatic parathyroid adenomas. While the patient has CHF, the hypercalcemia itself can worsen CHF. Therefore, addressing the source of hypercalcemia is crucial. The risk of surgery needs to be weighed against the risks of uncontrolled hypercalcemia.\n\nLet's consider the other options again:\n*   **B. Treatment with technetium-99:** This is a diagnostic scan, not a treatment.\n*   **C. Observation and repeat serum Ca2+ in two months:** This is inappropriate for symptomatic hypercalcemia.\n*   **D. Ultrasound-guided alcohol injection of the mass:** This is a less invasive option, but surgery is generally considered the gold standard for definitive treatment of symptomatic parathyroid adenomas, especially when there's a history of prior surgery.\n\nGiven the options, and the strong suspicion of a recurrent parathyroid adenoma causing symptomatic hypercalcemia, **repeat neck surgery (A)** is the most appropriate *definitive* management strategy, even with the cardiac compromise. The decision to proceed with surgery would involve a thorough risk-benefit assessment with the cardiology team. However, among the choices, it represents the most direct and effective way to resolve the underlying problem.\n\nThe final answer is $\\boxed{A}$.",
      "ground_truth": "Ultrasound-guided alcohol injection of the mass || Patient is a case of recurrent hyperparathyroidism, as she was operated previously for parathyroid adenoma. In the setting of recent myocardial infarction, CHF and atrial fibrillation, any operation carries a high risk. Ultrasound-guided alcohol injection in the mass is preferred in this setting.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following diuretics is contraindicated in the presence of cardiac failure? A. Mannitol | B. Spironolactone | C. Furosemide | D. Hydrochlorothiazide",
      "answer": "The correct answer is **A. Mannitol**.\n\nHere's why:\n\n*   **Mannitol** is an osmotic diuretic. It works by increasing the osmolarity of the glomerular filtrate, which draws water from the interstitial spaces into the renal tubules. This can lead to a rapid increase in extracellular fluid volume, which can worsen fluid overload and pulmonary edema in patients with cardiac failure.\n\nLet's look at why the other options are generally *not* contraindicated in cardiac failure:\n\n*   **B. Spironolactone:** This is a potassium-sparing diuretic that also has aldosterone-antagonist properties. It is often used in patients with heart failure to reduce mortality and hospitalizations by counteracting the effects of aldosterone, which can lead to sodium and water retention and potassium loss.\n*   **C. Furosemide:** This is a loop diuretic and is a cornerstone of treatment for acute and chronic heart failure. It effectively reduces preload by promoting rapid diuresis and sodium excretion, thereby alleviating symptoms of fluid overload.\n*   **D. Hydrochlorothiazide:** This is a thiazide diuretic. While less potent than loop diuretics, it is also used in the management of heart failure, particularly for milder cases or in combination with other diuretics, to help control fluid balance.\n\n**In summary:** Mannitol's mechanism of action can exacerbate fluid overload, making it dangerous in patients with compromised cardiac function. The other listed diuretics are commonly used to *treat* cardiac failure.",
      "ground_truth": "Mannitol ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "For the following statements, select whether it is applicable to any or all of the below medications.Inhibition of angiotensin converting enzyme I (ACE I) A. hydralazine | B. enalapril | C. spironolactone | D. metoprolol",
      "answer": "The correct answer is **B. enalapril**.\n\nHere's why:\n\n*   **Enalapril** is a well-known Angiotensin-Converting Enzyme (ACE) inhibitor. ACE inhibitors work by blocking the enzyme that converts angiotensin I to angiotensin II, a potent vasoconstrictor. This leads to vasodilation and reduced blood pressure.\n\nLet's look at why the other options are incorrect:\n\n*   **A. Hydralazine:** This is a direct vasodilator. It works by relaxing the smooth muscles in blood vessel walls, leading to vasodilation and lower blood pressure. It does not inhibit ACE.\n*   **C. Spironolactone:** This is a potassium-sparing diuretic and an aldosterone antagonist. It works by blocking the effects of aldosterone, which helps the body retain sodium and water. It does not inhibit ACE.\n*   **D. Metoprolol:** This is a beta-blocker. It works by blocking the effects of adrenaline on the heart and blood vessels, slowing the heart rate and reducing the force of contractions, thereby lowering blood pressure. It does not inhibit ACE.",
      "ground_truth": "enalapril || Enalapril may exert its effect by inhibiting formation of angiotensin II. This lowers systemic vascular resistance. In addition, ACE inhibitors have a natriuretic effect by inhibition of aldosterone secretion. They have been shown to improve mortality and decrease hospitalization in patients with CHF.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Cardiomyopathy is/are due to deficinency of: A. Selenium | B. Phosphorus | C. Boron | D. Zinc",
      "answer": "The correct answer is **A. Selenium**.\n\n**Explanation:**\n\nCardiomyopathy, particularly Keshan disease, is a severe heart muscle disease that has been strongly linked to a deficiency in selenium. Selenium is an essential trace mineral that plays a crucial role in antioxidant defense and the proper functioning of the heart muscle. When selenium levels are low, the heart muscle can become damaged, leading to cardiomyopathy.\n\nWhile other minerals like phosphorus and zinc are vital for overall health, including cardiovascular health, a direct deficiency of these is not the primary cause of cardiomyopathy in the same way that selenium deficiency is. Boron is also an essential mineral, but its role in cardiomyopathy is not as well-established as selenium's.",
      "ground_truth": "Selenium || Ans.: A (Selenium) ' Selenium deficiency causes Keshan disease(endemic cardiomyopathy)\"Shinde 7th/594Possible causes of cardiomyopathy include; www.may- odinic.com/heaith/cardiomyopa thy/DS00519/DSECTION# Long-term high blood pressure# Defects in heart valve# Heart tissue damage from a previous heart attack# Chronic rapid heart rate# Metabolic disorders, such as thyroid disease or diabetes# Nutritional defdencies of essential vitamins or minerals, such as thiamin (vitamin B-l), selenium, calcium and magnesium# Pregnancy# Excessive use of alcohol over many years# Abuse of cocaine or antidepressant medications, such as tricyclic antidepressantsUse of some chemotherapy drugs to treat cancerSome viral infections, which may injure the heart and trigger cardiomyopathyIron buildup in your heart muscle (hemochromatosis)Genetic conditionsReversible cardiomyopathy due to carnitine deficiency from renal tubular wasting.Table (Harrison 18th/595): Deficiencies of MetalsElementDeficiencyBoronNo biologic function determinedCalciumReduced bone mass, osteoporosisCopperAnemia,, growth retardation, defective keratinization and pigmentation of hair, hypothermia, degenerative changes in aortic elastin, osteopenia, mental deteriorationChromiumimpaired glucose toleranceFluoride| Dental cariesIodineThyroid enlargement, |T4, cretinismIronMuscle abnormalities, koilonychia, pica, anemia, 4work performance, impaired cognitive development, premature labor, Tperinatal maternal mortalityManganeseImpaired growth and skeletal development, reproduction, lipid and carbohydrate metabolism; upper body rashMolybdenumSevere neurologic abnormalitiesSeleniumCardiomyopathy, heart failure, striated muscle degenerationPhosphorusRickets (osteomalacia), proximal muscle weakness, rhabdomyolvsis, paresthesia, ataxia, seizure, confusion, heart failure, hemolysis, acidosisZincGrowth retardation, !taste and smell, alopecia, dermatitis, diarrhea, immune dysfunction, failure to thrive, gonadal atrophy, congenital malformations",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A one month old infant with a congenital cardiac lesion shows increased sweating during feeding. Which of the following is the sure sign of congestive cardiac failure in this infant? A. Basal crepitations | B. JVP | C. Pedal oedema | D. Liver enlargement",
      "answer": "The correct answer is **D. Liver enlargement**.\n\nHere's why:\n\n*   **Congestive Cardiac Failure (CCF) in Infants:** In infants, CCF can present differently than in adults. The signs are often more subtle and can be related to the body's compensatory mechanisms.\n*   **Increased Sweating During Feeding:** This is a common symptom of CCF in infants, often referred to as \"diaphoresis.\" It's a sign of increased metabolic demand and sympathetic nervous system activation due to the heart's inability to pump blood effectively.\n*   **Why the other options are less likely or not sure signs in a one-month-old:**\n    *   **A. Basal crepitations:** While pulmonary edema can occur in CCF, basal crepitations (crackles in the lungs) are not always present in very young infants and can be difficult to detect.\n    *   **B. JVP (Jugular Venous Pressure):** Measuring JVP is challenging and often unreliable in infants, especially in a one-month-old.\n    *   **C. Pedal oedema:** Peripheral edema (swelling in the feet and ankles) is uncommon in infants with CCF. Their fluid distribution tends to be more generalized.\n    *   **D. Liver enlargement (Hepatomegaly):** This is a **sure sign** of CCF in infants. The failing right ventricle leads to increased venous pressure, which backs up into the liver, causing it to enlarge. This is often one of the earliest and most consistent signs of CCF in this age group.",
      "ground_truth": "Liver enlargement || Congestive hea failure (CHF) is unusual in childhood. When it does present, it is usually as a manifestation of congenital hea disease and is seen in the first year of life. The classic triad of symptoms for pediatric CHF is tachypnea, tachycardia, and hepatomegaly. There may also be a history of poor feeding, sweating or color change with feeding, and poor weight gain. Lower extremity edema and jugular venous distention are less likely in the pediatric population. Ref: Stephan M., Caer C., Ashfaq S. (2011). Chapter 50. Pediatric Emergencies. In R.L. Humphries, C. Stone (Eds), CURRENT Diagnosis & Treatment Emergency Medicine, 7e.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A patient with hea failure developed recurrent sustained monomorphic vt .Treatment is/are - A. Encainide | B. Flecainide | C. Intracardiac Defibrilator | D. Beta-blockers",
      "answer": "The most appropriate treatment for recurrent sustained monomorphic VT in a patient with heart failure is **C. Intracardiac Defibrillator**.\n\nHere's why:\n\n*   **Heart Failure and VT:** Patients with heart failure are at a significantly increased risk of developing ventricular tachycardia (VT). This is often due to structural changes in the heart muscle that create electrical instability.\n*   **Recurrent Sustained VT:** Recurrent and sustained VT is a life-threatening arrhythmia that can lead to sudden cardiac death.\n*   **Antiarrhythmic Drugs (A & B):** Encainide and Flecainide are Class Ic antiarrhythmic drugs. While they can suppress VT, they are generally **contraindicated or used with extreme caution** in patients with structural heart disease, particularly heart failure. This is because they can have proarrhythmic effects, meaning they can actually *increase* the risk of dangerous arrhythmias in these patients.\n*   **Beta-blockers (D):** Beta-blockers are a cornerstone of heart failure management and can help reduce the risk of VT. However, in a patient who is already experiencing *recurrent sustained* VT, beta-blockers alone may not be sufficient to prevent life-threatening episodes. They are often used in conjunction with other therapies.\n*   **Intracardiac Defibrillator (ICD) (C):** An ICD is a device implanted under the skin that continuously monitors the heart rhythm. If it detects a life-threatening arrhythmia like sustained VT, it can deliver an electrical shock to restore a normal rhythm. For patients with recurrent sustained VT, especially those with underlying heart failure, an ICD is the most effective treatment to prevent sudden cardiac death.\n\n**In summary:** While beta-blockers are important for managing heart failure and can have some antiarrhythmic benefits, they are not the primary treatment for recurrent sustained VT in this population. Class Ic antiarrhythmics like encainide and flecainide are generally avoided. An ICD provides the most definitive protection against sudden cardiac death in this scenario.",
      "ground_truth": "Intracardiac Defibrilator || Sustained monomorphic VT associated with nonischemic cardiomyopathy is usually due to scar-related reentry. On cardiac MR imaging, scars are detectable as areas of delayed gadolinium enhancement and are more often intramural or sub-epicardial in location as compared with patients with prior MI. Any cardiomyopathic process can cause scars and VT, but cardiac sarcoidosis, Chagas disease, and cardiomyopathy due to Lamin A/C mutations are paicularly associated with monomorphic VT . An ICD is usually indicated with additional drugs or catheter ablation for control of recurrent VT. Harrison 20thed pg 1758",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A patient presents 12 hours following a Myocardial infarction. Which of the following enzymes will be elevated at this period - A. Lactate dehydrogenase | B. Serum glutamate oxaloacetate Transferase | C. Creatinine phosphokinase | D. Myoglobin",
      "answer": "The correct answer is **C. Creatinine phosphokinase**.\n\nHere's why:\n\n*   **Creatinine phosphokinase (CPK), specifically the MB isoenzyme (CK-MB), is a sensitive and relatively early marker for myocardial injury.** It begins to rise within 4-6 hours of an MI, peaks around 18-24 hours, and remains elevated for 2-3 days. Therefore, 12 hours post-MI, CPK would be significantly elevated.\n\nLet's look at why the other options are less ideal or incorrect for this specific timeframe:\n\n*   **A. Lactate dehydrogenase (LDH):** LDH is a less specific marker and rises later than CPK, typically starting to increase around 12-24 hours after an MI and remaining elevated for a longer period (up to 10-14 days). While it will eventually be elevated, CPK is a better indicator at the 12-hour mark.\n*   **B. Serum glutamate oxaloacetate transferase (SGOT), also known as Aspartate Aminotransferase (AST):** AST also rises after an MI, but it's less specific than CPK as it can be elevated in other conditions affecting the liver, muscles, and brain. It typically starts to rise around 8-12 hours post-MI, peaks at 24-48 hours, and returns to normal within 4-5 days. While it might be starting to rise at 12 hours, CPK is a more definitive and earlier marker.\n*   **D. Myoglobin:** Myoglobin is a very early marker of muscle damage, including cardiac muscle. It begins to rise as early as 1-2 hours after an MI and peaks within 4-12 hours. By 12 hours, myoglobin levels would likely be *declining* from their peak, although still elevated. However, CPK is a more specific marker for cardiac muscle damage and is still rising robustly at 12 hours.",
      "ground_truth": "Creatinine phosphokinase || Ref: R Alagappan - Manual of Practical Medicine 4th Edition.pg no:184 Cardiac Enzymes a. CPK-MB: This cardiac isoenzyme stas rising within 4-6 hrs after development of acute MI, peaks during the 2nd day (4 fold rise) and disappears in 2-3 days. Other causes of total CK elevation: 1. Skeletal diseases - Polymyositis, Muscle dystrophy, Myopathies 2. Electrical cardioversion 3. Skeletal muscle damage - trauma, convulsions, immobilisation 4. Hypothyroidism 5. Stroke 6. Surgery b. AST: Stas rising on the 1st day, peaks in 2-3 days (3 fold rise) and disappears by 3rd day. c. LDH1: Stas rising by second day, peaks around 3- 4 days ( 3 fold rise) and disappears in 10 days. d. Troponin T: Cardiac troponin T is a regulatory contractile protein not normally found in blood. Its detection in the circulation has been shown to be a sensitive and specific marker for myocardial cell damage. Troponin T and I reach a reliable diagnostic level in plasma by 12-16 hrs, maximal activity by 24-32 hrs, returns to normal in 10-12 days. Troponin I : 0-0.4 ng/ml Troponin T: 0-0.1 ng/ml Cardiac troponins are detected in the serum by using monoclonal antibodies. These antibodies have negligible cross reactivity to skeletal muscle. Cardiac troponins I and T sta to rise within 3-4 hours after myocardial infarction and remain raised for 4-10 daysOther causes of elevated cardiac troponins: Cardiac causes: * Cardiac contusion/surgery * Myocarditis * Cardiomyopathy * Hea failure * Cardioversion * Percutaneous coronary intervention * Cardiac amyloidosis * Radiofrequency ablation * Supraventricular tachycardia * Post-cardiac transplantation Non-cardiac causes: * Primary pulmonary hypeension * Pulmonary embolism * Cerebrovascular stroke * High dose chemotherapy * Sepsis and septic shock * Renal failure * Critically ill patients * Scorpion envenomation * Ultra-endurance exercise (marathon) e. Myoglobin It is increased within 2 hrs of onset of symptoms and remains increased for at least 7-12 hrs. Normal level is 20-100 mg/L.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "NADA's criteria are used for - A. Assessment of child for degree of dehydration | B. Assessment of child for degree of malnutrition | C. Assessment of child for presence of hea disease | D. Assessment of child for degree of mental retardation",
      "answer": "The correct answer is **A. Assessment of child for degree of dehydration**.\n\n**Explanation:**\n\nNADA's criteria, which stands for **North American Nursing Diagnosis Association**, is a standardized classification system for nursing diagnoses. While NADA itself doesn't have specific criteria *named* \"NADA's criteria\" for assessing dehydration, nursing diagnoses related to fluid volume deficit (dehydration) are well-established within the NANDA-I (North American Nursing Diagnosis Association - International) taxonomy.\n\nThese nursing diagnoses and their associated defining characteristics (signs and symptoms) are used by nurses to assess the degree of dehydration in children and adults. For example, common defining characteristics for \"Deficient Fluid Volume\" include decreased skin turgor, dry mucous membranes, decreased urine output, and increased heart rate, all of which are used to gauge the severity of dehydration.\n\nThe other options are incorrect:\n\n*   **B. Assessment of child for degree of malnutrition:** While nurses assess malnutrition, specific standardized criteria for this are often based on anthropometric measurements (weight, height, BMI) and clinical signs, not typically referred to as \"NADA's criteria.\"\n*   **C. Assessment of child for presence of heart disease:** Diagnosing heart disease involves specific medical evaluations, imaging, and tests, not a general nursing assessment framework like NANDA-I.\n*   **D. Assessment of child for degree of mental retardation:** Assessing intellectual disability involves standardized psychological testing and developmental assessments, not nursing diagnostic criteria.",
      "ground_truth": "Assessment of child for presence of hea disease || Ans. is 'c' i.e., Assessment of child for the presence of hea disease o The assessment of a child for the absence or presence of Hea disease can be done with the help of some guidelines suggested by NADA and are called NADA's criteria. NADA's Criteria o Either one major or two minor criteria are necessary for indicating the presence of hea disease. A) Major Criteria 1) Systolic murmur of grade III or more. The systolic murmur is classified into : ? a) Ejection systolic murmur b) Pansystolic murmur Pansystolic murmur is always abnormal no matter what is its intesity. Only three lesions produce pansystolic murmur --> i)VSD ii) MR iii) TR Ejection systolic murmur on the other hand may be organic or functional. If ejection systolic murmur is associated with thrill, it is always organic. If ejection systolic murmur is more than grade III intensity --) It is organic. Grade III or less ejection systolic murmur of a functional type may be heard in anemia or high fever in otherwise normal children. 2) Diastolic murmur Presence of diastolic murmur always indicates the presence of organic hea disease. There are two exceptions. i) Severe hypeension --> Reduction of BP may cause an AR murmur to disappear. ii) Anemia --> May result in delayed diastolic murmur across the tricuspid and mitral area. 3) Cyanosis Central cyanosis indicates presence of hea disease if lung disease has been excluded. 4) CHF Presence of CHF indicates presence of hea disease except in neonates and infants who get CHF from causes such as hypoglycemia and anemia. B) Minor criteria 1) Systolic murmur less than grade III in intensity. 2) Abnormal second hea sound Abnormal S2 always indicates presence of hea disease. It has been included as a minor criterian only because auscultation is an individual and subjective finding. 3) Abnormal ECG Main value of ECG lies in determining the : ? i) Mean QRS axis ii) Right or left atrial hyperophy iii) Right or left ventricular hyperophy 4) Abnormal X-ray If there is cardiomegaly in a good inspiratory film, it is highly suggestive for the presence of hea disease. 5) Abnormal BP",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 9-year-old girl is diagnosed with acute rheumatic fever. Instead of recovering as expected, her condition worsens and she dies. Which of the following is the most likely cause of death? A. Central nervous system involvement | B. Endocarditis | C. Myocarditis | D. Streptococcal sepsis",
      "answer": "The most likely cause of death in this scenario is **C. Myocarditis**.\n\nHere's why:\n\n*   **Acute Rheumatic Fever (ARF)** is an inflammatory disease that can affect the heart, joints, brain, and skin, typically occurring after a streptococcal infection.\n*   **Myocarditis** (inflammation of the heart muscle) is a serious complication of ARF. Severe myocarditis can lead to heart failure, arrhythmias, and ultimately, death. In children, this can progress rapidly.\n*   **Endocarditis** (inflammation of the inner lining of the heart chambers and valves) is also a complication of ARF, leading to valvular damage. While serious, it often causes chronic issues or can lead to complications like stroke, but acute, rapid death is more directly linked to severe myocarditis.\n*   **Central Nervous System Involvement (Sydenham's chorea)** is a hallmark of ARF but is typically a neurological manifestation and not directly fatal in the acute phase, although it can be very distressing.\n*   **Streptococcal sepsis** is a severe, life-threatening infection caused by the bacteria *Streptococcus pyogenes*. While ARF is triggered by a streptococcal infection, the ARF itself is an autoimmune response to the infection, not the active bacterial infection causing sepsis. If the patient had died from sepsis, it would imply a failure to clear the initial streptococcal infection, which is less likely to be the direct cause of worsening *after* the ARF diagnosis and expected recovery period.\n\nGiven the worsening condition and death, severe inflammation of the heart muscle (myocarditis) leading to acute heart failure is the most probable direct cause.",
      "ground_truth": "Myocarditis || The most common cause of death that occurs during acute rheumatic fever is cardiac failure secondary to myocarditis.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "True about mitochondrial inheritance A. An offspring bom to an affected male will be affected | B. An offspring born to an affected female will be affected | C. An offspring born to an affected female will be normal | D. All of the above",
      "answer": "The correct answer is **B. An offspring born to an affected female will be affected**.\n\nHere's why:\n\n*   **Mitochondrial inheritance** refers to the inheritance of genes located in the mitochondria, which are organelles within cells responsible for energy production.\n*   Mitochondria, and therefore their DNA, are almost exclusively inherited from the **mother** through the egg cell. Sperm contribute very little to the cytoplasm of the zygote, and thus very few mitochondria.\n*   Therefore, if a female has a mitochondrial disorder (meaning her mitochondria carry the mutation), all of her offspring will inherit those affected mitochondria and will also be affected.\n*   Conversely, if a male has a mitochondrial disorder, he cannot pass it on to his children because his sperm do not contribute the necessary mitochondria.\n\nLet's look at why the other options are incorrect:\n\n*   **A. An offspring born to an affected male will be affected:** This is incorrect. Males do not typically pass on mitochondrial DNA.\n*   **C. An offspring born to an affected female will be normal:** This is incorrect. As explained above, an affected female will pass on her affected mitochondria to all her offspring.\n*   **D. All of the above:** Since A and C are incorrect, this option is also incorrect.",
      "ground_truth": "An offspring born to an affected female will be affected || Ans. b (An offspring bom to an affected female will be affected) (Ref. Nelson paediatrics, Ch. 80. p. 496)Mitochondrial Inheritance# An individual's mitochondrial genome is entirely derived from the mother. Sperm contain few mitochondria, most of which are shed upon fertilization.# Mitochondrial disorders exhibit maternal inheritance; a woman with a mitochondrial genetic disorder will have only affected offspring of either sex, while an affected father will have no affected offspring.# Common manifestations include developmental delay, seizures, cardiac dysfunction, i strength and tone, as well as hearing and vision problems.# Examples include- NARP- MELAS (myopathy, encephalopathy, lactic acidosis, and strokelike episodes),- MERRF (myoclonic epilepsy associated with ragged red fibers),- Kearns-Sayre syndrome (ophthalmoplegia, pigmentary retinopathy, and cardiomyopathy).# Cells may contain a mixture of mutant and normal mitochondria, referred to as heteroplasmy.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Propranolol is useful in the treatment of all of the following EXCEPT: A. Angina | B. Partial atrioventricular block | C. Idiopathic hypertrophic subaortic cardiomyopathy | D. Familial tremor",
      "answer": "The correct answer is **B. Partial atrioventricular block**.\n\nHere's why:\n\n*   **Propranolol** is a non-selective beta-blocker. Beta-blockers work by blocking the effects of adrenaline and noradrenaline on the body, which can slow the heart rate, reduce blood pressure, and decrease the heart's workload.\n\nLet's look at why the other options are treated with propranolol:\n\n*   **A. Angina:** Propranolol reduces the heart's oxygen demand by slowing the heart rate and decreasing contractility, which helps to prevent chest pain associated with angina.\n*   **C. Idiopathic hypertrophic subaortic cardiomyopathy (IHSS):** In IHSS, the heart muscle thickens, obstructing blood flow. Propranolol can help by slowing the heart rate and reducing the force of contraction, which can decrease the obstruction.\n*   **D. Familial tremor:** Propranolol is a first-line treatment for essential tremor (often referred to as familial tremor) because it can reduce the amplitude of the tremor.\n\n**B. Partial atrioventricular block:** This condition involves a delay in the electrical signal traveling from the atria to the ventricles. Beta-blockers, like propranolol, can actually *worsen* AV block by further slowing conduction through the AV node. Therefore, propranolol is generally contraindicated in patients with significant AV block.",
      "ground_truth": "Partial atrioventricular block ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 32 year old carpenter presented to you with history of recurrent attacks of chest pain . You prescribe him sublingual nitroglycerin and advise him to take it at the time of pain. The patient revisits the hospital again after 2weeks and tells that the intensity of chest pain has increased on taking nitroglycerin. The patient is most likely suffering from A. Aortic regurgitation | B. Hypertrophic obstructive  cardiomyopathy | C. Aortic dissection | D. Aortic aneurysm",
      "answer": "The most likely diagnosis for this patient is **B. Hypertrophic obstructive cardiomyopathy (HOCM)**.\n\nHere's why:\n\n*   **Sublingual nitroglycerin** is typically prescribed for angina, which is chest pain caused by reduced blood flow to the heart muscle. It works by dilating blood vessels, improving blood flow.\n*   In **HOCM**, there is a thickening of the heart muscle, particularly the septum between the ventricles. This thickening can obstruct blood flow out of the left ventricle, especially during exertion or stress.\n*   **Nitroglycerin can worsen the obstruction in HOCM.** By dilating the peripheral blood vessels, it can decrease the pressure in the aorta. This can lead to a further decrease in the pressure gradient across the narrowed outflow tract, causing more blood to be trapped in the left ventricle and potentially increasing the obstruction and chest pain.\n\nLet's look at why the other options are less likely:\n\n*   **A. Aortic regurgitation:** This is a condition where the aortic valve doesn't close properly, allowing blood to leak back into the left ventricle. While it can cause chest pain, nitroglycerin typically helps relieve angina associated with coronary artery disease, not directly the chest pain from aortic regurgitation. In some cases, it might even worsen symptoms by causing a drop in blood pressure.\n*   **C. Aortic dissection:** This is a tear in the inner layer of the aorta. It typically presents with sudden, severe, tearing chest pain that often radiates to the back. Nitroglycerin is generally not the primary treatment for aortic dissection and can be dangerous if it causes significant hypotension.\n*   **D. Aortic aneurysm:** This is a bulging or swelling in the aorta. While large aneurysms can cause chest pain, it's usually a constant or pressure-like pain, not typically episodic angina that responds to nitroglycerin. If an aneurysm is dissecting or rupting, the pain is usually acute and severe.\n\n**In summary:** The patient's worsening chest pain with nitroglycerin is a key indicator that the medication is exacerbating the underlying problem. This paradoxical response is characteristic of hypertrophic obstructive cardiomyopathy.",
      "ground_truth": "Hypertrophic obstructive cardiomyopathy || Nitrates are vasodilator drugs which aggravate condition of HOCM , so it is generally not used in HOCM",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Premalignant bone lesion among the following is - A. Pagets disease | B. Osteoid osteoma | C. Osteochondroma | D. Enchondroma",
      "answer": "The correct answer is **A. Paget's disease**.\n\n**Explanation:**\n\n*   **Paget's disease of bone** is a chronic disorder that disrupts the body's normal bone recycling process, leading to enlarged and deformed bones. While not all cases of Paget's disease become cancerous, it is considered a premalignant condition because there is an increased risk of developing osteosarcoma (a type of bone cancer) in affected areas.\n\nLet's look at why the other options are not considered premalignant:\n\n*   **B. Osteoid osteoma:** This is a benign (non-cancerous) bone tumor that typically causes pain, especially at night, which is often relieved by NSAIDs. It does not have the potential to become cancerous.\n*   **C. Osteochondroma:** This is the most common type of benign bone tumor. It is a cartilage-capped bony projection arising from the external surface of a bone. Osteochondromas are generally benign and do not transform into malignant tumors, although very rarely, malignant transformation can occur.\n*   **D. Enchondroma:** This is a benign tumor of cartilage that typically grows within the medullary cavity of a bone. Enchondromas are benign and do not have a significant risk of becoming malignant.",
      "ground_truth": "Pagets disease || Ans. is 'a' i.e., Pagets disease Paget's disease o Paget s disease is characterized by increased bone turnover and enlargement and thickening of the bone the internal architecture is abnormal and the bone is usually brittle, o Primary defect is in osteolastic. o It is marked by regions of furious osteolastic bone resorption which is followed by a period of hectis bone formation. The net effect is gain in bone mass. o It has the following three stages Initial osteocytic stage Mixed osteoclast osteoblastic stage Burned out quiescent osteosclerotic stage o Following complications can occur in Paget's Increased risk of development of sarcomas (osteosarcoma chondrosarcoma) Fractures in weight bearing bones Osteoarthritis High output cardiac failure Cranial nerve compression Otoscleosis",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Labetalol is an A. Alpha 1 blocker | B. Alpha 2 blocker | C. Alpha 1 and selective beta 1 blocker | D. Alpha 1 and non-selective beta blocker",
      "answer": "The correct answer is **D. Alpha 1 and non-selective beta blocker**.\n\n**Explanation:**\n\nLabetalol is a unique antihypertensive medication because it possesses both alpha and beta-adrenergic blocking properties.\n\n*   **Alpha 1 blockade:** This action leads to vasodilation (widening of blood vessels), which reduces peripheral resistance and lowers blood pressure.\n*   **Non-selective beta blockade:** Labetalol blocks both beta-1 (primarily in the heart) and beta-2 (primarily in the lungs and blood vessels) receptors. Beta-1 blockade reduces heart rate and contractility, further contributing to lower blood pressure. Beta-2 blockade can have some bronchodilatory effects, but its clinical significance in this context is less pronounced than the alpha and beta-1 effects.\n\nLet's look at why the other options are incorrect:\n\n*   **A. Alpha 1 blocker:** This is only partially correct, as labetalol also has beta-blocking effects.\n*   **B. Alpha 2 blocker:** Labetalol does not primarily act as an alpha-2 blocker. Alpha-2 blockers are a different class of drugs.\n*   **C. Alpha 1 and selective beta 1 blocker:** Labetalol is *non-selective* in its beta blockade, meaning it affects both beta-1 and beta-2 receptors. Selective beta-1 blockers (like metoprolol or atenolol) are a different category.",
      "ground_truth": "Alpha 1 and non-selective beta blocker || Labetalol is a commonly used a 1 and non-selective b-adrenergic blockerDose: 200-2400mg/day, orally in two to three divided dosesIn an emergency: 20mg IV, followed by 20-80mg every 20min to a maximum of 220mg. Avoid in patients with Asthma, congestive cardiac failure, Liver failure(Ref: William's Obstetrics; 25th edition)",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 6 month old baby brought to emergency depament with features of cardiac failure. On examination, she found to have developmental delay and a large tongue. Echocardiography shows severe concentric LVH. The most probable diagnosis is: A. Pompe disease | B. Von Gierke's disease | C. Forbe's Disease | D. McArdle's disease",
      "answer": "The most probable diagnosis is **A. Pompe disease**.\n\nHere's why:\n\n*   **Pompe disease (Glycogen Storage Disease Type II)** is a lysosomal storage disorder caused by a deficiency of the enzyme acid alpha-glucosidase. This leads to the accumulation of glycogen in various tissues, particularly in muscle cells, including the heart.\n    *   **Cardiac Failure in Infancy:** Infantile-onset Pompe disease is characterized by severe, progressive muscle weakness and cardiac involvement. The accumulation of glycogen in the heart muscle leads to **severe concentric left ventricular hypertrophy (LVH)**, which is a hallmark finding on echocardiography and can result in heart failure.\n    *   **Developmental Delay:** Muscle weakness and the overall impact of the disease can lead to developmental delay.\n    *   **Large Tongue (Macroglossia):** Macroglossia is another common feature of infantile Pompe disease due to glycogen accumulation in the tongue muscles.\n\nLet's look at why the other options are less likely:\n\n*   **B. Von Gierke's disease (Glycogen Storage Disease Type I):** This is a defect in glucose-6-phosphatase, primarily affecting the liver and kidneys. While it causes hypoglycemia and hepatomegaly, it typically does not present with severe cardiac hypertrophy or macroglossia in infancy.\n*   **C. Forbes' Disease (Glycogen Storage Disease Type III):** This is a defect in debranching enzyme. It can cause hypoglycemia, hepatomegaly, and muscle weakness, but severe concentric LVH and macroglossia are not characteristic features.\n*   **D. McArdle's disease (Glycogen Storage Disease Type V):** This is a defect in muscle phosphorylase, affecting skeletal muscle. It typically presents with exercise intolerance, muscle pain, and weakness, usually in adolescence or adulthood, and does not involve cardiac hypertrophy or macroglossia in infancy.\n\nTherefore, the combination of cardiac failure with severe concentric LVH, developmental delay, and a large tongue in a 6-month-old infant strongly points towards **Pompe disease**.",
      "ground_truth": "Pompe disease || The type of glycogen storage disease that primarily involves the hea is Pompe disease (GSD IIa) in which acid maltase, necessary for hydrolysis of the outer branches of glycogen, is absent. There is marked deposition of glycogen within the myocardium. Affected infants are well at bih, but symptoms of growth and developmental delay, feeding problems, and cardiac failure occur by the sixth month of life. Physical examination reveals generalized muscular weakness, a large tongue, and cardiomegaly without significant hea murmurs. Chest radiographs reveal cardiomegaly with or without pulmonary venous congestion. The ECG shows a sho PR interval and LVH with ST depression and T-wave inversion over the left precordial leads. Echocardiography shows severe concentric LVH. Children with Pompe disease usually die before age 1 year. Death may be sudden or result from progressive HF. Ref: Darst J.R., Collins K.K., Miyamoto S.D. (2012). Chapter 20. Cardiovascular Diseases. In W.W. Hay, Jr., M.J. Levin, R.R. Deterding, J.J. Ross, J.M. Sondheimer (Eds), CURRENT Diagnosis & Treatment: Pediatrics, 21e.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "An epidemiologic study observes increased numbers of respiratory tract infections among children living in a community in which most families are at the poverty level. The infectious agents include Streptococcus pneumoniae, Haemophilus influenzae, and Klebsiella pneumoniae. Most of the children have had pneumonitis and rubeola infection. The study documents increased rates of keratomalacia, urinary tract calculi, and generalized papular dermatosis in these children as they reach adulthood. These children are most likely to have a deficiency of which of the following vitamins? A. Vitamin A | B. Vitamin B1 | C. Vitamin E | D. Vitamin D",
      "answer": "The correct answer is **A. Vitamin A**.\n\nHere's why:\n\n*   **Respiratory Tract Infections:** Vitamin A is crucial for maintaining the integrity of epithelial tissues, including those lining the respiratory tract. Deficiency weakens these defenses, making individuals more susceptible to infections caused by bacteria like *Streptococcus pneumoniae*, *Haemophilus influenzae*, and *Klebsiella pneumoniae*.\n*   **Pneumonitis:** This is inflammation of the lungs, a common consequence of severe respiratory infections, which are more frequent in vitamin A deficiency.\n*   **Rubeola (Measles):** Vitamin A deficiency is known to worsen the severity of measles and increase the risk of complications, including pneumonia and encephalitis.\n*   **Keratomalacia:** This is a severe form of xerophthalmia (dry eye) characterized by softening and ulceration of the cornea, leading to blindness. It is a hallmark sign of vitamin A deficiency.\n*   **Generalized Papular Dermatosis:** Vitamin A is essential for skin health and differentiation. Deficiency can lead to dry, scaly skin and various dermatological issues.\n*   **Urinary Tract Calculi:** While less directly linked than the other symptoms, some studies suggest a potential association between vitamin A deficiency and an increased risk of kidney stones, possibly due to altered epithelial function in the urinary tract.\n\n**Why the other options are less likely:**\n\n*   **Vitamin B1 (Thiamine):** Deficiency primarily affects the nervous system (beriberi) and cardiovascular system. It doesn't directly explain the prominent respiratory and ocular symptoms.\n*   **Vitamin E:** Primarily an antioxidant. While important for immune function, its deficiency is not typically associated with the specific constellation of symptoms described.\n*   **Vitamin D:** Crucial for bone health and calcium metabolism. Deficiency leads to rickets and osteomalacia. While it plays a role in immunity, it doesn't explain the severe ocular and respiratory manifestations as directly as vitamin A.",
      "ground_truth": "Vitamin A || Vitamin A is important in maintaining epithelial surfaces. Deficiency of this vitamin can lead to squamous metaplasia of respiratory epithelium, predisposing to infection. Increased keratin buildup leads to follicular plugging and papular dermatosis. Desquamated keratinaceous debris in the urinary tract forms the nidus for stones. Ocular complications of vitamin A deficiency include xerophthalmia and corneal scarring, which can lead to blindness. Vitamin B1 (thiamine) deficiency causes problems such as Wernicke disease, neuropathy, and cardiomyopathy. Vitamin D deficiency in children causes rickets, characterized by bone deformities. Vitamin E deficiency occurs rarely; it causes neurologic symptoms related to degeneration of the axons in the posterior columns of the spinal cord. Vitamin K deficiency can result in a bleeding diathesis.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 57 year old male suffering from acute pancreatitis develops sudden onset breathlessness with a CVP< 18mmHg. The chest xray shows bilateral infiltrates. The possible diagnosis is - A. ARDS | B. Myocardial infarction | C. Congestive left heart failure | D. Pulmonary embolism",
      "answer": "The most likely diagnosis is **A. ARDS (Acute Respiratory Distress Syndrome)**.\n\nHere's why:\n\n*   **Acute Pancreatitis:** This is a known trigger for ARDS. The inflammatory process in the pancreas can lead to a systemic inflammatory response that affects the lungs.\n*   **Sudden Onset Breathlessness:** This is a hallmark symptom of ARDS.\n*   **Bilateral Infiltrates on Chest X-ray:** This finding is characteristic of ARDS, indicating fluid accumulation in both lungs.\n*   **CVP < 18 mmHg:** A low central venous pressure (CVP) suggests that the patient is not fluid overloaded, which makes congestive left heart failure less likely. While myocardial infarction can lead to pulmonary edema, the low CVP is less typical for acute heart failure. Pulmonary embolism can cause breathlessness and infiltrates, but ARDS is a more direct and common complication of severe pancreatitis presenting with these findings.\n\n**Explanation of why other options are less likely:**\n\n*   **B. Myocardial Infarction:** While a myocardial infarction can cause breathlessness and pulmonary edema, the history of acute pancreatitis as the primary event makes ARDS a more direct and probable cause of the respiratory distress. A low CVP is also less typical for acute heart failure secondary to MI.\n*   **C. Congestive Left Heart Failure:** Congestive heart failure typically presents with breathlessness and bilateral infiltrates, but it is usually associated with elevated CVP due to fluid overload. The given CVP of < 18 mmHg makes this diagnosis less probable.\n*   **D. Pulmonary Embolism:** Pulmonary embolism can cause sudden breathlessness and infiltrates, but ARDS is a more common and direct complication of acute pancreatitis that presents with these findings.",
      "ground_truth": "ARDS || Ans. is 'a' i.e., ARDS ARDS Criteria 1. Acute, meaning onset over 1 week or less. 2. Bilateral opacities consistent with pulmonary edema must be present and may be detected on CT or chest radiograph. 3. PF ratio < 300 mmHg with a minimum of 5 cmH20 PEEP (or CPAP). 4. C VP < 18 mmHg. X-Ray showing bilateral infiltrates:",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Urine sample examinations is a useful investigation in infestation of A. S. haematobium | B. S. japonicum | C. S. mansoni | D. E.vermicularis",
      "answer": "The correct answer is **A. S. haematobium**.\n\n**Explanation:**\n\n*   **Schistosoma haematobium (S. haematobium)** is a parasitic worm that primarily infects the blood vessels of the bladder and urinary tract. Therefore, microscopic examination of a urine sample is a key diagnostic method to detect the presence of its eggs, which are shed in the urine.\n\n*   **Schistosoma japonicum (S. japonicum)** and **Schistosoma mansoni (S. mansoni)** are other species of schistosomes. While they also cause schistosomiasis, they primarily infect the blood vessels of the intestines and liver. Diagnosis for these species typically involves examining stool samples for eggs, or sometimes blood tests for antibodies.\n\n*   **Enterobius vermicularis (E. vermicularis)**, commonly known as pinworms, is a nematode (roundworm) that infects the intestines. Diagnosis is usually made by the \"tape test,\" where clear tape is pressed against the perianal skin to collect eggs, which are then examined under a microscope. Urine samples are not typically used for diagnosing pinworm infestations.",
      "ground_truth": "S. haematobium || Ans. a (S. hematobium) (Ref. H - 18th/ ch. 219)SCHISTOSOMIASIS (BILHARZIA)Distribution and important species of Schistosoma are:# S. japonica is found in Central and Eastern China, and the Philippines and nearby islands; and primarily affects the liver and intestines.# 5. mansoni is found in Africa, the Eastern Mediterranean, the Caribbean, and South America and primarily affects the liver and intestines.# S. haematobium is found in Africa, the Middle East, and Eastern Mediterranean and primarily affects the urinary tract.# S. mekongi is found in Southeast Asia and primarily affects the liver and intestines.Incubation:# Symptoms of acute schistosomiasis begin about a month after infection.Signs and Symptoms# Acute schistosomiasis ->>Katayama fever.Q# The last (chronic) stage varies according to species, i.e., S. japonica, 5. mansoni, and S. mekongi primarily affect liver and intestines; while S. haematobium primarily affects the urinary tract.# In general, patients with chronic schistosomiasis tend to present in developed countries with lethargy, colicky abdominal pain, mucoid/bloody diarrhea, or dysuria and hematuria.# Chronic hepatosplenic schistosomiasis is a consequence of eggs retained in tissue and prolonged infection - usually of > 10 years duration.# Fibrosis may cause portal hypertension, splenomegaly, or esophageal or gastric varices.Q# Chronic genitourinary schistosomiasis is associated with chronic 5. haematobium infection.# Hematuria and dysuria are common from the acute through chronic stages. Bladder cancer rates are increased in endemic areas. Salmonella infection concurrent with schistosomiasis is common and is resistant to treatment unless the schistosomiasis is also treated.Diagnosis# Diagnosis of S. japonicum and S. mansoni is by the presence of ova in feces or tissue. Diagnosis of S. haematobium is by the presence of ova in urine or tissue. However, ova loads are not always sufficient for diagnosis, especially in long-standing chronic illness. Immunofluorescent antibody tests and antigen detection assays are increasingly used.# \"Fetal head\" bladder calcification may be shown in X-rays in chronic S. haematobium infection. QTreatment# For S. haematobium and S. mansoni, praziquantel 20/kg po bid for one day; for S. japonica and S. mekongi, praziquantel 20/kg po tid for one day are the treatments of choice.# S. mansoni may also be treated with oxamniquine in a single po dose (with food) of 15 mg/kg. S. haematobium in North and East Africa may be treated with metrifonate 7.5-10 mg/kg every other week for a total of 3 doses.Also Know:# The second most common urologic cancer and the most frequent malignant tumor of the urinary tract is bladder cancer. Usually a transitional cell carcinoma. Most prevalent in men during the sixth and seventh decades. Risk factors include smoking, diets rich in meat and fat, schistosomiasis, chronic treatment with cyclophosphamide, and exposure to aniline dye (a benzene derivative).# Causes of portal hypertesnion are as follows: 1. Presinusoidal: Splenic or portal vein thrombosis, schistosomiasis. granulomatous disease. 2. Sinusoidal: Cirrhosis, granulomatous disease. 3. Postsinusoidal: Right heart failure, constrictive pericarditis, hepatic vein thrombosis.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Commonest cause of hea failure in infancy is ________ A. Myocarditis | B. Rheumatic fever | C. Cardiomyopathy | D. Congenital hea disease",
      "answer": "The correct answer is **D. Congenital heart disease**.\n\n**Explanation:**\n\n*   **Congenital heart disease (CHD)** refers to structural problems in the heart that are present at birth. These defects can affect how blood flows through the heart or how the heart pumps blood to the rest of the body, often leading to heart failure in infancy.\n*   **Myocarditis** (inflammation of the heart muscle) can cause heart failure, but it's less common as a primary cause in infancy compared to CHD.\n*   **Rheumatic fever** is an inflammatory condition that can affect the heart valves, but it typically occurs after a streptococcal infection and is more common in older children and adults, not usually in infancy.\n*   **Cardiomyopathy** (disease of the heart muscle) can lead to heart failure, but again, congenital structural defects are the most frequent underlying reason for heart failure in newborns and infants.",
      "ground_truth": "Congenital hea disease || Most common cause of congestive cardiac failure in infants is congenital hea disease. Ref : Ghai essential of pediatrics, eighth edition ,p.no:397",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Criteria for diagnosing SIRS all seen except: A. Temp > 38.5 degC or < 36 degC | B. RR > SD above normal for age | C. Children <1 year old persistent bradycardia over 0.5 hour | D. >50% immature neutrophils",
      "answer": "The correct answer is **C. Children <1 year old persistent bradycardia over 0.5 hour**.\n\nHere's why:\n\n*   **SIRS (Systemic Inflammatory Response Syndrome)** is a clinical syndrome characterized by a widespread inflammatory state. The diagnosis of SIRS is based on the presence of at least two of the following four criteria:\n    *   **A. Temperature:** Core body temperature > 38.5C (101.3F) or < 36C (96.8F). This is a standard SIRS criterion.\n    *   **B. Respiratory Rate (RR):** Tachypnea (elevated respiratory rate) is a criterion. While the exact threshold can vary slightly by age, \"RR > SD above normal for age\" is a way to express this, indicating a significantly elevated rate.\n    *   **D. White Blood Cell Count (WBC):** This criterion relates to the WBC count. A WBC count > 12,000/mm or < 4,000/mm, or a percentage of immature neutrophils (bands) > 10% are considered. Therefore, **>50% immature neutrophils** is a strong indicator of an elevated immature neutrophil count, which is a component of the WBC criterion for SIRS.\n\n*   **C. Children <1 year old persistent bradycardia over 0.5 hour:** Bradycardia (slow heart rate) is *not* a criterion for SIRS. In fact, tachycardia (fast heart rate) is often seen in SIRS due to the inflammatory process and increased metabolic demand. Persistent bradycardia in infants is a serious sign but is not directly indicative of SIRS.\n\n**In summary:** Criteria A, B, and D are all related to the established diagnostic criteria for SIRS. Criterion C, persistent bradycardia in infants, is not a SIRS criterion.",
      "ground_truth": ">50% immature neutrophils || D i.e. >50% immature neutrophilsRef: Nelson, Textbook of Pediatrics, 20th edition, page 522Explanation:Systemic Inflammatory Response Syndrome (SIRS)It's an inflammatory cascade that is initiated by the host in response to infection, occurs when the host defense system does not adequately recognize or clear the infection.InfectionSuspected or proven infection or a clinical syndrome associated with high probability of infectionSystemic Inflamma-tory Response Syndrome (SIRS)2 out of 4 criteria, 1 of which must be abnormal temperature or abnormal leukocyte count1. Core temperature >38.5degC or <36degC (rectal, bladder, oral, or central catheter)2. Tachycardia: Mean heart rate >2 SD above normal for age in absence of external stimuli, chronic drugs or painful stimuli; OR unexplained persistent elevation over 0.5-4 hr; OR in children <1 year old persistent bradycardia over 0.5 hr (mean heart rate <10th percentile for age in absence of vagal stimuli, (3 blocker drugs, or congenital heart disease)3. Respiratory rate >2 SD above normal for age or acute need for mechanical ventilation not related to neuromuscular disease or general anesthesia4. Leukocyte count elevated or depressed for age (not secondary to chemotherapy) or >10% immature neutrophilsSepsisSIRS plus a suspected or proven infectionSevere SepsisSepsis plus 1 of the following:1 Cardiovascular organ dysfunction defined as:Despite >40 mL/kg of isotonic intravenous fluid in 1 hrHypotension <5th percentile for age, systolic blood pressure <2 SD below normal for age OR Need for vasoactive drug to maintain blood pressure OR2 of the following:Unexplained metabolic acidosis: Base deficit >5 mEq/LIncreased arterial lactate >2 times upper limit of normalOliguria: Urine output <0.5 mL/kg/hrProlonged capillary refill 5 secCore to peripheral temperature gap >3degC2.Acute respiratory distress syndrome (ARDS) as defined by the presence of a Pa02/Fi02 ratio <300 mm Hg, bilateral infiltrates on chest radiograph and no evidence of left heart failureORSepsis plus 2 or more organ dysfunctions (respiratory, renal, neurologic, hematologic or hepatic)Septic ShockSepsis plus cardiovascular organ dysfunction as defined aboveMultiple Organ Dysfunction Syndrome (MODS)Presence of altered organ function such that homeostasis cannot be maintained without medical intervention",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "True statement regarding upper GI bleeds: A. It is bleeding up to ampulla of Vater | B. Most common cause is variceal bleeding | C. Rockall-Baylor scoring is used for risk stratification | D. Most common management is endoscopic banding",
      "answer": "The correct answer is **C. Rockall-Baylor scoring is used for risk stratification**.\n\nHere's why:\n\n*   **A. It is bleeding up to ampulla of Vater:** This is incorrect. Upper GI bleeds refer to bleeding originating from the esophagus, stomach, or duodenum proximal to the ligament of Treitz. The ampulla of Vater is located in the duodenum, but the definition of upper GI bleed extends beyond just this point.\n*   **B. Most common cause is variceal bleeding:** This is incorrect. While variceal bleeding is a serious cause of upper GI bleeds, the most common causes are peptic ulcers (gastric and duodenal ulcers) and erosive esophagitis/gastritis.\n*   **C. Rockall-Baylor scoring is used for risk stratification:** This is **true**. The Rockall score (and its modifications like the Baylor score) is a widely used clinical tool to assess the risk of rebleeding and mortality in patients with upper GI bleeds. It helps guide management decisions.\n*   **D. Most common management is endoscopic banding:** This is incorrect. Endoscopic banding is a primary treatment for **esophageal varices**, which are a specific cause of upper GI bleeding. The most common management for upper GI bleeds in general involves a combination of resuscitation (fluids, blood products), acid suppression (PPIs), and often endoscopic intervention (like cautery, clipping, or injection therapy) depending on the cause and severity. Endoscopic banding is not the most common management for all upper GI bleeds.",
      "ground_truth": "Rockall-Baylor scoring is used for risk stratification || UPPER GI BLEED: Bleeding up to Lig. of Treitz M/c cause- Non-variceal peptic ulcer bleeding Causes of upper gastrointestinal bleeding Condition % Ulcers 60 Oesophageal 6 Gastric 21 Duodenal 33 Erosions 26 Oesophageal 13 Gastric 9 Duodenal 4 Mallory-Weiss tear 4 Oesophageal varices 4 Tumour 0.5 Vascular lesions, e.g. Dieulafoy's disease 0.5 Others 5 Risk stratification system for UPPER GI BLEEDS: - Help to identify the patients at higher risk of major bleeding or death (facilitate patient triage) Commonly used scoring systems: - Rockall score -takes account of endoscopic findings, most useful - Blatchford score -during initial assessment, does not require endoscopic data. Commonly Used Risk Stratification Systems for Upper GI Bleeds Blatchford Score (PUSH + Melena/Syncope + Cardiac/Hepatic Dysfunction) Rockall & Baylor Score (CASDE) PulseQ Blood Urea nitrogenQ Systolic BPQ HemoglobinQ Presence of MelenaQ, SyncopeQ, HepaticQ or Cardiac dysfunctionQ Comorbid diseaseQ (cardia, hepatic, renal, or disseminated) * AgeQ (<60 years, 60-79 years >80 years) ShockQ (systolic BP <100 mm Hg. HR >100 beats/min) Diagnosis at the time of endoscopy (Mallory-Weiss non-malignant lesions, or malignant lesions) Endoscopic Stigmata of recent bleedQ",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Noonan syndrome is characterized by all except A. Hypertrophic cardiomyopathy | B. Dysplastic pulmonary stenosis | C. Pectus excavatum | D. Coarctation of aorta",
      "answer": "The correct answer is **D. Coarctation of aorta**.\n\n**Explanation:**\n\nNoonan syndrome is a genetic disorder that affects multiple parts of the body. While it is associated with a variety of congenital heart defects, coarctation of the aorta is **not** a typical or characteristic feature of Noonan syndrome.\n\nHere's why the other options are characteristic of Noonan syndrome:\n\n*   **A. Hypertrophic cardiomyopathy:** This is a very common and significant cardiac manifestation of Noonan syndrome, where the heart muscle becomes abnormally thick.\n*   **B. Dysplastic pulmonary stenosis:** Pulmonary stenosis, particularly a dysplastic form (abnormal development of the valve leaflets), is one of the most frequent heart defects seen in individuals with Noonan syndrome.\n*   **C. Pectus excavatum:** This is a chest wall deformity where the breastbone is sunken inward. It is frequently observed in individuals with Noonan syndrome.",
      "ground_truth": "Coarctation of aorta || Coarctation of aorta is not the cardiovascular manifestation in Noonan syndrome.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Cardiopulmonary manifestation of hyperthyroidism-a) Tachycardiab) Sinus bradycardiac) Cardiomegalyd) Low output cardiac failure A. a | B. bc | C. ac | D. b",
      "answer": "The correct answer is **A. a**.\n\nHere's why:\n\n*   **Hyperthyroidism** is a condition where the thyroid gland produces too much thyroid hormone. These hormones have a significant impact on the body's metabolism, including the cardiovascular system.\n\nLet's break down the options:\n\n*   **a) Tachycardia:** This is a rapid heart rate. Thyroid hormones increase the heart's sensitivity to catecholamines (like adrenaline), leading to an increased heart rate and contractility. This is a very common manifestation of hyperthyroidism.\n*   **b) Sinus bradycardia:** This is a slow heart rate. This is the opposite of what is typically seen in hyperthyroidism. In fact, hyperthyroidism can sometimes lead to atrial fibrillation, which is an irregular and often fast heart rhythm.\n*   **c) Cardiomegaly:** This refers to an enlarged heart. While prolonged, severe hyperthyroidism can lead to changes in the heart muscle and potentially contribute to heart enlargement over time, it's not as direct or consistent a manifestation as tachycardia.\n*   **d) Low output cardiac failure:** This is a type of heart failure where the heart cannot pump enough blood to meet the body's needs. While hyperthyroidism can lead to high-output cardiac failure (where the heart pumps a lot of blood, but it's not efficient enough), low-output failure is not a typical presentation.\n\nTherefore, **tachycardia** is the most direct and common cardiopulmonary manifestation of hyperthyroidism among the given options.",
      "ground_truth": "ac ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 74-year-old woman has symptoms of shortness of breath on exertion and waking up at night. Her physical examination reveals a JVP at 8 cm, extra third heart sound, lung crackles, and pedal edema. She is started on furosemide 80 mg/day for heart failure, while further investigations are performed.For the above patient with new symptoms, select the most likely acid base disorder. A. metabolic acidosis | B. metabolic alkalosis | C. respiratory acidosis | D. respiratory alkalosis",
      "answer": "The most likely acid-base disorder for this patient is **D. respiratory alkalosis**.\n\nHere's the explanation:\n\n*   **Symptoms of Heart Failure:** The patient's symptoms (shortness of breath on exertion, waking up at night, elevated JVP, third heart sound, lung crackles, pedal edema) are classic signs of **heart failure**.\n*   **Hyperventilation in Heart Failure:** In the setting of acute or worsening heart failure, the body often tries to compensate for impaired oxygenation and fluid overload by **hyperventilating**. This means breathing faster and deeper.\n*   **Effect of Hyperventilation on CO2:** Hyperventilation leads to an excessive exhalation of carbon dioxide (CO2). CO2 in the blood is acidic.\n*   **CO2 and pH:** When CO2 levels decrease, the blood becomes less acidic, leading to an increase in blood pH.\n*   **Respiratory Alkalosis:** A state where the blood pH is elevated due to a decrease in CO2 is known as **respiratory alkalosis**.\n\n**Why the other options are less likely:**\n\n*   **A. Metabolic Acidosis:** This would typically be associated with conditions like lactic acidosis, diabetic ketoacidosis, or kidney failure, which are not directly indicated by the presented symptoms.\n*   **B. Metabolic Alkalosis:** This can be caused by vomiting, diuretic use (though furosemide is a loop diuretic that can cause *both* alkalosis and acidosis depending on other factors, the primary driver here is the hyperventilation), or excessive bicarbonate intake. While diuretics can contribute to electrolyte imbalances, the prominent hyperventilation points more strongly to a respiratory cause.\n*   **C. Respiratory Acidosis:** This occurs when there is an accumulation of CO2 in the blood, usually due to hypoventilation (e.g., in severe COPD exacerbation, drug overdose). This patient is hyperventilating, not hypoventilating.\n\n**In summary:** The patient's symptoms suggest heart failure, which often triggers compensatory hyperventilation. This hyperventilation leads to a decrease in CO2, resulting in respiratory alkalosis.",
      "ground_truth": "metabolic alkalosis || Diuretics are a common cause of metabolic alkalosis. The disorder can occur in volume expanded patients in whom the alkalosis is unresponsive to sodium chloride loading, as in primary hyperaldosteronism or volume contraction with secondary hyperaldosteronism, as in this case.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which one of the following lysosomal storage disorder is associated with mental retardation? A. Metachromatic leucodystrophy | B. Fabry's disease | C. Tay Sach's disease | D. All of the above",
      "answer": "The correct answer is **D. All of the above**.\n\nHere's why:\n\n*   **Lysosomal storage disorders (LSDs)** are a group of genetic diseases where the body cannot break down certain molecules because of a deficiency in a specific enzyme. These undigested materials build up in the lysosomes of cells, leading to cellular dysfunction and damage. Many LSDs affect the central nervous system, which can result in intellectual disability or mental retardation.\n\nLet's look at each option:\n\n*   **A. Metachromatic leukodystrophy (MLD):** This disorder is caused by a deficiency in the enzyme arylsulfatase A, leading to the accumulation of sulfatides. MLD is characterized by progressive neurological deterioration, including severe mental retardation, motor deficits, and seizures.\n\n*   **B. Fabry's disease:** This X-linked disorder is caused by a deficiency in the enzyme alpha-galactosidase A, leading to the accumulation of globotriaosylceramide. While Fabry's disease is primarily known for its systemic manifestations (pain, kidney problems, heart issues), neurological complications, including stroke and cognitive impairment (which can manifest as mental retardation), can occur, especially in later stages or in affected females.\n\n*   **C. Tay-Sachs disease:** This autosomal recessive disorder is caused by a deficiency in the enzyme hexosaminidase A, leading to the accumulation of GM2 gangliosides, particularly in nerve cells. Tay-Sachs disease is characterized by severe and progressive neurological degeneration, including profound mental retardation, blindness, and paralysis, typically leading to death in early childhood.\n\nSince all three of these lysosomal storage disorders are associated with mental retardation, the correct answer is indeed **D. All of the above**.",
      "ground_truth": "All of the above || (D) All of the above# Metachromatic leukodystrophy (MLD, or Arylsulfatase A deficiency) is a lysosomal storage disease which is commonly listed in the family of leukodystrophies. Leukodystrophies affect the growth and/or development of myelin, the fatty covering which acts as an insulator around nerve fibers throughout the central and peripheral nervous systems. It involves sulfatide accumulation.> Like many other genetic disorders that affect lipid metabolism, there are several forms of MLD, which are late infantile, juvenile, arid adult.> Children with the juvenile form of MLD (onset between 3-10 years of age) usually begin with impaired school performance, mental deterioration, and dementia and then develop symptoms similar to the late infantile form but with slower progression.> Age of death is variable, but normally within 10 to 15 years of symptom onset although some juveniles can live for several decades or longer after onset.> Tay-Sachs disease (abbreviated TSD, also known as GM2 gangliosidosis or Hexosaminidase A deficiency) is an autosomal recessive genetic disorder.> In its most common variant, known as infantile Tay-Sachs disease, it causes a relentless deterioration of mental and physical abilities that commences around six months of age and usually results in death by the age of four.> Fabry disease (also known as Fabry's disease, Anderson.> Fabry disease, angiokeratoma corporis diffusum and alpha-galactosidase A deficiency) is a rare X-linked recessive (inherited) lysosomal storage disease, which can cause a wide range of systemic symptoms.Full body or localized pain to the extremities (known as acroparesthesia) or Gl tract is common in patients with Fabry disease.Kidney complications are a common and serious effect of the disease; renal insufficiency and renal failure may worsen throughout life.> Cardiac complications occur when glycolipids build up in different heart cells; heart related effects worsen with age and may lead to increased risk of heart disease.> Hypertension (high blood pressure) and cardiomyopathy are commonly observed.mental retardation is rare presentation",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 4-year-old male child presents with muscles weakness. His mother tells that her child has difficulty in climbing stairs and getting up from the floor. On muscle biopsy, small muscle fibrils and absent of dystrophic was found. What is the diagnosis out of given option? A. Beck's muscle dystrophy | B. Duchenne muscular dystrophy | C. Myotonic dystrophy | D. Limb-girdle muscular dystrophy",
      "answer": "The correct answer is **B. Duchenne muscular dystrophy**.\n\nHere's why:\n\n*   **Duchenne Muscular Dystrophy (DMD)** is a genetic disorder that causes progressive muscle degeneration and weakness. It typically presents in early childhood, often between the ages of 3 and 5. Children with DMD commonly experience difficulty with activities requiring leg strength, such as climbing stairs and getting up from a seated or lying position (Gowers' sign). The muscle biopsy findings of small muscle fibrils and absence of dystrophic changes are consistent with DMD, where there is a lack of dystrophin protein, leading to muscle fiber damage and regeneration without significant dystrophic features.\n\nLet's look at why the other options are less likely:\n\n*   **A. Beck's muscle dystrophy:** This is not a recognized medical term for a specific muscular dystrophy.\n*   **C. Myotonic dystrophy:** This condition is characterized by myotonia (difficulty relaxing muscles) in addition to muscle weakness. While it can affect children, the primary complaint is often stiffness and delayed relaxation, which isn't highlighted in the case description. Muscle biopsy findings can vary but often show ring fibers.\n*   **D. Limb-girdle muscular dystrophy (LGMD):** LGMD is a group of disorders that affect the muscles of the shoulders and hips. While it causes muscle weakness, the onset can be variable, and the specific biopsy findings described are more characteristic of DMD.\n\nTherefore, based on the age of presentation, the specific symptoms of muscle weakness (difficulty climbing stairs and getting up from the floor), and the muscle biopsy findings, Duchenne muscular dystrophy is the most likely diagnosis.",
      "ground_truth": "Duchenne muscular dystrophy || Duchenne Muscular Dystrophy Progressive weakness Calf muscle involvement Pseudo hyperophy Difficulty in climbing stairs Gowersign present (+) Wheel chair bound Patient Death - CHF/ Pneumonia CPK MM: Increased IOC: - PCR for dystrophin gene (Dystrophin gene absent) Rx: - Chest Physiotherapy NOTE:Immunohistochemical studies for dystrophin show Absence of the normal sarcolemma staining pattern in Duchenne muscular dystrophin Reduced staining in Becker muscular dystrophy.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Dystrophic calcification means- A. Calcification in destroyed tissue with normal calcium level in blood | B. t level of Ca++ deposits | C. Calcification in normal tissue seen in hyperparathyroidism | D. Calcification in destroyed tissues with hyper calcemia",
      "answer": "The correct answer is **A. Calcification in destroyed tissue with normal calcium level in blood**.\n\nHere's a breakdown of why:\n\n*   **Dystrophic calcification** occurs when there is **tissue damage or necrosis**. This damage can be due to various causes like infection, inflammation, trauma, or aging.\n*   In dystrophic calcification, the **serum calcium levels are normal**. The calcium deposits are localized to the damaged tissue and are a consequence of the cellular breakdown and altered local metabolism, not a systemic issue with calcium regulation.\n\nLet's look at why the other options are incorrect:\n\n*   **B. t level of Ca++ deposits:** This is too vague and doesn't explain the *context* of the calcification. \"t level\" is also unclear.\n*   **C. Calcification in normal tissue seen in hyperparathyroidism:** Calcification in normal tissue due to a systemic issue like hyperparathyroidism is typically referred to as **metastatic calcification**, not dystrophic calcification. Metastatic calcification occurs when there are elevated serum calcium levels, leading to calcium deposition in otherwise normal tissues.\n*   **D. Calcification in destroyed tissues with hypercalcemia:** This describes **metastatic calcification**, where both tissue damage and elevated blood calcium are present. Dystrophic calcification specifically occurs *without* hypercalcemia.",
      "ground_truth": "Calcification in destroyed tissue with normal calcium level in blood || Amyloidosis is the extracellular deposition of insoluble protein fibrils. <NL> AL- Primary systemic amyloidosis <NL> AA- Secondary amyloidosis <NL> AF- Familial <NL> A2M- In ESRD <NL> Diagnosed by abdominal fat pad aspiration showing apple green birefringence by polarized light microscopy with Congo red stain <NL> High ESR, High ALP <NL> Serum Immunofixation electrophoresis (SIFE), UIFE-sensitive to detect light chains (Lamda more common) <NL> Kidneys- most common involved. Nephrotic range proteinuria, azotemia seen <NL> Heart- second common organ; restrictive cardiomyopathy, low voltage complexes in ECG, sparkly appearance on ECHO heart <NL> Peripheral sensory neuropathy,carpal tunnel syndrome <NL> Large tongue, raccoon-eye sign-Factor X deficiency^ bleeding) <NL> Treatment- AL- Melphalan. dexamethasone, lenalidomide & bortezomib; <NL> HDM/SCT- Autologous stem cell transplantation after high-dose melphalan <NL> High BNP. pro-BNP, troponin T & I in cardiac involvement, used for prognosis too. <NL> AA Amyloidosis: secondary to chronic infections - tuberculosis, SABE or inflammatory conditions like RA, IBD, Castleman's disease <NL> Treat the primary disease, TNF & IL -1 antagonist. <NL> The new drug - Eprodisate for renal AA <NL> AF Amyloidosis: AD, mutant TTR (transthyretin/prealbumin) <NL> <NL>  Peripheral & autonomic neuropathy <NL>  Cardiac conduction defects <NL> <NL> A2M/ Amyloidosis: associated with ESRD. on hemodialysis <NL> Carpal tunnel syndrome, joint effusions, cystic bone lesions <NL> Decreases with stopping dialysis",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following finding is shown in the chest leads? A. Myocardial ischemia | B. Myocardial injury | C. Digoxin | D. Digoxin toxicity",
      "answer": "To answer this question accurately, I need to see the chest lead ECG findings. Without the actual ECG tracing or a description of the findings in the chest leads (V1-V6), I cannot determine which of the options is correct.\n\nPlease provide the ECG findings from the chest leads.\n\nOnce you provide the ECG findings, I can explain why a particular option is correct or incorrect. For example:\n\n*   **Myocardial ischemia** is often associated with ST-segment depression and/or T-wave inversion.\n*   **Myocardial injury** (acute infarction) is typically characterized by ST-segment elevation.\n*   **Digoxin** can cause various ECG changes, including ST-segment depression that can appear as a \"scooped\" or \"J-point\" depression, and T-wave flattening.\n*   **Digoxin toxicity** can lead to more pronounced ST-segment depression, arrhythmias (like AV block or ventricular arrhythmias), and hyperkalemia.",
      "ground_truth": "Myocardial ischemia || The hea rate is nearly 125bpm. Notice the predominant T wave inversion in V1-V3. This is seen in myocardial ischemia. Diagnosis of myocardial injury needs elevated cardiac biomarkers. Digoxin leads to ST segment depression Digoxin toxicity leads to Ventricular Bigeminy Causes of T wave inversion Normal in children Myocardial ischemia Bundle branch block Ventricular hyperophy Pulmonary embolism Hyperophic obstructive cardiomyopathy Raised intracranial pressure",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Following acute failure of the left ventricle is the hea is man, pulmonary edema generally begins to appear when left atrial pressure approaches A. 7 mm Hg | B. I5 mm Hg | C. 20 mm Hg | D. 30 mm Hg",
      "answer": "The correct answer is **C. 20 mm Hg**.\n\n**Explanation:**\n\nPulmonary edema, the accumulation of excess fluid in the lungs, is a common consequence of acute left ventricular failure. The left ventricle is responsible for pumping oxygenated blood from the lungs to the rest of the body. When it fails, blood backs up into the left atrium and then into the pulmonary veins and capillaries.\n\nThe pressure within the pulmonary capillaries is a critical factor in determining whether fluid will leak out of the vessels into the lung tissue. Normally, this pressure is relatively low. However, when left atrial pressure rises significantly due to left ventricular failure, it leads to a corresponding increase in pulmonary venous and capillary pressures.\n\nPulmonary edema generally begins to develop when the pulmonary capillary wedge pressure (a good estimate of left atrial pressure) approaches or exceeds **20 mm Hg**. At this pressure, the hydrostatic forces pushing fluid out of the capillaries overcome the oncotic forces that tend to keep fluid within the vessels, leading to fluid accumulation in the interstitial space and alveoli of the lungs.\n\n*   **A. 7 mm Hg:** This is within the normal range for left atrial pressure and would not typically cause pulmonary edema.\n*   **B. 15 mm Hg:** While elevated, this pressure might cause some mild interstitial fluid accumulation, but significant pulmonary edema is less likely to be present.\n*   **D. 30 mm Hg:** This is a very high left atrial pressure and would almost certainly result in severe pulmonary edema. The question asks when it *generally begins to appear*, making 20 mm Hg the more appropriate threshold.",
      "ground_truth": "20 mm Hg || Pulmonary edema is one of the most serious consequences of left ventricular cardiac failure. When the left ventricle fails or when the mitral valve fails, left atrial pressure (LAP) may increase substantially. The resulting increase in pulmonary capillary pressure (Pc) forces excess fluid filtration through the pulmonary capillary walls and into the lung tissue. At first, the fluid collects within the lung interstitial space. If LAP exceeds a critical level of ~25 mmHg, the volume of edema fluid will overwhelm the capacity of the interstitial spaces and fluid will flood the airways and alveoli (8). This airway edema directly interferes with gas exchange, and it can kill the patient. However, many people live for months or years with modestly elevated LAP (<25 mmHg). We believe that sustained, subcritical LAP elevations lead to two phases of change in the lungs. The first phase is the acute edema that develops in the first few hours of elevated LAP. The second phase concerns the effect of long-term (7 days or more) increases in LAP below the critical level. This review deals with the acute phase and long-term phase changes in the lung caused by modestly elevated LAP. The acute phase of pulmonary edema has been the subject of intense investigation for many years. In 1896, Starling (7) laid the foundation for our current understanding of pulmonary edema with his famous fluid filtration equation. The equation relates the rate of fluid filtration through the capillary wall (Jv) to the pressures across the capillary wall and to the filtration characteristics of the capillary membrane Ref: guyton and hall textbook of medical physiology 12 edition",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Cyanosis is not seen in- A. CHF | B. COPD | C. CO poisoning | D. High altitude",
      "answer": "The answer is **C. CO poisoning**.\n\nHere's why:\n\n*   **Cyanosis** is a bluish discoloration of the skin and mucous membranes due to a lack of oxygen in the blood. It typically occurs when the hemoglobin in the blood is not adequately saturated with oxygen.\n\nLet's look at each option:\n\n*   **A. CHF (Congestive Heart Failure):** In CHF, the heart's ability to pump blood effectively is impaired. This can lead to poor oxygenation of tissues and therefore cyanosis, especially in severe cases.\n*   **B. COPD (Chronic Obstructive Pulmonary Disease):** COPD involves chronic lung diseases that obstruct airflow. This makes it difficult to get enough oxygen into the lungs and blood, leading to hypoxemia and often cyanosis.\n*   **C. CO poisoning (Carbon Monoxide Poisoning):** Carbon monoxide (CO) binds to hemoglobin much more strongly than oxygen. This forms **carboxyhemoglobin (COHb)**. While COHb is present, the hemoglobin is *not* available to carry oxygen. However, COHb has a **cherry-red color**, not a bluish one. Therefore, a person with CO poisoning may appear pink or cherry-red, and **cyanosis is typically absent**, even though they are severely oxygen-deprived.\n*   **D. High altitude:** At high altitudes, the atmospheric pressure is lower, meaning there is less oxygen available in the air. This reduced oxygen intake can lead to hypoxemia and consequently, cyanosis.\n\n**In summary:** While CHF, COPD, and high altitude all lead to reduced oxygen in the blood and can cause cyanosis, CO poisoning causes a different type of hemoglobin issue that results in a cherry-red color rather than cyanosis.",
      "ground_truth": "CO poisoning || Ans. is 'c' i.e., CO poisoing Hypoxic hypoxia (hypoxemia)Anemic hypoxiaStagnant hypoxiaHistotoxic hypoxiao Cyanosis presentCauses :* Hypoventilation as seen in interstitial lung disease & COPD* Cyanotic CHD* Reduced diffusion capacity* Right to left shunt, e.g. A V malformation* V/Q mismatch* High altitudeo Cyanosis absent Causes :* Anemia* CO poisoningo Cyanosis presento Causes :* CHF* Shock* Peripheral vasoconstrictiono Cyanosis absento Causes:* Cyanide poisoning",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Malleus is derived from A. Meckel's cartilage | B. Reinche's cartilage | C. Third pharyngeal arch | D. Second pharyngeal arch",
      "answer": "The correct answer is **A. Meckel's cartilage**.\n\n**Explanation:**\n\n*   The malleus (one of the ossicles in the middle ear) and the incus are derived from the **first pharyngeal arch**.\n*   The first pharyngeal arch is associated with **Meckel's cartilage**.\n*   Reichert's cartilage is associated with the second pharyngeal arch and contributes to the stapes and styloid process.\n*   The third pharyngeal arch contributes to the hyoid bone and the stylopharyngeal muscle.\n*   The second pharyngeal arch contributes to the stapes, styloid process, and parts of the hyoid bone.",
      "ground_truth": "Meckel's cartilage || i.e. (Meckel's Cartilage): (316-109 IBS- Embryology 8th)* Malleus and Incus are derived from the dorsal end of the Meckel's cartilage (First arch)*** Stapes is formed from the dorsal end of the cartilage of second pharyngeal archNerves of pharyngeal arches and muscles supplied by themArchNerve of ArchMuscles of ArchCartilage of ArchFirstMandibularMedial and lateral pterygoids, MasseterTemporalis, Mylohyoid,Anterior belly of digastricTensor tympani, Tensor palatiMalleus Incus Sphenomandibular ligamentSecondFacialMuscles of face, Occipito frontalis, Platysma,Stylohyoid, Posterior belly of digastric, Stapedius,\\Auricular muscles* Stapes* Styloid process* Stylohyoid ligament* Smaller (lesser) comu of hyoid bone* Superior part of body of hyoid boneThirdGlossopharyngealStylopharyngeus* Greater comu of hyoid bone* Lower part of the body of hyoid boneFourthFifthSuperior laryngealRecurrent laryngealMuscles of larynx and pharynx* The cartilages of the larynx are derived from the fourth and sixth arches with a posible contribution from the fifth arch, but their exact derivation is controversial",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "26 year old man died while playing. His autopsy of the heart revealed myocyte hypertrophy. Diagnosis is - A. HOCM | B. DCM | C. Arrythmogenic cardiac problem | D. Restrictive cardiomyopathy",
      "answer": "The most likely diagnosis is **A. HOCM (Hypertrophic Obstructive Cardiomyopathy)**.\n\nHere's why:\n\n*   **Myocyte hypertrophy** (enlargement of heart muscle cells) is the hallmark pathological finding in hypertrophic cardiomyopathy.\n*   A young person dying suddenly while playing is a classic presentation for hypertrophic cardiomyopathy, often due to an underlying arrhythmia triggered by exertion.\n\nLet's look at why the other options are less likely:\n\n*   **B. DCM (Dilated Cardiomyopathy):** This condition is characterized by enlargement and weakening of the ventricles, not primarily hypertrophy of the myocytes.\n*   **C. Arrhythmogenic cardiac problem:** While an arrhythmogenic problem is the *cause* of death in many HOCM cases, \"arrhythmogenic cardiac problem\" is a broad category and doesn't specifically describe the underlying structural abnormality found on autopsy. HOCM is a specific structural cause that leads to arrhythmogenic problems.\n*   **D. Restrictive Cardiomyopathy:** This condition involves stiffening of the heart muscle, which impairs its ability to fill with blood. While there can be some myocyte changes, significant hypertrophy is not the primary feature.",
      "ground_truth": "HOCM ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Calabar swelling is produced by? A. Onchocerca volvulus | B. Loa loa | C. Burgia malayi | D. Wuchereria bancrofti",
      "answer": "The correct answer is **B. Loa loa**.\n\n**Explanation:**\n\nCalabar swelling, also known as fugitive swelling or Loa loa filariasis, is a characteristic symptom of infection with the parasitic worm *Loa loa*. These swellings are typically transient, itchy, and occur most commonly around the joints, especially the wrists and ankles.\n\nHere's why the other options are incorrect:\n\n*   **A. Onchocerca volvulus:** This parasite causes onchocerciasis (river blindness), which is characterized by skin lesions, itching, and visual impairment, but not typically Calabar swellings.\n*   **C. Brugia malayi:** This parasite causes lymphatic filariasis, which can lead to lymphedema (swelling of limbs), but the swellings are usually persistent and not the transient, localized Calabar swellings.\n*   **D. Wuchereria bancrofti:** This is the most common cause of lymphatic filariasis globally and also leads to lymphedema, often in the legs and genitals, but not the specific Calabar swellings.",
      "ground_truth": "Loa loa || Ans. is 'b' i.e., Loa - Loa Loiasis . Loiasis is caused by L. Loa (the African eye worm) . Habitat of adult worms is subcutaneous connective tissue of man; often in the sub-conjuctival tissue of the eye. . The worm passes its life cycle in two hosts : - Man - Chrysops (Mango or deer flies) . C/Fs --> Asymptomatic microfilaremia Calabar (fugitive) swelling - subcutaneous swelling Nephropathy Encephalopathy rare Cardiomyopathy Calabar swelling is due to hypersensitivity reaction to the adult worm.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Pulsus bisiferiens is seen in all, except - A. Aoic regurgitation + Aoic stenosis | B. obstructive cardiomyopathy | C. Hyperophic cardiomyopathy | D. Tetralogy of Fallot",
      "answer": "The correct answer is **D. Tetralogy of Fallot**.\n\nHere's why:\n\n*   **Pulsus bisiferiens** (also known as pulsus alternans or pulsus bigeminus, though technically pulsus alternans refers to a different phenomenon of alternating strong and weak beats) is characterized by a pulse with two distinct peaks during each cardiac cycle. This is often described as a \"water hammer\" pulse. It's caused by a rapid upstroke and a secondary, smaller upstroke.\n\nLet's break down why the other options can cause pulsus bisiferiens:\n\n*   **A. Aortic regurgitation + Aortic stenosis:** This combination creates a situation where there is both a significant regurgitant volume (leading to a wide pulse pressure and a rapid upstroke) and a narrowed outflow tract (aortic stenosis) that can cause a secondary peak in the pulse wave.\n*   **B. Obstructive cardiomyopathy:** In obstructive cardiomyopathies, there is a dynamic obstruction to blood flow out of the left ventricle. This obstruction can lead to a characteristic pulse pattern with a rapid upstroke followed by a sudden decrease in pressure, which can manifest as a bisferiens pulse.\n*   **C. Hypertrophic cardiomyopathy:** Similar to obstructive cardiomyopathy, hypertrophic cardiomyopathy can cause dynamic left ventricular outflow tract obstruction, leading to a bisferiens pulse.\n\n*   **D. Tetralogy of Fallot:** Tetralogy of Fallot is a congenital heart defect characterized by four abnormalities: ventricular septal defect, pulmonary stenosis, overriding aorta, and right ventricular hypertrophy. While it can cause a variety of pulse abnormalities, a pulsus bisiferiens is not a typical finding. The pulse in Tetralogy of Fallot is often described as normal or diminished, depending on the severity of the pulmonary stenosis.\n\n**In summary:** Pulsus bisiferiens is associated with conditions that cause a rapid ejection of blood followed by a secondary peak, often due to increased stroke volume and/or outflow obstruction. Tetralogy of Fallot, with its primary issue being pulmonary stenosis and right ventricular outflow obstruction, does not typically present with this specific pulse characteristic.",
      "ground_truth": "Tetralogy of Fallot || pulsus bisferiens, , is a sign where, on palpation of the pulse, a double peak per cardiac cycle can be appreciated. Bisferious means striking twice. Classically, it is detected when aoic insufficiency exists in association with aoic stenosis, but may also be found in isolated but severe aoic insufficiency and hyperophic obstructive cardiomyopathy. Normally, aerial pulses are best felt in radial aeries but character is better assessed in carotid aery. Pulsus bisferiens is best felt in brachial and femoral aeries. Ref Harrison 20th edition pg 1432",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Peripheral neuropathy can be as a side effect of all of the following anti-retroviral drugs, EXCEPT: A. Lamivudine | B. Didanosine | C. Stavudine | D. Zalcitabine",
      "answer": "The correct answer is **A. Lamivudine**.\n\nHere's why:\n\n*   **Peripheral neuropathy** is a known and relatively common side effect of certain nucleoside reverse transcriptase inhibitors (NRTIs), a class of antiretroviral drugs.\n*   **Didanosine (ddI), Stavudine (d4T), and Zalcitabine (ddC)** are all NRTIs that have a significant association with causing peripheral neuropathy.\n*   **Lamivudine (3TC)** is also an NRTI, but it has a much lower incidence of causing peripheral neuropathy compared to the other drugs listed. While it can occur, it's not considered a prominent or common side effect in the same way as with didanosine, stavudine, and zalcitabine.\n\nTherefore, lamivudine is the exception among the given options.",
      "ground_truth": "Lamivudine || Peripheral neuropathy is a rare side effect of Lamivudine. Side effects of lamivudine are headache, fatigue, nausea, anorexia and abdominal pain. Predominant side effect of stavudine is peripheral neuropathy. Predominant side effect of Zalcitabine is peripheral neuropathy, other side effects asssociated with it are pancreatitis, thrombocytopenia, neutropenia, hepatotoxicity and cardiomyopathy. Prominant dose related toxicity of Didanosine is pancreatitis and peripheral neuropathy.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Characteristic toxicity of daxorubicin - A. Pulmonary fibrosis | B. Cardiotoxicity | C. Peripheral neuropathy | D. Hemorrhagic cystitis",
      "answer": "The characteristic toxicity of doxorubicin is **B. Cardiotoxicity**.\n\n**Explanation:**\n\nDoxorubicin is an anthracycline chemotherapy drug known for its significant cardiotoxic effects. This toxicity can manifest as acute effects (like arrhythmias) or chronic effects (like dilated cardiomyopathy and heart failure), which can be dose-dependent and irreversible.\n\nWhile other options can be associated with chemotherapy, they are not the *characteristic* or most prominent toxicity of doxorubicin:\n\n*   **A. Pulmonary fibrosis:** While some chemotherapy agents can cause pulmonary toxicity, it's not the hallmark toxicity of doxorubicin.\n*   **C. Peripheral neuropathy:** This is more commonly associated with other classes of chemotherapy drugs, such as vinca alkaloids or platinum-based agents.\n*   **D. Hemorrhagic cystitis:** This is a well-known toxicity of cyclophosphamide, another chemotherapy drug, and can be managed with hydration and mesna. Doxorubicin does not typically cause hemorrhagic cystitis.",
      "ground_truth": "Cardiotoxicity || Ans. is 'b' i.e., Cardiotoxicity Anthracvclineso Anthracyclines are anticancer antibiotics and they include Doxorubicin (Adriamycin) and Daunorubicin.o The major toxicity of anthracyclines is potentially irreversible cumulative dose related toxicityo They may causes arrhythmias and cardiomyopathy. Because of their carditoxicity these drugs should be avoided in the patient with MI and CHF.o The antracyclines exert their anticancer activity through four major mechanisms -1. Inhibition of topoisomerase II2. Blockade of synthesis of DNA & RNA, and DNA strand scission.3. Alter fluidity and ion transport.4. Generation of semiquinone free radicals and oxygen free radicals - this free radical mechanism is the cause of cardiotoxicity.o This cardiootoxicity can be prevented by using dexrazoxane (a free radical scavenger) and a-tocopherol.o Liposomal forms of these drugs also reduce cardiac toxicity.o Adverse effects - Dose related myelosuppression with neutropenia, dose limiting mucositis, cardiotoxicity (AI 96, 94, AIIMS 93)o Uses of Doxorubicin# Ca Breast# Ca Endometrium# Ca ovary# Ca testicle# Ca thyroid# Ca lung# Hodgkin s disease# Non Hodgkin disease# Sarcomaso Uses of Daunorubicin# It has far narrower spectrum of activity than Doxorubicin# It is mainly used in acute leukemia.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Edema feet is not a feature of: A. Conn syndrome | B. Hypothyroid | C. CHF | D. Nephrotic syndrome",
      "answer": "The correct answer is **A. Conn syndrome**.\n\nHere's why:\n\n*   **Edema** (swelling) in the feet is a common symptom of fluid retention.\n*   **Conn syndrome** (primary hyperaldosteronism) is characterized by excessive production of aldosterone. Aldosterone promotes sodium and water retention, which can lead to hypertension and hypokalemia. While fluid retention can occur, significant peripheral edema like that seen in the other conditions is not a *primary* or consistent feature of Conn syndrome. In fact, some patients may have normal fluid balance or even be dehydrated due to potassium loss.\n*   **Hypothyroid (Hypothyroidism)**: In hypothyroidism, the body's metabolism slows down. This can lead to a buildup of a substance called mucin in the tissues, causing a characteristic type of non-pitting edema, often in the legs and feet.\n*   **CHF (Congestive Heart Failure)**: When the heart doesn't pump blood effectively, blood can back up in the veins, leading to fluid accumulation in the lower extremities, causing pitting edema in the feet and ankles.\n*   **Nephrotic syndrome**: This kidney disorder causes significant protein loss in the urine. This loss of protein, particularly albumin, reduces the oncotic pressure in the blood, leading to fluid shifting out of the blood vessels and into the tissues, resulting in widespread edema, including in the feet.",
      "ground_truth": "Conn syndrome || Ans. A. Conn syndromea. In Conn syndrome there is profound hypokalemia that leads to nephrogenic diabetes insipidus.b. Although excess of sodium is reabsorbed due to high amount aldosterone, but excess of water is lost. Hence edema feet is not a feature in Conn syndrome.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 43-year-old woman with chronic alcoholism presents with shortness of breath and edema. On examination, her blood pressure is 100/60 mm Hg, pulse 110/min, JVP is 8 cm, the cardiac apex is displaced and enlarged, there are bilateral inspiratory crackles, and there is pedal edema.For the patient with vitamin deficiency or excess, select the most likely diagnosis A. niacin | B. thiamine | C. pyridoxine | D. vitamin C",
      "answer": "The most likely diagnosis for this patient, considering her chronic alcoholism and presentation of shortness of breath, edema, elevated JVP, displaced cardiac apex, crackles, and pedal edema, is **B. thiamine**.\n\nHere's why:\n\n*   **Chronic Alcoholism and Thiamine Deficiency:** Chronic alcoholism is a major risk factor for thiamine (vitamin B1) deficiency. Alcohol interferes with thiamine absorption and metabolism.\n*   **Thiamine Deficiency and Heart Failure:** Severe thiamine deficiency can lead to a specific form of heart failure known as **wet beriberi**. The symptoms described by the patient are classic signs of heart failure:\n    *   **Shortness of breath:** Due to fluid buildup in the lungs (pulmonary edema).\n    *   **Edema:** Fluid accumulation in the extremities (pedal edema) and potentially other body cavities.\n    *   **Elevated JVP (Jugular Venous Pressure):** Indicates increased pressure in the right atrium, a sign of right-sided heart failure.\n    *   **Displaced and enlarged cardiac apex:** Suggests cardiomegaly (enlarged heart), often seen in heart failure.\n    *   **Bilateral inspiratory crackles:** Indicate fluid in the alveoli of the lungs.\n    *   **Hypotension and Tachycardia:** The low blood pressure (100/60 mm Hg) and rapid pulse (110/min) can be compensatory mechanisms in heart failure as the heart tries to maintain cardiac output.\n\nLet's consider why the other options are less likely:\n\n*   **A. Niacin (Vitamin B3):** Deficiency in niacin causes pellagra, which typically presents with the \"3 D's\": dermatitis, diarrhea, and dementia. While cardiovascular symptoms can occur in severe pellagra, the constellation of symptoms in this patient is more strongly suggestive of wet beriberi.\n*   **C. Pyridoxine (Vitamin B6):** Pyridoxine deficiency can cause peripheral neuropathy, anemia, and seizures. While it can indirectly affect the cardiovascular system, it's not the primary cause of the presented heart failure symptoms.\n*   **D. Vitamin C:** Vitamin C deficiency causes scurvy, characterized by bleeding gums, petechiae, poor wound healing, and fatigue. It does not directly cause heart failure.\n\nTherefore, given the patient's history of chronic alcoholism and her signs and symptoms of heart failure, **thiamine deficiency leading to wet beriberi** is the most likely diagnosis.",
      "ground_truth": "thiamine || Thiamine deficiency can cause high-output cardiac failure (wet beriberi) or neurologic symptoms (dry beriberi). In North America, thiamine deficiency occurs in alcoholics or those with chronic disease. In alcoholics, deficiency is secondary to low intake, impaired absorption and storage, and accelerated destruction. Genetic factors are important as clinical manifestations occur only in a small proportion of chronically malnourished individuals. Beriberi heart disease is characterized by peripheral vasodilatation, sodium and water retention, and high-output CHF.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following drugs is to be immediately stopped in a patient of diabetes with HTN and serum creatinine level of 5.6 mg? A. Metformin | B. Insulin | C. Metoprolol | D. Linagliptin",
      "answer": "The correct answer is **A. Metformin**.\n\nHere's why:\n\n*   **Metformin** is a first-line medication for type 2 diabetes. However, it is primarily cleared by the kidneys. When serum creatinine levels are significantly elevated (indicating impaired kidney function), metformin can accumulate in the body, increasing the risk of a rare but serious side effect called lactic acidosis. A serum creatinine of 5.6 mg/dL is a clear indication of severe kidney dysfunction, making metformin unsafe to continue.\n\nLet's look at why the other options are less likely to be immediately stopped:\n\n*   **B. Insulin:** Insulin is a hormone that regulates blood sugar. While kidney function can affect insulin clearance and dosing, insulin itself does not directly cause kidney damage and is generally safe to continue in patients with kidney disease, though dosage adjustments may be necessary.\n*   **C. Metoprolol:** Metoprolol is a beta-blocker commonly used to treat hypertension. While it is metabolized by the liver and excreted by the kidneys, it is not typically stopped solely based on a creatinine level of 5.6 mg/dL. Dosage adjustments might be considered, but immediate discontinuation is not usually warranted unless there are other specific contraindications or signs of adverse effects.\n*   **D. Linagliptin:** Linagliptin is a DPP-4 inhibitor used for diabetes management. Unlike metformin, linagliptin is not significantly cleared by the kidneys and is generally considered safe to use in patients with impaired renal function, even at high creatinine levels.\n\n**In summary:** The most critical drug to stop immediately in a diabetic patient with a serum creatinine of 5.6 mg/dL is metformin due to the high risk of lactic acidosis.",
      "ground_truth": "Metformin || ANS. AMetformin is contraindicated in patients with high creatinine because of the risk of lactic acidosis.# Specific side effects of OHAMetformin1. GI symptoms2. B12 deficiency3. Lactic acidosis (especially in patients with high creatinine, liver failure, alcoholism, cardiorespiratory insufficiency)Piogiitazone1. Unsafe in Renal failure, Liver failure, cardiac failure2. Increased risk of bladder cancer3. OsteoporosisDPP-4 inhibitors1. Upper respiratory tract infection2. Renal toxicity (Vildagliptin is hepatotoxic)(Safest DPP-4 inhibitor in renal failure is linagliptan)(asked in Nov AIIMS 2016 and May 2017)SGLT2 inhibitors1. UTI2. Risk of bladder cancer",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Pressure volume loop is shifted to left side in A. Aortic regurgitation | B. Mitral regurgitation | C. Aortic stenosis | D. Congestive cardiac failure",
      "answer": "The correct answer is **A. Aortic regurgitation**.\n\nHere's why:\n\n*   **Pressure-Volume Loop:** This loop graphically represents the relationship between ventricular pressure and volume during a cardiac cycle. The area enclosed by the loop represents stroke work, and its shape and position provide insights into ventricular function.\n\n*   **Aortic Regurgitation (AR):** In AR, the aortic valve doesn't close properly, leading to blood flowing back into the left ventricle during diastole. This results in:\n    *   **Increased End-Diastolic Volume (EDV):** The ventricle fills with more blood than normal.\n    *   **Increased Stroke Volume (SV):** The ventricle pumps out more blood to compensate for the regurgitant flow.\n    *   **Increased End-Systolic Volume (ESV):** Despite increased ejection, some blood still leaks back, so the ventricle doesn't empty completely.\n\n    These changes cause the pressure-volume loop to shift **upwards and to the left**. The leftward shift is primarily due to the increased EDV and SV.\n\n*   **Mitral Regurgitation (MR):** In MR, the mitral valve doesn't close properly, leading to blood flowing back into the left atrium during systole. This also increases EDV and SV, but the primary volume overload is into the left atrium, and the loop shift is generally less pronounced and can be more complex than in AR.\n\n*   **Aortic Stenosis (AS):** In AS, the aortic valve is narrowed, obstructing blood flow out of the left ventricle. This leads to:\n    *   **Increased End-Systolic Pressure (ESP):** The ventricle has to generate higher pressure to eject blood.\n    *   **Decreased Stroke Volume (SV):** Less blood is ejected.\n    *   **Increased End-Diastolic Volume (EDV):** The ventricle may dilate to accommodate the increased workload.\n\n    The loop in AS typically shifts **upwards and to the right**, reflecting increased afterload and reduced stroke volume.\n\n*   **Congestive Cardiac Failure (CCF):** CCF is a general term for the heart's inability to pump blood effectively. The pressure-volume loop in CCF can vary depending on the underlying cause and stage, but it often shows a **reduced stroke volume and increased end-diastolic volume**, leading to a loop that is typically shifted downwards and to the right (representing reduced contractility and increased filling pressures) or can be flattened.\n\n**In summary, the most characteristic shift of the pressure-volume loop to the left side, indicating increased ventricular filling and stroke volume due to volume overload, is seen in aortic regurgitation.**",
      "ground_truth": "Aortic stenosis || Ans. (c) Aortic stenosis(Ref: Ganong, 25th ed/p.540)In aortic stenosis,PV loop is shifted to left sideVentricular systolic pressure increases to overcome the stenosisThere is increase in End systolic volumeStroke volume decreases",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Digoxin acts by inhibiting: A. Na K ATPase | B. Ca channel | C. K channel | D. Adenyl cyclase",
      "answer": "The correct answer is **A. Na K ATPase**.\n\n**Explanation:**\n\nDigoxin's primary mechanism of action is to inhibit the **Na+/K+-ATPase pump** (also known as the sodium-potassium pump) in cardiac muscle cells.\n\nHere's how this leads to its therapeutic effects:\n\n1.  **Inhibition of Na+/K+-ATPase:** This pump normally works to maintain the electrochemical gradient across the cell membrane by pumping sodium ions (Na+) out of the cell and potassium ions (K+) into the cell. When digoxin inhibits this pump, intracellular sodium concentration increases.\n\n2.  **Increased Intracellular Sodium:** The elevated intracellular sodium then reduces the activity of the **sodium-calcium exchanger (NCX)**. The NCX normally uses the sodium gradient to pump calcium ions (Ca2+) out of the cell.\n\n3.  **Increased Intracellular Calcium:** With a reduced sodium gradient, the NCX is less effective at removing calcium. This leads to an accumulation of calcium ions within the cardiac muscle cell.\n\n4.  **Positive Inotropic Effect:** The increased intracellular calcium enhances the interaction between actin and myosin filaments, resulting in a stronger and more forceful contraction of the heart muscle. This is known as a **positive inotropic effect**, which is beneficial in conditions like heart failure.\n\n**Why the other options are incorrect:**\n\n*   **B. Ca channel:** While digoxin indirectly affects calcium levels, it does not directly block calcium channels.\n*   **C. K channel:** Digoxin can have some effects on potassium channels, but its primary and most significant action is on the Na+/K+-ATPase.\n*   **D. Adenyl cyclase:** Adenyl cyclase is involved in the production of cyclic AMP (cAMP), and while some cardiac drugs affect this pathway, it's not the primary target of digoxin.",
      "ground_truth": "Na K ATPase || Ans: a (Na K ATPase) Ref: Tripathi, 6th ed, p. 499All cardiac glycosides are potent and highly selective inhibitors of the active transport of Na+ and K+ across cell membranes by their reversible binding to the alpha subunit of the. Na+, K+- ATPase the elimination 11 /2 for digoxin is 36 hours in patients with nonnal renal function. Digoxin is excreted by the kidney with a clearance rate that is proportional to the glomerular filtration rate. It is now recommended that digoxin be reserved for patients with heart failure who are in atrial fibrillation, or for patients in sinus rhythm who remain symptomatic despite maximal therapy with ACE inhibitors and beta adrenergic receptor antagonists. Although the drug has no net effect on mortality, it reduces hospitalization and death, from progressive heart failure at the expense of an increase in sudden death.Other than heart failure digitalis is useful in the management of atrial arrhythmias because of its cardioselective parasympathomimetic effects. In atrial flutter and fibrillation, the depressant effect of the drug on atrioventricular conduction will help control an excessively high ventricular rate. Digitalis has also been used in the control of paroxysmal atrial and atrioventricular nodal tachycardia.ToxicityExtracardiacAnorexia, nausea, vomiting are usually first symptoms of toxicity. Other complaints include fatigue, malaise, headache, mental confusion, restlessness, disorientation, psychosis and visual disturbances.CardiacAlmost every type of arrhythmia can be produced by digitalis: pulsus bigeminis, nodal and ventricular extrasystoles, ventricular tachycardia and fibrillation. Partial to complete A-V block, severe bradycardia.Atrial extra systoles, AF or atrial flutter have also been noted.Treatmenta) For tachyarrythmias:KC1 infusion 20 m mol /hr IV or give orally in mild cases.b) For ventricular arrythmias: Lidocaine IV repeated as required is the drug of choice.c) For supraventricular arrythmias: Propranolol may be given IV or oral depending on urgencyd) For A-V block and bradycardia: Atropine 0.6-1.2 mg IM may help: otherwise cardiac pacing is recommended.Therapy of toxicity manifested as visual changes or gastrointestinal disturbances generally requires no more than reducing the dose of the drug.Immunotherapy with purified Fab fragments from bovine antidigoxin antisera (DIGIBIND) provides an effective antidote for lifethreatening digoxin toxicity.Precautions and contraindicationsHypokalaemia:enhances digitalis toxicityby increasing its binding to Na+ K+ATPase elderly, renal or severe hepatic disease Myocardial infarction: sever arrythmias are more likely thyrotoxicosis-reduces responsiveness to digitalis.Myxedema: these patienst eliminate digoxin more slowly, toxicity can appearVentricular tachycardia:digitalis is contraindicated, may precipitate ventricular fibrillationIt is explicitly contraindicated in patients with Wolff-Parkinson-White syndrome and atrial fibrillation",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "The mortality rate in Acute hemorrhagic pancreatitis is A. 20% | B. 40% | C. 50% | D. 60%",
      "answer": "The mortality rate in acute hemorrhagic pancreatitis can vary significantly depending on the severity of the condition and the availability of medical care. However, among the options provided, **B. 40%** is often cited as a representative figure for the mortality rate in severe or acute hemorrhagic pancreatitis.\n\n**Explanation:**\n\nAcute hemorrhagic pancreatitis is a severe and life-threatening form of acute pancreatitis characterized by bleeding within the pancreas. This bleeding can lead to widespread inflammation, organ damage, and shock. While milder forms of acute pancreatitis have lower mortality rates, the hemorrhagic variant is associated with a much higher risk of death.\n\n*   **20%** might represent the mortality for less severe forms of acute pancreatitis.\n*   **50% and 60%** represent extremely high mortality rates, which can occur in the most severe, fulminant cases or when complications are extensive and treatment is delayed or ineffective.\n\nTherefore, **40%** is a commonly referenced mortality rate for acute hemorrhagic pancreatitis, reflecting its significant severity.",
      "ground_truth": "20% || (20%) (1896-H) (628-CMDT-09) (2011-H17th)* The term hemorrhagic pancreatitis is less meaningful in a clinical sense because variable amounts of interstitial hemorrhage can be found in pancreatitis as well as in other disorders such as pancreatic trauma, pancreatic carcinoma, and severe CHF (1896-H)* Prognosis (674-CMDT-05)Mortality rate for acute pancreatitis have declined from at least 10% to around 5% in the past 20 years, but the mortality rate of severe acute pancreatitis (more than three Ranson criteria) remains at least 20%, especially when hepatic cardiovascular or renal impairment is present in association with pancreatic necrosis.* Recurrence are common in alcoholic pancreatitis* Mortality rate for undrained pancreatic abscess approaches 100% (1900-H)",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All of the following drugs are used in the management of acute Myocardial infarction except- A. Tissue plasminogen activator | B. Intravenous beta blockers | C. Acetylsalicylic acid | D. Calcium channel blockers",
      "answer": "The correct answer is **D. Calcium channel blockers**.\n\nHere's why:\n\n*   **Tissue plasminogen activator (tPA):** This is a thrombolytic agent used to dissolve blood clots that are blocking coronary arteries, a primary goal in acute myocardial infarction (MI) management.\n*   **Intravenous beta blockers:** These medications help reduce the heart's workload by slowing heart rate and decreasing blood pressure, which is beneficial in acute MI.\n*   **Acetylsalicylic acid (Aspirin):** This is an antiplatelet medication that prevents blood clots from forming or growing larger, a crucial intervention in acute MI.\n\n*   **Calcium channel blockers:** While calcium channel blockers can be used in certain situations related to heart disease (like angina or arrhythmias), they are **not** a first-line or routine treatment for the acute management of ST-elevation myocardial infarction (STEMI). Their role is more in managing complications or specific types of MI, but not as a primary intervention for reperfusion or immediate symptom relief in the way the other options are.",
      "ground_truth": "Calcium channel blockers || Ref : harrisons-manual-of-medicine-16th-edition pg no: 622-624 TREATMENT Initial Therapy Initial goals are to: (1) quickly identify if patient is candidate for reperfusion therapy, (2) relieve pain, and (3) prevent/treat arrhythmias and mechanical complications. * Aspirin should be administered immediately (162-325 mg chewed at presentation, then 162-325 mg PO qd), unless pt is aspirin-intolerant. * Perform targeted history, exam, and ECG to identify STEMI (\u00011 mmST elevation in two contiguous leads or new LBBB) and appropriateness of reperfusion therapy , which reduces infarct size, LV dysfunction, and moality. * Primary PCI is generally more effective than fibrinolysis and is preferred at experienced centers capable of performing procedure rapidly , especially when diagnosis is in doubt, cardiogenic shock is present, bleeding risk is increased, or if symptoms have been present for \u00013 h. * Proceed with IV fibrinolysis if PCI is not available or if logistics would delay PCI \u00011 h longer than fibrinolysis could be initiated (Fig. 123-1). Dooo- needle time should be \u0005 30 min for maximum benefit. Ensure absence of contraindications before administering fibrinolytic agent. Those treated within 1-3 h benefit most; can still be useful up to 12 h if chest pain is persistent or ST remains elevated in leads that have not developed new Q waves. Complications include bleeding, reperfusion arrhythmias, and, in case of streptokinase (SK), allergic reactions. Heparin should be initiated with fibrinolytic agents other than SK ; maintain aPTTT at 1.5-2.0 control (\u000150-70 s). * If chest pain or ST elevation persists \u000190 min after fibrinolysis, consider referral for rescue PCI. Later coronary angiography after fibrinolysis generally reserved for pts with recurrent angina or positive stress test. The initial management of NSTEMI (non-Q MI) is different . In paicular, fibrinolytic therapy should not be Additional Standard Treatment (Whether or not reperfusion therapy is undeaken): * Hospitalize in CCU with continuous ECG monitoring. * IV line for emergency arrhythmia treatment. * Pain control: (1) Morphine sulfate 2-4 mg IV q5-10min until pain is relieved or side effects develop ; (2) nitroglycerin 0.3 mg SL if systolic bp \u0001 100 mmHg; for refractory pain: IV nitroglycerin (begin at 10 g/min, titrate upward to maximum of 200 g/min, monitoring bp closely); do not administer nitrates within 24 h of sildenafil or within 48 h of tadalafil (used for erectile dysfunction); (3) -adrenergic antagonists * Oxygen 2-4 L/min by nasal cannula (maintain O2 saturation \u0001 90%). * Mild sedation (e.g., diazepam 5 mg PO qid). * Soft diet and stool softeners (e.g., docusate sodium 100-200 mg/d). * -Adrenergic blockers reduce myocardial O2 consumption, limit infarct size, and reduce moality. Especially useful in pts with hypeension, tachycardia, or persistent ischemic pain; contraindications include active CHF, systolic bp \u0005 95 mmHg, hea rate \u0005 50 beats/min, AV block,or history of bronchospasm. Administer IV (e.g., metoprolol 5 mg q5-10min to total dose of 15 mg), followed by PO regimen (e.g., metoprolol 25-100 mg bid). * Anticoagulation/antiplatelet agents: Pts who receive fibrinolytic therapy are begun on heparin and aspirin as indicated above. In absence of fibrinolytic therapy, administer aspirin, 160-325 mg qd, and low-dose heparin (5000 U SC q12h for DVT prevention). Full-dose IV heparin (PTT 2 control) or low-molecular-weight heparin (e.g., enoxaparin 1 mg/kg SC q12h) followed by oral anticoagulants is recommended for pts with severe CHF, presence of ventricular thrombus by echocardiogram, or large dyskinetic region in anterior MI. Oral anticoagulants are continued for 3 to 6 months, then replaced by aspirin. * ACE inhibitors reduce moality in pts following acute MI and should be prescribed within 24 h of hospitalization for pts with STEMI--e.g., captopril (6.25 mg PO test dose) advanced to 50 mg PO tid. ACE inhibitors should be continued indefinitely after discharge in pts with CHF or those with asymptomatic LV dysfunction ; if ACE inhibitor intolerant, use angiotensin receptor blocker (e.g., valsaan or candesaan). * Serum magnesium level should be measured and repleted if necessary to reduce risk of arrhythmias.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "In Epidemic dropsy disease, toxin is:- A. Ergot toxin | B. Sanguinarine | C. BOAA | D. Alkaloids",
      "answer": "The correct answer is **B. Sanguinarine**.\n\n**Explanation:**\n\nEpidemic dropsy is a disease caused by the consumption of edible oils contaminated with the alkaloid **sanguinarine**. Sanguinarine is a toxic compound produced by certain species of the Argemone (prickly poppy) plant. When these plants are accidentally harvested and processed along with mustard seeds or other oil-producing crops, their seeds can contaminate the edible oil. Ingestion of this contaminated oil leads to epidemic dropsy, characterized by swelling (dropsy), skin lesions, and other symptoms.\n\nLet's briefly look at why the other options are incorrect:\n\n*   **A. Ergot toxin:** Ergot toxins are produced by fungi that infect grains like rye and wheat, causing ergotism.\n*   **C. BOAA (-N-oxalyl-L-,-diaminopropionic acid):** BOAA is a neurotoxin found in the grass pea (Lathyrus sativus) and is associated with lathyrism, a neurological disorder.\n*   **D. Alkaloids:** While sanguinarine is an alkaloid, \"alkaloids\" is a broad category. The question asks for the specific toxin responsible for epidemic dropsy, which is sanguinarine.",
      "ground_truth": "Sanguinarine || Epidemic dropsy It is caused by contamination of mustard oil with 'Argemone oil'. Sanguinarine is the alkaloid toxin contained in argemone oil. The symptoms of epidemic dropsy consist of sudden,non-inflammatory, bilateral swelling of legs, often associated with diarrhoea, dyspnea, cardiac failure & death may follow. Some patients may develop glaucoma. The disease may occur at all ages except breast-fed infants. Moality varies from 5-50 per cent.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following can be found in ocular muscles? A. Trichinella | B. Ascaris | C. Enterobius | D. None",
      "answer": "The correct answer is **A. Trichinella**.\n\n**Explanation:**\n\n*   **Trichinella** is a genus of parasitic roundworms that can infect humans and other mammals. A common route of infection is through consuming undercooked meat containing the larvae. Once ingested, the larvae mature in the intestines and then migrate to various tissues, including skeletal muscles. Ocular muscles, being skeletal muscles, are a potential site for Trichinella larvae to encyst. This can lead to a condition called trichinellosis, which can manifest with symptoms like eye pain, swelling, and light sensitivity.\n\n*   **Ascaris** (specifically *Ascaris lumbricoides*) is a roundworm that primarily infects the intestines. While it can cause systemic symptoms, it does not typically encyst in ocular muscles.\n\n*   **Enterobius** (specifically *Enterobius vermicularis*, or pinworm) is another intestinal nematode. It is most commonly found in the perianal region and does not infect ocular muscles.",
      "ground_truth": "Trichinella || Trichinella spiralis <NL>  It is a parasite of pig. Man is an incidental host. <NL>  Infective form is encysted 1st stage larva which is transmitted by eating uncooked pork. <NL>  Larva penetrates intestine and migrates to muscles where it undergoes encystation. <NL>  Most commonly involved muscles are extraocular muscles followed by biceps and muscles of jaw and neck. <NL>  Most infections are asymptomatic. <NL>  Clinical manifestations may be: <NL> <NL> Abdominal - Diarrhea or constipation, abdominal pain, nausea, vomiting. <NL> Hypersensitivity reaction - Fever with eosinophilia, periorbital and facial edema, hemorrhages in the subconjunctiva, retina and nail beds (splinter hemorrhages). <NL> Rarely - Myocarditis with heart failure, encephalitis, pneumonitis. <NL> Symptoms due to encystment of larva in muscles - Myositis with myalgia, weakness. <NL> <NL>  Bachman intradermal test is used for Trichinella. <NL> Educational point <NL> The muscles most often invaded by Trichinella are highly vascularized muscles, such as eye muscles tongue, deltoid, pectoral, intercostal, diaphragm and gastrocnemius.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following is not a characteristic of right sided failure - A. Pulmonary oedema | B. Ascites | C. Oliguria | D. Dependent",
      "answer": "The correct answer is **A. Pulmonary oedema**.\n\nHere's why:\n\n*   **Right-sided heart failure** primarily affects the body's systemic circulation. When the right ventricle can't pump blood effectively, blood backs up into the veins returning to the heart. This leads to congestion in the body's organs and tissues.\n\n*   **Pulmonary oedema** is a hallmark of **left-sided heart failure**. In left-sided failure, the left ventricle struggles to pump blood to the rest of the body, causing blood to back up into the lungs, leading to fluid accumulation in the lung tissues.\n\nLet's look at the other options:\n\n*   **B. Ascites:** This is the accumulation of fluid in the abdominal cavity. It's a common symptom of right-sided heart failure due to increased pressure in the veins that drain the abdominal organs.\n*   **C. Oliguria:** This refers to decreased urine output. In right-sided heart failure, reduced blood flow to the kidneys can impair their function, leading to less urine production.\n*   **D. Dependent:** This refers to swelling (oedema) that is more pronounced in the lower parts of the body, such as the legs and ankles, due to gravity. This is a classic sign of fluid backup in the systemic circulation, characteristic of right-sided heart failure.",
      "ground_truth": "Pulmonary oedema || Ans. is 'a' i.e., Pulmonary edema Pulmonary edema is due to Lt sided hea failure that results in increased back pressure in pulmonary circulation. Signs of CHF in infants Left sided failure Tachypnea Tachycardia Cough Wheezing Rales in chest Hoarse Cry Failure of either side Cardiac enlargement Gallop rhythm (S3) Peripheral cyanosis Small volume pulse Absence of weight gain Oliguria Pulmonary edema Edema of feet Right sided failure Hepatomegaly Facial edema Jugar venous engrogment Ascites may occur in older children.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 52 year old woman has long standing rheumatoid ahritis (RA) and is being treated with coicosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs). Which of the following cardiac complications may arise in this clinical setting? A. Constrictive pericarditis | B. Dilated cardiomyopathy | C. Hypersensitivity myocarditis | D. Restrictive cardiomyopathy",
      "answer": "The most likely cardiac complication in this clinical setting is **A. Constrictive pericarditis**.\n\nHere's why:\n\n*   **Rheumatoid Arthritis (RA) and Pericarditis:** Rheumatoid arthritis is a systemic autoimmune disease that can affect various organs, including the heart. Inflammation of the pericardium (the sac surrounding the heart), known as pericarditis, is a known complication of RA.\n*   **Chronic Inflammation and Constriction:** Long-standing, chronic inflammation, as seen in long-standing RA, can lead to thickening and scarring of the pericardium. This scarring can restrict the heart's ability to fill properly with blood, leading to constrictive pericarditis.\n*   **Corticosteroids and NSAIDs:** While corticosteroids and NSAIDs are used to manage RA symptoms and inflammation, they do not typically prevent the development of chronic pericardial changes if the underlying RA is not well-controlled or has caused significant damage. In fact, long-term NSAID use can have its own cardiovascular risks, but constrictive pericarditis is more directly linked to the inflammatory process of RA itself.\n\nLet's look at why the other options are less likely:\n\n*   **B. Dilated cardiomyopathy:** This is characterized by enlargement and weakening of the heart's ventricles. While RA can sometimes be associated with cardiac involvement, dilated cardiomyopathy is not a primary or common complication directly linked to RA in the same way pericarditis is.\n*   **C. Hypersensitivity myocarditis:** This is an inflammatory condition of the heart muscle often triggered by medications or infections. While NSAIDs can rarely cause drug-induced myocarditis, hypersensitivity myocarditis is typically an acute reaction, not a long-term complication of RA itself.\n*   **D. Restrictive cardiomyopathy:** This condition involves stiffening of the heart muscle, impairing its ability to relax and fill. While some inflammatory conditions can lead to restrictive cardiomyopathy, constrictive pericarditis is a more direct and common consequence of chronic RA affecting the pericardium.\n\nTherefore, given the long-standing nature of RA and the potential for chronic inflammation, constrictive pericarditis is the most probable cardiac complication.",
      "ground_truth": "Restrictive cardiomyopathy || Long-standing inflammatory conditions such as rheumatoid ahritis (RA) are associated with deposition of a form of amyloid known as AA (amyloid-associated protein), which may involve kidneys, hea, liver, skeletal muscle, and skin, for example. Amyloid deposition in the myocardium results in decreased compliance and impaired diastolic filling, i.e., restrictive cardiomyopathy. The myocardium has a rigid and waxy texture. This form of amyloid, as well as any other biochemical form, can be visualized on tissue section by staining with Congo red, which acquires a characteristic apple-green birefringence under polarized light. Constrictive pericarditis is due to any pathologic process that results in fibrous thickening of the pericardium, with resultant impaired compliance. Clinically, therefore, this condition manifests with a picture similar to restrictive cardiomyopathy because of impaired diastolic filling. Constrictive pericarditis is usually caused by previous episodes of acute pericarditis, especially hemorrhagic, suppurative, and caseous pericarditis. Dilated cardiomyopathy is characterized by massive ventricular dilatation and may be caused by genetic alterations, myocarditis, toxic insults (alcohol), metabolic disorders (hemochromatosis), etc. Most cases are idiopathic. The main pathophysiologic alteration is impaired contractility. You may be tempted to think that this patient is prone to developing hypersensitivity myocarditis, but this form of myocardial disease has been repoed after treatment with some antihypeensive agents,antibiotics, diuretics and not with coicosteroids or NSAIDs. Fuhermore, myocarditis manifests acutely with arrhythmias and hea failure, and chronically with dilated cardiomyopathy and congestive hea failure. Ref: Hoit B.D. (2011). Chapter 34. Restrictive, Obliterative, and Infiltrative Cardiomyopathies. In V. Fuster, R.A. Walsh, R.A. Harrington (Eds), Hurst's The Hea, 13e.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Keshan disease is caused by deficiency of: A. Thiamine | B. Zinc | C. Selenium | D. Proteins",
      "answer": "The correct answer is **C. Selenium**.\n\n**Explanation:**\n\nKeshan disease is a cardiomyopathy (a disease of the heart muscle) that is endemic in certain regions of China. It is strongly linked to a deficiency in **selenium**, an essential trace mineral that plays a crucial role in antioxidant defense and thyroid hormone metabolism. When selenium levels are low, the body's ability to protect cells from damage is compromised, making the heart muscle particularly vulnerable to injury.\n\n*   **Thiamine (Vitamin B1):** Deficiency in thiamine causes beriberi, which affects the nervous system and cardiovascular system, but it is distinct from Keshan disease.\n*   **Zinc:** Zinc deficiency can lead to various health problems, including impaired immune function and growth retardation, but it is not the primary cause of Keshan disease.\n*   **Proteins:** Severe protein deficiency (protein-energy malnutrition) can lead to conditions like kwashiorkor and marasmus, which have different clinical presentations than Keshan disease.",
      "ground_truth": "Selenium || Ans. C. Selenium* Selenium is a constituent of glutathione peroxidase, an antioxidant in red blood cells and other tissues.* Glutathione peroxidase scavenges free Hydro peroxidases generated during fatty acid oxidation, thus protecting the cell from damage due to free radical formation.* Severe deficiency is the major cause of Keshan disease, which presents as cardiomyopathy in young children. Skeletal myopathies have also been reported.* Mild deficiency is associated with macrocytosis and loss of hair pigment.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "ASA grading is to assess? A. Cardiac status | B. Respiratory status | C. Risk factors | D. Mental status",
      "answer": "The correct answer is **C. Risk factors**.\n\n**Explanation:**\n\nThe ASA (American Society of Anesthesiologists) Physical Status Classification System is a system used by anesthesiologists to assess a patient's overall health and the risk associated with anesthesia and surgery. It categorizes patients into six classes based on their pre-existing medical conditions and the severity of their systemic disease.\n\n*   **ASA I:** A normal healthy patient.\n*   **ASA II:** A patient with mild systemic disease.\n*   **ASA III:** A patient with severe systemic disease.\n*   **ASA IV:** A patient with severe systemic disease that is a constant threat to life.\n*   **ASA V:** A moribund patient who is not expected to survive without the operation.\n*   **ASA VI:** A declared brain-dead patient whose organs are being removed for donor purposes.\n\nWhile cardiac and respiratory status are important components of a patient's overall health, the ASA grading is a broader assessment of **risk factors** that can impact the patient's response to anesthesia and surgery. Mental status is not directly assessed by the ASA grading system.",
      "ground_truth": "Risk factors || Ans is 'c' i.e. risk factors * ASA is the simplest and most widely used system for describing patient's physical status to assess the risk factors before anaesthesia.* Brain dead patient is ASA grade-2.American society of anaesthesiologist (asa) classification* ASA classification is for the Preoperative assessment to quantify the risk for patients who require anaesthesia for surgery. This is the simplest and most widely used system for describing patient's physical status (Rajasthan 01). Based on physical status, the patients are classified into six categories. The morbidity and mortality ishighest in grade V patients and minimum is grade I patients.ASA GradePatient conditionASA 1Normal healthy patient (no physical or mental illness)ASA 2Mild systemic disease not limiting functional activity(mild heart disease, DM Mild hypertension, Anemia, Old age, obesity, mild chronic bronchitis)ASA 3Severe systemic disease that limits activity but not incapaciating (Angina,Severe DM, cardiac failure)ASA 4Severe systemic disease that is life-threatening(Marked cardiac insufficiency; presistent angina; severe renal, respiratory or hepatic insufficiency)ASA 5Moribund patient who is not expected to survive whthout operationASA 6Brain dead patient (for organ donation)",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "False about pioglitazone? A. It PPARy agonist | B. Metabolized in liver | C. Not given in case of diastolic dysfunction | D. It acts on insulin gene and even in absence of insulin helps in metabolism of carbohydrate",
      "answer": "The correct answer is **D. It acts on insulin gene and even in absence of insulin helps in metabolism of carbohydrate**.\n\nHere's why:\n\n*   **A. It is a PPAR agonist:** This is **true**. Pioglitazone is a thiazolidinedione (TZD) and its primary mechanism of action is by activating peroxisome proliferator-activated receptor gamma (PPAR).\n*   **B. Metabolized in liver:** This is **true**. Pioglitazone is extensively metabolized in the liver, primarily by cytochrome P450 enzymes.\n*   **C. Not given in case of diastolic dysfunction:** This is generally considered **true**. TZDs, including pioglitazone, can cause fluid retention and edema, which can worsen heart failure, including diastolic dysfunction. Therefore, they are often contraindicated or used with extreme caution in patients with heart failure.\n*   **D. It acts on insulin gene and even in absence of insulin helps in metabolism of carbohydrate:** This is **false**. Pioglitazone *sensitizes* the body to insulin; it does not act on the insulin gene to produce more insulin, nor can it effectively help in carbohydrate metabolism in the *complete absence* of insulin. Its action is dependent on the presence of some insulin to exert its effects. It improves insulin sensitivity in peripheral tissues (muscle and fat) and reduces hepatic glucose production.",
      "ground_truth": "It acts on insulin gene and even in absence of insulin helps in metabolism of carbohydrate || Ans. is 'd' i.e., It acts on insulin gene and even in absence of insulin helps in metabolism of carbohydrate Pioglitazone has insulin sensitizing action, i.e., enhancing the effect of cinilating insulin. Therefore, insulin is neces? sary for the action of Pioglitazone, and it does not lower blood glucose in persons that lack endogenous insulin. o Pioglitazone is selective agonist for the nuclear PPAR-y which enhances the transcription of several insulin responsive genes. o Pioglitazone is contraindicated in CHF. Metabolism of Pioglitazone o Pioglitazone is extensively metabolized by hydroxylation and oxidation in liver. o Multiple CYP isoforms are involved in the metabolism of pioglitazone. The cytochrome p450 isoforms primarily involved are CYP 2C8 (major) and CYP3A4 (to a lesser degree).",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Centrilobular necrosis of liver may be seen with - A. Phosphorus | B. Arsenic | C. CCI4 | D. Ethanol",
      "answer": "The correct answer is **C. CCl4**.\n\n**Explanation:**\n\n*   **Centrilobular necrosis** refers to the death of liver cells (hepatocytes) that are concentrated around the central vein of the liver lobule. This pattern of injury is often associated with toxins that are metabolized in the centrilobular region, where cytochrome P450 enzymes are most abundant.\n\n*   **CCl4 (Carbon tetrachloride)** is a well-known hepatotoxin that causes centrilobular necrosis. It is metabolized by cytochrome P450 enzymes in the centrilobular hepatocytes into highly reactive free radicals, which damage cellular membranes and lead to cell death.\n\nLet's look at why the other options are less likely to be the primary cause of centrilobular necrosis in this context:\n\n*   **A. Phosphorus:** Phosphorus poisoning can cause liver damage, but it often leads to more diffuse necrosis or a zonal necrosis pattern that can vary.\n*   **B. Arsenic:** Arsenic poisoning can also affect the liver, but the pattern of injury is not as consistently centrilobular necrosis as with CCl4.\n*   **D. Ethanol:** Chronic ethanol abuse is a major cause of liver disease, but it typically leads to fatty liver, alcoholic hepatitis (which can involve inflammation and necrosis, but not exclusively centrilobular), and eventually cirrhosis. While some necrosis can occur, centrilobular necrosis is not the hallmark pattern of ethanol toxicity in the same way it is for CCl4.",
      "ground_truth": "CCI4 || Ans. is 'c' i.e., CC14 Hepatocellular necrosis: - o Liver necrosis is a common manifestation of many liver diseases and it can present in various ways, o If severe it can cause liver failure. o In some cases however the necrosis is subclinical, revealed only by elevations of liver enzymes in serum, o Various diseases can cause different patterns of necrosis. These are -] Focal Necrosis - Randomly occurring necrosis of single cells or small clusters of cells. It can involve any area of the lobule All lobules are not involved. Characteristic features on biopsy are - Councilman bodies Areas of lysed liver cells surrounded by collection of kupffer cells and inflammatory cells. Causes of Focal necrosis - Viral hepatitis, Bacterial infections, Toxic damage Zonal necrosis - The characteristic of zonal necrosis is that identical regions of liver lobules are involved. All liver lobules are involved. The necrosis is divided according to the zone involved (Note: In focal necrosis any area of lobule and some lobules are involved.) Types of zonal necrosis Centrizonal necrosis (centrilobular) ->> Necrosis in the cells surrounding central hepatic vein, seen in - i) Cardiac failure or shock iii) Chloroform toxicity ii) Carbon tetrachloride toxicity (CC14) iv) Viral hepatitis Peripheral zonal necrosis (periportal) - Necrosis is seen in areas around the portal tracts, Seen in i) Eclampsia ii) Phosphorus poisoning Midzonal necrosis - Rare, seen in yellow fever Also know - o Submassive necrosis - Occurrence of liver cell necrosis that is not limited by lobular boundaries i.e., the necrosis extends beyond lobular boundaries. o Massive liver necrosis - In this large areas of liver cell undergo necrosis. Only small areas are left intact, o Massive and submassive fiver necrosis are clinically manifested as. # Acute fiver failure of variable severity # Serum enzyme levels are very high",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which one of the following congenital heart diseases has cyanosis without cardiomegaly and/or congestive heart failure  A. Transposition of great arteries | B. Fallot's tetralogy | C. Congenital mitral regurgitaion | D. Congenital pulmonary stenosis",
      "answer": "The correct answer is **B. Fallot's tetralogy**.\n\nHere's why:\n\n*   **Fallot's tetralogy** is a complex congenital heart defect characterized by four main abnormalities:\n    1.  **Ventricular septal defect (VSD):** A hole between the ventricles.\n    2.  **Pulmonary stenosis:** Narrowing of the pulmonary valve, which restricts blood flow to the lungs.\n    3.  **Overriding aorta:** The aorta is positioned over both ventricles, receiving blood from both.\n    4.  **Right ventricular hypertrophy:** The right ventricle thickens due to increased workload.\n\n    The pulmonary stenosis is the key here. It limits blood flow to the lungs, leading to **cyanosis** (bluish discoloration due to low oxygen levels) because deoxygenated blood bypasses the lungs and mixes with oxygenated blood in the systemic circulation. However, the overall volume load on the heart is not significantly increased, and the heart may not be enlarged (cardiomegaly) or show signs of congestive heart failure in many cases, especially in milder forms.\n\nLet's look at why the other options are less likely:\n\n*   **A. Transposition of great arteries:** This condition involves the aorta and pulmonary artery being switched. While it causes cyanosis, it often leads to significant volume overload and cardiomegaly, and can progress to congestive heart failure.\n*   **C. Congenital mitral regurgitation:** This is a leaky mitral valve. Significant regurgitation leads to volume overload of the left atrium and left ventricle, causing **cardiomegaly** and often **congestive heart failure**. Cyanosis is not a primary feature unless there's severe pulmonary hypertension secondary to heart failure.\n*   **D. Congenital pulmonary stenosis:** While pulmonary stenosis can cause cyanosis, severe isolated pulmonary stenosis without other defects can lead to right ventricular hypertrophy and eventually right-sided heart failure, which can manifest as cardiomegaly. However, Fallot's tetralogy is a more classic example of cyanosis with *less* prominent cardiomegaly and CHF in its initial presentation compared to the other options.\n\nTherefore, Fallot's tetralogy is the congenital heart disease that most characteristically presents with cyanosis without significant cardiomegaly and/or congestive heart failure, especially in its milder forms.",
      "ground_truth": "Fallot's tetralogy || Cardiomegaly and CHF do not occur in Fallot's tetrology. <NL> No Cardiomegaly <NL> <NL> <NL> First you should know the following facts : - <NL> <NL> <NL> Pressure overload to ventricles causes concentric hypertrophy without dilatation. <NL> Volume overload to ventricles causes hypertrophy with dilatation  Eccentric hypertrophy. <NL> <NL> <NL> Due to pulmonary stenosis, there is pressure overload to right ventricle  Concentric hypertrophy of right ventricle without dilatation  No Cardiomegaly. <NL> <NL> No CHF <NL> <NL> The VSD of TOF is always large enough to allow free exit to the right to left shunt. <NL> Since the right ventricle is effectively decompressed by the VSD, CHF never occurs in TOF.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A twoyearold boy is brought to emergency with severe anemia (Hb = 2 gm%) and features of congestive heart failure. The most appropriate immediate therapy for this boy would be  A. Packed cell transfusion | B. Partial exchange transfusion | C. Whole blood transfusion | D. Parenteral iron injection",
      "answer": "The most appropriate immediate therapy for this boy would be **A. Packed cell transfusion**.\n\nHere's why:\n\n*   **Severe Anemia (Hb = 2 gm%):** This is a life-threatening level of anemia. The body's ability to carry oxygen is severely compromised.\n*   **Features of Congestive Heart Failure:** The heart is struggling to pump enough oxygenated blood to meet the body's demands. This is a direct consequence of the severe anemia.\n*   **Packed Cell Transfusion:** This involves transfusing only the red blood cells, which are responsible for oxygen transport. This is the most efficient way to rapidly increase the hemoglobin level and improve oxygen-carrying capacity, thereby alleviating the strain on the heart and addressing the congestive heart failure.\n\n**Explanation of why other options are less appropriate:**\n\n*   **B. Partial exchange transfusion:** This is typically used for conditions like severe hyperbilirubinemia or certain hemolytic anemias where removing the patient's blood and replacing it with donor blood is beneficial. It's not the primary treatment for simple severe anemia causing heart failure.\n*   **C. Whole blood transfusion:** While it contains red blood cells, whole blood also contains plasma, platelets, and other components. In this scenario, the primary need is to increase red blood cell mass. Transfusing whole blood might also lead to fluid overload, which could worsen the congestive heart failure.\n*   **D. Parenteral iron injection:** Iron injections are used to treat iron deficiency anemia, but their effect is slow. It takes time for the body to produce new red blood cells with the administered iron. This boy needs immediate correction of his severe anemia to prevent further deterioration and address his heart failure. Iron therapy would be a subsequent step once the acute crisis is managed.",
      "ground_truth": "Packed cell transfusion ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following statements regarding ACE inhibitors is true? A. These inhibit the conversion of angiotensinogen to angiotensin-1 | B. Omission of prior diuretic dose decreases the risk of postural hypotension | C. Lisinopril is shorter acting than enalapril | D. These are contra-indicated in diabetic patients.",
      "answer": "The correct answer is **B. Omission of prior diuretic dose decreases the risk of postural hypotension**.\n\nHere's why:\n\n*   **A. These inhibit the conversion of angiotensinogen to angiotensin-1:** This statement is **false**. ACE inhibitors block the enzyme Angiotensin-Converting Enzyme (ACE), which converts angiotensin I to angiotensin II. Angiotensinogen is converted to angiotensin I by renin.\n*   **B. Omission of prior diuretic dose decreases the risk of postural hypotension:** This statement is **true**. Diuretics can cause volume depletion, which, when combined with the vasodilatory effects of ACE inhibitors, can significantly increase the risk of postural hypotension (a sudden drop in blood pressure upon standing). Withholding the diuretic dose before starting an ACE inhibitor helps to mitigate this risk.\n*   **C. Lisinopril is shorter acting than enalapril:** This statement is **false**. Lisinopril is generally considered to have a longer duration of action than enalapril.\n*   **D. These are contra-indicated in diabetic patients:** This statement is **false**. ACE inhibitors are often **indicated** in diabetic patients, particularly those with hypertension or diabetic nephropathy, as they can help protect the kidneys and improve cardiovascular outcomes. While caution is needed with certain electrolyte imbalances, they are not a contraindication.",
      "ground_truth": "Omission of prior diuretic dose decreases the risk of postural hypotension || Ans. (B) Omission of prior diuretic dose decreases the risk of postural hypotension(Ref: KDT 8th/e p531)Angiotensin Converting Enzyme Inhibitors (ACEI)*This group of drugs inhibits the enzyme kininase II or ACE. So, these drugs decrease the activity of RAAS and also potentiate the vasodilatory action of bradykinin. Because these are preventing the conversion of angiotensin I to angiotensin II, so these can decrease the action of the former but not the latter.*ACEI are used for the treatment of hypertension, CHF, evolving MI, diabetic nephropathy, diabetic retinopathy, non-diabetic renal disease and also in scleroderma crisis. These drugs reduce proteinuria in diabetic as well as non-diabetic renal disease and also prevent the manifestations of scleroderma crisis which are mediated by angiotensin II.*This group of drugs is more effective in sodium depleted states (like diuretic use) because activity of RAAS is more in such cases (to compensate for salt loss). These drugs may cause postural hypotension in diuretic treated patients, which otherwise is a relatively rare adverse effect.*Lisinopril is longer acting than enalapril. Former can be given once daily whereas latter is required twice a day.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Dilutional hyponatremia is seen in ? A. Addison's disease | B. Vincristine | C. Diuretic therapy | D. Craniphyrangioma",
      "answer": "The correct answer is **C. Diuretic therapy**.\n\nHere's why:\n\n*   **Dilutional hyponatremia** occurs when there is an excess of water in the body relative to sodium. This dilutes the sodium concentration in the blood.\n*   **Diuretic therapy:** Many diuretics, particularly thiazide diuretics, work by increasing the excretion of sodium and water. However, they can sometimes lead to a disproportionate loss of sodium compared to water, or they can stimulate the release of antidiuretic hormone (ADH), which causes the kidneys to retain more water. This increased water retention, coupled with sodium loss, can result in dilutional hyponatremia.\n\nLet's look at why the other options are less likely or incorrect:\n\n*   **A. Addison's disease:** Addison's disease is characterized by adrenal insufficiency, leading to a deficiency in aldosterone. Aldosterone promotes sodium reabsorption and potassium excretion. In Addison's disease, there is often **salt wasting** and **hyponatremia**, but it's typically due to sodium loss rather than a primary dilutional effect from excess water.\n*   **B. Vincristine:** Vincristine is a chemotherapy drug that can cause **syndrome of inappropriate antidiuretic hormone secretion (SIADH)**. SIADH leads to excessive ADH release, causing the kidneys to retain water, which can result in dilutional hyponatremia. While vincristine *can* cause hyponatremia, it's through a specific mechanism (SIADH) rather than being a general characteristic of the drug itself in the way diuretics can cause it. Diuretic therapy is a more direct and common cause of dilutional hyponatremia.\n*   **D. Craniphyrangioma:** This term appears to be a misspelling or an uncommon medical term. Assuming it refers to a **craniopharyngioma**, which is a tumor in the pituitary region, it can cause hormonal deficiencies, including ADH deficiency (leading to diabetes insipidus and water loss, thus hypernatremia) or, less commonly, SIADH. However, it's not a primary or common cause of dilutional hyponatremia compared to diuretic therapy.\n\nTherefore, **diuretic therapy** is the most direct and common cause of dilutional hyponatremia among the given options.",
      "ground_truth": "Vincristine || Answer- B. VincristineAcute kidney injury (AKI) (ARF)CirrhosisNephrotic syndromeCardiac failureAnti cancer drugs",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Digitalis does not increase which parameter of heart- A. Force of contraction | B. Myocordial contractility | C. Myocardial oxygen demand | D. Cardiac output",
      "answer": "The correct answer is **C. Myocardial oxygen demand**.\n\nHere's why:\n\n*   **A. Force of contraction:** Digitalis (like digoxin) is a positive inotropic agent, meaning it *increases* the force of contraction of the heart muscle.\n*   **B. Myocardial contractility:** This is essentially the same as the force of contraction. Digitalis *increases* myocardial contractility.\n*   **D. Cardiac output:** By increasing the force of contraction, digitalis leads to a greater stroke volume, which in turn *increases* cardiac output (the amount of blood pumped by the heart per minute).\n*   **C. Myocardial oxygen demand:** While digitalis increases the heart's workload by making it pump more forcefully, this increased activity *does* lead to an *increase* in myocardial oxygen demand. The heart muscle needs more oxygen to fuel its stronger contractions. Therefore, digitalis does *not* decrease or leave unchanged myocardial oxygen demand; it increases it.",
      "ground_truth": "Myocardial oxygen demand || Ans. is 'c' i.e., Myocardial oxygen demand Effect of digitalis on hearto Main mechanism of action of digitalis is to increase in force of contraction of heart - a positive inotropic action.o Amongst given options, option d is the best choice - heart rate is decreased by digitalis and there is increase myocardial contractility without a propartionate increase in O2 consumption.How does digitalis decrease heart rate?# Heart rate is decreased by digitalis mainly in patients with CHF.# In CHF there is sympathetic overactivity and i vagal tone because of | CO2# Digitalis increases myocardial contractility (major action) - | CO and better emptying of ventricle - improvement in circulation - restoration of diminished vagal tone and abolish sympathetic overactivity - | Heart rate. Beside above main mechanism digitalis slows the heart rate by -A) Increased vagal tonei) Reflexly through nodosa ganglion.ii) Direct stimulation of vagal centre.iii) Sensitization of SA nodes to Ach.B) Extravagal - Direct depressant action on SA and AV nodes.\"The vagal action manifests early and can be blocked by atropine, whereas extravagal action becomes prominent later and cannot be reversed by atropine",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Digitalis acts in CHF by: A. Na+ K+ ATPase inhibition | B. Na+ K+ ATPase stimulation | C. Blockade of calcium channels | D. Increasing the refractory period of AV node",
      "answer": "The correct answer is **A. Na+ K+ ATPase inhibition**.\n\nHere's why:\n\n*   **Digitalis (specifically digoxin and digitoxin) works by inhibiting the Na+/K+-ATPase pump in cardiac myocytes.** This pump is responsible for maintaining the electrochemical gradient across the cell membrane by pumping sodium ions out of the cell and potassium ions into the cell.\n*   **Inhibition of the Na+/K+-ATPase pump leads to an increase in intracellular sodium concentration.**\n*   **This increased intracellular sodium then reduces the activity of the sodium-calcium exchanger (NCX).** The NCX normally pumps calcium out of the cell in exchange for sodium entering the cell.\n*   **With less calcium being pumped out, intracellular calcium levels rise.**\n*   **Increased intracellular calcium leads to more calcium available for binding to troponin C, which enhances the force of myocardial contraction (positive inotropy).** This is the primary mechanism by which digitalis improves cardiac output in heart failure.\n\nLet's look at why the other options are incorrect:\n\n*   **B. Na+ K+ ATPase stimulation:** Digitalis *inhibits*, not stimulates, this pump.\n*   **C. Blockade of calcium channels:** While calcium is involved, digitalis's primary mechanism is not direct blockade of L-type calcium channels. Some calcium channel blockers are used in heart failure, but they have different mechanisms and indications.\n*   **D. Increasing the refractory period of the AV node:** Digitalis *does* increase the refractory period of the AV node, which can be beneficial in certain arrhythmias like atrial fibrillation. However, this is a secondary effect and not the primary mechanism by which it treats heart failure. The question specifically asks how it acts *in CHF*.",
      "ground_truth": "Na+ K+ ATPase inhibition ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "The maintenance dose of digoxin A. 0.25 mg/day | B. 2.5 mg/day | C. 25 mg/day | D. 250 mg/day",
      "answer": "The correct answer is **A. 0.25 mg/day**.\n\n**Explanation:**\n\nDigoxin is a medication used to treat heart conditions like heart failure and atrial fibrillation. The maintenance dose is the amount of medication taken regularly to keep the condition under control.\n\n*   **0.25 mg/day** is a common maintenance dose for digoxin in adults.\n*   **2.5 mg/day, 25 mg/day, and 250 mg/day** are significantly higher than typical maintenance doses and would likely lead to toxicity. The therapeutic window for digoxin is narrow, meaning the difference between an effective dose and a toxic dose is small.\n\nIt's important to note that the exact maintenance dose of digoxin can vary depending on individual factors such as age, kidney function, and the specific condition being treated. This is why it's crucial for a healthcare professional to determine and monitor the appropriate dosage.",
      "ground_truth": "0.25 mg/day || Slow digitalization: Here maintenance dose of Digoxin (average 0.25 mg/day) is given from the beginning. Full response takes 5-7 days to develop, but the procedure is much safer. In case an adequate response is not seen after I week, increase the dose to 0.375 and then to 0.5 mg after another week.Rapid oral digitalization: Here Digoxin 0.5 - 1.0 mg stat dose given followed by 0.25 mg every 6 hours with careful monitoring and watch for toxicity till response occurs - generally takes 6-24 hours (total dose 0.75 - 1.5 mg). This is seldom practised now.Emergency digitalization: It is practised rarely now, only as a desperate measure in CHF or in atrial fibrillation. Digoxin 0.25 mg followed 0.1 mg hourly is given by slow IV. Injection with close ECG, BP and CVP monitoring till response occurs (2-6 hours, total dose 0.5 - 1.0 mg)",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Pulsus paradoxus is seen in- A. Shock | B. Elderly | C. Emphysema/Asthma | D. High output state",
      "answer": "The correct answer is **C. Emphysema/Asthma**.\n\n**Explanation:**\n\nPulsus paradoxus, also known as paradoxical pulse, is an abnormally large drop in systolic blood pressure during inspiration. This phenomenon is most commonly associated with conditions that cause increased intrathoracic pressure during breathing, such as:\n\n*   **Emphysema and Asthma:** In these obstructive lung diseases, air trapping and increased resistance to airflow during inspiration lead to a significant increase in negative intrathoracic pressure. This increased negative pressure pulls more blood into the chest, causing a temporary decrease in venous return to the left ventricle and thus a drop in stroke volume and systolic blood pressure during inspiration.\n\nLet's look at why the other options are less likely or incorrect:\n\n*   **A. Shock:** While shock can lead to abnormal pulses, pulsus paradoxus is not a defining characteristic of all types of shock. Some forms of shock might have a weak or thready pulse, but the paradoxical drop during inspiration is not a consistent finding.\n*   **B. Elderly:** Age itself does not directly cause pulsus paradoxus. While elderly individuals may have underlying conditions that can lead to it, it's not a normal physiological change of aging.\n*   **D. High output state:** A high output state (e.g., severe anemia, sepsis, arteriovenous fistulas) is characterized by increased cardiac output. This typically leads to a bounding or hyperdynamic pulse, not a paradoxical drop in blood pressure during inspiration.",
      "ground_truth": "Emphysema/Asthma || * Pulsus paradoxus describes an exaggeration of the normal variation in systolic aerial blood pressure seen with respiration (normally falls by <10 mm on inspiration). * It is seen in the presence of- Airway obstruction. - Pericardial tamponade. - Massive pulmonary embolism. * Some conditions associated with pulsus paradoxus are - Constrictive pericarditis, -Restrictive cardiomyopathy, - Cardiac tamponade.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following is true about diazoxide except A. K+ channel opener | B. >Can be used as antihypeensive agent | C. >Causes severe hypoglycemia | D. >Used in insulinoma",
      "answer": "The correct answer is **C. Causes severe hypoglycemia**.\n\nHere's why:\n\n*   **A. K+ channel opener:** This is **true**. Diazoxide is a potassium channel opener. This mechanism is key to its therapeutic effects.\n*   **B. Can be used as antihypertensive agent:** This is **true**. By opening potassium channels in vascular smooth muscle, diazoxide causes vasodilation, which lowers blood pressure.\n*   **C. Causes severe hypoglycemia:** This is **false**. Diazoxide actually **inhibits insulin release** by opening potassium channels in pancreatic beta cells. This leads to **hyperglycemia**, not hypoglycemia.\n*   **D. Used in insulinoma:** This is **true**. Insulinoma is a tumor that produces excessive insulin, leading to hypoglycemia. Diazoxide's ability to suppress insulin release makes it a useful treatment for managing the hypoglycemia associated with insulinoma.\n\nTherefore, the statement that is **not true** about diazoxide is that it causes severe hypoglycemia.",
      "ground_truth": ">Causes severe hypoglycemia || Causes severe hypoglycemia Diazoxide Diazoxide is a direct acting aeriolar dilator. Diazoxide causes aeriolar dilatation with little effect on veins. Diazoxide prevents smooth muscle contraction and relaxes the aerioles Diazoxide is a potassium channel activator which causes local relaxation in smooth muscle by increasing membrane permeability to potassium ions. This switches off voltage gated calcium ion channel which inhibits the generation of action potential. When used as an intravenous antihypeensive agent diazoxide causes excessive hypotension. Diazoxide was formerlyused as an intravenous bolus dose for the at of hypeensive emergencies. But the dangers of excessive hypotension are now recognized to outweigh the benefit, and its emergency use is obsolete. Hypotension due to diazoxide has resulted in stroke and myocardial infarction. - The reflex sympathetic response due to hypotension can provoke angina, electrocardiographic evidence of ischemia and cardiac failure in patients with ischemic hea disease and diazoxide should be avoided in this situation. Diazoxide produces hyperglycemia by increasing insulin secretion, therefore it is used to treat various forms of hypoglycemia Diazoxide activates the same potassium channel in the pancreatic islet cells that is blocked by sulfonylureas. SullOnylureas close the potassium channels and increase insulin secretion whereas diazoxide opens the potassium channel in pancreatic islet cells and decrease insulin secretion. Due to its hyperglycemic action it is a useful drug for patients with chronic hypoglycemia from excess endogenous insulin secretion, either from an iselt cell tumour (insulinoma) or islet cell hyperplasia. According to Lawerence Diazoxide stimulates the ATP dependent r channel that is blocked by the sulphonylureas. Therefore its chronic use as an antihypeensive agent is precluded by the development of diabetes. Indeed its use in therapeutics should now be confined to rare indication of treating hypoglycemia due to islet cell tumour (insulinoma). Diazoxide is chemically related to thiazide diuretics. But in contrast to the structurally related thiazide diuretics, diazoxide causes renal salt and water retention.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Aortic sinus of Valsalva contributes to left ventricular outflow tract (LVOT) function by A. Increasing aortic radius during ejection phase | B. Decreasing aortic regurgitation (normally) | C. Promoting non-turbulent flow in coronary arteries | D. All of the above",
      "answer": "The correct answer is **D. All of the above**.\n\nHere's why:\n\n*   **A. Increasing aortic radius during ejection phase:** The aortic sinuses are dilations of the aorta at the root, just above the aortic valve. During ventricular ejection, as blood is forcefully pumped into the aorta, these sinuses expand slightly. This expansion contributes to accommodating the increased volume of blood and can be thought of as a temporary increase in the aortic radius, which helps to smooth out the pressure pulse and reduce the peak pressure.\n\n*   **B. Decreasing aortic regurgitation (normally):** The shape and function of the aortic sinuses are crucial for proper valve closure. When the aortic valve leaflets coapt (close), they seat within the sinuses. This configuration helps to prevent blood from flowing backward into the left ventricle (aortic regurgitation) during diastole. In a healthy heart, the sinuses contribute to a competent seal.\n\n*   **C. Promoting non-turbulent flow in coronary arteries:** The openings of the coronary arteries are located within the aortic sinuses. The gentle expansion and the shape of the sinuses help to direct blood flow into the coronary arteries in a more laminar (non-turbulent) fashion, especially during the early part of diastole when coronary perfusion is most significant. Turbulent flow can be less efficient for delivering oxygen and nutrients.\n\nTherefore, all three mechanisms contribute to the overall function of the left ventricular outflow tract by influencing the dynamics of blood flow and valve function.",
      "ground_truth": "All of the above || Ans. D (All of the above) (Ref. Gray's anatomy 39th ed., 1009, 1016)The right and left coronary arteries to originate from the right and left aortic sinuses (the sinuses of Valsalva), which are bulges at the origin of the ascending aorta immediately beyond, or distal to, the aortic valve.The left ventricular outflow tract extends from the tip of the anterior mitral valvar leaflet to the junction of the sinuses of Valsalva with the ascending aorta.VEINS OF THE HEART# The coronary sinus is the main vein of the coronary circulation.- It lies in the posterior coronary sulcus.- It drains to an opening in the right atrium.# All veins of the heart (including the great cardiac vein, the posterior vein of the left ventricle, the oblique vein of the left atrium, and the right marginal vein) except anterior cardiac and venae Cordis minimis (which open directly into the right atrium) drain into the coronary sinus which opens into the right atrium.Educational point:Ruptured sinus of Valsalva aneurysm# Any of the three aortic sinuses of Valsalva may become aneurysmal and rupture. The right and non-coronary cusps are most often affected; rupture of the non-coronary sinus aneurysm is nearly always into the right atrium and of the right coronary sinus into the right ventricle or atrium. Rupture usually occurs in early adulthood and may be precipitated by endocarditis. If sudden, it is accompanied by tearing chest pain, breathlessness, and congestive cardiac failure with a loud continuous murmur. The diagnosis and site of the rupture is confirmed angiographically prior to surg repair. Transcatheter closure has been reported.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All are features of Pompe's disease except A. Hyperglycemia | B. Cardiomyopathy | C. Skeletal myopathy | D. Hepatomegaly",
      "answer": "The correct answer is **A. Hyperglycemia**.\n\nHere's why:\n\n*   **Pompe's disease** is a rare genetic disorder caused by a deficiency of the enzyme acid alpha-glucosidase (GAA). This enzyme is crucial for breaking down glycogen, a form of stored glucose, in lysosomes. When GAA is deficient, glycogen accumulates in various tissues, particularly muscle cells.\n\nLet's look at why the other options are features of Pompe's disease:\n\n*   **B. Cardiomyopathy:** The accumulation of glycogen in the heart muscle leads to thickening of the heart walls, a condition known as cardiomyopathy. This is a hallmark feature, especially in infantile-onset Pompe's disease.\n*   **C. Skeletal myopathy:** Glycogen accumulation in skeletal muscles causes progressive muscle weakness and degeneration, leading to skeletal myopathy. This affects motor development and function.\n*   **D. Hepatomegaly:** In some forms of Pompe's disease, particularly infantile-onset, glycogen can also accumulate in the liver, leading to an enlarged liver (hepatomegaly).\n\n*   **A. Hyperglycemia:** Pompe's disease is characterized by **hypoglycemia** (low blood sugar) rather than hyperglycemia (high blood sugar). This is because the body's ability to break down stored glycogen for energy is impaired, leading to a lack of glucose available for release into the bloodstream.",
      "ground_truth": "Hyperglycemia || Type II(Pompe) disease results from lysosomal storage of glycogen in skeletal muscles,cardiac muscles, and central nervous system. <NL> There is progressive cardiomyopathy.ECG shows left axis deviation,short PR interval & large QRS.Heart failure with dyspnoea and cyanosis may occur.Skeletal muscles show hypotonia and marked weakness.The tongue is large & protruding.It is also characterised by hepatomegaly and hypoglycemia.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Anti androgen used in hea failure ? A. Carvedilol | B. Sampatrilat | C. Spironolactone | D. Abiraterone",
      "answer": "The correct answer is **C. Spironolactone**.\n\nHere's why:\n\n*   **Spironolactone** is a potassium-sparing diuretic that also acts as an **aldosterone antagonist**. Aldosterone is a hormone that can contribute to fluid retention and fibrosis in the heart, which are detrimental in heart failure. By blocking aldosterone, spironolactone helps reduce these effects, improving outcomes in heart failure. While it's not a direct \"anti-androgen\" in the typical sense of blocking testosterone production or action for conditions like prostate cancer, its mechanism of action in heart failure is related to its hormonal effects.\n\nLet's look at why the other options are incorrect:\n\n*   **A. Carvedilol:** This is a beta-blocker and alpha-blocker used in heart failure to reduce heart rate and blood pressure, and improve the heart's pumping efficiency. It does not have anti-androgen properties.\n*   **B. Sampatrilat:** This is a dual endothelin and angiotensin receptor antagonist. It was investigated for heart failure but was withdrawn due to safety concerns. It does not have anti-androgen properties.\n*   **D. Abiraterone:** This is a potent **anti-androgen** medication used primarily to treat prostate cancer. It works by inhibiting an enzyme (CYP17A1) that is crucial for the production of androgens. It is not used in the management of heart failure.",
      "ground_truth": "Spironolactone || Ans. is 'c' i.e., Spironolactone o Spironolactone and eplerenone are the aldosterone antagonists. They are used as potassium sparing diuretics. Their diurectic effect is quite feeble, but in CHF these drugs reduce the moality (at doses lower than diuretic doses) by antagonizing the effect of aldosterone (reversal of remodelling). Spironolactone also possesses anti- androgenic effects.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Drug used for hypertension and pulmonary edema due to scorpion sting: A. Prazosin | B. Clonidine | C. Furosemide | D. Mannitol",
      "answer": "The correct answer is **C. Furosemide**.\n\nHere's why:\n\n*   **Pulmonary edema** is a condition where fluid accumulates in the lungs. **Furosemide** is a potent diuretic (water pill) that works by increasing the excretion of sodium and water from the body, which helps to reduce fluid overload and alleviate pulmonary edema.\n*   **Hypertension** (high blood pressure) can also be a complication of scorpion stings. While furosemide can contribute to lowering blood pressure by reducing fluid volume, its primary role in this scenario is to address the life-threatening pulmonary edema.\n\nLet's look at why the other options are less suitable:\n\n*   **A. Prazosin** and **B. Clonidine** are alpha-blockers and alpha-agonists, respectively, primarily used for hypertension. While they might help with blood pressure, they do not directly address the fluid accumulation in the lungs characteristic of pulmonary edema.\n*   **D. Mannitol** is an osmotic diuretic. It's typically used to reduce intracranial pressure or intraocular pressure, not as a first-line treatment for pulmonary edema caused by venomous stings.",
      "ground_truth": "Prazosin || Ans. (A) Prazosin(Ref: Harrison 20th/e p3329)Scorpion sting is a dreadful medical emergency.Scorpion stings cause a wide range of symptoms, from severe local reactions to cardiovascular, respiratory and neurological manifestations.Alpha-receptors play vital role in the pathogenesis of cardiac failure and pulmonary edema due to scorpion sting.Prazosin is a selective alpha-1 adrenergic receptor blocker. It dilates veins and arterioles, thereby reducing pre-load and left ventricular impedance without rise in heart rate and renin secretion. It also inhibits sympathetic outflow in central nervous system. It enhances insulin secretion, which is inhibited by venom action. It has also been found useful even in cases with hypotension. Thus, its pharmacological properties can antagonize the hemodynamic, hormonal and metabolic effects of scorpion venom action.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "When can one diagnose acute respiratory distress in a child? A. Within 7 days of known insult | B. Respiratory failure not fully explained by cardiac failure | C. No left ventricular dysfunction | D. All of the above",
      "answer": "The correct answer is **D. All of the above**.\n\nHere's why:\n\nAcute Respiratory Distress Syndrome (ARDS) in children is diagnosed based on a combination of criteria, and all the options provided are essential components of that diagnosis.\n\n*   **A. Within 7 days of known insult:** ARDS is an acute condition, meaning it develops relatively quickly. The presence of a clear trigger or \"insult\" (like pneumonia, sepsis, aspiration, etc.) within the past week is a key indicator.\n*   **B. Respiratory failure not fully explained by cardiac failure:** This is a crucial distinction. ARDS is a problem with the lungs themselves, leading to impaired gas exchange. It's important to rule out that the respiratory distress is primarily due to the heart's inability to pump blood effectively (cardiac failure).\n*   **C. No left ventricular dysfunction:** This is closely related to option B. Left ventricular dysfunction (the main pumping chamber of the heart not working well) would suggest a cardiac cause for the respiratory distress, not ARDS.\n\nTherefore, all these conditions must be met to diagnose ARDS in a child.",
      "ground_truth": "All of the above || Diagnostic criteria of ARDS in children: BERLIN DEFINITION CRITERIA Timing Within 1 wk of a known clinical insult or new or worsening respiratory symptoms Chest X-rays or tomography scan Bilateral opacities not fully explained by effusions, lobar/lung collapse, or nodules Origin of edema Respiratory failure not fully explained by cardiac failure or fluid overload Oxygenation Mild: PaO2/FiO2 - 200-300 mm Hg Moderate: PaO2/FiO2 - 100-200 mm Hg Severe: PaO2/FiO2 <100 mm Hg",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Keshan's disease is due to deficiency of: A. Selenium | B. Zinc | C. Copper | D. Iron",
      "answer": "The correct answer is **A. Selenium**.\n\n**Explanation:**\n\nKeshan disease is a cardiomyopathy (a disease of the heart muscle) that is endemic in certain regions of China. It is strongly linked to a deficiency in **selenium**, an essential trace mineral that plays a crucial role in antioxidant defense and thyroid hormone metabolism. When selenium levels are low, the body's ability to protect cells from oxidative damage is compromised, which can lead to the development of heart muscle problems.",
      "ground_truth": "Selenium || Keshan's Disease Deficiency of Selenium (Se) Affects: Children Women of child bearing age CLINICAL FEATURES: Cardiomyopathy Muscle weakness Hypothyroidism Eczema Increased risk of stroke Hypeension Cancer Selenium Sources- seafood and meat, nuts Deficiency - Keshan's disease Toxicity - Selenium toxicity lead to Selenosis",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Kamli Rath 75 yrs old woman present with post-myocardial infarction after 6 weeks with mild CHF. There was past H/O neck surgery for parathyroid adenoma 5 years ago, EKG shows slow atrial fibrillation. Serum Ca+2 13.0 mg/L and urinary Ca2+ is 300 mg/ 24 hr. On examination, there is small mass in the Para tracheal position behind the right clavicle. Appropriate management at this time is - A. Repeat neck surgery | B. Treatment with technetium - 99 | C. Observation and repeat serum Ca+2 in two months | D. Ultrasound-guided alcohol injection of the mass",
      "answer": "Here's a breakdown of the case and the reasoning behind the appropriate management:\n\n**Understanding the Key Findings:**\n\n*   **Post-MI with mild CHF:** This indicates a recent heart attack and ongoing heart failure, which needs careful management and stabilization.\n*   **Past H/O neck surgery for parathyroid adenoma:** This is a crucial piece of history. Parathyroid adenomas are benign tumors of the parathyroid glands, which regulate calcium levels.\n*   **EKG shows slow atrial fibrillation:** This is an abnormal heart rhythm.\n*   **Serum Ca+2 13.0 mg/L:** This is significantly elevated (normal range is typically 8.5-10.2 mg/dL or 2.1-2.6 mmol/L). This is hypercalcemia.\n*   **Urinary Ca2+ is 300 mg/ 24 hr:** This is also elevated (normal range is typically <250 mg/24 hr or <6.2 mmol/24 hr). This indicates excessive calcium excretion.\n*   **Small mass in the paratracheal position behind the right clavicle:** This location is consistent with the possibility of a parathyroid adenoma, especially given the history.\n\n**Connecting the Dots:**\n\nThe combination of a history of parathyroid adenoma, significantly elevated serum calcium, elevated urinary calcium, and a palpable mass in a location consistent with parathyroid tissue strongly suggests a **recurrent or new parathyroid adenoma causing hyperparathyroidism**. Hyperparathyroidism is the most common cause of hypercalcemia.\n\n**Evaluating the Options:**\n\n*   **A. Repeat neck surgery:** While surgery is the definitive treatment for symptomatic parathyroid adenomas, it's a significant intervention. Given the patient's recent MI and mild CHF, immediate surgery might carry higher risks. However, it remains a strong consideration if the hypercalcemia is severe or causing significant symptoms.\n*   **B. Treatment with technetium-99:** Technetium-99m sestamibi scanning is a diagnostic tool used to locate parathyroid adenomas, not a treatment.\n*   **C. Observation and repeat serum Ca+2 in two months:** This is a reasonable approach for *mild, asymptomatic* hypercalcemia. However, this patient has a palpable mass and significantly elevated calcium levels, which are concerning. While CHF needs management, the hypercalcemia itself can worsen cardiac function and lead to other complications.\n*   **D. Ultrasound-guided alcohol injection of the mass:** This is a less invasive treatment option for parathyroid adenomas, particularly smaller ones. It can be effective in reducing parathyroid hormone production and lowering calcium levels. Given the patient's cardiac status, a less invasive approach might be preferred initially, especially if the mass is amenable to this treatment.\n\n**The Most Appropriate Management:**\n\nConsidering the patient's overall condition, the most appropriate management at this time would be to **address the likely cause of the hypercalcemia while being mindful of her cardiac status.**\n\nWhile surgery (Option A) is definitive, it's a more invasive step. Observation (Option C) might be too passive given the elevated calcium and palpable mass. Technetium-99 (Option B) is diagnostic, not therapeutic.\n\nTherefore, **ultrasound-guided alcohol injection (Option D)** offers a less invasive approach to manage the hypercalcemia, which could improve her overall condition and potentially reduce the burden on her heart. If this is unsuccessful or the mass is not suitable, then surgical intervention would be reconsidered.\n\n**However, without further information about the exact size and characteristics of the mass, and the severity of her CHF, it's difficult to definitively choose one option without nuance.** In a real clinical scenario, a multidisciplinary approach involving cardiology and endocrinology would be crucial.\n\n**Given the provided options, and assuming the mass is amenable to injection, Option D is the most likely *initial* appropriate management to consider for a symptomatic hypercalcemia in a patient with cardiac compromise.**\n\n**The final answer is $\\boxed{D}$.**",
      "ground_truth": "Ultrasound-guided alcohol injection of the mass || This patient operated previously for parathyroid adenoma, is having recurrent hyperparathyroidism. <NL> In the setting of recent myocardial infarction, CHF and atrial fibrillation, any operation carries a high risk. Furthermore, an operation on a previously operated neck is quite difficult. <NL> Alcohol ablation of the mass with ultrasound guidance or angiographic embolization is preferred in this setting.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Lung is characteristically involved in - A. Churg-Strauss syndrome | B. HSP | C. PAN | D. ITP",
      "answer": "The correct answer is **A. Churg-Strauss syndrome**.\n\n**Explanation:**\n\n*   **Churg-Strauss syndrome (Eosinophilic granulomatosis with polyangiitis - EGPA)** is a systemic vasculitis that characteristically involves the lungs. Pulmonary manifestations are common and can include asthma, eosinophilia in the lungs, infiltrates, and even hemorrhage.\n\nLet's look at why the other options are less characteristic for lung involvement:\n\n*   **B. HSP (Henoch-Schnlein Purpura):** While HSP can affect multiple organs, the most common and characteristic involvement is the skin (purpura), joints (arthritis), gastrointestinal tract (abdominal pain, bleeding), and kidneys (nephritis). Lung involvement is rare.\n*   **C. PAN (Polyarteritis Nodosa):** PAN is a systemic vasculitis that primarily affects medium-sized arteries. While it can involve various organs, lung involvement is not a *characteristic* feature. Common organ involvement includes the kidneys, heart, liver, and nervous system.\n*   **D. ITP (Idiopathic Thrombocytopenic Purpura):** ITP is an autoimmune disorder characterized by low platelet counts, leading to bleeding. It primarily affects the blood and spleen. Lung involvement is not a typical feature of ITP.",
      "ground_truth": "Churg-Strauss syndrome || Ans. is 'a' i.e., Churg-Strauss syndromeChurg- strauss syndrome o Also known as allergic granulomatosis and angitis.o It is a medium and small size vasculitis, invoves mainly the blood vessels of lungs, GIT, peripheral nerves, hea, skin, kidney.o As it is allergic, vasculitis it is associated with eosinophilia and asthma.o It is granulomatous necrotizing vasculitis.o It is associated with p-ANCA.StagesThis disease has three distinct stages ?o Stage l --> Involves the sinuses and the onset of allergies ---> nasal polyp, allergic rhinitis.o Stage 2 --> Acute asthma occurs.o Stage 3 --> The third and final stage involves the various organ systems -1. Peripheral nervous system --> Mononeuritis multiplex with severe neural pain.2. Skin -3 Palpable purpura, papules, ulcer, vesiculobillous lesion.3. Hea --> CHF4. Kidney Pauciimmune glomerulonephritis.5. Joints --> Migratory ahritis.6. Ear Conductive deafness.7. There is eosinophilia and raised IgE as occur with allergic conditions.8. Lung --> Nonfixed migratory pulmonary infiltrates.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Heart failure cells are? A. Neutrophills | B. Macrophages | C. Lymphocytes | D. Lymphocytes",
      "answer": "The correct answer is **B. Macrophages**.\n\n**Explanation:**\n\nHeart failure cells, also known as siderophages, are a specific type of macrophage found in the lungs. They are characterized by the presence of hemosiderin, an iron-storage complex, within their cytoplasm. This accumulation of hemosiderin occurs when red blood cells break down (hemolysis) in the lung tissue, and macrophages engulf the released hemoglobin. This process is commonly seen in conditions that lead to fluid buildup in the lungs, such as heart failure.",
      "ground_truth": "Macrophages || Ans. is 'b' i.e., Macrophages o Heart failure cells are Hemosiderin laden alveolar macrophages.o Heart failure cells are a manifestation of pulmonary congestion and edema (as seen in heart failure)o Pulmonary edema & pulmonary infarction can be differentiated by the presence of heart failure cells in pulmonary edema.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "BETA-blockers are used in all, EXCEPT A. Hypertension | B. Thyrotoxicosis | C. Variant angina | D. All of the above",
      "answer": "The correct answer is **D. All of the above**.\n\n**Explanation:**\n\nBeta-blockers are a class of medications that work by blocking the effects of adrenaline (epinephrine) and noradrenaline on the body's beta receptors. This leads to a decrease in heart rate, blood pressure, and the force of heart contractions. Due to these effects, beta-blockers are commonly used in the management of several conditions:\n\n*   **A. Hypertension (High Blood Pressure):** By reducing heart rate and the force of contraction, beta-blockers lower the overall workload on the heart and decrease the pressure within the arteries.\n*   **B. Thyrotoxicosis (Overactive Thyroid):** In thyrotoxicosis, the thyroid gland produces excessive thyroid hormones, leading to symptoms like rapid heart rate, palpitations, tremors, and anxiety. Beta-blockers can effectively control these adrenergic symptoms by blocking the effects of excess thyroid hormone on the cardiovascular system.\n*   **C. Variant Angina (Prinzmetal's Angina):** This type of angina is caused by spasms of the coronary arteries, which can reduce blood flow to the heart muscle. Beta-blockers can help prevent these spasms and improve blood flow, thereby reducing chest pain.\n\nSince beta-blockers are used in hypertension, thyrotoxicosis, and variant angina, the statement \"All of the above\" is the correct exception to a scenario where they are *not* used.",
      "ground_truth": "Variant angina || Ans. is 'c' i.e., Variant angina [Ref: K.D.T. 5th/e page 127\\We all know that attacks of variant angina occur due to coronary vasospasm.So, the drugs which relieve coronary vasospasms will used in variant angina (C.C.B.'S, Nitrates) b blockers are contraindicated in these patients because b blockers, instead of dilating the coronary arteries constrict the coronary arteries (due to unopposed a mediated constriction).Remember, b blockers are useful in classical angina. (They cause favourable redistribution of blood)Uses of b blocker: -HypertensionCardiac arrhythmiasMyocardial infarctionEssential tremorCHFGlaucomaDissecting aneurysmHOCMPheochromocytomaThyrotoxicosisAngina pectoris (classical)MigraineAnxiety",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "In Peripaum cardiomyopathy, cardiac failure occurs at:- A. Within 7 days after delivery. | B. Within 6 weeks after delivery. | C. Within 24 months after delivery. | D. Within 5 months after delivery.",
      "answer": "The correct answer is **B. Within 6 weeks after delivery.**\n\n**Explanation:**\n\nPeripartum cardiomyopathy (PPCM) is a rare form of heart failure that affects women in the last month of pregnancy or within five months after delivery. While the question offers \"within 6 weeks after delivery\" as an option, the broader diagnostic window for PPCM is generally considered to be from the last month of pregnancy up to five months postpartum. However, among the given choices, \"within 6 weeks after delivery\" is the most accurate and commonly cited timeframe for the onset of symptoms in a significant portion of PPCM cases.\n\nIt's important to note that the exact timing can vary, and some sources may extend the window slightly. However, options A, C, and D are less precise or incorrect for the typical presentation of PPCM.",
      "ground_truth": "Within 5 months after delivery. || Diagnostic criteria for Peripaum cardiomyopathy - A) Development of cardiac failure in the last month of pregnancy or within 5 months after delivery. B) Absence of an identifiable cause for the cardiac failure. C) Absence of recognizable hea disease prior to the last month pf pregnancy D) Left ventricular systolic dysfunction demonstrated by classic echocardiographic criteria, such as depressed ejection fraction along with a dilated left ventricle",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "The Loop diuretic acts at A. PCT | B. DCT | C. Ascending loop | D. Descending loop",
      "answer": "The correct answer is **C. Ascending loop**.\n\n**Explanation:**\n\nLoop diuretics, such as furosemide, bumetanide, and torsemide, primarily exert their action in the **thick ascending limb of the loop of Henle**. Here, they inhibit the Na+-K+-2Cl- cotransporter (NKCC2). This inhibition leads to decreased reabsorption of sodium, potassium, and chloride, resulting in increased excretion of these ions and water.",
      "ground_truth": "Ascending loop || (C) Ascending loop # Loop diuretics: are diuretics that act on the ascending loop of Henle in the kidney.> They are primarily used in medicine to treat hypertension and edema often due to congestive heart failure or renal insufficiency.# Mechanism of action:> Loop diuretics act on the Na+-K+-2CI' symporter (cotransporter) in the thick ascending limb of the loop of Henle to inhibit sodium & chloride reabsorption. This is achieved by competing for the Cl' binding site.> Because magnesium and calcium reabsorption in the thick ascending limb is dependent on sodium and chloride concentrations, loop diuretics also inhibit their reabsorption> By disrupting the reabsorption of these ions, loop diuretics prevent the urine from becoming concentrated and disrupt the generation of a hypertonic renal medulla",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All are toxicities seen with Amiodarone therapy except - A. Pulmonary fibrosis | B. Corneal micro-deposits | C. Cirrhosis of liver | D. Productive cough",
      "answer": "The correct answer is **D. Productive cough**.\n\nHere's why:\n\n*   **A. Pulmonary fibrosis:** This is a well-known and serious toxicity of amiodarone, characterized by scarring of the lung tissue.\n*   **B. Corneal micro-deposits:** These are very common with amiodarone and usually asymptomatic, appearing as grayish or yellowish deposits in the cornea.\n*   **C. Cirrhosis of liver:** While less common than pulmonary toxicity, amiodarone can cause liver damage, including steatosis, hepatitis, and in some cases, cirrhosis.\n*   **D. Productive cough:** A dry, non-productive cough is a more common respiratory symptom associated with amiodarone-induced pulmonary toxicity. A **productive cough** (one that brings up mucus) is not a typical or direct toxicity of amiodarone.",
      "ground_truth": "Productive cough || Ans. is 'd' i.e., Productive cough Amiodarone is a class III antiarrhythmic drug and thus blocks potassium channel. It acts by increasing the action potential duration and effective refractory period.In spite of its present classification as class 3 drug, amiodarone also significantly blocks inactivated sodium channels. It also has weak adrenergic and calcium channel blocking actions.Consequence of these actions include slowing of the heart rate and AV node conduction.Amiodarone is the most powerful antiarrhythmic drug available for the treatment and prevention of both atrial and ventricular arrhythmias.Adverse effect:-Even short term use of Amiodarone causes serious toxicity.Amiodarone accumulates in many tissues which includes heart, lung, liver and skin.Pulmonary toxicityIt is the most important adverse effect.It is dose related. Fatal pulmonary fibrosis may be observed even in low doses.Patient usually presents with cough, chest pain and shortness of breath. Symptoms usually start with dry cough and dyspnoea. Remember, that patients on amiodarone often have dyspnoea attributable to other problems such as heart failure, so amiodarone lung toxicity is difficult to diagnose.Liver toxicityAbnormal liver function and hepatitis develops during amiodarone therapy. (I have not got any documented evidence of liver cirrhosis).Skin depositsSkin deposits results in photodermatitis and gray blue skin discoloration in sun exposed areas e.g. the malar region.Corneal micro depositsCorneal micro deposits are seen in virtually all patients treated with Amiodarone after few weeks of treatment.Sometimes optic neuritis may develop and progress to blindness.Effect of Amiodarone on ThyroidAmiodarone is a potential source of large amount of inorganic iodine and it also blocks the peripheral conversion of thyroxine (T4) to triiodothyronine (T3).Thus Amiodarone may result in hypothyroidism or hyperthyroidism.Thyroid function should be evaluated prior to initiation of treatment and monitored periodically.Cardiac toxicityAmiodarone may produce symptomatic bradycardia and heart block in patients with preexisting sinus or A-V node disease.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "In . sided hemithorax on chest X-ray PA view what can be excluded: A. CCF | B. TB | C. Pulmonary infarct | D. None of the above",
      "answer": "The answer is **D. None of the above**.\n\nHere's why:\n\n*   **Hemithorax:** This refers to one side of the chest cavity.\n*   **Chest X-ray PA view:** This is a standard posterior-anterior view of the chest X-ray.\n\nA unilateral (one-sided) abnormality on a chest X-ray can be caused by a variety of conditions affecting that specific side of the chest. Let's consider why the other options cannot be excluded:\n\n*   **A. CCF (Congestive Cardiac Failure):** While CCF often presents with bilateral pleural effusions (fluid in both sides of the chest), it can sometimes manifest with a unilateral effusion, especially if there's an underlying asymmetry or a more dominant process on one side.\n*   **B. TB (Tuberculosis):** Pulmonary tuberculosis can affect one lung more than the other, leading to findings like infiltrates, cavities, or pleural effusions localized to one hemithorax.\n*   **C. Pulmonary infarct:** A pulmonary infarct (tissue death in the lung due to a blocked blood vessel, often from a pulmonary embolism) typically affects a specific lobe or segment of the lung, which would be visible on one side of the chest X-ray.\n\nTherefore, a finding of a unilateral hemithorax abnormality on a chest X-ray PA view does not allow you to definitively exclude any of the listed conditions. Further investigation and clinical context would be necessary to determine the cause.",
      "ground_truth": "CCF || A i.e. CCF Congestive cardiac failure is a condition which presents with B/L changes in chest X RayQ - so it can be excluded by seeing U/L hemithorax on chest X Ray, if it is normal.;",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All are causes of hypervolemic hyponatremia except A. Hypothyroidism | B. Cirrhosis | C. Chronic renal failure | D. Nephrotic syndrome",
      "answer": "The correct answer is **A. Hypothyroidism**.\n\nHere's why:\n\n*   **Hypervolemic hyponatremia** occurs when there is an excess of total body water and sodium, but the water excess is proportionally greater than the sodium excess, leading to a dilution of sodium in the blood. This is often associated with conditions that impair the body's ability to excrete free water.\n\nLet's break down why the other options cause hypervolemic hyponatremia:\n\n*   **B. Cirrhosis:** In cirrhosis, impaired liver function leads to decreased synthesis of albumin, which reduces oncotic pressure. This can cause fluid to shift into the interstitial space (edema) and also activate the renin-angiotensin-aldosterone system (RAAS). The RAAS promotes sodium and water retention, contributing to hypervolemia. Furthermore, the reduced effective circulating volume can stimulate the release of antidiuretic hormone (ADH), leading to increased free water reabsorption and hyponatremia.\n*   **C. Chronic renal failure:** Damaged kidneys have a reduced ability to excrete both sodium and water. This leads to fluid overload (hypervolemia) and impaired ability to dilute the blood, resulting in hyponatremia.\n*   **D. Nephrotic syndrome:** In nephrotic syndrome, significant protein loss in the urine (proteinuria) leads to hypoalbuminemia. This reduces oncotic pressure, causing fluid to shift into the interstitial space and leading to edema and hypervolemia. Similar to cirrhosis, the reduced effective circulating volume can stimulate ADH release, causing free water retention and hyponatremia.\n\n*   **A. Hypothyroidism:** While hypothyroidism can cause **hyponatremia**, it is typically **euvolemic hyponatremia** or sometimes **hypovolemic hyponatremia**, not hypervolemic. In hypothyroidism, the reduced metabolic rate can lead to decreased glomerular filtration rate (GFR) and impaired free water excretion. However, the fluid retention is usually not as pronounced as in the other conditions, and significant edema and hypervolemia are not the hallmark features. The hyponatremia in hypothyroidism is primarily due to increased ADH secretion and increased water reabsorption in the collecting ducts, leading to dilution.\n\n**In summary:** Cirrhosis, chronic renal failure, and nephrotic syndrome all lead to impaired sodium and water excretion or shifts in fluid distribution that result in both hypervolemia and hyponatremia. Hypothyroidism primarily causes hyponatremia through increased ADH, but typically without significant hypervolemia.",
      "ground_truth": "Hypothyroidism || Causes of hypervolemic hyponatremia Urine sodium concentration >20 mmol/L Acute or chronic renal failure Urine sodium concentration <20 mmol/L Nephrotic syndrome Cirrhosis Cardiac failure Causes of Euvolemic hyponatremia Glucocoicoid deficiency Hypothyroidism Stress Drugs Syndrome of inappropriate antidiuretic hormone secretion Ref: Harrison 19e pg: 299",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Euvolemic hyponatremia is seen in: A. Adrenocortical failure | B. Burns | C. SIADH | D. Cirrhosis",
      "answer": "The correct answer is **C. SIADH**.\n\nHere's why:\n\n*   **Euvolemic hyponatremia** means that the patient has a normal total body water and sodium, but the sodium concentration in the blood is low.\n*   **SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion)** is a condition where the body produces too much ADH. ADH causes the kidneys to retain water, leading to dilution of sodium in the blood. In SIADH, the body is retaining water but not necessarily losing sodium or having an excess of total body water, hence it's often euvolemic.\n\nLet's look at why the other options are less likely to be the primary cause of *euvolemic* hyponatremia:\n\n*   **A. Adrenocortical failure (Addison's disease):** This typically leads to *hypovolemic* hyponatremia because the lack of aldosterone causes sodium and water loss.\n*   **B. Burns:** Severe burns often lead to *hypovolemic* hyponatremia due to significant fluid and electrolyte losses from the damaged skin.\n*   **D. Cirrhosis:** Cirrhosis is usually associated with *hypervolemic* hyponatremia. The liver damage leads to fluid retention and ascites, and the body tries to compensate by retaining more water, diluting the sodium.",
      "ground_truth": "SIADH || Ans. C. SIADHHypervolemic hyponatremia -- Both sodium & water content increase: Increase in sodium content leads to hypervolemia and water content to hyponatremia. Total body water and sodium are regulated independently* Cirrhosis of the liver* Congestive heart failure* Nephrotic syndrome in the kidneys* Massive edema of any causeEuvolemic hyponatremia -- there is no volume expansion in the body, no edema, but hyponatremia occurs* States of severe pain or nausea* In the setting of trauma or other damage to the brain* SIADH (and its many causes)* Hypothyroidism* Glucocorticoid (steroid) deficiencyHypovolemic hyponatremia -- THE hypovolemia (extracellular volume loss) is due to total body sodium loss. The hyponatremia is caused by a relatively smaller loss in total body water.* Any cause of hypovolemia such as prolonged vomiting, decreased oral intake, severe diarrhea* Diuretic use (due to the diuretic causing a volume depleted state and thence ADH release, and not a direct result of diuretic-induced urine sodium loss)* Addison's disease and congenital adrenal hyperplasia in which the adrenal glands do not produce sufficient steroid hormones (combined glucocorticoid and mineralocorticoid deficiency)",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Allergic bronchopulmonary aspergillosis is characterized by all EXCEPT A. Bronchial asthma | B. Pleural effusion | C. Centra bronchiectasis | D. Not respond to steroid",
      "answer": "The correct answer is **B. Pleural effusion**.\n\nHere's why:\n\n*   **Allergic bronchopulmonary aspergillosis (ABPA)** is an inflammatory lung disease that occurs in people with a hypersensitivity to the fungus *Aspergillus fumigatus*.\n*   **A. Bronchial asthma:** This is a hallmark of ABPA. Patients with ABPA often have a history of or develop asthma-like symptoms.\n*   **C. Central bronchiectasis:** This is another characteristic feature. The inflammation caused by the allergic reaction leads to damage and widening of the airways, particularly those closer to the center of the lungs.\n*   **D. Not respond to steroid:** Corticosteroids are a cornerstone of ABPA treatment. They help to suppress the inflammatory response and improve symptoms. Therefore, ABPA typically *does* respond to steroids.\n*   **B. Pleural effusion:** While other lung conditions can cause pleural effusion (fluid in the space between the lungs and chest wall), it is **not** a typical or characteristic feature of ABPA.",
      "ground_truth": "Not respond to steroid || (Not respond to steroid) (241-CMDT-10) (1259-H17th)* High doses of prednisone for at least 2 months is treatment of choice\"* ABPA occurs in atopic asthmatic (particularly glucocorticoid dependent) individuals of age 20-40 years and non asthmatic individuals eg cystic fibrosisDiagnostic criteria for Bronchopulmoanry-AspergillosisPrimarySecondaryi. A clinical h/o Asthma**ii. Peripheral eosinophilea**iii. Immediate skin reactivity to aspergillus antigeniv. Precipitating Ab to aspergillus antigenv. |S.IgEvi. Pulmonary infiltrates* (transient or fixed)vii. Central bronchiectasis*** Identification of Asp.antigin sputum* H/o brown flesked sputum* Late skin reactivity to asp.antigen* Patients with corticosteroid dependent may benefited from itraconazole without toxicity* TRANSDATES PLEURAL EFFUSION (283-CMDT-10) causes CHF (90% of cases), cirrhosis with ascites, Nephrotic syndrome, peritoneal dialysis, Myxedema, Acute atlectasis, constrictive pericarditis, SVC obstruction, pulmonary embolism* Pleural tapping in mid-axillary line, muscle NOT pierced is Transversus thoracis (Sternocostalis)**",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Normal pregnancy can be continued in aEUR' A. Primary pulmonary hypeension | B. Wolf-Parkinson-White syndrome | C. Eisenmenger syndrome | D. Marfan syndrome with dilated aoic root",
      "answer": "The correct answer is **B. Wolff-Parkinson-White syndrome**.\n\nHere's why:\n\n*   **Wolff-Parkinson-White (WPW) syndrome** is a condition where there's an extra electrical pathway in the heart. While it can cause arrhythmias, it is generally considered compatible with a normal pregnancy, with careful monitoring and management.\n\nLet's look at why the other options are generally not compatible with a normal pregnancy:\n\n*   **A. Primary pulmonary hypertension:** This is a severe condition characterized by high blood pressure in the arteries of the lungs. Pregnancy significantly increases the workload on the heart and lungs, making primary pulmonary hypertension extremely dangerous and often contraindicated for pregnancy due to a high risk of maternal mortality.\n*   **C. Eisenmenger syndrome:** This is a complex congenital heart defect that leads to irreversible pulmonary hypertension and shunting of blood. Pregnancy in women with Eisenmenger syndrome is associated with very high maternal and fetal mortality rates and is generally contraindicated.\n*   **D. Marfan syndrome with dilated aortic root:** Marfan syndrome is a genetic disorder affecting connective tissue. A dilated aortic root is a serious complication that increases the risk of aortic dissection or rupture. Pregnancy places significant stress on the cardiovascular system, and a dilated aortic root significantly elevates the risk of life-threatening cardiovascular events during pregnancy. Therefore, pregnancy is often contraindicated in such cases.",
      "ground_truth": "Wolf-Parkinson-White syndrome || Wolf Parkinson-While syndrome Marfan's syndrome Ideally, a patient with Marfan's syndrome contemplating pregnancy should have a preconceptional echocardiography to determine the diameter of the aoic root risk depends upon the diagmeter of aoic root. If it is greater than 4.0 cm, she is at significant risk for aoic dissection and she should be offered surgery. If the patient is in early pregnancy, she should be informed that termination of pregnancy is an option. Eisenmengher syndrome & Pulmonary hypeension Pulmonary vascular disease whether secondary to a reversed large left to right shunt such as VSD, Eisenmenger's syndrome or lung or connective tissue disease (e.g., scleroderma) or due to primary pulmonary hyeension is extremely dangerous in pregnancy and women known to have significant pulmonary vascular disease should be adviced from an early age to avoid pregnancy and be given appropriate contraceptive advice. Arias says \"Pregnancy is deleterious to patients with primary pulmonary hypeension. The maternal moality is approximately 40% and the fetal outcome is also poor with frequent spontaneous aboions and fetal demises secondary to maternal deaths.\" According to Dutta, Absolute indications for termination of pregnancy are:? a) Primary pulmonary hypeension b) Eisenmengers syndrome c) Pulmonary veno-occlusive disease Relative indications are a) Parous woman with grade HI and grade IV cardiac lesions. b) Grade I or II with previous history of cardiac failure in early month or in between pregnancy. The termination should be done within 12 weeks by suction evacuation (MVA) or by conventional D & E.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All are true about hypertrophic obstructive cardiomyopathy except A. Assymetrical septal hypertrophy | B. Systolic ventricular dysfunction is absent | C. Anterior leaflet movement is delayed | D. Cardiac output is diminished",
      "answer": "The correct answer is **B. Systolic ventricular dysfunction is absent**.\n\nHere's why:\n\n*   **A. Asymmetrical septal hypertrophy:** This is a hallmark feature of hypertrophic obstructive cardiomyopathy (HOCM). The septum (the wall between the ventricles) is significantly thicker than the free wall of the left ventricle.\n*   **B. Systolic ventricular dysfunction is absent:** This is **false**. In HOCM, while the primary issue is often diastolic dysfunction (impaired relaxation and filling), systolic function can also be affected, especially in more advanced stages or with significant obstruction. The thickened muscle can contract forcefully, but the obstruction can impede effective ejection of blood.\n*   **C. Anterior leaflet movement is delayed:** This refers to the systolic anterior motion (SAM) of the anterior mitral valve leaflet. This is a characteristic finding in HOCM, where the anterior leaflet of the mitral valve is pulled towards the septum during systole, contributing to the obstruction.\n*   **D. Cardiac output is diminished:** This is **true**. The obstruction to outflow caused by the thickened septum and SAM of the mitral valve significantly impedes the heart's ability to pump blood effectively, leading to a reduced cardiac output.\n\nTherefore, the statement that is **not** true about hypertrophic obstructive cardiomyopathy is that systolic ventricular dysfunction is absent.",
      "ground_truth": "Anterior leaflet movement is delayed ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Nitrates are not used in? A. CHF | B. Cyanide poisioning | C. renal colic | D. Esophageal spasm",
      "answer": "The correct answer is **B. Cyanide poisoning**.\n\nHere's why:\n\n*   **Nitrates** are primarily used to treat conditions related to vasodilation, such as angina (chest pain due to reduced blood flow to the heart), heart failure (CHF), and esophageal spasms. They work by relaxing and widening blood vessels.\n*   **Cyanide poisoning** is a medical emergency where cyanide interferes with cellular respiration, preventing cells from using oxygen. The treatment for cyanide poisoning involves antidotes that bind to cyanide and help the body eliminate it, or that restore cellular respiration. Nitrates would not be beneficial and could potentially worsen the situation by causing a drop in blood pressure.\n*   **CHF (Congestive Heart Failure)**: Nitrates can be used to reduce the workload on the heart and improve symptoms in CHF by dilating blood vessels.\n*   **Renal colic**: While not a primary treatment, nitrates can sometimes be used adjunctively in renal colic to help relax the ureters and potentially facilitate the passage of kidney stones.\n*   **Esophageal spasm**: Nitrates are effective in relieving the pain and spasms of the esophagus by relaxing the smooth muscle.",
      "ground_truth": "renal colic || C; renal colic",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "The most impoant cause of the death in septic shock is- A. Renal failure | B. Cardiac failure | C. Respiratory failure | D. DIC",
      "answer": "The most important cause of death in septic shock is **D. DIC (Disseminated Intravascular Coagulation)**.\n\nHere's why:\n\n*   **Septic shock** is a life-threatening condition that occurs when a severe infection leads to dangerously low blood pressure and organ dysfunction.\n*   **DIC** is a serious complication of sepsis. In DIC, the body's clotting system becomes overactive, leading to the formation of small blood clots throughout the bloodstream. This consumes clotting factors and platelets, paradoxically leading to both excessive clotting and bleeding.\n*   The widespread clotting in DIC can block blood flow to vital organs, causing them to fail. The subsequent bleeding can also be severe and difficult to control.\n\nWhile renal failure, cardiac failure, and respiratory failure are all serious complications that can occur in septic shock and contribute to mortality, DIC is often the underlying mechanism that drives the multi-organ failure and ultimately leads to death.",
      "ground_truth": "Cardiac failure || Hypotension is the most common cause of death in septic shock Cardiac output is decreased in septic shock, leading to hypotension Ref: Sabiston 20th edition Pgno :554",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All of the following are features of Friadreich's Ataxia, Except: A. Prograssive Ataxia is the most common presentation | B. Cardiomyopathy is a common association | C. Diabetes mellitus may be associated | D. Extensor plantar with brisk lower limb reflexes.",
      "answer": "The correct answer is **D. Extensor plantar with brisk lower limb reflexes.**\n\nHere's why:\n\n*   **Friedreich's Ataxia (FA)** is a rare, inherited neurodegenerative disorder that affects the nervous system. It primarily impacts the cerebellum, spinal cord, and peripheral nerves.\n\nLet's break down why the other options are features of FA:\n\n*   **A. Progressive Ataxia is the most common presentation:** This is a hallmark symptom of FA. Patients typically experience a gradual worsening of their coordination and balance, leading to difficulty walking and performing fine motor tasks.\n*   **B. Cardiomyopathy is a common association:** Hypertrophic cardiomyopathy is a frequent complication of FA, affecting a significant percentage of individuals with the condition.\n*   **C. Diabetes mellitus may be associated:** While not as common as cardiomyopathy, diabetes mellitus can occur in individuals with FA, particularly in later stages of the disease.\n\nNow, let's explain why option D is the exception:\n\n*   **D. Extensor plantar with brisk lower limb reflexes:** In FA, the damage to the nervous system typically leads to **absent or diminished** deep tendon reflexes (like the knee-jerk reflex) and a **flexor plantar response** (toes curl downwards when the sole of the foot is stroked). An **extensor plantar response** (Babinski sign, where the big toe extends upwards and other toes fan out) and **brisk reflexes** are indicative of upper motor neuron lesions, which are not the primary pathology in Friedreich's Ataxia. Instead, FA is characterized by lower motor neuron and cerebellar dysfunction.",
      "ground_truth": "Extensor plantar with brisk lower limb reflexes. || Answer is D (Extensor plantar with brisk lower limb reflexes): Friedreich's Ataxia, is characteristically associated with an extensor plantar response but absent lower limb reflexes. Lower limb reflexes are characteristically absent (in most patients) and not brisk. Cardiomyopathy is a common association seen in up to 90% of patients Diabetes mellitus may be associated in up to 25% of cases Progressive ataxia is the most common presenting symptom.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "In a patient post myocardial infarction developed arrial fibrillation. Subsequently the ECHO showed a mural thrombus. The management is by A. Warfarin | B. Cardioversion | C. Digoxin | D. Propranolol",
      "answer": "The correct answer is **A. Warfarin**.\n\nHere's why:\n\n*   **Mural thrombus** (a blood clot attached to the wall of the heart chamber) in the setting of atrial fibrillation after a myocardial infarction indicates a high risk of systemic embolization (blood clot traveling to other parts of the body, potentially causing stroke or other organ damage).\n*   **Warfarin** is an anticoagulant medication that is the cornerstone of treatment for patients with atrial fibrillation and a mural thrombus. Its primary goal is to prevent the formation of new clots and reduce the risk of embolization.\n\nLet's look at why the other options are less appropriate as the *primary* management for the mural thrombus:\n\n*   **B. Cardioversion:** This is a procedure to restore a normal heart rhythm. While it might be considered for the atrial fibrillation itself, it does not directly address the existing mural thrombus and can even increase the risk of embolization if the thrombus is not adequately anticoagulated beforehand.\n*   **C. Digoxin:** This medication is used to control the heart rate in atrial fibrillation, but it does not prevent clot formation or treat an existing thrombus.\n*   **D. Propranolol:** This is a beta-blocker that can also help control heart rate in atrial fibrillation, but like digoxin, it does not address the mural thrombus.\n\n**In summary:** The presence of a mural thrombus in a patient with atrial fibrillation post-MI necessitates anticoagulation to prevent serious embolic complications. Warfarin is the standard treatment for this indication.",
      "ground_truth": "Warfarin || (A) Warfarin # Patients with an anterior location of the infarction, severe LV dysfunction, CHF, a history of embolism, two-dimensional echocardiographic evidence of mural thrombus, or atrial fibrillation are at increased risk of systemic or pulmonary thromboembciism.> Such individuals should receive full therapeutic levels of antithrombin therapy (UFH or LMWHs) while hospitalized, followed by at least 3 months of warfarin therapy.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All are seen in diphtheric outcome except A. Pseudomembrane formation | B. Cardiomyopathy | C. Endotoxemia | D. Polyneuropathy",
      "answer": "The correct answer is **C. Endotoxemia**.\n\nHere's why:\n\n*   **Diphtheria** is caused by the bacterium *Corynebacterium diphtheriae*. This bacterium produces a potent toxin.\n*   **A. Pseudomembrane formation:** This is a hallmark of diphtheria, particularly in the throat. The toxin causes inflammation and the formation of a thick, gray, adherent membrane composed of dead cells, fibrin, and bacteria.\n*   **B. Cardiomyopathy:** Diphtheria toxin can affect the heart muscle, leading to myocarditis and subsequent cardiomyopathy. This is a serious complication.\n*   **D. Polyneuropathy:** The diphtheria toxin can also damage peripheral nerves, causing a demyelinating polyneuropathy. This can manifest as weakness, paralysis, and sensory disturbances.\n*   **C. Endotoxemia:** Endotoxemia refers to the presence of endotoxins in the bloodstream. Endotoxins are lipopolysaccharides found in the outer membrane of Gram-negative bacteria. *Corynebacterium diphtheriae* is a Gram-positive bacterium and does not produce endotoxins. Therefore, endotoxemia is not a feature of diphtheria.",
      "ground_truth": "Endotoxemia ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Continuous murmur is present in A. cardiomyopathy | B. MS | C. PDA | D. cardiac tamponade",
      "answer": "The correct answer is **C. PDA**.\n\nHere's why:\n\n*   **PDA (Patent Ductus Arteriosus):** This is a congenital heart defect where the ductus arteriosus, a blood vessel that connects the aorta and pulmonary artery in a fetus, fails to close after birth. This allows oxygenated blood from the aorta to flow into the pulmonary artery, creating a continuous murmur that is often described as \"machinery-like\" and is heard throughout the cardiac cycle (systole and diastole).\n\nLet's look at why the other options are less likely to present with a *continuous* murmur:\n\n*   **A. Cardiomyopathy:** Cardiomyopathy refers to diseases of the heart muscle. While it can cause various murmurs (e.g., due to valve dysfunction or turbulent blood flow), a continuous murmur is not a defining characteristic.\n*   **B. MS (Mitral Stenosis):** Mitral stenosis is a narrowing of the mitral valve. This typically causes a diastolic murmur, meaning it's heard during the relaxation phase of the heart (diastole), not continuously.\n*   **D. Cardiac Tamponade:** Cardiac tamponade is a medical emergency where excess fluid builds up in the pericardial sac, compressing the heart. While it can cause muffled heart sounds and signs of shock, a continuous murmur is not a typical finding. The primary issue is impaired filling of the heart chambers.",
      "ground_truth": "PDA || A continuous murmur is predicated on a pressure gradient that persists between two cardiac chambers or blood vessels across systole and diastole.The murmurs <NL> typically begin in systole, envelop the second heart sound (S 2 ), and continue through some portion of diastole. <NL> They can often be difficult to distinguish from individual systolic and diastolic murmurs in patients with mixed valvular heart disease. <NL> The classic example of a continuous murmur is that associated with a patent ductus arteriosus, which usually is heard in the second or third interspace at a slight distance from the sternal border. Other causes of a continuous murmur include a ruptured sinus of Valsalva aneurysm with creation of an aorticright atrial or right ventricular fistula, a coronary or great vessel arteriovenous fistula, and an arteriovenous fistula constructed to provide dialysis access.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All the following are Causes of acute renal failure except A. Hypovolemia | B. Rhadomyolysis | C. Snake bite | D. Pyelonephritis",
      "answer": "The correct answer is **D. Pyelonephritis**.\n\nHere's why:\n\n*   **Acute Renal Failure (ARF)**, also known as Acute Kidney Injury (AKI), is a sudden loss of kidney function.\n*   **Hypovolemia** (low blood volume) leads to decreased blood flow to the kidneys, causing pre-renal ARF.\n*   **Rhabdomyolysis** (muscle breakdown) releases myoglobin, which is toxic to the kidneys and can cause intrinsic ARF.\n*   **Snake bites** can cause ARF through various mechanisms, including direct nephrotoxicity, rhabdomyolysis, or venom-induced coagulopathy leading to kidney damage.\n*   **Pyelonephritis** is an infection of the kidney. While severe or chronic pyelonephritis can lead to kidney damage over time, it is typically a cause of **chronic** kidney disease rather than acute renal failure. Acute pyelonephritis itself usually doesn't cause a sudden, complete loss of kidney function unless there are complications like sepsis or obstruction.",
      "ground_truth": "Pyelonephritis || Other Causes : <NL> Congestive cardiac failure. <NL> NSAIDs. <NL> Cyclosporine. <NL> Acute glomerulonephritis.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All of the following are true about staing betablocker therapy in cases of CHF, Except A. They should be initiated at the effective doses | B. They should be gradually increased over weeks | C. Special precautions should be taken in NYHA class III & IV | D. Carvedilol and Metoprolol are the preferred drugs",
      "answer": "The correct answer is **A. They should be initiated at the effective doses**.\n\nHere's why:\n\n*   **A. They should be initiated at the effective doses:** This is **false**. Beta-blockers in heart failure (CHF) should be initiated at very low doses and gradually increased. This is crucial to avoid worsening heart failure symptoms, bradycardia, and hypotension.\n*   **B. They should be gradually increased over weeks:** This is **true**. The titration of beta-blockers in CHF is a slow process, often taking weeks to months, to allow the heart to adapt to the medication and reach the target dose.\n*   **C. Special precautions should be taken in NYHA class III & IV:** This is **true**. Patients with more severe heart failure (NYHA class III and IV) are at higher risk of decompensation when starting or increasing beta-blocker therapy. They require even more careful monitoring and slower titration.\n*   **D. Carvedilol and Metoprolol are the preferred drugs:** This is **true**. Carvedilol and metoprolol succinate are the beta-blockers that have demonstrated mortality benefit in large clinical trials for patients with CHF and are therefore considered the preferred agents.\n\n**Explanation:**\n\nThe initiation and titration of beta-blockers in heart failure are a cornerstone of management, but they require a cautious approach. The goal is to gradually introduce the medication to allow the heart to adapt and to avoid precipitating acute heart failure exacerbations. Starting at effective doses would likely lead to significant adverse effects and is contraindicated.",
      "ground_truth": "They should be initiated at the effective doses || Answer is A (They should be initiated at the effective doses) Beta blocker should be initiated at lower than effective doses in CHF Beta blockers should be initiated at lower than effective doses in CHF and be 'Beta blockers should be initiated at low doses followed by gradual increments in the dose if lower doses have been well tolerated. The dose of beta blockers should be increased until the doses used are similar to those that have been repoed effective in clinical trials. The titration of beta blockers should proceed no more rapidly than at 2 week intervals because the initiation and / or increased dosing of these agents may lead to worsening fluid retention' -- Harrison's 17th/1450 Special precaution should be taken in NYHA class III & IV 'Although data suggests that patients with NYHA class IHB and IV CHF may tolerate beta blockers and benefit from their use, this group of patients should be approached with considerable caution' --Goodman & Gillman's Manual of Pharmacology (2007)/570 Carvedilol and Metoprolol are the preferred beta blockers in CHF `Non selective third generation beta blockers (Bucindolol, Carvedilol) as well a the Beta-I selective agent (Metoprolol) are generally well tolerated by patients with CHF'. -'Current Diagnosis & Treatment in Cardiology' 3,1/217",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Orthopnea is heart failure develops due to A. Reservoir function of pulmonary veins | B. Reservoir function of leg veins | C. Reservoir function of pulmonary arteries | D. Reservoir function of leg arteries",
      "answer": "The correct answer is **A. Reservoir function of pulmonary veins**.\n\n**Explanation:**\n\nOrthopnea is the sensation of breathlessness that occurs when lying flat and is relieved by sitting or standing up. It is a classic symptom of heart failure.\n\nHere's why the reservoir function of the pulmonary veins is involved:\n\n*   **Heart Failure and Pulmonary Congestion:** In heart failure, the heart's pumping ability is weakened. This leads to a backup of blood in the circulatory system.\n*   **Pulmonary Veins as Reservoirs:** The pulmonary veins carry oxygenated blood from the lungs to the left atrium of the heart. When the left side of the heart is unable to effectively pump blood forward, blood can back up into the pulmonary veins. These veins have a certain capacity to hold blood (reservoir function).\n*   **Effect of Lying Down:** When a person with heart failure lies down, gravity no longer assists in returning blood from the lower extremities to the heart. This increased venous return, combined with the already compromised pumping function of the heart, causes more blood to pool in the pulmonary circulation, specifically in the pulmonary veins.\n*   **Increased Pulmonary Vascular Pressure:** The increased volume of blood in the pulmonary veins leads to increased pressure within these vessels and subsequently in the capillaries of the lungs.\n*   **Fluid Transudation:** This elevated pressure forces fluid from the capillaries into the interstitial spaces of the lungs and eventually into the alveoli. This is known as pulmonary edema.\n*   **Orthopnea:** The presence of fluid in the lungs impairs gas exchange and makes breathing difficult, leading to the sensation of shortness of breath (dyspnea) when lying flat. When the person sits or stands up, gravity helps to shift blood away from the pulmonary circulation, reducing the congestion and relieving the orthopnea.\n\n**Why the other options are incorrect:**\n\n*   **B. Reservoir function of leg veins:** While leg veins do have reservoir function and can hold a significant amount of blood, their role in orthopnea is indirect. Increased venous return from the legs can contribute to the overall blood volume returning to the heart, but the direct congestion that causes orthopnea occurs in the pulmonary circulation.\n*   **C. Reservoir function of pulmonary arteries:** Pulmonary arteries carry blood from the right ventricle to the lungs. While they are part of the pulmonary circulation, their primary role is not as a reservoir that directly leads to orthopnea when compromised in this way.\n*   **D. Reservoir function of leg arteries:** Arteries are high-pressure vessels that carry blood away from the heart. They do not function as reservoirs in the way veins do, and their reservoir function is not directly implicated in the development of orthopnea.",
      "ground_truth": "Reservoir function of pulmonary arteries || When a normal individual lies down, the pulmonary blood volume increases by up to 400 mL <NL> When the person stands up this blood is discharged into the general circulation. <NL> This shift is the cause of the decrease in vital capacity in the supine position and is responsible for the occurrence of orthopnea in heart failure.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 50-year-old man with aortic stenosis is doing exercise for 11 minutes according to Bruce protocol. Exercise had to be stopped due to fatigue. He had a peak sytolic gradient of 60 mmHg across the aortic valve at rest. What is the best management for this patient? A. Medical management | B. Aortic valve replacement | C. Aortic valve balloon dilatation to prevent further worsening | D. Coronary angiography",
      "answer": "The best management for this patient is **B. Aortic valve replacement**.\n\nHere's why:\n\n*   **Aortic Stenosis (AS):** The patient has aortic stenosis, which means the aortic valve is narrowed, restricting blood flow from the left ventricle to the aorta.\n*   **Symptoms and Exercise Intolerance:** The fact that he had to stop exercising due to fatigue is a significant symptom of AS. Exercise intolerance is a key indicator that the AS is hemodynamically significant and impacting his quality of life and potentially his prognosis.\n*   **Peak Systolic Gradient:** A peak systolic gradient of 60 mmHg across the aortic valve at rest is considered moderate to severe AS. While not the most severe, combined with symptoms, it warrants intervention.\n*   **Bruce Protocol:** The Bruce protocol is a standardized exercise test used to assess cardiovascular function. Stopping at 11 minutes due to fatigue suggests his heart is struggling to meet the increased demands of exercise due to the stenotic valve.\n\n**Explanation of why other options are less suitable:**\n\n*   **A. Medical management:** Medical management for AS primarily focuses on symptom relief and managing comorbidities. It does not address the underlying mechanical problem of the stenotic valve. While medications might be used to manage symptoms like heart failure if they arise, they won't fix the stenosis itself.\n*   **C. Aortic valve balloon dilatation to prevent further worsening:** Aortic valve balloon dilatation is a palliative procedure that can temporarily open a stenotic valve. However, it is generally not a durable solution, especially in adults with calcific AS, and the stenosis often recurs. It is more commonly used in specific situations like congenital AS in children or as a bridge to definitive therapy. It does not prevent further worsening in the long term as effectively as replacement.\n*   **D. Coronary angiography:** Coronary angiography is used to assess the coronary arteries for blockages. While it's important to rule out significant coronary artery disease in patients undergoing cardiac procedures, it is not the primary management strategy for aortic stenosis itself. The patient's symptoms are directly attributable to the aortic valve, not necessarily his coronary arteries.\n\n**In summary:** A symptomatic patient with moderate to severe aortic stenosis, as indicated by the exercise intolerance and gradient, is a strong candidate for aortic valve replacement to relieve symptoms, improve quality of life, and improve survival.",
      "ground_truth": "Aortic valve replacement || Ans. b > a (Aortic valve replacement > Medical Management) (Ref: ACC/AHA guidelines; European Cardiology Society Guidelines: http:// circ. ahajountals.org/ content/ 122/17/ 1734.full.pdf+html; Braunwald's Heart Disease: 9/e p1474)The patient in question has asymptomatic aortic stenosis but develops symptoms on exercise (abnormal/positive exercise test). Also the presence of mean pressure gradient of 60mm Hg put this patient into the category of 'Very Severe Aortic Stenosis' or 'Critical Aortic Stenosis'.Optimal management of asymptomatic severe Aortic Stenosis continues to be a source of ongoing clinical controversy. Surgical Aortic Valve Replacement and Watchful waiting with frequent reassessments (observation), both continue to be legitimate though debatable treatment options. Since the patient in question has 'Very Severe AS' and 'Abnormal Stress Testing' he should be considered for surgical intervention in the form of Aortic Valve Replacement (AVR).50-year-old patient with Asymptomatic Severe Aortic StenosisPositive Exercise Stress TestMean Pressure Gradient > 60 mm HgSymptoms during exercise such as dyspnea, angina, and syncope or near syncope constitute positive criteria indicating an abnormal stress test in patients with asymptomatic aortic stenosis.Mean pressure gradient >60 mm Hg and or aortic valve area < 0.6 cm2 and /or aortic jet velocity >5.0 m per second is classified as 'Extremely Severe Aortic Stenosis' (Critical Aortic Stenosis)Severe aortic stenosis with an abnormal response to exercise is considered a Class lIb indication for aortic valve replacement according to the ACC/AHA Guidelines.' Severe aortic stenosis with an abnormal response to exercise is considered a Class IC indication for aortic valve replacement according to European Cardiology Society Guidelines (ECS Guidelines)''Extremely severe aortic stenosis (mean gradient > 60 mm Hg) is considered a class lIb indication for aortic valve replacement according to the ACC/AHA Guidelines.' Indications of AVR in Asymptomatic Severe Aortic StenosisClass IClass lIb* Patients undergoing cardiac surgery for other indications (Coronary artery bypass graft surgery or aortic surgery)* Left ventricular ejection fraction <_50 %* Abnormal hemodynamic response to exercise (Symptoms or asymptomatic hypotension)* High probability of rapid progression (Age, Calcification, Concomitant CAD)* Asymptomatic 'very severe AS'",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 63-year-old man who has been previously healthy is admitted to the hospital with a 2-day history of cough, rigors, fever, and right-sided pleuritic chest pain. Chest x-ray shows consolidation of the right lower lobe (RLL) and a free-flowing right pleural effusion. Thoracentesis is performed, and the pleural fluid has the following characteristics:Cell count=1110/mm3Glucose=75 mg/dL (serum glucose=85 mg/dL)Protein=4.0 g/dL (serum protein=7.0 g/dL)LDH=400 U/Lserum LDH=200 U/L, normal=100-200 U/LpH=7.35What is the pathogenesis of the pleural effusion? A. Increase in hydrostatic pressure | B. Decrease in oncotic pressure | C. Increased permeability of visceral pleural membrane capillaries | D. Bacterial infection in the pleural space",
      "answer": "The correct answer is **D. Bacterial infection in the pleural space**.\n\nHere's why:\n\n*   **Understanding Pleural Effusions:** Pleural effusions are abnormal collections of fluid in the pleural space. They are broadly classified as transudates or exudates.\n    *   **Transudates** are caused by systemic factors that alter hydrostatic or oncotic pressures (e.g., heart failure, cirrhosis, nephrotic syndrome).\n    *   **Exudates** are caused by local factors that increase pleural permeability or directly introduce fluid into the pleural space (e.g., inflammation, infection, malignancy).\n\n*   **Analyzing the Pleural Fluid:** The provided pleural fluid characteristics are crucial for classification:\n    *   **Cell Count (1110/mm):** This is elevated, suggesting an inflammatory or infectious process.\n    *   **Protein (4.0 g/dL):** This is significantly higher than what would be expected in a transudate. The **Light's criteria** are used to differentiate between transudates and exudates. One of the criteria is a pleural fluid protein to serum protein ratio > 0.5. In this case, 4.0/7.0 = 0.57, which meets this criterion.\n    *   **LDH (400 U/L):** This is elevated. Another of Light's criteria is a pleural fluid LDH to serum LDH ratio > 0.6. Here, 400/200 = 2.0, which also meets this criterion.\n    *   **Glucose (75 mg/dL):** While not extremely low, a pleural fluid glucose < 60 mg/dL is suggestive of an exudate, especially if it's significantly lower than serum glucose. In this case, the glucose is similar to serum, which doesn't strongly point to infection but doesn't rule it out.\n    *   **pH (7.35):** A pleural fluid pH < 7.30 is often seen in complicated parapneumonic effusions or empyema, indicating a more severe inflammatory or infectious process. A pH of 7.35 is borderline but leans towards an exudative process.\n\n*   **Connecting to the Clinical Presentation:** The patient's symptoms of cough, rigors, fever, and pleuritic chest pain, along with the chest x-ray showing consolidation and effusion, are highly suggestive of **pneumonia with a parapneumonic effusion**. A parapneumonic effusion is an effusion that develops in the setting of pneumonia.\n\n*   **Evaluating the Options:**\n    *   **A. Increase in hydrostatic pressure:** This is a cause of transudative effusions, which is not supported by the pleural fluid analysis.\n    *   **B. Decrease in oncotic pressure:** This is also a cause of transudative effusions, not supported by the fluid analysis.\n    *   **C. Increased permeability of visceral pleural membrane capillaries:** While increased permeability is a mechanism for exudate formation, it's often a consequence of an underlying process like infection or inflammation. Option D is more specific to the likely cause.\n    *   **D. Bacterial infection in the pleural space:** This is the most likely pathogenesis. The pneumonia has likely led to inflammation and exudation into the pleural space, potentially with direct bacterial invasion or a reactive inflammatory response. The elevated protein, LDH, and the clinical picture strongly support this.\n\n**In summary, the pleural fluid analysis, particularly the elevated protein and LDH, along with the clinical presentation of pneumonia, points to an exudative effusion caused by a bacterial infection in the pleural space (or a parapneumonic effusion secondary to pneumonia).**",
      "ground_truth": "Increased permeability of visceral pleural membrane capillaries || Clinical conditions associated with either an increase in hydrostatic pressure (such as congestive heart failure) or a decrease in oncotic pressure (such as nephrotic syndrome) are associated with transudative pleural effusions. This patient's pleural fluid is exudative by all three of the Light criteria: pleural fluid/serum protein ratio is greater than 0.5, pleural fluid LDH/serum LDH ratio is greater than 0.6, and pleural fluid LDH is greater than two-thirds the upper limits of the normal serum LDH. The most likely explanation for an exudative pleural effusion in the setting of an acute pneumonia is a parapneumonic effusion. Parapneumonic effusions occur in about 40% of patients with bacterial pneumonia. Parapneumonic effusions are exudative due to the fact that there is increased permeability of the visceral pleural membrane capillaries, and interstitial fluid moves across the visceral pleura into the pleural space. Parapneumonic effusions may be simple or complicated. Simple parapneumonic effusions are sterile and free flowing. If bacteria invade the pleural space, neutrophils move into the pleural space and anaerobic metabolism of glucose results in a low pleural fluid pH (<7.20) and glucose (<60). The characteristics of this patient's pleural fluid suggest that bacterial invasion of the pleural space has not occurred, and that this is a simple parapneumonic effusion. Hemorrhage into the pleural space occurs with trauma, cancer, and pulmonary embolism, but rarely with pneumonia.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Cardiomyopathy is caused by A. Actinomycin D | B. Doxorubicin | C. Mitomycin C | D. Mitoxantrone",
      "answer": "The correct answer is **B. Doxorubicin**.\n\n**Explanation:**\n\nDoxorubicin is an anthracycline chemotherapy drug that is well-known for its cardiotoxic side effects, which can lead to cardiomyopathy. This is a serious concern during treatment with doxorubicin, and patients are often monitored for cardiac function.\n\nThe other options are less commonly associated with causing cardiomyopathy:\n\n*   **A. Actinomycin D:** While it can have side effects, cardiotoxicity is not a primary or frequent concern.\n*   **C. Mitomycin C:** This drug is also associated with various toxicities, but cardiomyopathy is not a prominent or common side effect.\n*   **D. Mitoxantrone:** While mitoxantrone can have cardiac side effects, it is generally considered less cardiotoxic than doxorubicin. However, it can still contribute to cardiac dysfunction.\n\nTherefore, among the given options, **Doxorubicin** is the most definitively and commonly recognized cause of cardiomyopathy.",
      "ground_truth": "Doxorubicin || Ref: Katzung 14th ed. pg. 964-65; KDTy 6th ed. pg. 826-27* Doxorubicin and daunorubicin are anti-tumor antibiotics. Activity of Daunorubicin is limited to acute leukemia while doxorubicin is effective in several solid tumors.# MOA: Cause breaks in DNA strands by activating topoisomerse II and generating quinolone type free radicals.# Doxrorubicin and daunorubicin both these antibiotics produce cardiotoxicity as a unique adverse effect.* Actinomycin D (Dactinomycin) It is a very potent antineoplastic drug, highly efficacious in Wilms' tumour and rhabdomyosarcoma# Prominent adverse effects are vomiting, stomatitis, diarrhoea, erythema and desquamation of skin, alopecia and bone marrow depression* Mitoxantrone: Recently introduced analogue of doxorubicin with lower cardiotoxicity, probably because it does not produce quinine type free radicals. Though cardiomyopathy can occur, major toxicity is marrow depression and mucosal inflammation.* Mitomycin C: This highly toxic drug is used only in resistant cancers of stomach, cervix, colon, rectum, bladder, etc# Bone marrow and GIT are the primary targets of toxicity.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Restrictive and constrictive cardiomyopathy occurs together in A. Radiation | B. Adriamycin | C. Post cardiotomy | D. Amyloidosis",
      "answer": "The correct answer is **D. Amyloidosis**.\n\nHere's why:\n\n*   **Amyloidosis** is a condition where abnormal proteins (amyloid) deposit in organs, including the heart. These deposits can stiffen the heart muscle (restrictive cardiomyopathy) and also thicken the heart walls, leading to impaired filling and relaxation (constrictive cardiomyopathy).\n\nLet's look at why the other options are less likely to cause both restrictive and constrictive cardiomyopathy simultaneously:\n\n*   **A. Radiation:** Radiation therapy to the chest can cause various cardiac issues, including fibrosis and thickening of the pericardium, which can lead to constrictive pericarditis. While it can affect myocardial function, it's less commonly associated with the simultaneous development of both restrictive and constrictive cardiomyopathy as the primary presentation.\n*   **B. Adriamycin (Doxorubicin):** This chemotherapy drug is known to cause a dose-dependent cardiomyopathy, primarily characterized by **dilated cardiomyopathy** and systolic dysfunction. While it can lead to heart failure, it's not typically associated with the restrictive and constrictive patterns seen in amyloidosis.\n*   **C. Post cardiotomy:** This refers to the period after open-heart surgery. While complications like pericardial effusion or tamponade can occur, leading to constrictive physiology, the primary issue isn't usually the development of both restrictive and constrictive cardiomyopathy as a direct, simultaneous consequence of the surgery itself.\n\nTherefore, amyloidosis is the condition most strongly associated with the co-occurrence of restrictive and constrictive cardiomyopathy.",
      "ground_truth": "Amyloidosis || The etiologies of RCM may be grouped into broad categories as follows: Primary/idiopathic: Endomyocardial fibrosis (EMF), loeffler eosinophilic endomyocardial disease Secondary: Infiltrative, amyloidosis (the most common cause of RCM in the United States), sarcoidosis , progressive systemic sclerosis (scleroderma) , hemochromatosis, , carcinoid hea disease, glycogen storage disease of the hea, radiation/treatment induced, metastatic malignancy, anthracycline toxicity Ref Davidson 23rd edition pg 467",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following drug have high volume of distribution of drug? A. Lipophilic | B. Hydrophilic | C. Highly protein bound | D. Drug with low therapeutic index",
      "answer": "The correct answer is **A. Lipophilic**.\n\nHere's why:\n\n*   **Volume of Distribution (Vd):** This is a pharmacokinetic parameter that represents the apparent volume into which a drug is distributed in the body. A high Vd means the drug distributes widely into tissues outside of the bloodstream.\n\n*   **Lipophilic Drugs:** These drugs are fat-soluble. They can readily cross cell membranes and accumulate in fatty tissues (like adipose tissue) and organs with high lipid content. This extensive distribution into tissues leads to a high volume of distribution.\n\nLet's look at why the other options are less likely to have a high volume of distribution:\n\n*   **B. Hydrophilic Drugs:** These drugs are water-soluble. They tend to remain in the bloodstream and extracellular fluid, as they have difficulty crossing lipid-rich cell membranes. This results in a lower volume of distribution.\n\n*   **C. Highly Protein Bound:** Drugs that are highly bound to plasma proteins (like albumin) are largely confined to the bloodstream. Only the unbound (free) drug can distribute into tissues. Therefore, high protein binding generally leads to a *lower* volume of distribution.\n\n*   **D. Drug with Low Therapeutic Index:** A low therapeutic index means the difference between the effective dose and the toxic dose is small. This is a measure of drug safety, not its distribution characteristics. While some drugs with low therapeutic indices might have high Vd, it's not a direct cause-and-effect relationship. The lipophilicity of the drug is the primary determinant of high Vd.",
      "ground_truth": "Lipophilic || Ans. A. Lipophilic. (Ref KDT 6th/pg. 19; Harrison's 17th edition, page 29)APPARENT VOLUME OF DISTRIBUTION (Theoretical volume occupied by the total absorbed drug amount at the plasma concentration.)# Vd = amount of drug in the body / plasma drug concentrationFactors governing the volume of drug distribution:# Lipid: Water partition Co-efficient of the drug: Lipid insoluble drugs do not enter cells - V approximates extracellular fluid volume, e.g. streptomycin, gentamicin 0.25L/kg.# pKa value of the drug.# Degree of plasma protein binding: The volume of distribution of drugs extensively bound to plasma proteins but not to tissue components approaches plasma volume (are largely restricted to the vascular compartment) and hence have low V values e.g. diclofenac and warfarin (99% bound) V = 0.15L/kg.# Affinity for different tissues: By contrast, for drugs highly bound to tissues, the volume of distribution can be far greater than any physiologic space. Thus, drugs sequestrated in tissues may have, V much more than total body water or even body mass, e.g. digoxin 6 L/kg, propranolol 4L/kg, morphine 3.5 L/kg, because most of the drug is present in other tissues and plasma concentration is low. Thus, in case of poisoning, drugs with large volume of distribution are not easily removed by hemodialysis.# Fat: lean body mass ratio, which can very with age, sex, obesity, etc.# Diseases like CHF, uremia, cirrhosisVd COMPARTMENT DRUG TYPESLowBlood (4-8 L)Large/charged molecules; plasma protein boundMediumECFSmall hydrophilic moleculesHighAll tissues including fatSmall lipophilic molecules, especially if bound to tissue proteinHarrison's 17th edition, page 29.............DRUG DISTRIBUTIONIn a typical 70-kg human, plasma volume is ~3 L, blood volume is ~5.5 L, and extracellular water outside the vasculature is ~42 L. The volume of distribution of drugs extensively bound to plasma proteins but not to tissue components approaches plasma volume; warfarin is an example. By contrast, for drugs highly bound to tissues, the volume of distribution can be far greater than any physiologic space. For example, the volume of distribution of digoxin and tricyclic antidepressants is hundreds of liters, obviously exceeding total-body volume. Such drugs are not readily removed by dialysis, an important consideration in overdose.Only when distribution is near-complete does the concentration of digoxin in plasma reflect pharmacologic effect. For this reason, there should be a 6-8 h wait after administration before plasma levels of digoxin are measured as a guide to therapy.Educational pointsClinical Implications of Altered Protein BindingThe acute-phase reactant ?l-acid glycoprotein binds to basic drugs, such as lidocaine or quinidine, and is increased in a range of common conditions, including myocardial infarction, surgery, neoplastic disease, rheumatoid arthritis, and burns. This increased binding can lead to reduced pharmacologic effects at therapeutic concentrations of total drug. Conversely, conditions such as hypoalbuminemia, liver disease, and renal disease can decrease the extent of drug binding, particularly of acidic and neutral drugs, such as phenytoin. Here, plasma concentration of free drug is increased, so drug efficacy and toxicity are enhanced if total (free + bound) drug concentration is used to monitor therapy.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All of the following statements regarding total anomalous pulmonary connection are true except  A. The total pulmonary venous blood reaches the right atrium | B. Always associated with a VSD | C. The oxygen saturation of the blood in the pulmonary artery is higher than that in the aorta | D. Infracardiac type is always obstructive",
      "answer": "The correct answer is **B. Always associated with a VSD**.\n\nHere's why:\n\n*   **A. The total pulmonary venous blood reaches the right atrium:** This is **true**. In total anomalous pulmonary venous connection (TAPVC), the pulmonary veins do not connect to the left atrium. Instead, they drain into a common venous collector that ultimately empties into the right atrium, either directly or indirectly through systemic veins.\n\n*   **B. Always associated with a VSD:** This is **false**. While a ventricular septal defect (VSD) is a common associated anomaly in TAPVC, it is **not always present**. The presence of a VSD can influence the hemodynamics and clinical presentation of TAPVC, but its absence does not rule out the diagnosis.\n\n*   **C. The oxygen saturation of the blood in the pulmonary artery is higher than that in the aorta:** This is **true**. Because all the oxygenated blood from the lungs returns to the right atrium and mixes with deoxygenated systemic venous blood, the blood that is then pumped into the pulmonary artery (via the right ventricle) will have a higher oxygen saturation than the blood in the aorta. This is due to shunting of oxygenated blood from the left atrium (or a pulmonary venous collector) to the right side of the heart.\n\n*   **D. Infracardiac type is always obstructive:** This is **true**. The infracardiac type of TAPVC, where the pulmonary venous collector drains below the diaphragm, is almost always associated with obstruction. This obstruction can occur at the level of the diaphragm, within the venous collector, or at the point of connection to the systemic venous circulation, leading to significant pulmonary venous hypertension and edema.\n\nTherefore, the statement that is **not true** regarding total anomalous pulmonary connection is that it is always associated with a VSD.",
      "ground_truth": "Always associated with a VSD || Hemodynamics of TAPVC <NL> <NL> TAPVC results in the pulmonary venous blood reaching the right atrium which also receives the systemic venous blood. <NL> This results in volume overload to right atrium -p Right atrial enlargement. <NL> Larger volume of blood reaches the right ventricle --> Right ventricle enlargement. <NL> The blood flow to the left atrium is through patent foramen ovale or ASD. <NL> Because there is mixing of unoxygenated blood from systemic circulation and oxygenated blood from pulmonary circulation in the right atrium > The oxygen saturation of blood in pulmonary artery is higher or identical to that in Aorta. <NL> TAPVC can be divided into : - <NL> <NL> i) TAPVC with pulmonary venous obstruction <NL> <NL> Pulmonary venous obstruction results in pulmonary arterial hypertension. Pulmonary obstruction > T back pressure > 1' Pulmonary capillary pressure <NL> <NL> T Pulmonary artery pressure <NL> u Because of pulmonary venous obstruction oxygenated blood cannot reach heart > Cyanosis and CHF during first week of life. <NL> ii) TAPVC without obstruction (more common) <NL> <NL> In TAPVC without obstruction, pulmonary blood flow is high. <NL> Patients develops CHF at around 6-8 weeks when the fetal pulmonary resistance falls maximally and pulmonary circulation reaches the maximum. <NL> Infracardiac type of TAPVC is always obstructive whereas cardiac and supracardiac type may be obstructive or nonobstructive.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following drugs should not be used in a setting of severe hypeension in elderly on empirical basis A. Enalapril | B. Amlodipine | C. Chlohiazide | D. Prazosin",
      "answer": "The correct answer is **D. Prazosin**.\n\nHere's why:\n\n*   **Severe Hypertension in the Elderly:** In elderly patients with severe hypertension, the goal is to lower blood pressure effectively but also safely. Elderly individuals can be more susceptible to adverse effects from certain medications, especially those that can cause rapid drops in blood pressure or other systemic issues.\n\n*   **Prazosin:** Prazosin is an alpha-1 blocker. While it can be effective in lowering blood pressure, it is known for causing **first-dose hypotension**. This means that the very first dose, or subsequent doses after a period of discontinuation, can lead to a significant and sudden drop in blood pressure, potentially causing dizziness, fainting, and falls. This risk is particularly concerning in the elderly, who are already at higher risk for falls due to age-related changes in balance and proprioception. Therefore, it's generally not recommended for empirical use in severe hypertension in this population without careful monitoring and titration.\n\nLet's look at why the other options are generally acceptable (though individual patient factors always matter):\n\n*   **A. Enalapril:** This is an ACE inhibitor. ACE inhibitors are commonly used for hypertension and are generally well-tolerated in the elderly. While they can cause hypotension, it's usually more gradual than with prazosin, and they offer cardiovascular protective benefits.\n*   **B. Amlodipine:** This is a dihydropyridine calcium channel blocker. Calcium channel blockers are effective antihypertensives and are frequently used in the elderly. They generally have a predictable effect and are not associated with the same degree of first-dose hypotension as prazosin.\n*   **C. Chlorthalidone (assuming Chlothiazide is a typo and Chlorthalidone is intended, as Chlorthalidone is a more commonly used thiazide diuretic for hypertension):** Thiazide diuretics are a cornerstone of hypertension management, including in the elderly. They are effective and generally safe, although electrolyte imbalances need to be monitored. Chlorthalidone is a long-acting thiazide diuretic. If Chlothiazide itself was intended, it's a shorter-acting thiazide, but still generally considered safe for empirical use.\n\n**In summary:** Prazosin's risk of significant first-dose hypotension makes it unsuitable for empirical use in severe hypertension in the elderly.",
      "ground_truth": "Prazosin || Postsynaptic, selective a-adrenoreceptor antagonists lower blood pressure by decreasing peripheral vascular resistance. They are effective antihypeensive agents used either as monotherapy or in combination with other agents. However, in clinical trials of hypeensive patients, alpha blockade has not been shown to reduce cardiovascular morbidity and moality or to provide as much protection against CHF as other classes of antihypeensive agents. These agents are also effectivein treating lower urinary tract symptoms in men with prostatic hyperophy. Nonselective a-adrenoreceptor antagonists bind to postsynaptic and presynaptic receptors and are used primarily for the management of patients with pheochromocytoma. ref:harrison&;s principles of internal medicine,ed 18,pg no 4279",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A patient underwent thyroidectomy for Hyperthyroidism. Two days later he presented with features of thyroid storm. What is the most likely cause?(AIIMS November 2015. COMED K 2007) A. Poor antibiotic coverage | B. Rough handling during surgery | C. Removal of parathyroid | D. Inadequate preoperative preparation",
      "answer": "The most likely cause of thyroid storm in a patient who underwent thyroidectomy for hyperthyroidism, presenting two days later, is **D. Inadequate preoperative preparation**.\n\nHere's why:\n\n*   **Thyroid storm** is a life-threatening exacerbation of hyperthyroidism. It is often precipitated by a stressor in a patient with poorly controlled hyperthyroidism.\n*   **Inadequate preoperative preparation** means that the patient's hyperthyroidism was not adequately controlled with antithyroid medications before surgery. This leaves the patient in a hypermetabolic state, making them highly susceptible to developing thyroid storm when subjected to the stress of surgery.\n\nLet's look at why the other options are less likely:\n\n*   **A. Poor antibiotic coverage:** While infection can precipitate thyroid storm, poor antibiotic coverage itself doesn't directly cause the storm. It would be the underlying infection that's the trigger.\n*   **B. Rough handling during surgery:** While excessive manipulation of the thyroid gland can release thyroid hormones and potentially worsen hyperthyroidism, it's less likely to be the *most likely* cause of a full-blown thyroid storm two days post-operatively compared to pre-existing, poorly controlled hyperthyroidism.\n*   **C. Removal of parathyroid:** Removal of parathyroid glands leads to hypocalcemia (low calcium), which presents with symptoms like tetany, paresthesias, and muscle cramps. These are distinct from the symptoms of thyroid storm (fever, tachycardia, altered mental status, etc.).\n\nTherefore, the most critical factor in preventing postoperative thyroid storm is ensuring the patient's hyperthyroidism is well-controlled before surgery.",
      "ground_truth": "Inadequate preoperative preparation || Ans. d. Inadequate preoperative preparation (Ref: Schwartz 9/e p1355: Sabiston 19/e p897; Bailey 26/e p762, 25/e p786- 787; Harrison 18/e p2927)Thyrotoxic crisis (storm) is an acute exacerbation of hyperthyroidism. It occurs if a thyrotoxic patient has been inadequately prepared for thyroidectomy.\"Thyrotoxic crisis (storm): This is an acute exacerbation of hyperthyroidism. It occurs if a thyrotoxic patient has been inadequately prepared for thyroidectomy and is now extremely rare. Very rarely, a thyrotoxic patient presents in a crisis and this may follow an unrelated operation. Symptomatic and supportive treatment is for dehydration, hyperpyrexia and restlessness. This requires the administration of intravenous fluids, cooling the patient with ice packs, administration of oxygen, diuretics for cardiac failure, digoxin for uncontrolled atrial fibrillation, sedation and intravenous hydrocortisone. Specific treatment is by carbimazole 10-20 mg 6-hourly, LugoVs iodine 10 drops 8-hourly by mouth or sodium iodide Ig i.v. Propranolol intravenously (1--2 mg) or orally (40 mg 6-hourty) will block b-adrenergic effects. \" --Bailey 26/e p762Thyroid Storm (Thyrotoxic crisis)It is an emergency due to decompensated hyperthyroidismQ.Treatment of Thyroid Storm (Thyrotoxic crisis)Non-selective beta--blocker (Propranolol):Most valuable measure in thyroid stormQ,In thyroid storm most of the symptoms are because of adrenergic over activity due to increased tissue sensitivity to catecholamines in hyperthyroidism.This increased sensitivity is due to increased number of beta receptorsQ.Quick relief is obtained by blocking beta-receptors.Propylthiouracil:Antithyroid drug of choice for thyroid stormQReduces hormone synthesis as well as peripheral conversion of T4 to T3QCorticosteroids (Hydrocortisone):Inhibits both release of thyroid hormone from the gland and peripheral conversion of T4 to T3QIodides (Potassium iodide or lopanoic acid):Used to inhibit further hormone releaseQ from the gland.Other Measures:Diltiazem, if tachycardia is not controlled by propranolol alone.Rehydration, anxiolytics, external cooling & appropriate antibiotics",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Miliary mottling found in  a) Rheumatoid arthritisb) TBc) Pneumocystis carinii pneumoniad) Congestive heart failuree) Pulmonary edema A. abc | B. bcd | C. cde | D. abe",
      "answer": "The correct answer is **A. abc**.\n\nHere's why:\n\n*   **Miliary mottling** refers to a pattern of small, diffuse opacities on a chest X-ray, resembling millet seeds. This pattern is often indicative of a widespread process affecting the lungs.\n\nLet's break down the options:\n\n*   **a) Rheumatoid arthritis:** While not a direct cause of miliary mottling, rheumatoid arthritis can lead to interstitial lung disease, which in some advanced or complicated cases can present with a miliary pattern.\n*   **b) TB (Tuberculosis):** Miliary tuberculosis is a well-known and classic cause of miliary mottling. This occurs when the TB bacteria spread widely throughout the bloodstream to various organs, including the lungs.\n*   **c) Pneumocystis carinii pneumonia (PCP):** PCP, especially in immunocompromised individuals (like those with HIV/AIDS), can cause diffuse interstitial infiltrates that often appear as miliary mottling on imaging.\n*   **d) Congestive heart failure (CHF):** CHF typically causes cardiomegaly, pleural effusions, and interstitial edema, often described as Kerley B lines or bat-wing distribution, rather than a true miliary pattern.\n*   **e) Pulmonary edema:** While pulmonary edema can cause diffuse opacities, it's usually described as hazy or fluffy infiltrates, often with a perihilar distribution, and not typically the discrete, millet-seed appearance of miliary mottling.\n\nTherefore, miliary mottling is most commonly associated with TB and PCP, and can be seen in certain presentations of rheumatoid arthritis-related lung disease.",
      "ground_truth": "abe ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Antihypertensive of choice in pregnancy is: A. Hydralazine | B. Propranolol | C. Alpha methyl dopa | D. Labetalol",
      "answer": "The correct answer is **C. Alpha methyl dopa**.\n\n**Explanation:**\n\n*   **Alpha-methyl dopa** is generally considered the first-line antihypertensive medication for chronic hypertension in pregnancy. It has a long history of use, a good safety profile for both mother and fetus, and is effective in controlling blood pressure.\n\nWhile the other options can be used in specific situations during pregnancy, they are not typically the first choice for chronic hypertension:\n\n*   **A. Hydralazine:** This is an intravenous vasodilator often used for acute, severe hypertension in pregnancy (hypertensive emergencies) or when other agents are not effective. It's not usually the first choice for chronic management.\n*   **B. Propranolol:** Beta-blockers like propranolol can be used in pregnancy, but they are often considered second-line agents due to potential concerns about fetal growth restriction and neonatal effects, although these are generally rare.\n*   **D. Labetalol:** Labetalol is a combined alpha and beta-blocker that is also a very effective and commonly used antihypertensive in pregnancy, particularly for acute severe hypertension and sometimes for chronic hypertension. However, alpha-methyl dopa is still often preferred as the initial agent for chronic hypertension due to its established safety profile and efficacy.",
      "ground_truth": "Labetalol || Ref: Dana Textbook of Obstetrics, 5th ed pg 506 Explanation: See the following table Antihypertensives Used in Pregnancy MOA Side effects Remarks Methyl dopa Centrally acting anti-adrenergic * Drowsiness * Headache * Postnatal depression * Postural hypotension * Liver dysfunction * Leukopenia * Hemolytic anemia Contraindicated in patients taking * MAO inhibitors * Lithium * Liver failure * Positive Coombs test Clonidine Centrally acting sympathetic inhibitor * Drowsiness * Dry mouth * Dry eyes * Nausea * Reduced fetal heart rate Sudden stoppage should be avoided due to pressor effect Oxprenolot Beta blocker * Nightmares Labetalol Alpha and beta blocker * Worsening asthma * Cough * Nightmares * Bradycardia Contraindicated in asthmatics Avoided in * Pbemochoromocytoma * Heart failure, bradycardia * Peripheral vascular disease * Raynaud's phenomenon Nifedipine Calcium channel blocker * Headache * Edema * Palpitations * Nausea * Dizziness Metabolised through CYT P450-3A4 - Possible interaction with phenytoin and cisapride Hydralazine Peripheral vasodilator * Flushing * Palpitations * Headache * Nausea 2nd or 3rd line agent. Can cause autoimmune lupus",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 50-year-old male presented with signs and symptoms of restrictive hea disease. A right ventricular endomyocardial biopsy revealed deposition of extracellular eosinophilic hyaline material. On transmission electron microscopy, this material is most likely to reveal the presence of A. Non branching filaments of 7.5 to 10 nm | B. Cross banded fibres with 67 m periodicity | C. Weber Palade bodies | D. Concentric whorls of lamellar structures",
      "answer": "The correct answer is **A. Non branching filaments of 7.5 to 10 nm**.\n\nHere's the explanation:\n\n*   **Restrictive Heart Disease and Eosinophilic Hyaline Material:** The description of restrictive heart disease with deposition of extracellular eosinophilic hyaline material in an endomyocardial biopsy is highly suggestive of **amyloidosis**. Amyloidosis is a group of diseases characterized by the abnormal deposition of amyloid proteins in various organs, including the heart.\n\n*   **Amyloid Composition on Electron Microscopy:** Amyloid deposits, when examined under transmission electron microscopy, are typically composed of **non-branching fibrils** with a diameter of approximately **7.5 to 10 nm**. These fibrils are primarily composed of misfolded proteins that aggregate into an insoluble beta-pleated sheet structure.\n\nLet's look at why the other options are incorrect:\n\n*   **B. Cross banded fibres with 67 m periodicity:** This description is characteristic of **collagen**, which is a major component of connective tissue but not the primary material deposited in amyloidosis.\n\n*   **C. Weber Palade bodies:** These are **Weibel-Palade bodies**, which are found in endothelial cells and contain von Willebrand factor and P-selectin. They are not related to amyloid deposition in the myocardium.\n\n*   **D. Concentric whorls of lamellar structures:** This morphology is characteristic of **basement membranes** or certain types of **glycogen storage diseases**, not amyloid.\n\nTherefore, the presence of non-branching filaments of 7.5 to 10 nm on transmission electron microscopy is the most likely finding in a biopsy showing extracellular eosinophilic hyaline material consistent with amyloidosis.",
      "ground_truth": "Non branching filaments of 7.5 to 10 nm || Amyloidosis is the major cause of restrictive cardiomyopathyCardiac amyloid is classically suspected from thickened ventricular walls with an ECG that shows low voltage.By electron microscopy, all types of amyloid consist of continuous, nonbranching fibrils with a diameter of approximately 7.5 to 10 nm. X-ray crystallography and infrared spectroscopy demonstrate a characteristic cross-b-pleated sheet conformationHarrison 19e pg: 1567",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 52-year-old woman presents with exeional fatigue and ascites. She is noted to have a rapid, irregular pulse rate. The chest X-ray reveals a small hea with calcification seen on the lateral view. The 12-lead ECG demonstrates low QRS voltage. Clinical diagnosis is? A. Rheumatic pan-carditis | B. Constrictive pericarditis | C. Restrictive cardiomyopathy | D. Acute cor-pulmonale",
      "answer": "The correct answer is **B. Constrictive pericarditis**.\n\nHere's why:\n\n*   **Exceptional fatigue and ascites:** These are classic signs of right-sided heart failure, which can be caused by impaired filling of the ventricles.\n*   **Rapid, irregular pulse rate:** This suggests an underlying issue affecting the heart's electrical system or its ability to pump effectively.\n*   **Small heart with calcification seen on the lateral view (chest X-ray):** A small heart can be seen in constrictive pericarditis due to the thickened, inelastic pericardium restricting ventricular filling. Pericardial calcification is a hallmark finding in chronic constrictive pericarditis, often a sequela of previous inflammation (like rheumatic fever, viral pericarditis, or tuberculosis).\n*   **Low QRS voltage on ECG:** This is a characteristic finding in constrictive pericarditis. The thickened pericardium acts as an electrical insulator, reducing the amplitude of the QRS complexes recorded on the surface ECG.\n\nLet's look at why the other options are less likely:\n\n*   **A. Rheumatic pan-carditis:** While rheumatic fever can cause pericarditis, \"pan-carditis\" implies inflammation of all layers of the heart (endocardium, myocardium, and pericardium). The findings, particularly the calcification and low QRS voltage, are more specific to chronic pericardial disease rather than acute pancarditis.\n*   **C. Restrictive cardiomyopathy:** This condition also leads to impaired ventricular filling and symptoms of heart failure. However, restrictive cardiomyopathy typically involves intrinsic myocardial disease, and while it can cause low voltage, the presence of pericardial calcification on X-ray strongly points towards a pericardial etiology.\n*   **D. Acute cor-pulmonale:** This refers to acute right ventricular failure due to pulmonary hypertension. While it can cause fatigue and ascites, the typical cause is a pulmonary embolism or severe COPD exacerbation, and the ECG findings and chest X-ray findings (especially calcification) are not characteristic of acute cor-pulmonale.",
      "ground_truth": "Constrictive pericarditis || Calcification & low QRS voltage - indicates Constrictive pericarditis Other option: 1. Restrictive cardiomyopathy -No calcification 2. Acute Cor pulmonale- clots will be present 3. Rheumatic pan carditis - affects children",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following is a contraindication to the use of Beta Blockers:- A. Glaucoma | B. Tachycardia | C. Bronchial asthma | D. Hypeension",
      "answer": "The correct answer is **C. Bronchial asthma**.\n\n**Explanation:**\n\nBeta-blockers work by blocking the effects of adrenaline (epinephrine) on the body. While this can be beneficial for conditions like high blood pressure and rapid heart rate, it can also affect the smooth muscles in the airways.\n\n*   **Bronchial asthma:** In individuals with asthma, the airways are already narrowed and prone to spasms. Beta-blockers can further constrict these airways, leading to bronchospasm and potentially a severe asthma attack. Therefore, bronchial asthma is a significant contraindication for the use of beta-blockers.\n\nLet's look at why the other options are not contraindications:\n\n*   **A. Glaucoma:** Certain beta-blockers (like timolol) are actually used topically in eye drops to treat glaucoma by reducing the production of aqueous humor, which lowers intraocular pressure.\n*   **B. Tachycardia:** Tachycardia (a rapid heart rate) is often a *reason* to prescribe beta-blockers, as they help to slow down the heart rate.\n*   **D. Hypertension:** Hypertension (high blood pressure) is one of the primary indications for the use of beta-blockers. They help to lower blood pressure by reducing heart rate and the force of heart contractions.",
      "ground_truth": "Bronchial asthma || * Contraindication of Blocker:- Asthma AV Block Acute CHF Diabetes Mellitus * ss Blocker uses:- Hypeension Migraine Hypehyroidism Angina pretoirs MI",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following results in thirst A. Cardiac failure | B. Decreased plasma levels of angiotensin II | C. Distension of the cardiac atria | D. Distension of the stomach",
      "answer": "The correct answer is **C. Distension of the cardiac atria**.\n\nHere's why:\n\n*   **Cardiac atria distension** is a key indicator of increased blood volume. When the atria are distended, it signals to the brain that there is sufficient fluid in the circulatory system. This leads to the release of **atrial natriuretic peptide (ANP)**. ANP has several effects, including promoting sodium and water excretion by the kidneys, which ultimately *reduces* thirst. Conversely, a *lack* of distension (i.e., decreased blood volume) would stimulate thirst.\n\nLet's look at why the other options are incorrect:\n\n*   **A. Cardiac failure:** While cardiac failure can lead to fluid imbalances, it doesn't directly cause thirst in the way described by the other options. In fact, severe cardiac failure can sometimes lead to fluid retention and edema, which might suppress thirst.\n*   **B. Decreased plasma levels of angiotensin II:** Angiotensin II is a potent stimulator of thirst. Therefore, a *decrease* in its levels would likely *reduce* thirst, not cause it.\n*   **D. Distension of the stomach:** Stomach distension is primarily related to the presence of food or liquid in the stomach. While it can contribute to a feeling of fullness, it doesn't directly trigger the physiological mechanisms that lead to thirst. Thirst is primarily driven by changes in blood osmolality and blood volume.",
      "ground_truth": "Cardiac failure || Control of ThirstIncrease thirstDecrease thirst| Plasma osmolarity| Plasma osmolarity| Blood volume| Blood volume| Blood pressure| Blood pressure| Angiotensin II| Angiotensin IIDry mouthGastric distentionRef: Guyton; 13th edition; Chapter 29; Urine Concentration and Dilution",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Most important side effect of insulin: A. Hypoglycaemia | B. Lipodystrophy | C. Insulin resistance | D. Antibodies to insulin",
      "answer": "The most important side effect of insulin is **A. Hypoglycaemia**.\n\n**Explanation:**\n\n*   **Hypoglycaemia (low blood sugar)** is the most immediate and potentially dangerous side effect of insulin therapy. It occurs when too much insulin is administered, or when insulin is given without adequate food intake or with excessive physical activity. Symptoms can range from mild (shakiness, sweating, confusion) to severe (seizures, coma, and even death).\n\nLet's look at why the other options are less important in this context:\n\n*   **B. Lipodystrophy:** This refers to changes in fat tissue at the injection site. While it can be a concern and affect insulin absorption, it is generally manageable with proper injection technique and rotation of sites. It is not as acutely life-threatening as hypoglycemia.\n*   **C. Insulin resistance:** This is a condition where the body's cells don't respond well to insulin. While it can develop in some individuals, it's often a consequence of the underlying diabetes itself or other factors, rather than a direct, common side effect of insulin therapy in the same way hypoglycemia is. In fact, insulin therapy is often used to overcome insulin resistance.\n*   **D. Antibodies to insulin:** The body can develop antibodies to injected insulin, especially animal-derived insulins. However, with modern human insulins, this is less common and usually doesn't lead to significant clinical problems or dangerous side effects.",
      "ground_truth": "Hypoglycaemia || Ans: a (Hypoglycaemia) no referance needed for this one !!!CAUSES OF HYPOGLYCAEMIAFasting (Postabsorptive) Hypoglycemia DrugsEndogenous hyperinsulinismEspecially insulin, sulfonylureas, ethanolInsulinomaSometimes quinine, pentamidineOther beta cell disordersRarely salicylates, sulfonamides, othersInsulin secretagogue (sulfonylurea)Critical illnessesAutoimmune (autoantibodies to insulinHepatic, renal, or cardiac failureor the insulin receptor)SepsisEctopic insulin secretionInanitionDisorders of infancy or childhoodHormone deficienciesTransient intolerance of fastingCortisol, growth hormone, or bothCongenital hyperinsulinismGlucagon and epinephrineInherited enzyme deficiencies(in insulin -deficient diabetes) Non-beta-cell tumors Reactive (Postprandial) HypoglycaemiaAlimentary (postgastrectomy) hypoglycaemiaNoninsulinoma pancreatogenous hypoglycaemia syndromeIn the absence of prior surgeryFollowing Roux-en-Y gastric bypass.Other causes of endogenous hyperinsulinismHereditary fructose intolerance, galactosaemiaIdiopathic",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All of the following diseases are associated with trinucleotide repeat sequence except: A. Huntington's disease | B. Fredreich's ataxia | C. Myotonica dystrophy | D. Hereditary motor-sensory neuropathy",
      "answer": "The correct answer is **D. Hereditary motor-sensory neuropathy**.\n\nHere's why:\n\n*   **Trinucleotide repeat expansion disorders** are a group of genetic diseases caused by an abnormally high number of repeating three-nucleotide sequences (trinucleotides) in the DNA. This expansion can lead to altered protein function or gene silencing, resulting in disease.\n\n*   **A. Huntington's disease:** This is a classic example of a trinucleotide repeat expansion disorder, specifically an expansion of a CAG repeat in the *HTT* gene.\n\n*   **B. Friedreich's ataxia:** This is also a trinucleotide repeat expansion disorder, characterized by an expansion of a GAA repeat in the first intron of the *FXN* gene.\n\n*   **C. Myotonic dystrophy:** This is another well-known trinucleotide repeat expansion disorder. There are two types:\n    *   Myotonic dystrophy type 1 (DM1) is caused by a CTG repeat expansion in the *DMPK* gene.\n    *   Myotonic dystrophy type 2 (DM2) is caused by a CCTG repeat expansion in the *CNBP* gene.\n\n*   **D. Hereditary motor-sensory neuropathy (HMSN):** While there are many different types of HMSN, and some *can* be caused by genetic mutations, the *defining characteristic* of HMSN as a broad category is not trinucleotide repeat expansion. Many forms of HMSN are caused by mutations in genes involved in myelin production or maintenance, axonal transport, or nerve structure, which are not typically trinucleotide repeat expansions. For example, Charcot-Marie-Tooth disease (a common type of HMSN) can be caused by mutations in genes like *PMP22*, *MPZ*, or *GJB1*, none of which are primarily characterized by trinucleotide repeat expansions.\n\nTherefore, hereditary motor-sensory neuropathy is the exception among the listed diseases as not being *universally* or *characteristically* associated with trinucleotide repeat sequence expansion.",
      "ground_truth": "Hereditary motor-sensory neuropathy || Rest of the options are associated with trinucleotide repeat sequence. Triple-repeat mutations (Allelic expansion disorders) Due to an increase in the number of nucleotide repeats above a ceain threshold Length of the nucleotide repeat often correlates with the severity of the disease Anticipation: When repeat length increases from one generation to the next, disease manifestations may worsen or be observed at an earlier age. Disease Repeats Clinical features Fragile X-Syndrome CGG Mental retardation, large ears and jaws, macroorchidism in males Myotonic Dystrophy (Chromosome 19) CTG Muscle loss, cardiac arrhythmia , cataracts , frontal balding Huntington&;s disease CAG Affective disorder Spinocerebellar ataxia type 1 CAG Progressive ataxia, dysahria, dysmetria Friedreich&;s ataxia GAA Progressive ataxia, dysahria , hyperophic cardiomyopathy Ref: Nelson textbook of Medical Physiology 21st edition Pgno: 647",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Whichof the following is NOT true about the use of Beta blocker in CHF A. These should be staed at very low dose and sowly titrated upwards | B. Carvedilol is most widely used beta blocker | C. These are drug of choice in acute decompensated hea failure. | D. These can reduce moality in CHF patients",
      "answer": "The correct answer is **C. These are drug of choice in acute decompensated heart failure.**\n\nHere's why:\n\n*   **A. These should be started at very low dose and slowly titrated upwards:** This is **true**. Beta-blockers can initially worsen heart failure symptoms due to their negative inotropic effect (reducing the force of contraction). Therefore, they are always started at a low dose and gradually increased to allow the heart to adapt.\n*   **B. Carvedilol is most widely used beta blocker:** This is generally considered **true** in the context of heart failure management. Carvedilol, along with metoprolol succinate and bisoprolol, are the three beta-blockers proven to improve outcomes in CHF. Carvedilol is frequently prescribed.\n*   **C. These are drug of choice in acute decompensated heart failure:** This is **NOT true**. In acute decompensated heart failure, the primary goal is to stabilize the patient and improve symptoms. Beta-blockers are generally *withheld* or even *discontinued* during an acute exacerbation because they can further depress cardiac function and worsen the situation. Once the patient is stabilized, beta-blockers are typically reintroduced.\n*   **D. These can reduce mortality in CHF patients:** This is **true**. Beta-blockers are a cornerstone of chronic heart failure management and have been shown in numerous studies to significantly reduce mortality and hospitalizations in patients with systolic heart failure.",
      "ground_truth": "These are drug of choice in acute decompensated hea failure. || Ref KDT 6/e p544 Beta blockers are contra-indicated in acute decompensated hea failure.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All of the following are true about Graves disease except A. Cardiac failure is common | B. Hypertrophy and hyperplasia or thyroid gland is due to TSH- Rab | C. Remissions and exacerbations are not infrequent | D. It is highly vascular with audible bruit",
      "answer": "The correct answer is **C. Remissions and exacerbations are not infrequent**.\n\nHere's why:\n\n*   **Graves' disease is an autoimmune disorder** where the immune system produces antibodies (specifically, TSH receptor antibodies or TRAbs) that mimic the action of thyroid-stimulating hormone (TSH). These antibodies bind to the TSH receptors on the thyroid gland, causing it to overproduce thyroid hormones (hyperthyroidism).\n\nLet's break down why the other options are true:\n\n*   **A. Cardiac failure is common:** Chronic hyperthyroidism puts a significant strain on the heart. The increased heart rate, contractility, and metabolic demand can lead to conditions like atrial fibrillation, dilated cardiomyopathy, and eventually, high-output cardiac failure.\n*   **B. Hypertrophy and hyperplasia of the thyroid gland is due to TSH-Rab:** The TSH receptor antibodies (TRAbs) continuously stimulate the thyroid follicular cells. This constant stimulation leads to both an increase in the size of the cells (hypertrophy) and an increase in the number of cells (hyperplasia), resulting in an enlarged thyroid gland (goiter).\n*   **D. It is highly vascular with audible bruit:** The overactive thyroid gland in Graves' disease has increased blood flow due to the constant stimulation. This increased vascularity can be so pronounced that a turbulent blood flow can be heard with a stethoscope over the thyroid gland, producing a characteristic \"bruit.\"\n\n**Explanation for why C is incorrect:**\n\n*   **C. Remissions and exacerbations are not infrequent:** Graves' disease is typically a **chronic and persistent** condition. While there can be fluctuations in the severity of symptoms, spontaneous remissions where the disease resolves completely are **rare**. The autoimmune process is usually ongoing, leading to a need for long-term management, which may include medication, radioactive iodine therapy, or surgery. Therefore, it's more accurate to say that remissions are infrequent, and the disease tends to be persistent rather than characterized by frequent remissions and exacerbations.",
      "ground_truth": "Remissions and exacerbations are not infrequent ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 16-year-old boy was found to have a grade 2 ejection systolic murmur along the left sternal border, which decreased with squatting and increased with sudden standing. An ECG shows left ventricular hyperophy . His cousin brother died at the age of 20 years while playing hockey due to some hea disease. What is the recommendation regarding his paicipation in spos? A. Only non contact competitive spos is allowed | B. Paicipation in competitive spos is not allowed | C. Non contact competitive spos with beta-blocker therapy is allowed | D. High-intensity competitive spos are acceptable with beta-blocker therapy",
      "answer": "The correct answer is **B. Participation in competitive sports is not allowed.**\n\nHere's the explanation:\n\n*   **Ejection systolic murmur along the left sternal border that changes with maneuvers:** This type of murmur, especially when associated with left ventricular hypertrophy (LVH) on ECG, is highly suggestive of **hypertrophic cardiomyopathy (HCM)**. The murmur's behavior with squatting (increased venous return, increased preload) and standing (decreased venous return, decreased preload) is characteristic of dynamic outflow tract obstruction, a hallmark of HCM.\n*   **Left ventricular hypertrophy (LVH) on ECG:** This further supports the suspicion of HCM, as the thickened heart muscle leads to increased electrical activity.\n*   **Family history of sudden cardiac death in a young relative:** This is a critical piece of information. HCM is a genetic condition, and a family history of sudden cardiac death in a young individual significantly increases the suspicion and concern for HCM in this patient. Sudden cardiac death in young athletes is often attributed to HCM.\n\n**Why other options are incorrect:**\n\n*   **A. Only non-contact competitive sports is allowed:** While non-contact sports might seem safer, the underlying condition (likely HCM) can still pose a risk even in less physically demanding activities due to the potential for arrhythmias.\n*   **C. Non-contact competitive sports with beta-blocker therapy is allowed:** Beta-blockers are often used to manage symptoms of HCM and can reduce the risk of arrhythmias. However, for individuals with significant LVH and a murmur suggestive of dynamic obstruction, even with beta-blockers, the risk of sudden cardiac death during competitive sports remains elevated.\n*   **D. High-intensity competitive sports are acceptable with beta-blocker therapy:** This is the most dangerous option. High-intensity competitive sports place significant stress on the heart. In the context of suspected HCM, this type of activity is strongly discouraged due to the high risk of life-threatening arrhythmias and sudden cardiac death.\n\n**Recommendation:**\n\nGiven the constellation of findings (murmur characteristics, LVH, and family history), the most prudent recommendation is to **restrict participation in all competitive sports**, especially those involving high intensity or significant physical exertion. Further diagnostic evaluation, including an echocardiogram to confirm HCM and assess the degree of outflow tract obstruction, is crucial. Genetic testing may also be considered. Until a definitive diagnosis and risk stratification are performed, a conservative approach of avoiding competitive sports is essential to prevent a potentially fatal event.",
      "ground_truth": "Paicipation in competitive spos is not allowed || This examination findings, ECG findings and family history are consistent with hyperophic cardiomyopathy. Diagnosis is typically done by echocardiogram. For people with HCM who don't have symptoms, Lifestyle changes and medications for conditions that may contribute to cardiovascular disease are recommended. Current recommendations are that competitive spos not be allowed in hyperophic cardiomyopathy. Low intensity spos may be allowed.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Stunning of myocardium without any acute coronary syndrome is:- A. Subendocardial infarction | B. Restrictive cardiomyopathy | C. Takotsubo cardiomyopathy | D. Transmural infarction",
      "answer": "The correct answer is **C. Takotsubo cardiomyopathy**.\n\nHere's why:\n\n*   **Stunning of myocardium without any acute coronary syndrome (ACS)** refers to a temporary weakening of the heart muscle that is not caused by a blockage of the coronary arteries.\n*   **Takotsubo cardiomyopathy**, also known as stress-induced cardiomyopathy or broken heart syndrome, is characterized by a sudden, temporary weakening of the heart muscle, often triggered by severe emotional or physical stress. It mimics a heart attack but without the presence of blocked coronary arteries. The \"stunning\" refers to the temporary dysfunction of the heart muscle.\n\nLet's look at why the other options are incorrect:\n\n*   **A. Subendocardial infarction** and **D. Transmural infarction** both refer to types of myocardial infarction (heart attack), which are caused by acute coronary syndromes (blockages in the coronary arteries).\n*   **B. Restrictive cardiomyopathy** is a condition where the heart muscle becomes stiff and less flexible, making it difficult for the heart to fill with blood. While it affects heart muscle function, it's a chronic condition and not typically described as \"stunning\" without ACS.",
      "ground_truth": "Takotsubo cardiomyopathy || A/k as broken hea syndrome High degree of emotional stress Increase catecholamines Coronary aery vasospasm | Ischemic dilatedcardiomyopathy M/E: Acute stage a necrosis + contraction band necrosis - Histologically, acute cases may show microscopic areas of necrosis characterized by myocyte hypercontraction (contraction band necrosis); subacute and chronic cases may exhibit microscopic foci of granulation tissue and/or scar. - Elevated levels of catechols also increase hea rate and myocardial contractility, exacerbating ischemia caused by the vasospasm. The outcome of such vasospasm can be sudden cardiac death (usually caused by a fatal arrhythmia) or an ischemic dilated cardiomyopathy, so-called takotsubo",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 26 year old man died suddenly during spoing activity. At autopsy the hea revealed chamber and septum Hyperophy. The most likely diagnosis is A. HOCM | B. DCM | C. Arrhythmogenic cardiac problem | D. Restrictive cardiomyopathy",
      "answer": "The most likely diagnosis is **A. HOCM**.\n\n**Explanation:**\n\n*   **Hypertrophic Cardiomyopathy (HOCM)** is a genetic condition characterized by thickening of the heart muscle, particularly the left ventricle and septum. This thickening can obstruct blood flow and lead to arrhythmias, which can cause sudden cardiac death, especially during strenuous physical activity. The autopsy findings of chamber and septum hypertrophy are classic for HOCM.\n\nLet's look at why the other options are less likely:\n\n*   **B. Dilated Cardiomyopathy (DCM):** In DCM, the heart chambers, especially the left ventricle, are enlarged and weakened, leading to reduced pumping function. Autopsy findings would typically show dilated chambers, not hypertrophy.\n*   **C. Arrhythmogenic cardiac problem:** While an arrhythmogenic cardiac problem is the *mechanism* of death in many cases, it's not the underlying *diagnosis* of the structural heart abnormality. HOCM is a common cause of such arrhythmias. Other arrhythmogenic problems might not present with significant chamber and septum hypertrophy.\n*   **D. Restrictive Cardiomyopathy:** In restrictive cardiomyopathy, the heart muscle becomes stiff and less flexible, impairing its ability to fill with blood. While there can be some thickening, it's usually more diffuse and the primary issue is impaired filling, not necessarily the obstructive hypertrophy seen in HOCM.",
      "ground_truth": "HOCM || Answer is A. (HOCM): Sudden death following competitive spos in young individuals is characteristic of hyperophic obstructive cardiomyopathy (HOCM). The presence of chamber and septal hyperophy on autopsy confirms the suspected diagnosis of HOCM",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Hyperchloremic acidosis with hypokalemia is a feature of A. Renal tubular acidosis | B. Addison's disease | C. Pyloric stenosis | D. Primary hyperaldosteronism",
      "answer": "The correct answer is **A. Renal tubular acidosis**.\n\nHere's why:\n\n*   **Renal Tubular Acidosis (RTA):** This is a group of disorders where the kidneys are unable to properly excrete acids or reabsorb bicarbonate, leading to metabolic acidosis.\n    *   **Hyperchloremic acidosis** is a hallmark of RTA because the kidneys lose bicarbonate and retain chloride to maintain electrical neutrality.\n    *   **Hypokalemia** (low potassium) is often seen in certain types of RTA (like Type 1 and Type 2) due to increased potassium excretion in the urine.\n\nLet's look at why the other options are less likely:\n\n*   **B. Addison's disease:** This is characterized by adrenal insufficiency, leading to a deficiency in aldosterone. Aldosterone promotes sodium reabsorption and potassium excretion. Therefore, Addison's disease typically causes **hyperkalemia** (high potassium) and metabolic acidosis, but not usually hyperchloremic acidosis with hypokalemia.\n*   **C. Pyloric stenosis:** This is a condition where the pylorus (the opening from the stomach to the small intestine) narrows, causing obstruction. Vomiting is a common symptom. Severe vomiting leads to loss of gastric acid (HCl) and potassium, resulting in **metabolic alkalosis** with hypokalemia and hypochloremia, the opposite of hyperchloremic acidosis.\n*   **D. Primary hyperaldosteronism:** This condition involves the overproduction of aldosterone. As mentioned with Addison's disease, aldosterone promotes sodium reabsorption and potassium excretion. Therefore, primary hyperaldosteronism typically leads to **hypokalemia** and **metabolic alkalosis**, not acidosis.",
      "ground_truth": "Renal tubular acidosis || Ans. a (Renal tubular acidosis). (Ref. Harrison's Medicine 16th/pg. 265, 1702)METABOLIC ACIDOSIS: There are two major categories of clinical metabolic acidosis:# High anion-gap (AG) and# Normal-AG, or hyperchloremic acidosis:Hyperchloremic (nongap) metabolic acidosis# Alkali can be lost from the gastrointestinal tract in diarrhea or from the kidneys (renal tubular acidosis, RTA). In these disorders, reciprocal changes in and result in a normal AG.# In pure hyperchloremic acidosis, therefore, the increase in above the normal value approximates the decrease in . The absence of such a relationship suggests a mixed disturbance.# Metabolic acidosis due to gastrointestinal losses with a high urine pH can be differentiated from RTA because urinary NH4 excretion is typically low in RTA and high with diarrhea.# Urinary NH4 -levels can be estimated by calculating the urine anion gap (UAG):- UAG = -.# When > , and the urine gap is negative, the urine ammonium level is appropriately increased, suggesting an extrarenal cause of the acidosis.# Conversely, when the urine anion gap is positive, urine ammonium level is low, sugg. renal acidosis.The typical findings in classic distal RTA (type 1 RTA) include:# Hypokalemia,# Hyperchloremic acidosis,# Low urinary NH4\"# Excretion (positive uag, low urine [NH4U, and# Inappropriately high urine pH (pH -5.5).# Most have hypocitraturia and hypercalciuria, so nephrolithiasis, nephrocalcinosis, bone ds common.# Proximal RTA (type 2 RTA) is most often due to generalized proximal tubular dysfunction manifested by glycosuria, generalized aminoaciduria, and phosphaturia (Fanconi syndrome).# In type 4 RTA, hyperkalemia is disproportionate to the reduction in GFR because of coexisting dysfunction of potassium and acid secretion.FindingType 1 RTAType 2 RTAType 4 RTAGI Bicarbonate LossNormal anion-gap acidosisYesYesYesYesMinimum urine pH>5.5<5.5<5.55 to 6% Filtered bicarbonate excreted<10>15<10<10Serum potassiumLowLowHighLowFanconi syndromeNoYesNoNoStones/nephrocalcinosisYesNoNoNoDaily acid excretionLowNormalLowHighUrine anion gapPositiveNegativePositiveNegativeDaily bicarbonate replacement needs<4 mmol/kg>4 mmol/kg<4 mmol/kgVariableTable: COMPARISON OF NORMAL ANION-GAP ACIDOSISAlso remember:FUNCTIONAL CONSEQUENCES OF TUBULOINTERSTITIAL DISEASEDefectCause(s)1Reduced GFRObliteration of microvasculature and obstruction of tubules2Fanconi syndromeDamage to proximal tubular reabsorption of glucose, amino acids, phosphate, and bicarbonate3Hyperchloremic acidosis1. Reduced ammonia production2. Inability to acidify the collecting duct fluid (distal renal tubular acidosis).3. Proximal bicarbonate wasting4Tubular/small-molecular weight proteinuriaFailure of proximal tubule protein reabsorption5Polyuria, isothenuriaDamage to medullary tubules and vasculature6HyperkalemiaPotassium secretory defects including aldosterone resistance7Salt wastingDistal tubular damage with impaired sodium reabsorptionPRIMARY HYPERALDOSTERONISM (Conn's syndrome)# Conn's adenoma is very sensitive to ACTH as is glucocorticoid suppressible hyperaldosteronism, hence morning levels of ACTH and aldosterone are low.# Idiopathic bilateral adrenal hyperplasia is common than adrenal adenoma,# K+ levels are normal in 70% cases.# Increased plasma and urinary aldosterone.# Decreased plasma renin activity.6# Its dexamethasone suppressive hyperaldosteronism.# 18 OH cortisol levels are very high in Conn's adenoma and glucocorticoid suppressible hyperplasia.# Spironolactone is drug of choice.Secondary hyperaldosteronism results from:# Nephritic syndrome,# Cirrhosis,# Heart failure and# Barter's syndrome.'Spirolactone bodies' are seen in ATCH secreting adrenal adenomas treated with Spironolactone.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following is not a cause of absent ankle jerks and up-going plantars? A. Freidreichs ataxia | B. B12 deficiency | C. MS | D. Cord compression",
      "answer": "The correct answer is **C. MS**.\n\nHere's why:\n\n*   **Absent ankle jerks and up-going plantars** (Babinski sign) are indicative of upper motor neuron lesions affecting the corticospinal tract. The corticospinal tract controls voluntary movement and also influences reflexes. Damage to this pathway can lead to hyperreflexia (exaggerated reflexes like the ankle jerk) and the Babinski sign.\n\nLet's break down why the other options *can* cause these findings:\n\n*   **A. Friedreich's ataxia:** This is a genetic disorder that primarily affects the spinal cord and peripheral nerves. It often leads to degeneration of the spinocerebellar tracts and posterior columns, which can result in absent or diminished ankle jerks. While it can also affect upper motor neurons, the classic presentation often includes absent reflexes. However, in some stages or presentations, upper motor neuron signs can emerge.\n*   **B. B12 deficiency:** Vitamin B12 deficiency can cause a neurological syndrome known as subacute combined degeneration of the spinal cord. This condition affects the posterior columns (responsible for vibration and proprioception) and the corticospinal tracts. Damage to the corticospinal tracts can lead to absent ankle jerks and up-going plantars.\n*   **D. Cord compression:** Compression of the spinal cord, especially in the thoracic or cervical regions, can damage the corticospinal tracts. This damage will manifest as upper motor neuron signs, including absent ankle jerks and up-going plantars, along with other neurological deficits depending on the location and severity of the compression.\n\n*   **C. MS (Multiple Sclerosis):** While MS can affect the central nervous system and cause a wide range of neurological symptoms, including motor deficits, it typically causes **hyperreflexia** (exaggerated reflexes) and **up-going plantars** (Babinski sign) due to lesions in the corticospinal tracts. **Absent ankle jerks** are more characteristic of lower motor neuron involvement or sensory neuropathy, which are not the primary or typical findings of MS lesions affecting the corticospinal tract. In fact, hyperactive reflexes are a hallmark of upper motor neuron lesions, which MS commonly causes.\n\n**In summary:** Friedreich's ataxia, B12 deficiency, and cord compression can all lead to a combination of absent ankle jerks and up-going plantars. Multiple Sclerosis, when affecting the corticospinal tract, typically causes hyperreflexia and up-going plantars, not absent ankle jerks.",
      "ground_truth": "MS || Causes of absent ankle jerks and upgoing plantars is a common question as it implies both upper and lower motor neuron involvement. The more common single causes include cord compression involving both the cord (UMN) and nerve ganglia roots (LMN) as well as subacute combined degeneration of the cord. Other more common causes include the presence of more than one pathology, e.g. stroke (UMN) with superimposed peripheral neuropathy (LMN)  usually in a diabetic patient. In Friedrichs ataxia, both cord and peripheral nerve involvement accompany cerebellar degeneration. These patients also have sensory loss, pescavus and may have complications such as diabetes and hypertrophic cardiomyopathy. Multiple sclerosis may cause a mixture of pyramidal signs (UMN), sensory loss (dorsal columns) and ataxia (cerebellum), but will never involve the LMN.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Drug used in CHF for relief of congestive symptoms and restoration of cardiac performance but does not have an inotropic action is - A. Digoxin | B. Dobutamine | C. Amrinone | D. Nebivolol",
      "answer": "The correct answer is **D. Nebivolol**.\n\nHere's why:\n\n*   **Congestive Heart Failure (CHF):** CHF is a condition where the heart can't pump blood effectively to meet the body's needs. This leads to fluid buildup (congestion) in the lungs, legs, and abdomen, causing symptoms like shortness of breath, swelling, and fatigue.\n*   **Inotropic Action:** Inotropic drugs affect the contractility of the heart muscle. Positive inotropic drugs increase the force of contraction, while negative inotropic drugs decrease it.\n*   **Relief of Congestive Symptoms and Restoration of Cardiac Performance:** Medications for CHF aim to reduce the workload on the heart, improve its pumping efficiency, and alleviate the symptoms of congestion.\n\nLet's look at the options:\n\n*   **A. Digoxin:** Digoxin is a cardiac glycoside that has a **positive inotropic effect**, meaning it increases the force of heart contractions. It also slows the heart rate and can help with congestive symptoms.\n*   **B. Dobutamine:** Dobutamine is a **potent positive inotropic agent** used intravenously to improve cardiac output in severe heart failure.\n*   **C. Amrinone:** Amrinone (and its successor milrinone) are **phosphodiesterase inhibitors** that have **positive inotropic effects** and also cause vasodilation, helping to reduce the heart's workload and improve pumping.\n*   **D. Nebivolol:** Nebivolol is a **beta-blocker**. While beta-blockers are crucial in the long-term management of CHF, they primarily work by **reducing heart rate, blood pressure, and the heart's workload**, which indirectly improves cardiac performance and helps with congestion. They **do not have a direct inotropic action** (they are not positive inotropes). In fact, they can have a slight negative inotropic effect initially, but their long-term benefits in CHF are well-established due to their effects on the sympathetic nervous system and remodeling.\n\nTherefore, Nebivolol is the drug among the options that provides relief of congestive symptoms and contributes to the restoration of cardiac performance in CHF without having a direct inotropic action.",
      "ground_truth": "Nebivolol || Ans. is 'd' i.e., Nebivolol * There are two distinct goals of drug therapy in CHF:a) Relief of congestive/low output symptoms and restoration of cardiac performance. This can be achieved by:* Inotropic drugs --Digoxin, dobutamine/ dopamine, amrinone/milrinone* Diuretics--Furosemide, thiazides* RAS inhibitors--ACE inhibitors/ARBs* Vasodilators--hydralazine, nitrate, nitroprusside* b blocker--Metoprolol, bisoprolol, carvedilol, Nebivololb) Arrest/reversal of disease progression and prolongation of survival, possible with:* ACE inhibitors/ ARBs, b blockers* Aldosterone antagonist--Spironolactone, eplerenone",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All are features of Paget's disease except ? A. Defect in osteoclasts | B. Common in female | C. Can cause deafness | D. Can cause osteosarcoma",
      "answer": "The correct answer is **B. Common in female**.\n\nHere's why:\n\n*   **Paget's disease** is a chronic disorder that disrupts the body's normal bone remodeling process. This leads to abnormal bone formation, resulting in enlarged, deformed, and weakened bones.\n\nLet's break down the options:\n\n*   **A. Defect in osteoclasts:** This is a key feature of Paget's disease. Osteoclasts are cells responsible for breaking down bone. In Paget's disease, osteoclasts are overactive, leading to excessive bone resorption.\n*   **B. Common in female:** Paget's disease is actually **more common in men** than in women.\n*   **C. Can cause deafness:** When Paget's disease affects the bones of the skull, particularly the temporal bone, it can compress the auditory nerve or ossicles, leading to hearing loss or deafness.\n*   **D. Can cause osteosarcoma:** While rare, Paget's disease is a known risk factor for developing osteosarcoma, a type of bone cancer.\n\nTherefore, the statement that is **not** a feature of Paget's disease is that it is common in females.",
      "ground_truth": "Common in female || Ans. is 'b' i.e., Common in female Paget disease Paget's disease is characterized by increased bone turnover and enlargement and thickening of the bone, but the internal architecture is abnormal and the bone is usually brittle. Primary defect is in osteoclasts with increased osteoclastic activity. This results secondarily increase in osteoblastic activity (normal osteoclasts and osteoblasts act in a co-ordinated manner). So, characteristic cellular change is a marked increase in osteoclastic and osteoblastic activity. Bone turnover is acclerated, plasma alkaline phosphatase is raised (a sign of osteoblastic activity) and there is increased excretion of hydroxyproline in urine (due to osteoclastic activity). Clinical features of Paget's disease Paget's disease is slightly more common in males and is seen after 40 years of age. The pelvis and tibia being the commonest sites, and femur, skull, spine (veebrae) and clavicle the next commonest o Most of the patient with Paget's disease are asymptomatic, the disorder being diagnosed when an x-ray is taken for some unrelated condition or after the incidental discovery of raised serum alkaline phosphatase. When patients does present, they present because any of the three : - Pain : - Dull constant ache Deformities : - Bowing of long bones, platybasia. Complications of the disease Complications of Paget's disease Following complications can occur in Paget's disease : - Fracture : Are common in weight bearing bones Cranial nerve compression : - May cause impaired vision, facial palsy, trigeminal neuralgia or deafness. Otosclerosis : - Another cause of deafness in Paget's disease. Spinal canal stenosis and nerve root compression High output cardiac failure Osteoahritis : of Hip and knee Rarely osteosarcoma",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Atenolol is indicated in all except A. Hypertension | B. Partial heart block | C. Hypertrophic obstructive cardiomyopathy | D. Classical angina",
      "answer": "The correct answer is **B. Partial heart block**.\n\nHere's why:\n\n*   **Atenolol** is a beta-blocker. Beta-blockers work by blocking the effects of adrenaline (epinephrine) and noradrenaline (norepinephrine) on the body's beta receptors. This leads to a decrease in heart rate, blood pressure, and the force of heart contractions.\n\nLet's look at each option:\n\n*   **A. Hypertension:** Beta-blockers like atenolol are commonly used to treat high blood pressure (hypertension) by reducing heart rate and the force of contraction, thus lowering blood pressure.\n*   **B. Partial heart block:** This is a condition where the electrical signals from the upper chambers of the heart to the lower chambers are slowed down or blocked. Beta-blockers can **worsen** heart block by further slowing down the conduction of electrical impulses through the heart. Therefore, atenolol is **contraindicated** in most cases of heart block.\n*   **C. Hypertrophic obstructive cardiomyopathy (HOCM):** In HOCM, the heart muscle thickens, which can obstruct blood flow out of the heart. Beta-blockers can help by reducing the heart rate and the force of contraction, which can decrease the obstruction and improve symptoms.\n*   **D. Classical angina:** Angina is chest pain caused by reduced blood flow to the heart muscle. Beta-blockers like atenolol reduce the heart's workload by decreasing heart rate and contractility, which lowers the heart's oxygen demand and can help prevent or relieve angina.\n\n**In summary:** Atenolol is indicated for hypertension, hypertrophic obstructive cardiomyopathy, and classical angina. It is generally **not** indicated for partial heart block and can be harmful in such cases.",
      "ground_truth": "Partial heart block || Ans. (B) Partial heart block(Ref: KDT 8th/e p160-161)b -blockers are contraindicated in partial or complete heart block as they cause bradycardia.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Nerve damaged in case of numbness of little and ring finger, atrophy of hypothenar muscles A. Palmar cutaneous branch of ulnar | B. Deep branch of ulnar | C. Ulnar nerve before division into superficial and deep branches | D. Posterior cord of brachial plexus",
      "answer": "The correct answer is **B. Deep branch of ulnar**.\n\nHere's why:\n\n*   **Numbness of the little and ring finger:** These two fingers are primarily innervated by the ulnar nerve.\n*   **Atrophy of the hypothenar muscles:** The hypothenar muscles are located on the palm side of the hand, beneath the little finger. These muscles are also innervated by the ulnar nerve.\n\nThe **deep branch of the ulnar nerve** is responsible for innervating the intrinsic muscles of the hand, including the hypothenar muscles, and also provides sensory innervation to the little finger and the ulnar half of the ring finger. Therefore, damage to the deep branch of the ulnar nerve would result in both the sensory symptoms (numbness) and motor symptoms (atrophy) described.\n\nLet's look at why the other options are less likely:\n\n*   **A. Palmar cutaneous branch of ulnar:** This branch provides sensory innervation to the skin of the palm, but not the intrinsic muscles of the hand or the little and ring fingers.\n*   **C. Ulnar nerve before division into superficial and deep branches:** Damage at this level would affect both the superficial and deep branches, leading to a broader range of symptoms than described. While it *could* cause these symptoms, the deep branch is the more specific culprit for the combination of motor and sensory deficits in the little and ring fingers and hypothenar muscles.\n*   **D. Posterior cord of brachial plexus:** The posterior cord gives rise to the radial nerve and axillary nerve, among others. While it contributes to nerves that eventually innervate the hand, damage here would typically result in more widespread and different patterns of weakness and sensory loss, not specifically isolated to the little and ring fingers and hypothenar muscles.",
      "ground_truth": "Palmar cutaneous branch of ulnar || Ans. c. Ulnar nerve before division into superficial and deep branchesNerve damaged in case of numbness of little and ring finger, atrophy of hypothenar muscles is ulnar nerve, before division into superficial and deep branches.Supplied musclesUlnar Nerve (C8T,)Musician's NervMedian Nerve (C5678T1)Laborer's nervedegAxilla and ArmNo branchNo branchForearmFlexor carpi ulnarisdegFlexor digitorum profundus(medial half)degFlexor carpi radialisFlexor digitorum profundus (lateral Flexor digitorum superficialisdegFlexor pollicis longusPalmaris longusPronator teres and quadratusdegHandLast two (3rd and 4th)lumbricalsdegPalmar and dorsal interosseidegThenar muscles:Adductor pollicisdegHypothenar muscles:Palmaris brevisAbductor digiti minimiFlexor digiti minimiOpponens digiti minimi1st two (1st and 2sd)lumbricalsdegThenar musclesAbductor pollicis b.revisdegFlexor pollicis brevisdegOpponens pollicisdeg",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Most common hea disease which is associated with maximum moality during pregnancy A. >Eisenmenger syndrome | B. >MS | C. >AS | D. >VSD",
      "answer": "The correct answer is **A. Eisenmenger syndrome**.\n\n**Explanation:**\n\n*   **Eisenmenger syndrome** is a severe complication of congenital heart disease where a shunt reverses direction due to increased pulmonary vascular resistance. This leads to cyanosis and significant strain on the heart. Pregnancy places a very high hemodynamic burden on the cardiovascular system, which the already compromised heart in Eisenmenger syndrome cannot tolerate. This makes it the most dangerous heart condition for pregnant individuals, associated with the highest maternal mortality.\n\nLet's briefly look at why the other options are less likely to be the *most* common cause of maximum mortality:\n\n*   **B. MS (Mitral Stenosis):** While significant mitral stenosis can be problematic in pregnancy, it is generally less acutely life-threatening than Eisenmenger syndrome. Medical management and interventions can often mitigate the risks.\n*   **C. AS (Aortic Stenosis):** Severe aortic stenosis also poses risks in pregnancy due to increased cardiac workload. However, similar to mitral stenosis, it is typically associated with lower mortality rates compared to Eisenmenger syndrome.\n*   **D. VSD (Ventricular Septal Defect):** Small to moderate VSDs are often well-tolerated in pregnancy. Larger VSDs, especially those with pulmonary hypertension, can lead to complications, but Eisenmenger syndrome represents a more advanced and severe stage of pulmonary vascular disease that is inherently more dangerous in pregnancy.",
      "ground_truth": ">Eisenmenger syndrome || Eisenmenger syndrome This syndrome is secondary pulmonary hypeension that can develop with any cardiac lesion in which pulmonary vascular resistance becomes greater than the systemic vascular resistance and there should also be some right to left shunting. The most common underlying defects are atrial or ventricular septal defects and persistent ductus aeriosus. Patients usually are asymptomatic but eventually pulmonary hypeension becomes severe enough to cause right to left shunting. The prognosis for pregnancy depends upon the severity of pulmonary hypeension. The moality rate in Eisenmenger's syndrome is 50%. It is the maximum moality for any cardiovascular disorder in pregnancy. So termination of pregnancy is done in most cases. Maternal tolerance to specific hea conditions Well tolerated * Pulmonary stenosis * Aoic insufficiency * Mitral insufficiency * Congenital hea block Well tolerated if pulmonary hypeension is not present * Atrial septal defects * Ventricular septal defects * Patent ductus Variable tolerance depending on the functional capacity of the hea * Uncomplicated Aoic coarctation * Aoic stenosis * Mitral regurgitation * Aoic regurgitation Poorly tolerated and source of significant problems during pregnancy. * Mitral stenosis * Peripaum cardiomyopathy * Primary pulmonary hypeension * Eisenmenger's syndrome * Marfan's syndrome with dilated aoic root * Metallic valve prosthesis * Congenital cyanotic hea disease * Conditions listed in group C if pulmonary hypeension is present. * Any class III or IV lesion.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Methyl alcohol poisoning is treated with A. Disulfiram | B. Ethyl alcohol | C. Flumazenil | D. Clonidine",
      "answer": "The correct answer is **B. Ethyl alcohol**.\n\n**Explanation:**\n\nMethyl alcohol (methanol) is toxic because it is metabolized in the body to formic acid, which can cause severe metabolic acidosis, visual disturbances, and even death.\n\n*   **Ethyl alcohol (ethanol)** acts as a competitive inhibitor of the enzyme alcohol dehydrogenase. This enzyme is responsible for metabolizing both methanol and ethanol. By administering ethanol, it saturates the alcohol dehydrogenase, preventing the metabolism of methanol into its toxic byproducts. This allows the body to excrete the methanol unchanged.\n\nLet's look at why the other options are incorrect:\n\n*   **A. Disulfiram:** This medication is used to treat chronic alcoholism by causing an unpleasant reaction when alcohol is consumed. It is not used for methanol poisoning.\n*   **C. Flumazenil:** This is a benzodiazepine antagonist and is used to reverse the effects of benzodiazepine overdose. It has no role in methanol poisoning.\n*   **D. Clonidine:** This is an alpha-2 adrenergic agonist used to treat high blood pressure and other conditions. It is not used for methanol poisoning.",
      "ground_truth": "Ethyl alcohol || Ans. b (Ethyl alcohol). (Ref. Harrison, Medicine, 18th/Ch. 47)TREATMENT OF METHYL ALCOHOL POISONING# Patient in quiet, dark room# Gastric lavage with sodabicarb and Combat acidosis by IV sodabicarb infusion (the most vital measure, prevents retinal damage).# Ethanol 100mg/dl (retards methanol metabolism), Fomepizole (specific alcohol dehydrogenase inhibitor) and Haemodialysis are useful.PoisioningFeaturesRxEthylene Glycol (anti-freeze)High anion gap Metabolic acidosis and severe damage to the CNS, heart, lungs, and kidneys.Prompt institution of a saline or osmotic diuresis, thiamine and pyridoxine supplements, fomepizole or ethanol, and hemodialysis.Methanol (wood alcohol)Causes high anion gap metabolic acidosis, and its metabolites formaldehyde and formic acid cause severe optic nerve and CNS damage.Similar to that for ethylene glycol intoxication, including general supportive measures, fomepizole, and hemodialysis .Isopropyl Alcohol (as little as 150 ml of rubbing alcohol, solvent, or de-icer can be fatal)A plasma level >400 mg/dL is life-threatening. Isopropyl alcohol differs from ethylene glycol and methanol in that the parent compound, not the metabolites, causes toxicity, and an AG acidosis is not present because acetone is rapidly excreted. Ethylene glycol, Methanol and Isoporpyl alcohol, all 3 cause an elevated osmolal gap, but only the first two cause a high-AG acidosis.Treated by watchful waiting and supportive therapy; IV fluids, pressors, ventilatory support if needed, and occasionally hemodialysis for prolonged coma or levels >400 mg/dL.Treat Benzodiazepines overdose with flumazenil (competitive antagonist at GABA receptor).",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Lactic acidosis is not seen in - A. Methanol poisoning | B. Respiratory failure | C. Circulatory failure | D. Tolbutamide",
      "answer": "The correct answer is **D. Tolbutamide**.\n\nHere's why:\n\n*   **Lactic acidosis** is a condition characterized by an excessive buildup of lactic acid in the bloodstream. Lactic acid is a byproduct of anaerobic metabolism, which occurs when cells don't have enough oxygen.\n\nLet's look at why the other options can lead to lactic acidosis:\n\n*   **A. Methanol poisoning:** Methanol is metabolized into formic acid, which can inhibit cellular respiration and lead to anaerobic metabolism and lactic acidosis.\n*   **B. Respiratory failure:** When the lungs cannot adequately oxygenate the blood (respiratory failure), tissues become hypoxic. This leads to anaerobic metabolism and lactic acid production.\n*   **C. Circulatory failure:** If the heart cannot pump enough blood to the tissues (circulatory failure or shock), oxygen delivery is compromised. This also results in anaerobic metabolism and lactic acidosis.\n\n*   **D. Tolbutamide:** Tolbutamide is an oral antidiabetic medication. While it can have side effects, lactic acidosis is not a typical or common complication associated with its use. In rare cases, other sulfonylureas have been linked to lactic acidosis, but tolbutamide itself is not a primary cause.",
      "ground_truth": "Tolbutamide || An increase in plasma l-lactate may be secondary to *poor tissue perfusion (type A)--circulatory insufficiency (shock, cardiac failure), severe anemia, mitochondrial enzyme defects, and inhibitors (carbon monoxide, cyanide) * aerobic disorders (type B)-- malignancies, nucleoside analogue reverse transcriptase inhibitors in HIV, diabetes mellitus, renal or hepatic failure, thiamine deficiency, severe infections (cholera, malaria), seizures, or drugs/toxins (biguanides, ethanol, methanol, propylene glycol, isoniazid, and fructose). *Unrecognized bowel ischemia or infarction *Pyroglutamic acidemia has been repoed in critically ill patients receiving acetaminophen, which is associated with depletion of glutathione. d-Lactic acid acidosis, which",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 72-year-old man undergoes a subtotal colectomy for a cecal perforation due to a sigmoid colon obstruction. He has had a prolonged recovery and has been on total parenteral nutrition (TPN) for 2 weeks postoperatively. After regaining bowel function, he experienced significant diarrhea. Examination of his abdominal wound demonstrates minimal granulation tissue. He complains that he has lost his taste for food. He also has increased hair loss and a new perioral pustular rash. Which of the following deficiencies does he most likely have? A. Zinc | B. Selenium | C. Molybdenum | D. Chromium",
      "answer": "The patient's symptoms strongly suggest a **Zinc deficiency**. Here's why:\n\n*   **Diarrhea:** Zinc plays a crucial role in maintaining the integrity of the intestinal lining and immune function. Deficiency can lead to impaired gut barrier function and diarrhea.\n*   **Minimal granulation tissue in wound:** Zinc is essential for wound healing and cell proliferation. A deficiency would impair the formation of granulation tissue, leading to delayed wound healing.\n*   **Loss of taste (dysgeusia):** Zinc is vital for the function of taste receptors. A deficiency can significantly alter or diminish the sense of taste.\n*   **Increased hair loss (alopecia):** Zinc is involved in hair follicle development and maintenance. Deficiency can lead to hair thinning and loss.\n*   **Perioral pustular rash:** This is a classic dermatological manifestation of zinc deficiency, often appearing around the mouth, nose, and eyes.\n\nLet's consider why the other options are less likely:\n\n*   **B. Selenium:** Selenium is an antioxidant and important for thyroid function. While deficiency can cause muscle weakness and hair loss, the constellation of symptoms, particularly the rash and taste disturbance, is less characteristic of selenium deficiency.\n*   **C. Molybdenum:** Molybdenum is a cofactor for several enzymes involved in amino acid metabolism and detoxification. Deficiencies are rare and typically present with neurological issues and other metabolic derangements, not the symptoms described.\n*   **D. Chromium:** Chromium is involved in glucose metabolism and insulin sensitivity. Deficiency can lead to impaired glucose tolerance, but it doesn't typically cause the prominent gastrointestinal, dermatological, and sensory symptoms seen here.\n\nThe prolonged period on TPN without adequate zinc supplementation, especially after a major surgery, makes zinc deficiency a highly probable diagnosis.\n\nThe final answer is $\\boxed{A}$.",
      "ground_truth": "Zinc || The patient has a zinc deficiency. Alopecia, poor wound healing, night blindness or photophobia, anosmia, neuritis, and skin rashes are all characteristic of patients with zinc deficiency, which often results in the setting of excessive diarrhea. Selenium deficiency is characterized by the development of a cardiomyopathy. Molybdenum deficiency is manifested by encephalopathy due to toxic accumulation of sulfur-containing amino acids. Chromium deficiency can occur in patients on long-term TPN and is characterized by difficult-to-control hyperglycemia and peripheral neuropathy and encephalopathy. Thiamine deficiency results in beriberi, which includes symptoms of encephalopathy and peripheral neuropathy; patients with beriberi can also develop cardiovascular symptoms and cardiac failure.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following is contraindicated in diabetics with Congestive hea failure A. Empagliflozin | B. Metformin | C. Linagliptin | D. Pioglitazone",
      "answer": "The correct answer is **D. Pioglitazone**.\n\nHere's why:\n\n*   **Congestive Heart Failure (CHF) and Diabetics:** Patients with diabetes are at an increased risk of developing CHF. When a diabetic patient already has CHF, certain medications can worsen their condition.\n\n*   **Pioglitazone (a Thiazolidinedione - TZD):** Pioglitazone, and other TZDs, work by improving insulin sensitivity. However, a known and significant side effect of this class of drugs is fluid retention. This fluid retention can exacerbate existing CHF by increasing the workload on the heart and leading to pulmonary edema. Therefore, pioglitazone is generally contraindicated in patients with symptomatic CHF.\n\nLet's look at why the other options are generally *not* contraindicated:\n\n*   **A. Empagliflozin (an SGLT2 inhibitor):** Empagliflozin and other SGLT2 inhibitors have actually shown cardiovascular benefits, including a reduction in the risk of hospitalization for heart failure in patients with type 2 diabetes, even those with established cardiovascular disease or multiple risk factors. They are often *recommended* in diabetics with CHF.\n\n*   **B. Metformin:** Metformin is a first-line medication for type 2 diabetes. While it can cause lactic acidosis in rare cases, particularly in patients with severe renal impairment or acute illness, it is generally considered safe in diabetics with stable CHF. In fact, it's often continued in patients with CHF.\n\n*   **C. Linagliptin (a DPP-4 inhibitor):** Linagliptin and other DPP-4 inhibitors are generally considered safe in patients with diabetes and heart failure. They do not typically cause fluid retention or have significant negative cardiovascular effects.\n\n**In summary:** Pioglitazone's mechanism of action can lead to fluid retention, which is detrimental in patients already suffering from congestive heart failure.",
      "ground_truth": "Pioglitazone || Thiazolidinediones are associated with weight gain (2-3 kg), a small reduction in the hematocrit, and a mild increase in plasma volume. Peripheral edema and CHF are more common in individuals treated with these agents. These agents are contraindicated in patients with liver disease or CHF (class III or IV). Ref Harrison 20th edi page no 2867",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All are features of Pompe&;s disease except A. Cardiomyopathy | B. Skeletal myopathy | C. Hyperglycemia | D. Hepatomegaly",
      "answer": "The correct answer is **C. Hyperglycemia**.\n\nHere's why:\n\n*   **Pompe disease** is a rare genetic disorder that affects the body's ability to break down a sugar called glycogen. This leads to a buildup of glycogen in the cells, particularly in the muscles.\n\nLet's look at the options:\n\n*   **A. Cardiomyopathy:** This is a common and significant feature of Pompe disease, especially in infantile-onset forms. The heart muscle is weakened and enlarged due to glycogen accumulation.\n*   **B. Skeletal myopathy:** This is also a hallmark of Pompe disease. The skeletal muscles become weak and progressively damaged, leading to difficulties with movement, breathing, and swallowing.\n*   **C. Hyperglycemia:** This refers to high blood sugar levels. Pompe disease is characterized by **hypoglycemia** (low blood sugar) due to impaired glycogen breakdown and utilization.\n*   **D. Hepatomegaly:** Enlargement of the liver can occur in Pompe disease, particularly in infantile forms, as glycogen can also accumulate in liver cells.\n\nTherefore, **hyperglycemia** is the feature that is *not* characteristic of Pompe disease; in fact, hypoglycemia is more commonly associated with it.",
      "ground_truth": "Hyperglycemia || Type II(Pompe) disease results from lysosomal storage of glycogen in skeletal muscles,cardiac muscles, and central nervous system.There is progressive cardiomyopathy.ECG shows left axis detion,sho PR interval & large QRS.Hea failure with dyspnoea and cyanosis may occur.Skeletal muscles show hypotonia and marked weakness.The tongue is large & protruding.It is also characterised by hepatomegaly and hypoglycemia. the disease usually presents within the first three months of life with rapidly progressive muscle weakness ('floppy infants'), diminished muscle tone (hypotonia), respiratory deficiency, and a type of hea disease known as hyperophic cardiomyopathy, a condition characterized by abnormal thickening of the walls of the hea (mainly the left chamber and the wall between the left and right chamber) resulting in diminished cardiac function. These problems together culminate in cardio-respiratory failure within the first 2 years of life. Reference:Essential pediatrics-Ghai,8th edition,page no:657.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "An infant presents with cardiac failure. Examination reveals a weaker femoral pulse when compared to the radial pulse. What is the probable diagnosis? A. PDA | B. COA | C. Aorto-illiac vasculitis | D. VSD",
      "answer": "The probable diagnosis is **B. COA**.\n\n**Explanation:**\n\n*   **Coarctation of the Aorta (COA)** is a congenital narrowing of the aorta, typically in the region of the ductus arteriosus. This narrowing obstructs blood flow to the lower body.\n*   **Weaker femoral pulse compared to the radial pulse** is a classic sign of COA. The radial pulse (in the arm) will be strong because it receives blood directly from the aorta before the narrowing. The femoral pulse (in the leg) will be weaker because it receives blood that has passed through the constricted area of the aorta.\n*   **Cardiac failure** in an infant with COA is due to the increased workload on the left ventricle, which has to pump harder to overcome the aortic obstruction.\n\nLet's look at why the other options are less likely:\n\n*   **A. PDA (Patent Ductus Arteriosus):** A PDA is an abnormal connection between the aorta and the pulmonary artery. While it can cause cardiac failure, it typically results in **bounding pulses** in both the upper and lower extremities due to increased blood flow.\n*   **C. Aorto-illiac vasculitis:** Vasculitis affecting the aorta and iliac arteries can cause reduced pulses, but it's a less common cause of cardiac failure in infants compared to COA and the pulse discrepancy might not be as consistently localized to femoral vs. radial.\n*   **D. VSD (Ventricular Septal Defect):** A VSD is a hole between the ventricles. Large VSDs can lead to cardiac failure due to increased pulmonary blood flow, but they typically do not cause a significant difference between femoral and radial pulses. Pulses are usually normal or bounding.",
      "ground_truth": "COA || Ref: Nelson's Textbook of Pediatrics. 19th Edition.Explanation:Weak femoral pulse is indicative of Coarctation of aorta. Normally, the femoral pulse occurs slightly before the radial pulse. Weak femoral pulse or femoral pulse felt after radial pulse is a characteristic feature of COACoarctation of aorta (COA)Constrictions of the aorta of varying degrees may occur at any point from the transverse arch to the iliac bifurcation, hut 98% occur just below the origin of the left subclavian artery at the origin of the ductus arteriosus i juxtaductal coarctation).The anomaly occurs twice as often in males as in females.Coarctation of the aorta may be a feature of Turner syndrome and is associated with a bicuspid aortic valve in more than 70% of patients.Mitral valve abnormalities (a supravalvular mitral ring or parachute mitral valve) and subaortic stenosis are potential associated lesions.When this group of left-sided obstructive lesions occurs together, they are referred to as the Shone complex.Clinical ManifestationsMostly asymptomaticSome children or adolescents complain about weakness or pain in the legs after exerciseSilent hypertension diagnosed on routine physical examination.Disparity in pulsation and blood pressure in the arms and legs.The femoral, popliteal, posterior tibia], and dorsalis pedis pulses are weak (or absent in up to 40%' of patients), in contrast to the bounding pulses of the arms and carotid vessels.The radial and femoral pulses should always be palpated simultaneously for the presence of a radial-femora] delay.Normally, the femoral pulse occurs slightly before the radial pulse. A radial-femoral delay occurs when blood flow to the descending aorta is dependent on collaterals, in which case the femora] pulse is felt after the radial pulse.In normal persons, systolic blood pressure in the legs obtained by the cuff method is 10-20 mm Hg higher than that in the arms.In coarctation of the aorta, blood pressure in the legs is lower than that in the arms.The precordial impulse and heart sounds are usually normal.The presence of a systolic ejection click or thrill in the suprasternal notch suggests a bicuspid aortic valve (present in 709c of cases).A short systolic murmur is often heard along the left sternal border at the 3rd and 4th intercostal spaces.In older patients with well-developed collateral blood flow, systolic or continuous murmurs may be heard over the left and right sides of the chest laterally and posteriorly. (SUZMAN SIGN)In these patients, a palpable thri 11 can occasionally be appreciated in the intercostal spaces on the back.DiagnosisCardiac enlargement and pulmonary congestion are noted in infants with severe coarctation.The enlarged left subclavian artery commonly produces a prominent shadow in the left superior mediastinum.Notching of the inferior border of the ribs from pressure erosion by enlarged collateral vessels is common by late childhood.In most instances, the descending aorta has an area of poststenotic dilatation.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All of the following blood vessels are a part of Kiesselbachfs plexus except- A. Anterior Ethmoidal artery | B. Posterior ethmoidal artery | C. Greater palatine artery | D. Superior labial artery",
      "answer": "The correct answer is **B. Posterior ethmoidal artery**.\n\n**Explanation:**\n\nKiesselbach's plexus, also known as the Little's area, is a vascular network located in the anterior part of the nasal septum. It is a common site for nosebleeds (epistaxis) due to its rich blood supply from several arteries.\n\nThe arteries that contribute to Kiesselbach's plexus are:\n\n*   **Anterior Ethmoidal Artery:** This branch of the ophthalmic artery supplies the anterior and superior parts of the nasal septum.\n*   **Greater Palatine Artery:** This branch of the maxillary artery supplies the inferior and anterior parts of the nasal septum.\n*   **Superior Labial Artery:** This branch of the facial artery supplies the anterior-inferior part of the nasal septum.\n\nThe **Posterior Ethmoidal Artery**, also a branch of the ophthalmic artery, supplies the posterior and superior parts of the nasal cavity but does **not** typically contribute to the vascular network of Kiesselbach's plexus.",
      "ground_truth": "Posterior ethmoidal artery || Ans. is 'b' i.e., Posterior ethmoidal artery o Four arteries contribute to little's area:# Anterior ethmoidal artery# Septal branch of superior labial artery (Branch of facial A).# Septal branch of sphenopalatine artery (Branch of maxillary A).# Greater palatine artery (Branch of maxillary A).o These arteries anastomose to form a vascular plexus called \"Kiesselbach's plexus\".",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following is seen in hyperemia? A. Decreased arteriolar blood flow to the tissue | B. Increased arteriolar blood flow to the tissue | C. Increased venous blood flow in the tissue | D. Decrease venous blood flow in the tissue",
      "answer": "The correct answer is **B. Increased arteriolar blood flow to the tissue**.\n\n**Explanation:**\n\nHyperemia is a condition characterized by an **increase in blood flow** to a particular organ or tissue. This increase is primarily driven by the dilation of arterioles, which are small arteries that lead into capillaries. This dilation allows more blood to enter the capillary network of the tissue.\n\nLet's break down why the other options are incorrect:\n\n*   **A. Decreased arteriolar blood flow to the tissue:** This is the opposite of what happens in hyperemia.\n*   **C. Increased venous blood flow in the tissue:** While venous outflow might eventually increase to accommodate the increased arterial inflow, the *primary* event that defines hyperemia is the *increased inflow* from the arterioles. Increased venous flow is a consequence, not the defining characteristic.\n*   **D. Decrease venous blood flow in the tissue:** This would lead to congestion and edema, which is a different pathological process (e.g., passive hyperemia or congestion).",
      "ground_truth": "Increased arteriolar blood flow to the tissue || Ans. is 'b' i.e., Increased arteriolar blood flow to the tissue * Hypermia and congestion are the terms used for increased volume of blood within dilated vessels of an organ or tissue.* Hyperemia is an active process resulting from augmented blood flow to tissue because of arteriolar dilatation, at the site of inflammation or in skeletal muscle during exercise.Hyperemia is one of the cardinal sign of inflammation, i.e. redness (rubor) is due to hyperemia.* Congestion is a passive process resulting from impaired venous outflow from a tissue. It occurs in heart failure, portal venous obstruction and other local causes of obstruction. In right heart failure there is hepatic (liver) congestion and in left heart failure there is pulmonary congestion.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Hydroxyethyl starch is a- A. Vasodilator | B. Inotrope | C. Plasma expander | D. Diuretic",
      "answer": "The correct answer is **C. Plasma expander**.\n\n**Explanation:**\n\nHydroxyethyl starch (HES) is a colloid solution that is used to increase the volume of fluid in the bloodstream. It does this by drawing fluid from the interstitial spaces into the blood vessels, thereby expanding the plasma volume. This makes it a **plasma expander**.\n\nLet's look at why the other options are incorrect:\n\n*   **A. Vasodilator:** Vasodilators are substances that widen blood vessels, which can lower blood pressure. HES does not primarily act as a vasodilator.\n*   **B. Inotrope:** Inotropes are drugs that alter the contractility of the heart muscle. HES does not directly affect cardiac contractility.\n*   **D. Diuretic:** Diuretics are substances that increase the production of urine, leading to fluid loss from the body. HES, in fact, can sometimes impair kidney function and reduce urine output, the opposite of a diuretic.",
      "ground_truth": "Plasma expander || Ans. is 'c' i.e., Plasma expander Plasma expanders o These are high molecular weight substances which exes colloidal osmotic (oncotic) pressure, and when infused i.v. retain fluid in the vascular compament. o Human plasma or reconstituted huma albumin are the best, However, the former carries the risk of transmitting serum hepatitis, AIDS, and latter is expensive. Therefore synthetic colloids are more often used. o Desirable propeies of plasma expander are : Should exe oncotic pressure comparable to plasma. Should remain in circulation and not leak out in tissues, or be too rapidly disposed. Should be pharmacodynamically ine. Should not be pyrogenic or antigenic. Should not interfere with grouping and cross-matching of blood. Should be stable, easily sterilizable and cheap. o Substances used are - Human albumin, Dextran, Degraded gelatin polymer, Hydroxy ethyl starch, polyvinyl pyrrolidone. o Albumin has all desirable propeies except it is expensive. o Uses of plasma expanders ---> to correct hypovolemia, e.g. in burns, hypovolemic and endotoxic shock, severe trauma. o Contraindications --3 Severe anaemia, cardiac failure, pulmonary edema, renal insufficiency.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Advantage of using digoxin in CHF is: A. It is used to provide relief of symptoms | B. It reverses the pathological changes of CHF | C. It prolongs the survival of CHF patient | D. All of these",
      "answer": "The correct answer is **A. It is used to provide relief of symptoms**.\n\nHere's why:\n\n*   **Digoxin's primary role in Congestive Heart Failure (CHF) is symptom management.** It helps to improve the heart's pumping ability, which can lead to reduced shortness of breath, fatigue, and swelling.\n\nLet's look at why the other options are not the primary advantage:\n\n*   **B. It reverses the pathological changes of CHF:** Digoxin does not reverse the underlying structural and functional changes that cause CHF. It helps to manage the symptoms of the condition.\n*   **C. It prolongs the survival of CHF patient:** While improving symptoms can indirectly contribute to a better quality of life, digoxin has not been consistently shown to prolong survival in CHF patients. In fact, in some studies, it has been associated with an increased risk of mortality, especially at higher doses. Newer medications have demonstrated more significant benefits in terms of survival.\n*   **D. All of these:** Since B and C are not accurate primary advantages, this option is incorrect.",
      "ground_truth": "It is used to provide relief of symptoms || Digitalis (By increasing cardiac contractility) and Diuretics (by decreasing fluid overload) are used as symptomatic therapy of CHF. These drugs do not retard cardiac remodelling or prolong survival in CHF patients.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Sudden death, right sided heart failure (cor pulmonate or cardiovascular collapse occur when A. Small pulmonary embolism | B. Massive pulmonary embolism | C. 60% or more of pulmonary artery is obstructed with emboli | D. End artery obliteration",
      "answer": "The correct answer is **C. 60% or more of pulmonary artery is obstructed with emboli**.\n\nHere's why:\n\n*   **Pulmonary embolism (PE)** occurs when a blood clot (or other material) travels to the lungs and blocks an artery.\n*   **Right-sided heart failure (cor pulmonale)** develops when the right side of the heart has to work harder to pump blood through the lungs due to increased resistance.\n*   **Cardiovascular collapse** is a severe and life-threatening condition where the circulatory system fails, leading to a drastic drop in blood pressure and inadequate blood flow to vital organs.\n\n**Explanation:**\n\n*   **A. Small pulmonary embolism:** While small PEs can cause symptoms like shortness of breath or chest pain, they are generally not life-threatening and do not typically lead to sudden death or cardiovascular collapse.\n*   **B. Massive pulmonary embolism:** This is a significant PE, but the term \"massive\" is often used to describe a PE that causes hemodynamic instability (low blood pressure). While it can lead to sudden death, the specific threshold of obstruction is more precise.\n*   **C. 60% or more of pulmonary artery is obstructed with emboli:** This level of obstruction significantly impairs blood flow through the lungs. The right ventricle of the heart must generate very high pressures to overcome this blockage, leading to acute right ventricular strain and failure. This can rapidly progress to cardiovascular collapse and sudden death.\n*   **D. End artery obliteration:** This refers to the blockage of a terminal artery. While this can cause tissue damage in the area supplied by that artery, it's not the primary mechanism for widespread cardiovascular collapse from a pulmonary embolism.\n\nTherefore, a substantial obstruction of the pulmonary artery (60% or more) is the critical factor that can precipitate sudden death due to right-sided heart failure or cardiovascular collapse.",
      "ground_truth": "60% or more of pulmonary artery is obstructed with emboli || CONSEQUENCES OF PULMONARY EMBOLISM <NL> i) Sudden death. Massive pulmonary embolism(60% or moreof pulmonary artery) results in instantaneous death, without occurrence of chest pain or <NL> dyspnoea. However, if the death is somewhat delayed, the clinical features resemble myocardial infarction i.e. severe <NL> chest pain, dyspnoea and shock. <NL> ii) Acute cor pulmonale. Numerous small emboli may obstruct most of the pulmonary circulation resulting in acute <NL> right heart failure. Another mechanism is by release of vasoconstrictor substances from platelets or by reflex <NL> vasoconstriction of pulmonary vessels. <NL> iii) Pulmonary infarction. Obstruction of relatively smallsized pulmonary arterial branches may result in pulmonary <NL> infarction . The clinical features include chest pain due to fibrinous pleuritis, haemoptysis and dyspnoea due <NL> to reduced functioning pulmonary parenchyma. <NL> iv) Pulmonary haemorrhage. Obstruction of terminal branches (endarteries) leads to central pulmonary <NL> haemorrhage. The clinical features are haemoptysis, dyspnoea, and less commonly, chest pain due to central <NL> location of pulmonary haemorrhage. Sometimes, there may be concomitant pulmonary infarction. <NL> v) Resolution. Vast majority of small pulmonary emboli (60-80%) are resolved by fibrinolytic activity. These patients <NL> are clinically silent owing to bronchial circulation so that lung parenchyma is adequately perfused. <NL> vi) Pulmonary hypertension, chronic cor pulmonale and pulmonary arteriosclerosis. These are the sequelae of <NL> multiple small thromboemboli undergoing healing rather <NL> than resolution.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Laplace's law for cylinder? A. P = T/R PT ( 1/rl - l/r2) | B. P = 2T/R | C. P = T/R | D. None of the above",
      "answer": "The correct answer is **B. P = 2T/R**.\n\nHere's the explanation:\n\nLaplace's law, when applied to a cylinder, describes the relationship between the pressure difference across the wall of the cylinder (P), the tension in the wall (T), and the radius of the cylinder (R).\n\n*   **P:** Pressure difference across the wall.\n*   **T:** Tension in the wall per unit length.\n*   **R:** Radius of the cylinder.\n\nFor a cylinder, the tension in the wall is distributed across two perpendicular directions (circumferential and longitudinal). However, the primary pressure-generating force is the **circumferential tension**. This tension is effectively acting across the diameter of the cylinder.\n\nTherefore, the pressure is directly proportional to the tension and inversely proportional to the radius. The formula for a cylinder is:\n\n**P = 2T/R**\n\nLet's look at why the other options are incorrect:\n\n*   **A. P = T/R PT ( 1/rl - l/r2)**: This formula is more complex and resembles Laplace's law for a sphere or a more general curved surface, not a simple cylinder.\n*   **C. P = T/R**: This formula is closer to Laplace's law for a sphere (where P = 2T/R, but the tension is distributed differently). For a cylinder, the factor of 2 is crucial due to the way tension acts across the diameter.\n*   **D. None of the above**: Since option B is correct, this is incorrect.",
      "ground_truth": "P = T/R || Ans. c (P = T/R) (Ref. Ganong Physiology 22nd/584)LAPLACE'S LAW states that wall tension (T) is proportional to the product of intraventricular pressure (P) and ventricular radius (r).-----------------------------T. p.r# P = 2T/R.... IN A SPHERE (BECAUSE R1=R2).# P = T/r.... In a Cylinder like blood vessel (one radius is infinite).Wall Tension: Law of LaolaceT = p x r# Tension (T) in wall# | pressure and radius -| tensionApplicationsArterial aneurysm:# Weak wall balloons# Vessel radius |, causing | wall tension# Tension causes radius (vicious cycle), increasing risk of ruptureDilated heart failure:# | ventricular volume-| ventricular radius, which in turn causes t wall tension# Dilated ventricle must work harder than normal heart",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A young, tall, thin male with arachnodactyly has ectopia lentis in both eyes. The most likely diagnosis is A. Marfan's Syndrome | B. Marchesani's Syndrome | C. Homocystinuria | D. Ehler's Danlos syndrome",
      "answer": "The most likely diagnosis is **A. Marfan's Syndrome**.\n\nHere's why:\n\n*   **Marfan's Syndrome** is a genetic disorder that affects connective tissue. Key features include:\n    *   **Tall stature and long limbs:** This aligns with the \"young, tall, thin male\" description.\n    *   **Arachnodactyly:** This refers to long, slender fingers and toes, which is a classic sign.\n    *   **Ectopia lentis:** This is the displacement of the lens of the eye, and it is a very common and characteristic finding in Marfan's syndrome, often affecting both eyes.\n\nLet's look at why the other options are less likely:\n\n*   **B. Marchesani's Syndrome:** This is characterized by short stature, brachydactyly (short fingers and toes), and often ectopia lentis, but the patient's description is of tall stature and arachnodactyly.\n*   **C. Homocystinuria:** While homocystinuria can cause ectopia lentis and tall stature, it is typically associated with other features like intellectual disability, skeletal abnormalities (though not always arachnodactyly), and thromboembolic events. Arachnodactyly and ectopia lentis are more strongly and consistently associated with Marfan's syndrome.\n*   **D. Ehlers-Danlos Syndrome:** This is a group of inherited disorders affecting connective tissue. While some types can involve joint hypermobility and skin hyperextensibility, ectopia lentis is not a common or defining feature of most Ehlers-Danlos syndromes. Arachnodactyly can occur in some subtypes, but the combination with prominent ectopia lentis strongly points away from EDS and towards Marfan's.",
      "ground_truth": "Marfan's Syndrome || Marfan Syndrome Marfan syndrome is a disorder of connective tissues,manifested principally by changes in the skeleton, eyes,and cardiovascular system. Its prevalence is estimated to be 1 in 5000. Approximately 70% to 85% of cases are familial and transmitted by autosomal dominant inheri- tance. The remainder are sporadic and arise from new mutations. Pathogenesis. Marfan syndrome results from an inherited defect in an extracellular glycoprotein called fibrillin 1. There are two fundamental mechanisms by which loss of fibrillin leads to the clinical manifestations of Marfan syndrome: loss of structural suppo in microfibril rich connective tissue and excessive activation of TGF-b signaling. Each of these is discussed below. * Fibrillin is the major component of microfibrils found in the extracellular matrix . These fibrils provide a scaffolding on which tropoelastin is deposited to form elastic fibers. Although microfibrils are widely distributed in the body, they are paicularly abundant in the aoa, ligaments, and the ciliary zonules that suppo the lens; these tissues are prominently affected in Marfan syndrome. Fibrillin occurs in two homologous forms, fibrillin-1 and fibrillin-2, encoded by two separate genes, FBN1 and FBN2, mapped on chromo- somes 15q21.1 and 5q23.31, respectively. Mutations of FBN1 underlie Marfan syndrome; mutations of the related FBN2 gene are less common, and they give rise to congenital contractural arachnodactyly, an autosomal dominant disorder characterized by skeletal abnormalities. Mutational analysis has revealed more than 600 distinct mutations of the FBN1 gene in individuals with Marfan syndrome. Most of these are missense mutations that give rise to abnormal fibrillin-1. These can inhibit polymerization of fibrillin fibers (dominant negative effect). Alternatively, the reduction of fibrillin content below a ceain threshold weakens the connective tissue (haploinsufficiency). * While many clinical manifestations of Marfan syndrome can be explained by changes in the mechanical propeies of the extracellular matrix resulting from abnormalities of fibrillin, several others such as bone overgrowth and myxoid changes in mitral valves cannot be attributed to changes in tissue elasticity. Recent studies indicate that loss of microfibrils gives rise to abnormal and excessive activation of transforming growth factor-b (TGF-b), since normal microfibrils sequester TGF-b and thus control the bioavailability of this cytokine. Excessive TGF-b signaling has deleterious effects on vascular smooth muscle development and it also increases the activity of metalloproteases, causing loss of extracellular matrix. This schema is suppoed by two sets of observations. First, in a small number of individuals with clinical features of Marfan syndrome (MFS2), there are no mutations in FBN1 but instead gain-of-function mutations in genes that encode TGF-b receptors. Second, in mouse models of Marfan syndrome generated by mutations in Fbn1, administrationof antibodies to TGF-b prevents alterations in the aoa and mitral valves. Clinical Features. Although mitral valve lesions are more frequent, they are clinically less impoant than aoic lesions. Loss of connective tissue suppo in the mitral valve leaflets makes them soft and billowy, creating a so-called floppy valve . Valvular lesions, along with lengthening of the chordae tendineae, frequently give rise to mitral regurgitation. Similar changes may affect the tricuspid and, rarely, the aoic valves. Echocardiography greatly enhances the ability to detect the cardiovascular abnormalities and is therefore extremely valuable in the diagnosis of Marfan syndrome. The great majority of deaths are caused by rupture of aoic dissections, followed in impoance by cardiac failure. Ref Robbins 9/e pg 145",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which one of the following is a cause for \"Restrictive cardiomyopathy\" - A. Alcohol | B. Hemochromatosis | C. Amyloidosis | D. Sarcoidosis",
      "answer": "The correct answer is **C. Amyloidosis**.\n\nHere's why:\n\n*   **Restrictive cardiomyopathy (RCM)** is a condition where the heart muscle becomes stiff and less flexible, making it difficult for the ventricles to fill with blood.\n*   **Amyloidosis** is a disease where abnormal proteins (amyloid) build up in organs, including the heart. This buildup can stiffen the heart muscle, leading to restrictive cardiomyopathy.\n\nLet's look at why the other options are less direct causes of RCM:\n\n*   **A. Alcohol:** Chronic heavy alcohol use can lead to **dilated cardiomyopathy**, where the heart chambers enlarge and weaken.\n*   **B. Hemochromatosis:** This is a condition of iron overload. While iron overload can affect the heart, it more commonly leads to **dilated cardiomyopathy** or **hypertrophic cardiomyopathy** (thickening of the heart muscle), rather than restrictive.\n*   **D. Sarcoidosis:** This is an inflammatory disease that can affect various organs, including the heart. While sarcoidosis can cause heart problems, it often leads to **arrhythmias**, **conduction abnormalities**, or **dilated cardiomyopathy**. It can sometimes cause restrictive physiology, but amyloidosis is a more direct and common cause of RCM.",
      "ground_truth": "Amyloidosis ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All are true about hyperophic cardiomyopathy except A. Systolic dysfunction | B. Concenteric hyperophy | C. Diastolic dysfunction | D. Double apical impulse",
      "answer": "The correct answer is **A. Systolic dysfunction**.\n\nHere's why:\n\n*   **Hypertrophic cardiomyopathy (HCM)** is a condition where the heart muscle (myocardium) becomes abnormally thick.\n*   **B. Concentric hypertrophy:** This is a hallmark of HCM. The thickening typically occurs in a concentric pattern, meaning the walls of the left ventricle thicken uniformly.\n*   **C. Diastolic dysfunction:** The thickened heart muscle is stiff and less able to relax and fill with blood during diastole (the relaxation phase of the heart). This is a primary problem in HCM.\n*   **D. Double apical impulse:** In some individuals with HCM, the thickened left ventricle can cause a palpable double impulse at the apex of the heart during systole (contraction). This is due to the forceful contraction of the thickened muscle.\n*   **A. Systolic dysfunction:** While severe HCM can eventually lead to systolic dysfunction (impaired ability of the heart to pump blood effectively), it is **not** a primary or universal feature. In fact, many individuals with HCM have normal or even hyperdynamic systolic function, meaning their heart pumps with great force. The main problem is the impaired filling due to stiffness.\n\nTherefore, systolic dysfunction is the statement that is **not** always true about hypertrophic cardiomyopathy.",
      "ground_truth": "Systolic dysfunction || Ref Harrison 19 th ed pg 1568 Biopsy is not needed to diagnose hyperophic cardiomyopathy but can be used to exclude infiltrative and metabolic diseases. Rigorous athletic training (athlete's hea) may cause intermediate degrees of physiologic hyperophy difficult to differentiate from mild hyperophic cardiomyopathy. Unlike hyper- trophic cardiomyopathy, hyperophy in the athlete's hea regresses with cessation of training, and is accompanied by supernormal exer- cise capacity (VO2max >50 mL/kg/min), mild ventricular dilation, and normal diastolic function.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "The ground glass ventricular septum is seen in A. TOF | B. HOCM | C. TGA | D. CHF",
      "answer": "The correct answer is **D. CHF**.\n\n**Explanation:**\n\n*   **Ground glass ventricular septum** is a descriptive term used in echocardiography to refer to a thickened and echogenic (brightly appearing) interventricular septum. This appearance is often associated with increased interstitial fluid and fibrosis within the septum.\n\nLet's look at why the other options are less likely:\n\n*   **A. TOF (Tetralogy of Fallot):** This is a congenital heart defect characterized by four specific abnormalities, including a ventricular septal defect (VSD), pulmonary stenosis, overriding aorta, and right ventricular hypertrophy. While a VSD is present, the ground glass appearance of the septum is not a hallmark of TOF.\n*   **B. HOCM (Hypertrophic Obstructive Cardiomyopathy):** HOCM is characterized by asymmetric septal hypertrophy, where the septum is significantly thickened, particularly near the outflow tract. While there is septal thickening, the \"ground glass\" description specifically points to a different underlying pathology than the primary hypertrophy seen in HOCM.\n*   **C. TGA (Transposition of the Great Arteries):** TGA is a congenital defect where the aorta and pulmonary artery are switched. This condition involves abnormal great vessel connections, not typically a ground glass appearance of the ventricular septum itself.\n*   **D. CHF (Congestive Heart Failure):** In chronic congestive heart failure, particularly with dilated cardiomyopathy or long-standing pressure/volume overload, there can be interstitial edema and fibrosis within the myocardium, including the ventricular septum. This can lead to the thickened, echogenic \"ground glass\" appearance on echocardiography.\n\nTherefore, the ground glass ventricular septum is most commonly seen in the context of **Congestive Heart Failure (CHF)**.",
      "ground_truth": "HOCM || Four bump heaMS/MR Due to left atrial appendage enlargementGlassy hea on ECHOAmyloidosisDouble Cardiac shadow, Double density sign, Bedford signLeft Atrial EnlargementDock&;s sign, E-Sign, Figure of 3 sign, Reversed E sign, Inveed 3 signCoarctation of the aoaDouble aoic knuckleAoic dissectionJughandle appearancePrimary pulmonary hypeensionMaladie de Roger effectsmall VSDHilar dance (Pulmonary plethora)ASDBox-shaped heaTricuspid atresiaWater bottle / Flask shaped hea / Leather bottle / Pear shaped / money bag hea/Purse like hea/Epicardial fat pad signPericardial effusionCoeur en Sabot ie., Boot shaped heaTetrology of heaSpade-like deformity on ECHOAtypical HOCMEgg in Cup appearance, Square root signConstrictive PericarditisInveed moustache signMitral stenosisEgg on side appearance, Egg shaped hea, Egg in StringD-Transposition of great aeries (D-TGA)Convex left hea borderL-TGAGround glass ventricular septumHyperophic Obstructive Cardiomyopathy (HOCM)Straight left upper cardiac borderEbstein&;s anomalyConcave main pulmonary segment and right aoic archPersistent TruncusAeriosusSnowman sign, Figure of 8 sign, Cottage loaf signTotal Anomalous Pulmonary Venous Connection (TAPVC)Gooseneck signAtrio-ventricular septal defectTubular heaEmphysemaStag antler / Hands up signCCFSchimitar sign / Turkish sword appearanceCongenital venolobar syndromeSitting duck signpersistent TruncusAeriosusYin Yang SignPseudoaneurysmSmall hea signTension PneumopericardiumHigh attenuating Crescent signImpending rupture of an abdominal aoic aneurysmDraped Aoa signContained rupture of an abdominal aoic aneurysm(Ref: Problem Solving in Radiology: Cardiovascular Imaging by SuhnyAbbara and SanjeevaKalva)",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Hypeension in childhood typically complicates A. Post-streptococcal glomerulonephritis | B. Minimal change disease | C. Appendicitis | D. Peptic ulceration",
      "answer": "The correct answer is **A. Post-streptococcal glomerulonephritis**.\n\n**Explanation:**\n\n*   **Hypertension** (high blood pressure) is a common complication of **post-streptococcal glomerulonephritis (PSGN)**. PSGN is an inflammatory condition of the kidneys that can occur after a streptococcal infection (like strep throat or scarlet fever). The inflammation in the glomeruli (tiny filtering units in the kidneys) impairs their ability to filter waste and excess fluid from the blood, leading to fluid retention and increased blood volume, which in turn raises blood pressure.\n\nLet's look at why the other options are less likely to typically complicate with hypertension in childhood:\n\n*   **B. Minimal change disease:** This is a cause of nephrotic syndrome in children, characterized by significant protein loss in the urine. While some children with nephrotic syndrome can develop hypertension, it's not as consistently or typically a complication as it is with PSGN.\n*   **C. Appendicitis:** This is an inflammation of the appendix. While severe illness or complications of appendicitis can lead to systemic effects, hypertension is not a typical or direct complication.\n*   **D. Peptic ulceration:** This involves sores in the lining of the stomach or duodenum. While pain and bleeding can occur, hypertension is not a characteristic complication.",
      "ground_truth": "Post-streptococcal glomerulonephritis || Hypeension complicates 60-70% of post-streptococcal glomerulonephritis and it can result in cardiac failure and hypeensive encephalopathy.Post-streptococcal glomerulonephritis- Labile Hypeension as it resolves within 4-6 weeks of onset.In minimal change nephrotic syndrome, hypeension is absent.PSGN occurs 1-3 weeks following infection with nephritogenic strains (throat strain- M1, M4, M25 and skin strain -M49) of group A beta-hemolytic streptococci",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Not a feature of diabetes mellitus in pregnancy A. Postdatism | B. Hydramnios | C. Neonatal hyperglycemia | D. congenital defect",
      "answer": "The correct answer is **C. Neonatal hyperglycemia**.\n\nHere's why:\n\n*   **Diabetes Mellitus in Pregnancy (Gestational Diabetes Mellitus or pre-existing diabetes)**: In pregnancy, uncontrolled maternal diabetes can lead to a condition where the fetus is exposed to high levels of glucose. The fetus responds by producing more insulin. When the baby is born, the maternal glucose supply is cut off, but the baby's pancreas is still producing a high level of insulin. This can cause the baby's blood sugar to drop too low, leading to **neonatal hypoglycemia**, not hyperglycemia.\n\nLet's look at the other options:\n\n*   **A. Postdatism**: Babies born to mothers with diabetes in pregnancy are at a higher risk of being large for gestational age (macrosomia) and can sometimes have delayed maturation of the placenta, which can contribute to post-term delivery (postdatism).\n*   **B. Hydramnios**: High blood glucose levels in the mother can lead to increased fetal urination, which in turn can cause an excessive amount of amniotic fluid (hydramnios or polyhydramnios).\n*   **D. Congenital Defects**: Poorly controlled diabetes in early pregnancy is a known risk factor for various congenital anomalies in the developing fetus, particularly affecting the heart, brain, and spine.",
      "ground_truth": "Neonatal hyperglycemia || Neonatal complications Respiratory distress syndrome Hypoglycemia Polycythemia Hyperbilirubinemia Hyperviscosity Cardiomyopathy Bih trauma Reference: Textbook of Obstetrics; Sheila Balakrishnan, 2nd edition; Page no: 241",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Aschoff bodies are seen in A. Arrhythmogenic right ventricular cardiomyopathy | B. Kawasaki disease | C. Rheumatic heart disease | D. Infective endocarditis",
      "answer": "The correct answer is **C. Rheumatic heart disease**.\n\n**Explanation:**\n\nAschoff bodies are characteristic microscopic lesions found in the heart tissue of individuals with **rheumatic heart disease**. They are inflammatory nodules that form as a result of the body's immune response to a streptococcal infection (specifically, *Streptococcus pyogenes*). These bodies are composed of activated macrophages (Anitschkow cells), lymphocytes, and plasma cells.\n\nLet's briefly look at why the other options are incorrect:\n\n*   **A. Arrhythmogenic right ventricular cardiomyopathy (ARVC):** This is a genetic disorder that affects the muscle of the right ventricle, leading to arrhythmias. Aschoff bodies are not a feature of ARVC.\n*   **B. Kawasaki disease:** This is an inflammatory condition that affects blood vessels, particularly in children. While it can affect the heart, the characteristic lesions are different from Aschoff bodies.\n*   **D. Infective endocarditis:** This is an infection of the heart valves or inner lining of the heart. While inflammation is present, Aschoff bodies are not the typical pathological finding.",
      "ground_truth": "Rheumatic heart disease || Aschoff bodies are pathognomonic of Rheumatic heart disease.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 45-year-old woman underwent a modified radical mastectomy 4 years ago. She was treated for multiple bone metastases with cyclophosphamide, doxorubicin, and fluorouracil for 6 months. She is complaining of exeion on exercise, swelling of the legs, and swelling around eyes in the morning. On examination, she has bilateral rales in the lungs, Sl, S2 audible, S3, S4 gallop present. Her BP is 149/117 mm Hg, PR is 80/min, and RR is 18/min. What is the most likely cause for her cardiac condition? A. Systolic dysfunction CHF | B. Drug induced cardiac toxicity | C. Metastatic cardiac disease | D. Pneumonia",
      "answer": "The most likely cause for her cardiac condition is **B. Drug induced cardiac toxicity**.\n\nHere's why:\n\n*   **History of Chemotherapy:** The patient received a regimen including doxorubicin (Adriamycin). Doxorubicin is a well-known cardiotoxic agent that can cause cumulative damage to the heart muscle, leading to heart failure. The fact that she received this treatment 4 years ago and is now presenting with cardiac symptoms is consistent with the delayed onset of doxorubicin-induced cardiomyopathy.\n*   **Symptoms of Heart Failure:** Her symptoms of \"exeion on exercise\" (likely meaning exertion on exercise), swelling of the legs, and swelling around the eyes in the morning are classic signs of congestive heart failure (CHF).\n*   **Physical Examination Findings:**\n    *   **Bilateral rales in the lungs:** This indicates fluid accumulation in the lungs, a hallmark of CHF.\n    *   **S3 and S4 gallop:** These are abnormal heart sounds that suggest impaired ventricular filling and stiffness, often seen in heart failure.\n    *   **Elevated Blood Pressure (149/117 mm Hg):** While hypertension can contribute to heart failure, the combination of her history and other findings points more strongly to a drug-induced cause.\n\nLet's consider why the other options are less likely:\n\n*   **A. Systolic dysfunction CHF:** While she likely has systolic dysfunction as part of her CHF, this is a description of the *type* of heart failure, not the underlying *cause*. Drug-induced toxicity is a specific cause that leads to systolic dysfunction.\n*   **C. Metastatic cardiac disease:** While breast cancer can metastasize to the heart, it's less common than other sites. The presentation with bilateral rales and gallops is more typical of a functional impairment of the heart muscle rather than direct infiltration by tumor.\n*   **D. Pneumonia:** Pneumonia can cause rales and shortness of breath, but it typically presents with fever, cough, and sputum production, which are not mentioned. The presence of S3 and S4 gallops and leg swelling are not primary features of pneumonia.\n\n**Explanation of Drug-Induced Cardiac Toxicity (specifically Doxorubicin):**\n\nDoxorubicin is an anthracycline chemotherapy drug that can cause dose-dependent cardiotoxicity. It damages cardiomyocytes (heart muscle cells) by various mechanisms, including generating reactive oxygen species and interfering with cellular processes. This damage can lead to a weakening of the heart muscle's ability to pump effectively (systolic dysfunction), resulting in heart failure. The cardiotoxicity can manifest months or even years after treatment has concluded.",
      "ground_truth": "Drug induced cardiac toxicity || Answer is B (Drug induced cardiac toxicity) Features of cardiac failure in a patient on doxorubicin suggests the possibility of Anthracycline induced cardiac toxity.Risk of Anthracyclinc induced cardiac toxicity is increased with concomitent radiation and cyclophosphamide. cardiac failure after 6 months of chemotherapy with doxorubicin (anthracycline) and cyclophosphamide, is consistent with a diagnosis of drug induced cardiac toxity which is the single best answer of choice.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Inhalational agent of choice for neurosurgery ? A. Halothane | B. Enflurane | C. Isoflurane | D. N20",
      "answer": "The answer is **C. Isoflurane**.\n\nHere's why:\n\n*   **Isoflurane** is generally considered the inhalational agent of choice for neurosurgery. It has a relatively low blood-gas partition coefficient, meaning it's eliminated quickly from the body, allowing for faster emergence from anesthesia. It also has a good safety profile and is less likely to cause cerebral vasodilation compared to some other agents, which is important in neurosurgery to avoid increasing intracranial pressure.\n\nLet's look at why the other options are less ideal:\n\n*   **A. Halothane:** While historically used, Halothane is largely replaced due to its association with a higher risk of cardiac arrhythmias and hepatotoxicity. It also has a slower emergence profile.\n*   **B. Enflurane:** Enflurane can cause cerebral vasodilation and has a potential for seizure activity, making it less desirable for neurosurgical procedures where maintaining stable cerebral hemodynamics is crucial.\n*   **D. N2O (Nitrous Oxide):** Nitrous oxide is often used as an adjunct in anesthesia, but it's not typically the sole inhalational agent for neurosurgery. It can diffuse into air-filled cavities (like the lungs or bowel) and expand them, which can be problematic in certain surgical scenarios. It also doesn't provide sufficient anesthetic depth or muscle relaxation on its own for many neurosurgical procedures.",
      "ground_truth": "Isoflurane || Ans. is 'c' i.e., Isoflurane Anaesthetic agents of choice for vaous conditions Day care : Ischemic hea disease : Congenital hea disease Left to right shunt : Right to left shunt : CHF : Shock To produce delibrate hypotenion Epilepsy : For electroconvulsive therapy : Thyrotoxicosis : Cardiac surgery : Neurosurgery : Propofol Etomidate Isoflurane Ketamine Ketamine Ketamine Isoflurane Thiopentone Methohexitone Thiopentone Isoflurane Isoflurane",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Wilson disease is due to accumulation of: September 2005 A. Copper | B. Iron | C. Zinc | D. Nickel",
      "answer": "The correct answer is **A. Copper**.\n\n**Explanation:**\n\nWilson disease is a rare genetic disorder that prevents the body from getting rid of excess copper. Copper is an essential mineral, but too much of it can be toxic. In Wilson disease, copper builds up in the liver, brain, and other organs, leading to a variety of health problems.",
      "ground_truth": "Copper || Ans. A: Copper In Wilson disease, main sites of copper accumulation are the liver and the brain, and consequently liver disease and neuropsychiatric symptoms are the main features that lead to diagnosis. Liver disease may present as tiredness, increased bleeding tendency or confusion (due to hepatic encephalopathy) and poal hypeension. On examination, signs of chronic liver disease such as spider naevi (small distended blood vessels, usually on the chest) may be observed. Chronic active hepatitis has caused cirrhosis of the liver in most patients by the time they develop symptoms. About 5% of all patients are diagnosed only when they develop fulminant acute liver failure, often in the context of a hemolytic anemia. About half the patients with Wilson's have neurological or psychiatric problems. Specific neurological symptoms then follow, often in the form of parkinsonism (increased rigidity and slowing of routine movements) with or without a typical hand tremor, masked facial expressions, slurred speech, ataxia (lack of coordination) or dystonia (twisting and repetitive movements of pa of the body). Various medical conditions have been linked with copper accumulation in Wilson's disease: Eyes: Kayser-Fleischer rings (KF rings) may be visible around the iris. They are due to copper deposition in Descemet's membrane of the cornea. They do not occur in all patients and may only be visible on slit lamp examination. Wilson's disease is also associated with sunflower cataracts, brown or green pigmentation of the anterior and posterior lens capsule. Kidneys: renal tubular acidosis, a disorder of bicarbonate handling by the PCT leads to nephrocalcinosis (calcium accumulation in the kidneys), weakening of the bone (due to calcium and phosphate loss) and occasionally aminoaciduria. Hea: cardiomyopathy and arrythmias Hormones: hypoparathyroidism, infeility and habitual aboion.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Kussumau's sign is most commonly seen in- A. Restrictive cardiomyopathy | B. Pericardial tamponade | C. Constrictive pericarditis | D. Right ventricular infarct",
      "answer": "The correct answer is **C. Constrictive pericarditis**.\n\n**Explanation:**\n\nKussmaul's sign is characterized by an abnormal increase in jugular venous pressure (JVP) during inspiration. Normally, the JVP falls during inspiration due to decreased intrathoracic pressure and increased venous return to the right atrium.\n\n*   **Constrictive pericarditis:** In this condition, the pericardium (the sac surrounding the heart) becomes thickened and stiff, restricting the heart's ability to fill properly during diastole. This restriction leads to elevated right atrial pressure, and during inspiration, the already elevated pressure cannot decrease as it normally would, resulting in Kussmaul's sign.\n\nLet's look at why the other options are less likely:\n\n*   **A. Restrictive cardiomyopathy:** While this condition also involves impaired diastolic filling, the primary issue is with the heart muscle itself, not the pericardium. Kussmaul's sign is not as consistently or characteristically seen as in constrictive pericarditis.\n*   **B. Pericardial tamponade:** In pericardial tamponade, there is a large amount of fluid in the pericardial sac, compressing the heart. This leads to elevated JVP, but typically, the JVP will *decrease* during inspiration (though it may be very high at all times). The paradoxical rise seen in Kussmaul's sign is not the hallmark of tamponade.\n*   **D. Right ventricular infarct:** A right ventricular infarct can lead to right heart failure and elevated JVP. However, Kussmaul's sign is not a specific or consistent finding in isolated RV infarcts. The mechanism of impaired filling due to a stiff pericardium is more directly linked to Kussmaul's sign.",
      "ground_truth": "Constrictive pericarditis || Kussmaul sign is a paradoxical rise in jugular venous pressure (JVP) on inspiration, or a failure in the appropriate fall of the JVP with inspiration. It can be seen in some forms of hea disease and is usually indicative of limited right ventricular filling due to right hea dysfunction. The differential diagnosis generally associated with Kussmaul sign is constrictive pericarditis, as well as with restrictive cardiomyopathy. With cardiac tamponade, jugular veins are distended and typically show a prominent x descent and an absent y descent as opposed to patients with constrictive pericarditis (prominent x and y descent), see Beck's triad Other possible causes of Kussmaul's sign include: Right ventricular infarction - low ventricular compliance Right hea failure Cardiac tumours Tricuspid stenosis Restrictive cardiomyopathy Pulmonary embolism Constrictive pericarditis Ref Harrison 20th edition pg 1435",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Beta blockers are not indicated in A. Acute CHF | B. Hypeension | C. Chronic CHF | D. Arrhythmia",
      "answer": "The correct answer is **A. Acute CHF**.\n\nHere's why:\n\n*   **Beta-blockers** work by blocking the effects of adrenaline (epinephrine) and noradrenaline on the heart. This leads to a slower heart rate, reduced force of contraction, and lower blood pressure.\n\n*   **Acute CHF (Congestive Heart Failure):** In acute heart failure, the heart is already struggling to pump effectively. Administering beta-blockers in this situation can further depress the heart's contractility, worsening the condition and potentially leading to decompensation. Therefore, they are generally **contraindicated** in acute decompensated heart failure.\n\n*   **Hypertension (High Blood Pressure):** Beta-blockers are a common and effective treatment for hypertension because they lower heart rate and reduce the force of contraction, thereby decreasing blood pressure.\n\n*   **Chronic CHF (Congestive Heart Failure):** In stable, chronic heart failure, beta-blockers are a cornerstone of therapy. They have been shown to improve symptoms, reduce hospitalizations, and increase survival rates by allowing the heart to work more efficiently over time and preventing remodeling.\n\n*   **Arrhythmia (Irregular Heartbeat):** Beta-blockers are frequently used to manage various types of arrhythmias, particularly those involving a fast heart rate (tachyarrhythmias), by slowing down the electrical conduction through the heart.\n\n**In summary:** While beta-blockers are beneficial in chronic CHF, hypertension, and many arrhythmias, they are generally avoided in acute decompensated heart failure.",
      "ground_truth": "Acute CHF || Ref: HL Sharma 3rd ed pg no: 193 Beta blockers are not used in CCF except metoprolol and carvedilol due to their antioxidant propeies they are used only in chronic CHF not in acute in acute CCF or CHF, diuretics , digoxin are used",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Gottron papules are seen in - A. Dermatomyositis | B. Inclusion body myositis | C. Polymyositis | D. DLE",
      "answer": "The correct answer is **A. Dermatomyositis**.\n\n**Explanation:**\n\nGottron papules are a characteristic skin finding associated with dermatomyositis. They appear as erythematous to violaceous papules and plaques over the dorsal aspects of the metacarpophalangeal (MCP) and interphalangeal (IP) joints.\n\nHere's why the other options are incorrect:\n\n*   **B. Inclusion body myositis:** While inclusion body myositis is a type of inflammatory myopathy, it typically does not present with Gottron papules.\n*   **C. Polymyositis:** Polymyositis is another inflammatory myopathy, but it primarily affects muscle strength and does not typically involve the characteristic skin manifestations like Gottron papules.\n*   **D. DLE (Discoid Lupus Erythematosus):** DLE is a chronic form of cutaneous lupus erythematosus. While it causes skin lesions, they are usually well-demarcated, scaly plaques that can lead to scarring and atrophy, and are distinct from Gottron papules.",
      "ground_truth": "Dermatomyositis || Ans. is 'a' i.e., Dermatomyositis Cutaneous signs of dermatomvosits1. Gottron's papules: - lilac or violaceous papules on knuckle, dorsa of hands.2 Gottron's sign : - Violaceous erythema with edema over shoulder, arms, forearms.Heliotrope sign : - Violaceous erythema with edema over eyelids, periorbital region.Poikiloderma : - Atrophy of skin, hypopigmentaion, dilated blood vessels over trunk.Mechanic hand : - Symmetric hyperkeratosis along ulnar aspect of thumb and radial aspect of fingers.Shawl Sign : - Violaceous erythema extending from dorsolateral aspect of hands, forearms, and arms to shoulder & neck.Calcinosis cutis : - Calcium deposits in skin (in Juvenile variant).Miscellaneous signs : - Photosensitivity, vasculitis, panniculitis, Nail-fold telangiectasia.Extracutaneous involvement1. Proximal myositis3) Raynaud's phenomenon2 Cardiomyopathy4) Arthralgia",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Digoxin toxicity is precipitated by all except: A. Electrolyte disturbance | B. Acute myocardial infarction | C. Hepatic disease | D. Renal disease",
      "answer": "The correct answer is **C. Hepatic disease**.\n\nHere's why:\n\n*   **Digoxin toxicity** occurs when the level of digoxin in the body becomes too high, leading to adverse effects.\n*   **A. Electrolyte disturbance:** Hypokalemia (low potassium), hypomagnesemia (low magnesium), and hypercalcemia (high calcium) can all increase the risk of digoxin toxicity. These electrolyte imbalances can make the heart more sensitive to digoxin.\n*   **B. Acute myocardial infarction (AMI):** An AMI can lead to impaired cardiac function and altered electrolyte balance, both of which can predispose a patient to digoxin toxicity.\n*   **D. Renal disease:** The kidneys are the primary route of digoxin excretion. Impaired renal function leads to decreased digoxin clearance, resulting in higher drug levels and an increased risk of toxicity.\n*   **C. Hepatic disease:** While the liver plays a role in drug metabolism, digoxin is primarily excreted by the kidneys. Therefore, hepatic disease has a much less significant impact on digoxin levels and toxicity compared to renal disease or electrolyte imbalances.\n\n**In summary:** Renal disease, electrolyte disturbances, and acute myocardial infarction can all contribute to digoxin toxicity by affecting its elimination or the heart's sensitivity to the drug. Hepatic disease, however, is not a primary precipitating factor for digoxin toxicity.",
      "ground_truth": "Hepatic disease || Ans. is 'c' Hepatic disease Digoxin toxicity is enhanced by renal failure as it is excreted through kidneys where as digitoxin toxicity is enhanced by liver failure because it is eliminated by hepatic metabolism.Other factors precipitating Digitalis toxicityAdvanced ageAcute myocardial infarction or ischemiaHypoxemiaHypomagnesemiaRenal insufficiencyHypercalcemiaElectrical cardioversionHypothyroidismHypokalemia (most common precipitating cause of digitalis intoxication. This often occurs in patients with heart failure as a result of diuretic therapy and secondary hyperaldosteronism).ALSO REMEMBERThe administration of following drugs raises the serum concentration of Digoxin by reducing both the renal and non renal elimination of digoxin and by reducing its volume of distribution.QuinidineVerapamilAmiodaronePropafenone",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Tako-Tsubo Cardiomyopathy is a type of - A. Dilated Cardiomyopathy | B. Restrictive Cardiomyopathy | C. Hypertrophic Cardiomyopathy | D. Toxic Cardiomyopathy",
      "answer": "The correct answer is **A. Dilated Cardiomyopathy**.\n\n**Explanation:**\n\nTako-Tsubo cardiomyopathy, also known as stress-induced cardiomyopathy or broken heart syndrome, is a temporary weakening of the heart muscle. While it has distinct features, it is classified under the umbrella of dilated cardiomyopathies because it leads to a significant enlargement and impaired pumping function of the left ventricle, similar to other forms of dilated cardiomyopathy.\n\nHere's why the other options are incorrect:\n\n*   **B. Restrictive Cardiomyopathy:** This type of cardiomyopathy involves stiffening of the heart muscle, making it difficult for the ventricles to fill with blood.\n*   **C. Hypertrophic Cardiomyopathy:** This is characterized by thickening of the heart muscle, which can obstruct blood flow.\n*   **D. Toxic Cardiomyopathy:** This refers to heart muscle damage caused by toxins, such as alcohol or certain medications.",
      "ground_truth": "Dilated Cardiomyopathy || Ans. is 'a' i.e., Dilated Cardiomyopathy [Ref: Harrison 18th/e p. 1964)o Stress cardiomyopathy, also called apical ballooning syndrome, broken heart syndrome, tako-tsubo cardiomyopathy, and stress induced cardiomyopathy is an increasingly reported syndrome characterized by transient systolic dysfunction of the apical and/or mild segments of the left ventricle that mimics myocardial infarction but in the absence of obstructive coronary artery disease.o Stress cardiomyopathy is typically triggered by an acute medical illness or by intense emotional or physical stress, although triggering event is not always present.o Stress cardiomyopathy may account for approximately 2% of suspected acute coronary syndrome,o Common presenting features included : -# ECG abnormalities, often anterior ST elevation,# Elevated cardiac biomarkers# Substernal chest pain and dyspnoea.o Proposed diagnostic criteria include# Presence of transient regional wall motion abnormalities# Absence of angiographic evidence of obstructive coronary disese or acute plaque rupture# Presence of new ECG abnormalities or modest troponin elevation absence ofpheochromocytoma.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Sudden death can be seen in- A. AS | B. MS | C. MR | D. MR",
      "answer": "The answer is **A. AS**.\n\nHere's why:\n\n*   **AS** stands for **Aortic Stenosis**. Severe aortic stenosis, where the aortic valve is significantly narrowed, can lead to sudden cardiac death. This is because the heart has to work much harder to pump blood through the narrowed valve. This increased workload can cause arrhythmias (irregular heartbeats) and, in severe cases, sudden cardiac arrest.\n\nLet's look at why the other options are less likely to cause sudden death as a primary presentation:\n\n*   **MS** stands for **Mitral Stenosis**. While severe mitral stenosis can lead to significant symptoms like shortness of breath and fatigue, sudden cardiac death is not its most common or direct presentation.\n*   **MR** stands for **Mitral Regurgitation**. Similar to mitral stenosis, severe mitral regurgitation can cause heart failure symptoms, but sudden death is not as directly associated with it as it is with severe aortic stenosis.\n\n**In summary:** Severe aortic stenosis is a well-established cause of sudden cardiac death due to the extreme strain it places on the heart.",
      "ground_truth": "AS || Ans. 'a' i.e., AS o The patients with Aortic stenosis are asymptomatic for a prolonged periods despite the obstruction and increased pressure load on the left ventricle.o The classic symptoms of Aortic stenosis areHeart failure, syncope andAnginaHowever, the classic symptoms reflect end stage diseaseo In general symptoms in patients with Aortic stenosis and normal left ventricualr systolic function rarely occur until the valve area is < 1.0 cm1, the jet velocity is over 4.0 m/s and the mean transvalvular gradient exceeds 40 mmHg.o In patients with known Aortic stenosis who are followed prospectively, the most common symptoms are decreased exercise tolerance and dyspnoea on exertion.o Once symptoms develop, even when mild, prompt surgical intervention is needed because average survivalwithout valve replacement is only two to three years with a high risk of sudden death.Sudden cardiac death in Aortic stenosiso Symptomatic severe Aortic stenosis is associated with a high risk of sudden cardiac death. Sudden cardiac death has been obser\\>ed in 0-5% of adults with asymptomatic aortic stenosis and in 8-34% with symptomatic aortic stenosis.o The mechanism of sudden death has not been established.o Potential causes include an abnormal BezoldJariseh reflex with hypotension or bradyarryhthmia or malignant ventricular tachyarryhthmia.o However a relationship between NS IT and sudden death has not been established.o The risk of sudden death is reduced by valve replacement, so prompt valve replacement, is generally recommended for symptomatic Aortic stenosis.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "The pulseless disease is - A. Giant cell arteritis | B. Takayasu arteritis | C. Kawasaki disease | D. Polyarteritis nodosa",
      "answer": "The correct answer is **B. Takayasu arteritis**.\n\n**Explanation:**\n\nTakayasu arteritis is a rare inflammatory disease that affects the large arteries, particularly the aorta and its branches. It is characterized by inflammation and thickening of the arterial walls, which can lead to narrowing or blockage of the arteries. This narrowing or blockage can significantly reduce blood flow, leading to a diminished or absent pulse in the affected limbs, hence the term \"pulseless disease.\"\n\nHere's why the other options are incorrect:\n\n*   **A. Giant cell arteritis:** While also a form of vasculitis affecting large arteries, giant cell arteritis typically affects older individuals (over 50) and commonly involves the temporal arteries, leading to symptoms like headache and jaw claudication. It's less commonly associated with the widespread pulselessness seen in Takayasu arteritis.\n*   **C. Kawasaki disease:** This is an acute febrile illness that primarily affects children and is characterized by inflammation of blood vessels throughout the body, particularly the coronary arteries. While it can lead to aneurysms, it's not typically described as \"pulseless disease.\"\n*   **D. Polyarteritis nodosa:** This is a systemic vasculitis that affects medium-sized arteries. It can cause a variety of symptoms depending on the organs involved, but it's not specifically known for causing absent pulses in the limbs as its defining characteristic.",
      "ground_truth": "Takayasu arteritis || Takayasu arteritis <NL> <NL> Takayasu arteritis is granulomatous vasculitis of large and medium arteries. <NL> It is characterized principally by ocular disturbance and marked weakening of pulses in the upper extremities Pulseless disease. <NL> It is also characterized by a strong predilection for aortic arch and its branches  Aortic arch syndrome. <NL> It is more common in Adolescent girls and young women. <NL> Morphological changes in vessel wall are same as in giant cell arteritis. <NL> <NL> Clinical presentation <NL> <NL> Symptoms are mainly according to the involved vessel - <NL> C Subclavian artery : <NL> Most commonly involved vessel <NL> Symptoms are - Arm claudication, lower BP and weaker pulse in upper limb than in lower limb, Raynaud's phenomenon. <NL> Common carotid  Visual disturbances, stroke, TIA, syncope. <NL> Abdominal aorta or coeliac artery or superior mesenteric artery  Abdominal pain, nausea, vomiting <NL> <NL> <NL> <NL> Renal  Hypertension, Renal failure <NL> Aortic root  Aortic regurgitation, CHF <NL> Vertebral  Visual disturbances <NL> Iliac  Leg claudication <NL> Pulmonary  Pulmonary hypertension, dysnea, chest pain. <NL> Coronary  Angina, MI <NL> Constitutional symptoms  As with other vasculitis malaise, fatigue, anorexia and weight loss are common. <NL> Elevated ESR and Anemia (as with other vasculitis)",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A multi-parous P3L3 young lady who delivered normally 3 weeks ago suddenly developed dyspnea with cardiac failure. She has no H/O cardiac disease before /during pregnancy. She had tachycardia and peripheral edema. Her hemoglobin was 9 gm/dl. Her Echo has revealed an EF of 35%. Which one of the following is the most likely diagnosis? A. Acute MI | B. Deep vein thrombosis with pulmonary embolism | C. Amniotic fluid embolism | D. Peri-paum cardiomyopathy",
      "answer": "The most likely diagnosis is **D. Peri-partum cardiomyopathy**.\n\nHere's why:\n\n*   **Peri-partum cardiomyopathy (PPCM)** is a form of heart failure that occurs in the last month of pregnancy or within five months after delivery. Key features that point to this diagnosis in the given scenario include:\n    *   **New onset cardiac failure:** The patient developed dyspnea and signs of cardiac failure (tachycardia, peripheral edema) suddenly.\n    *   **Timing:** The symptoms appeared 3 weeks postpartum, which falls within the typical window for PPCM.\n    *   **No prior cardiac history:** The absence of pre-existing heart disease or complications during pregnancy makes PPCM more likely than other cardiac issues.\n    *   **Reduced Ejection Fraction (EF):** An EF of 35% indicates significant systolic dysfunction, a hallmark of heart failure.\n    *   **Anemia:** While not directly causing the cardiomyopathy, the hemoglobin of 9 gm/dl could exacerbate symptoms of heart failure.\n\nLet's consider why the other options are less likely:\n\n*   **A. Acute MI (Myocardial Infarction):** While possible, acute MI in a young, otherwise healthy woman without risk factors (like hypertension, diabetes, or a strong family history) is less common than PPCM in the postpartum period. The presentation is more suggestive of a gradual or subacute onset of heart failure rather than a sudden ischemic event.\n*   **B. Deep vein thrombosis with pulmonary embolism (DVT/PE):** DVT/PE can cause dyspnea and tachycardia, and can lead to right-sided heart strain. However, it typically doesn't present with such profound global cardiac failure and a significantly reduced EF (35%) as the primary manifestation. While PE can contribute to cardiac dysfunction, the overall picture strongly favors a primary myocardial issue.\n*   **C. Amniotic fluid embolism (AFE):** AFE is a rare but catastrophic event that typically occurs during labor or immediately after delivery. Its presentation is usually very sudden and dramatic, often involving respiratory distress, cardiovascular collapse, coagulopathy, and neurological symptoms. While it can lead to cardiac arrest, the patient's presentation 3 weeks postpartum makes AFE highly unlikely.\n\nTherefore, given the patient's age, parity, postpartum timing, sudden onset of cardiac failure, and echocardiographic findings, peri-partum cardiomyopathy is the most fitting diagnosis.",
      "ground_truth": "Peri-paum cardiomyopathy || Acute Ml Ruled out as chest pain at rest, elevated cardio-markers or ECG changes are not present. DVT with PE Develops suddenly and is a close answer but point against is Echo finding of only low ejection fraction. In PE, Echo shows RV dyskinesia with or without tricuspid regurgitation. The interventricular septal detion is also seen Amniotic fluid embolism Ruled out as it occurs immediately during active labour Peri-paum cardiomyopathy PPCM is diagnosed when the following 3 criteria are met: 1. Hea failure develops in the last month of pregnancy or within 5 months of delivery. 2. Hea pumping function is reduced, with an ejection fraction (EF) less than 45% 3. No other cause for hea failure with reduced EF can be found. In this question anemia, Ml and Pulmonary embolism have been ruled out",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following symptoms suggests CHF in a newborn? A. Diaphoresis with feedings | B. Fever | C. Cyanosis | D. Persistent irritability",
      "answer": "The correct answer is **A. Diaphoresis with feedings**.\n\nHere's why:\n\n*   **Diaphoresis with feedings (sweating during feeding):** This is a classic sign of increased work of breathing and metabolic demand in newborns with heart failure. Their bodies are working harder to pump blood and oxygenate themselves, leading to excessive sweating, especially when they exert themselves by feeding.\n\nLet's look at why the other options are less specific for CHF in a newborn:\n\n*   **B. Fever:** Fever is a sign of infection or inflammation, not typically a primary symptom of congenital heart failure (CHF).\n*   **C. Cyanosis:** While cyanosis (bluish discoloration of the skin) can be a symptom of certain congenital heart defects that lead to CHF, it's not a universal or the most specific early sign of CHF itself. Cyanosis indicates poor oxygenation, which can have many causes.\n*   **D. Persistent irritability:** Irritability can be a sign of many issues in newborns, including hunger, discomfort, or even neurological problems. While a baby with CHF might be irritable due to discomfort or poor feeding, it's not as directly indicative of the cardiac strain as diaphoresis with feedings.\n\n**Explanation of CHF in Newborns:**\n\nCongenital heart failure (CHF) in newborns occurs when the heart cannot pump blood effectively to meet the body's needs. This can be due to structural defects in the heart or problems with the heart muscle. When the heart is struggling, the body has to work harder, leading to symptoms like increased respiratory effort and diaphoresis, especially during activities like feeding.",
      "ground_truth": "Diaphoresis with feedings || The signs of congestive hea failure in the newborn are,Tachypnea TachycardiaHepatomegalyDiaphoresisFeeding difficultiesFailure to thriveSigns and symptoms of CHF occur when the hea is unable to meet the metabolic demands of the tissues.Clinical findings are frequently due to homeostatic mechanisms attempt to compensate for this imbalance.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 59 years old female patient taking medications for hypertension and congestive cardiac failure. She suddenly develops skin rashes along with swelling of tongue, lips as well as eyes, causing her breathing difficulty. Which one of the following medications is the reason for the untoward effects? A. Propranolol | B. Hydrochlorthiazide | C. Captopril | D. Clonidine",
      "answer": "The answer is **C. Captopril**.\n\n**Explanation:**\n\nThe patient's symptoms  skin rashes, swelling of the tongue, lips, and eyes, and breathing difficulty  are highly suggestive of **angioedema**. Angioedema is a serious allergic reaction that causes swelling in the deeper layers of the skin.\n\nAmong the given medications, **ACE inhibitors (like Captopril)** are well-known to cause angioedema as a significant side effect. This reaction can occur at any time during treatment, even after prolonged use.\n\nLet's look at why the other options are less likely:\n\n*   **A. Propranolol:** While beta-blockers like propranolol can cause skin rashes, angioedema is a much rarer side effect compared to ACE inhibitors.\n*   **B. Hydrochlorothiazide:** Thiazide diuretics like hydrochlorothiazide can cause skin rashes, but angioedema is not a common or characteristic side effect.\n*   **D. Clonidine:** Clonidine is an alpha-2 adrenergic agonist. While it can cause side effects like dizziness and dry mouth, angioedema is not a typical or frequent adverse reaction.\n\nTherefore, given the classic presentation of angioedema, Captopril is the most likely culprit.",
      "ground_truth": "Captopril || Answer: c) Captopril.* In 0.1% to 0.5% of patients, ACE inhibitors induce a rapid swelling in the nose, throat, mouth, glottis, larynx, lips, and/or tongue.* This untoward effect, called angioedema, apparently is not dose-related, and if it occurs, it does so within the first week of therapy, usually within the first few hours after the initial dose.* Airway obstruction and respiratory distress may lead to death.* It may involve accumulation of bradykinin, induction of tissue-specific autoantibodies, or inhibition of complement 1-esterase inhibitor.* Once ACE inhibitors are stopped, angioedema disappears within hours.* Although it is rare, angioedema of the intestine (visceral angioedema) also has been reported in association with ACE inhibitors.* Visceral angioedema is characterized by emesis, watery diarrhea, and abdominal pain.* Most cases of visceral angioedema occur in the absence of oropharyngeal edema.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Following is the advantage of anastrazole over tamoxifen in cases of breast carcinoma - A. Not a teratogen | B. Causes more cardiomegaly | C. Prevents estrogen production from extraovarian sources | D. All of the above",
      "answer": "The correct answer is **C. Prevents estrogen production from extraovarian sources**.\n\nHere's why:\n\n*   **Anastrazole** is an aromatase inhibitor. Aromatase is an enzyme responsible for converting androgens into estrogens. In postmenopausal women, the primary source of estrogen is the conversion of androgens in peripheral tissues (like fat and muscle), which is mediated by aromatase. Anastrazole effectively blocks this conversion, thus reducing estrogen levels from these extraovarian sources.\n*   **Tamoxifen** is a selective estrogen receptor modulator (SERM). It works by blocking the effects of estrogen on breast cancer cells but can also act as an estrogen agonist in other tissues (like the uterus and bone). Tamoxifen does not directly prevent estrogen production.\n\nLet's look at why the other options are incorrect:\n\n*   **A. Not a teratogen:** Both anastrazole and tamoxifen are generally contraindicated in pregnancy due to potential teratogenic effects. Therefore, anastrazole is not an advantage over tamoxifen in this regard.\n*   **B. Causes more cardiomegaly:** Tamoxifen is associated with an increased risk of endometrial cancer and thromboembolic events. Anastrazole, while having its own side effects (like bone loss and joint pain), is not typically associated with causing *more* cardiomegaly than tamoxifen. In fact, some studies suggest potential cardiovascular benefits with aromatase inhibitors in certain contexts, though this is complex and not a straightforward advantage.\n*   **D. All of the above:** Since A and B are incorrect, D is also incorrect.\n\n**In summary:** The primary advantage of anastrazole over tamoxifen in treating breast carcinoma, particularly in postmenopausal women, is its ability to significantly reduce circulating estrogen levels by inhibiting aromatase, thereby blocking estrogen production from extraovarian sources.",
      "ground_truth": "Prevents estrogen production from extraovarian sources || Ans. is 'c' i.e., Prevents estrogen production from extraovarian sources o Both the drugs anastrazole and tamoxifene are used in the medical management of patients with breast carcinoma. These patients mostly belong to old age group and the main source of estrogen is from peripheral conversion of androgen to estrogen using aromatase enzyme.o Tamoxifene antagonizes the action of estrogen on breast and so is used in breast carcinoma management, it does not have an effect on the peripheral conversion of androgen to estrogen.o Anastrazole on the other hand is an aromatase inhibitor and is responsible to block the peripheral conversion of androgen to estrogen; thus blocking the main source of estrogen in post menopausal older age group women. This is an advantage of using anastrazole over tamoxifene.Note:# Letrozole group of drugs (anastrazole) are highly teratogenic and should be avoided during pregnancy.# Cardiomyopathy is a serious side effect of tamoxifene.# Drug of choice for Her2/Neu +ve carcinoma breast is transtuzumab.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A young athlete died of sudden cardiac arrest after atheletic activity. Postmoem finding revealed interventricular septal hyperophy. What is the most probable diagnosis? A. Dilated Cardiomyopathy (DCM) | B. Hyperophic Obstructive Cardiomyopathy (HOCM) | C. Aoic Stenosis (AS) | D. Ventricular Septal Defect (VSD)",
      "answer": "The most probable diagnosis is **B. Hypertrophic Obstructive Cardiomyopathy (HOCM)**.\n\n**Explanation:**\n\n*   **Sudden cardiac arrest in young athletes** is a concerning symptom that often points to underlying cardiac conditions.\n*   **Interventricular septal hypertrophy** (thickening of the wall between the ventricles) is a hallmark finding of hypertrophic cardiomyopathy.\n*   **Hypertrophic Obstructive Cardiomyopathy (HOCM)** is a genetic condition where the heart muscle, particularly the interventricular septum, becomes abnormally thick. This thickening can obstruct blood flow out of the left ventricle, especially during exertion, leading to symptoms like chest pain, shortness of breath, and in severe cases, sudden cardiac arrest.\n\nLet's look at why the other options are less likely:\n\n*   **A. Dilated Cardiomyopathy (DCM):** In DCM, the heart chambers, particularly the left ventricle, are enlarged and weakened, leading to reduced pumping function. This is characterized by dilation, not hypertrophy, of the heart muscle.\n*   **C. Aortic Stenosis (AS):** Aortic stenosis is a narrowing of the aortic valve, which restricts blood flow from the left ventricle to the aorta. While it can lead to left ventricular hypertrophy over time as the heart works harder, the primary finding in the postmortem would be the stenotic valve, not necessarily prominent interventricular septal hypertrophy as the *most probable* cause of sudden death in this context.\n*   **D. Ventricular Septal Defect (VSD):** A VSD is a hole in the wall between the ventricles. This would typically lead to abnormal blood flow between the ventricles and can cause heart enlargement, but not typically the severe interventricular septal hypertrophy seen in HOCM.",
      "ground_truth": "Hyperophic Obstructive Cardiomyopathy (HOCM) || Syncope and sudden death following competitive spos in young individuals is characteristic of Hyperophic Obstructive Cardiomyopathy (HOCM). The presence of interventricular septal hyperophy in postmoem confirms the diagnosis of HOCM. Ref: Harrison's Principles of Internal Medicine, 16th Edition, Pages 1410-11; Davidson's Principles and Practice of Medicine, 19th Edition, Page 476",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 45-year-old woman underwent a modified radical mastectomy 4 years ago. She was treated for multiple bone metastases with cyclophosphamide, doxorubicin, and fluorouracil for 6 months. She is complaining of exeion on exercise, swelling of the legs, and swelling around eyes in the morning. On examination, she has bilateral rales in the lungs. S1, S2 audible, S3 and S4 gallop is present. Her BP is 149/117 mm Hg, PR is 80/min, and RR is 18/min. What is the MOST likely cause of her cardiac condition? A. Systolic dysfunction CHF | B. Drug induced cardiac toxicity | C. Metastatic cardiac disease | D. Pneumonia",
      "answer": "The MOST likely cause of her cardiac condition is **B. Drug induced cardiac toxicity**.\n\nHere's why:\n\n*   **History of Chemotherapy:** The patient received a regimen including doxorubicin (Adriamycin). Doxorubicin is a well-known cardiotoxic agent that can cause heart failure, often presenting with symptoms like those described. The toxicity can manifest years after treatment.\n*   **Symptoms of Heart Failure:**\n    *   **Exertion on exercise:** This is a classic symptom of the heart's inability to pump enough blood to meet the body's demands during activity.\n    *   **Swelling of the legs (peripheral edema):** This indicates fluid backup due to the heart's reduced pumping efficiency.\n    *   **Swelling around eyes in the morning (periorbital edema):** This can also be a sign of fluid retention, common in heart failure.\n    *   **Bilateral rales in the lungs:** These are crackling sounds heard during auscultation, indicating fluid accumulation in the alveoli, a hallmark of pulmonary edema secondary to left-sided heart failure.\n    *   **S3 and S4 gallop:** These are abnormal heart sounds that can be indicative of a stiff or failing ventricle, often associated with heart failure.\n*   **Hypertension:** While not directly causing the heart failure, the elevated blood pressure (149/117 mm Hg) can exacerbate existing cardiac dysfunction and contribute to the overall picture.\n\nLet's consider why the other options are less likely:\n\n*   **A. Systolic dysfunction CHF:** While she likely has systolic dysfunction contributing to her CHF, the *cause* of that dysfunction is more specifically pointed to by her history. Drug-induced toxicity is a specific etiology for systolic dysfunction.\n*   **C. Metastatic cardiac disease:** While breast cancer can metastasize to the heart, it's less common than drug-induced cardiotoxicity, especially given the specific chemotherapy regimen. Cardiac metastases would typically present with different symptoms or findings, such as arrhythmias, pericardial effusion, or obstruction of blood flow, rather than the diffuse signs of heart failure seen here.\n*   **D. Pneumonia:** Pneumonia can cause shortness of breath and rales, but it typically presents with fever, cough, and sputum production, which are not mentioned. While severe pneumonia can strain the heart, the constellation of symptoms and the history of cardiotoxic chemotherapy strongly point away from pneumonia as the primary cardiac issue.",
      "ground_truth": "Drug induced cardiac toxicity || This patient is showing features of congestive hea failure which has most probably resulted from the use of doxorubicin. It is a leading cause of chemotherapy induced hea disease, it cause this during therapy, weeks after completion of therapy or unexpectedly after years. Traditionally, the cardiac-limiting dose of doxorubicin has been described as 550 mg/m2, when this drug is combined with cyclophosphamide cardiotoxicity is noted at a lower dose of 300 mg/m2. During acute therapy ECG changes occur in 30% of patients and usually regress in weeks. The occurrence of early ECG abnormalities does not predict cardiomyopathy and is not an indication to discontinue therapy. If an otherwise stable oncology patient develops persistent sinus tachycardia, ventricular dysfunction and impending CHF should be suspected. Ref: Hurst's The Hea, 13e chapter 94, By Andrew L. Smith; Wendy M. Book.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Thyroid storm is seen in - A. Thyroid surgery | B. Neonatal thyrotoxicosis | C. Peri-operative infection | D. All of the above",
      "answer": "The correct answer is **D. All of the above**.\n\nHere's why:\n\n*   **Thyroid storm** is a life-threatening exacerbation of hyperthyroidism. It's a medical emergency.\n*   **A. Thyroid surgery:** Patients undergoing thyroid surgery, especially if they have underlying hyperthyroidism, are at risk for thyroid storm due to manipulation of the thyroid gland and potential release of thyroid hormones.\n*   **B. Neonatal thyrotoxicosis:** This is a condition where a newborn has an overactive thyroid. While less common than in adults, severe cases can lead to thyroid storm.\n*   **C. Peri-operative infection:** Infections, particularly in the peri-operative period (around surgery), can act as a significant stressor that can precipitate thyroid storm in individuals with pre-existing hyperthyroidism.\n\nTherefore, thyroid storm can be seen in all of these situations.",
      "ground_truth": "All of the above || Ans. is 'd' i.e., All of the above o Thyroid storm is a rare, life-threatening condition characterized by severe clinical manifestations of thyrotoxicosis.Risk factorso Although thyroid storm can develop in patients with long-standing untreated hyperthyroidism (Graves' disease,, toxic multinodular goiter solitary? toxic adenoma), it is often precipitated by* an acute event such as# Thyroid or nonthyroidal surgery;# Traum# Infection# An acute iodine load# Parturition# Irregular use or discontinuation of antithyroid drugs.o The advent ofappropriate preoperative preparation of hyperthyroid patients undergoing nonthyroidal surgery or thyroidectomy for hyperthyroidism has led to a dramatic reduction in the prevalence ofsurgically-induced thyroid storm.Clinical featureso Patients with severe and life-threatening thyrotoxicosis typically have an exaggeration of the usual symptoms of hyperthyroidism.Symptoms and signso Cardiovascular symptoms in tachycardia can 140 beats/minute.# Congestive heart failure.# Hypotension# Cardiac arrhythmia# Death from cardiovascular collapse may occur.# >60 percent having severe tachycardia and/or atrial fibrillation. o Hyperpyrexia to 104 to 106degF.o Agitationo Anxietyo Deliriumo Psychosiso Stuporo Comao Altered mentationLaboratory findings# Low thyroid-stimulating hormone (TSH)# High free thyroxine (T4) and/or triiodothyronine (T3) concentrations.o The degree of thyroid hormone excess typically is not more profound than that seen in patients with uncomplicated thyrotoxicosis.o Other nonspecific laboratory findings may include:# Mild hyperglycemia# Mild hypercalcemia# Abnormal liver function tests, leukocytosis, or leukopenia.Diagnosiso The diagnosis of thyroid storm is based upon the presence ofsevere and life-threatening symptoms {hyperpyrexia, cardiovascular dysfunction, altered mentation) in a patient with biochemical evidence of hyperthyroidism (elevation of free thyroxine and/or triiodothyronine and suppression of thyroid-stimulating hormone ).Treatmento The principles of treatment:# A beta blocker to control the symptoms and signs induced by increased adrenergic tone.# A thionamide to block new hormone synthesis.# An iodine solution to block the release of thyroid hormone.# An iodinated radiocontrast agent (if available) to inhibit the peripheral conversion of thyroxine (T4) to triiodothyronine (T3).# Glucocorticoids to reduce T4-to-T3 conversion, promote vasomotor stability, and possibly treat an associated relative adrenal insufficiency.# Bile acid sequestrants to decrease enterohepatic recycling of thyroid hormones,",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Poor prognostic factors in a child with kwashiorkar include all of the following- A. Hypothermia | B. Hepatomegaly | C. Purpura | D. Dermatosis",
      "answer": "The answer is **B. Hepatomegaly**.\n\nHere's why:\n\n*   **Kwashiorkor** is a severe form of malnutrition characterized by protein deficiency.\n*   **Poor prognostic factors** are indicators that a patient is at higher risk of complications or death.\n\nLet's break down the options:\n\n*   **A. Hypothermia:** Children with kwashiorkor often have impaired thermoregulation, making them prone to hypothermia. Hypothermia is a serious complication and a poor prognostic sign.\n*   **B. Hepatomegaly:** While hepatomegaly (enlarged liver) is a characteristic feature of kwashiorkor due to fatty infiltration, it is generally considered a **reversible** sign and not a primary poor prognostic factor in itself, especially when compared to other complications. The underlying malnutrition is the main driver of poor prognosis.\n*   **C. Purpura:** Purpura (bruising) can indicate coagulopathy (problems with blood clotting), which is common in severe malnutrition due to deficiencies in vitamin K and other clotting factors. Coagulopathy is a serious complication and a poor prognostic sign.\n*   **D. Dermatosis:** Dermatosis (skin lesions) is a hallmark of kwashiorkor, often presenting as flaky, peeling skin, hyperpigmentation, and desquamation. Severe or widespread dermatosis indicates a more severe state of malnutrition and is associated with a poorer prognosis due to increased risk of infection and fluid/electrolyte loss.\n\nTherefore, while hepatomegaly is a sign of kwashiorkor, it is less of a direct indicator of immediate poor prognosis compared to hypothermia, purpura, and severe dermatosis, which point to more critical systemic derangements.",
      "ground_truth": "Hepatomegaly || Ans. is 'b' i.e., Hepatomegaly o Hepatomegaly is one of the essential diagnostic feature of kwashiorkor, it does not indicate poor prognosis. o Poor prognostic factors in PEM, which can lead to early death ? Hypothermia 4. Diarrhea 7. Cardiac failure Hypoglycemia 5. Severe anemia 8. Dehydration or overhydration Systemic infections 6. Liver failure 9. Fluid & electrolyte imbalance",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "All of the following are indication for Treadmill testing, except- A. To evaluate unstable angina | B. To evaluate unstable myocardial infarction | C. To assess outcome after coronary revascularization | D. TO diagnosis and evaluate the treatment of exercise induced arrhythmias",
      "answer": "The correct answer is **B. To evaluate unstable myocardial infarction**.\n\nHere's why:\n\n*   **Treadmill testing (also known as exercise stress testing)** is a diagnostic tool used to assess the heart's response to physical exertion. It's generally performed when a patient is stable.\n\nLet's break down why the other options are indications:\n\n*   **A. To evaluate unstable angina:** While \"unstable\" might seem contradictory, treadmill testing can be used in a *controlled* setting to assess the severity and triggers of angina in patients who are *currently stable* but have a history of unstable symptoms. The goal is to understand their exercise tolerance and risk.\n*   **C. To assess outcome after coronary revascularization:** After procedures like angioplasty or bypass surgery, treadmill testing is often used to see how well the heart is functioning and if the revascularization has improved exercise capacity and reduced symptoms.\n*   **D. To diagnosis and evaluate the treatment of exercise induced arrhythmias:** Some arrhythmias (irregular heartbeats) only occur during physical activity. Treadmill testing is a primary method to provoke and diagnose these exercise-induced arrhythmias and to assess the effectiveness of treatment.\n\n**Why unstable myocardial infarction is NOT an indication:**\n\n*   **Unstable myocardial infarction (heart attack)** is an acute, life-threatening event. Patients experiencing an active heart attack require immediate medical intervention, including stabilization, pain relief, and reperfusion therapy (if indicated). Treadmill testing would be dangerous and inappropriate in this acute phase. The focus is on saving heart muscle, not on provoking further stress.",
      "ground_truth": "To evaluate unstable angina || Ref: KV Krishna Das - Clinical Medicine 4th Edition pg no:212 Exercise Electrocardiography (Syn: Stress Tests, Treadmill Test) This refers to the recording of the electrical activity of the hea while the individual is subjected to the stress of graded exercises. The bicycle ergometer or the treadmill is currently used for most exercise testing programs. There are various exercise protocols such as the Bruce protocol or the Naughton protocol to assess effo tolerance. In all these protocols the subject is made to exercise in stages of increasing workloads until the end points are achieved. During exercise, various parameters like occurrence of symptoms, fluctuations in blood pressure changes in the ST segment, and changes in cardiac rate and rhythm are closely monitored. Although the stress test is fairly safe, it has to be done only under close medical supervision. Currently the main indications for stress testing are: 1. As a diagnostic tool in the evaluation of symptoms like effo induced chest pain, or palpitation. 2. To assess the prognosis and in the risk stratification of patients with coronary aery disease, either after acute events like myocardial infarction or angina, or after therapeutic interventions like coronary angioplasty or by pass surgery. 3. To assess the functional capacity in patients with ischemic hea disease, valvular hea disease, cardiomyopathy and patients undergoing cardiac surgery. 4. As a screening test for ischemic hea disease in subjects with an intermediate or high probability for the disease. The test is considered positive if there is flat or down sloping ST segment depression of 1 mm or more, ST segment elevation, inversion of U waves, fall in blood pressure and ischemic symptoms associated with ECG changes. Standard contraindications to exercise testing include acute myocardial infarction, high risk unstable angina pectoris, severe aoic stenosis, congestive cardiac failure, acute pulmonary embolism or infarction, acute myocarditis or pericarditis, aoic dissection, uncontrolled severe systemic hypeension > 200/100 mm Hg, high grade hea blocks, uncontrolled symptomatic cardiac arrhythmias, any acute systemic illness or an unwilling patient. The indications to terminate exercise testing includes inappropriate drop in blood pressure or deceleration of the hea rate with increasing workload and exercise, moderate to severe angina, sustained VT, ST depression more than 3 mm or ST elevation in non Q leads, hypeensive response > 250/115 mm Hg, patient exhaustion, fatigue, leg cramps or claudication pain and subject's desire to stop the test. Exercise stress testing has a sensitivity of about 80 to 85% and a specificity of 85 to 90% for the diagnosis of coronary aery disease. In patients with ischemic hea disease, positive stress test is an indication for fuher tests such as coronary angiography.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "A 27 year old man in noted to have blood pressure of 170/100 mmHg. He has prominent aoic ejection click and murmurs heard over the ribs on the both sides anteriorly and over the back posterioly. In addition.the pulses in the lower extremities are feeble and he complains of mild claudication with exeion. The most likely diagnosis is A. Aial septal defect | B. Aoic stenosis | C. Coarctation of the aoa | D. Cardiomyopathy",
      "answer": "The most likely diagnosis is **C. Coarctation of the aorta**.\n\nHere's why:\n\n*   **Elevated blood pressure (170/100 mmHg):** This is a significant finding, and coarctation of the aorta is a common cause of hypertension, particularly in younger individuals.\n*   **Prominent aortic ejection click and murmurs:** While these can be seen in aortic stenosis, in the context of coarctation, they can be related to turbulent blood flow across the narrowed aorta.\n*   **Murmurs heard over the ribs on both sides anteriorly and over the back posteriorly:** This is a classic finding in coarctation of the aorta. The narrowing of the aorta causes collateral circulation to develop, with blood flowing through dilated intercostal arteries. These dilated arteries can be heard as murmurs over the ribs.\n*   **Feeble pulses in the lower extremities and mild claudication with exertion:** This is a hallmark of coarctation of the aorta. The narrowing restricts blood flow to the lower body, leading to diminished pulses and pain in the legs during activity due to insufficient oxygen supply.\n\nLet's look at why the other options are less likely:\n\n*   **A. Atrial septal defect (ASD):** ASDs typically cause a fixed splitting of the second heart sound and a systolic ejection murmur at the left upper sternal border. They do not typically cause hypertension or diminished pulses in the lower extremities.\n*   **B. Aortic stenosis:** While aortic stenosis can cause an ejection click and murmur, it usually presents with symptoms like chest pain, syncope, and heart failure. It doesn't typically cause hypertension in the upper extremities with diminished pulses in the lower extremities.\n*   **D. Cardiomyopathy:** Cardiomyopathy is a disease of the heart muscle. While it can lead to various heart conditions, the specific combination of hypertension, murmurs over the ribs, and diminished lower extremity pulses is not characteristic of most cardiomyopathies.",
      "ground_truth": "Coarctation of the aoa || Answer is C (Coarctation of aoa) Hypeension in upper extremity with absence, dimunition or delay in pulsations in lower extremity suggests the diagnosis of coarctation of aoa. Other options have been explained in the previous questions.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Important clues of diagnosis chronic renal failure(CRF) Except A. Bilateral contracted kidney | B. Massive proteinuria | C. Osteodystrophy | D. Hypertension",
      "answer": "The answer is **B. Massive proteinuria**.\n\nHere's why:\n\n*   **Chronic Renal Failure (CRF)** is a progressive and irreversible loss of kidney function.\n*   **A. Bilateral contracted kidney:** This is a classic finding on imaging (like ultrasound or CT scan) in chronic kidney disease. The kidneys shrink and become scarred over time.\n*   **C. Osteodystrophy:** This refers to bone abnormalities that occur due to impaired calcium and phosphate metabolism, a common complication of CRF.\n*   **D. Hypertension:** High blood pressure is both a cause and a consequence of CRF. Damaged kidneys are less effective at regulating blood pressure.\n\n*   **B. Massive proteinuria:** While proteinuria (protein in the urine) is a significant sign of kidney damage, **massive proteinuria** (often defined as >3.5 grams per day) is more characteristic of **nephrotic syndrome**, which can be a cause of kidney disease but isn't a universal or defining clue for *all* cases of chronic renal failure. Many patients with CRF have proteinuria, but it might be moderate rather than massive, or it might be absent in some stages.\n\nTherefore, massive proteinuria is the least consistent or \"except\" clue among the options for diagnosing chronic renal failure.",
      "ground_truth": "Hypertension || D. i.e. (Hypertension) (269 - H17th)SyndromeImportant clues to DiagnosisFindings that are common Azotemia for > 3 monthsProteinuriaCHRONICProlonged symptoms or sign of uremiaCastsRENALSymptoms or sign of renal osteodystrophyPolyuria nocturiaFAILUREKidney reduced in size bilaterallyEdema Hypertension Broad casts in urinary sedimentsElectrolyte disorder.** Normal individuals excrete <150 mg/ day of total protein and < 30 mg / d of albumin** Selective proteinuria occurs in Minimal change disease*** Restless leg syndrome is seen in CRF*** Anemia in CRF is due to eiythropoietin deficiency**Reversible causes of Renal Failure (804 - CMDT - 09)* Infections* Obstructions* ECF volume depletion* Hypokalemia* Hypercalemia* Hyperuricemia* Nephrotoxic agents* Hypertension* CHF",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "The best possible intervention for acute myocardial infarction is- A. Streptokinase | B. Streptokinase and aspirin | C. Early primary coronary intervention | D. Streptokinase and heparin",
      "answer": "The best possible intervention for acute myocardial infarction (MI) is **C. Early primary coronary intervention**.\n\nHere's why:\n\n*   **Acute Myocardial Infarction (MI):** This is a medical emergency where blood flow to a part of the heart muscle is severely reduced or blocked, causing damage to the heart muscle. The primary goal is to restore blood flow as quickly as possible.\n\n*   **Early Primary Coronary Intervention (PCI):** This refers to a procedure called angioplasty with stenting. It involves:\n    *   **Angioplasty:** A balloon is inserted into the blocked coronary artery and inflated to open the blockage.\n    *   **Stenting:** A small mesh tube (stent) is usually placed in the artery to keep it open.\n    *   **\"Primary\"** means it's the initial treatment of choice for STEMI (ST-elevation myocardial infarction), the most severe type of heart attack.\n    *   **\"Early\"** emphasizes the critical importance of performing this procedure as soon as possible after symptom onset.\n\n*   **Why PCI is superior:** PCI is generally considered the gold standard because it directly opens the blocked artery with a high success rate and is often more effective than thrombolytic therapy (clot-busting drugs) in restoring blood flow and improving outcomes, especially when performed promptly.\n\nLet's look at why the other options are less ideal as the *best possible* intervention:\n\n*   **A. Streptokinase:** This is a thrombolytic agent (clot-buster). While it can be effective in dissolving blood clots, it's not as effective as PCI in opening the artery and carries a higher risk of bleeding complications. It's often used when PCI is not readily available.\n\n*   **B. Streptokinase and aspirin:** Aspirin is an antiplatelet medication that is crucial in managing MI. However, combining it with streptokinase is still a form of thrombolytic therapy, which is generally less preferred than primary PCI when available.\n\n*   **D. Streptokinase and heparin:** Heparin is an anticoagulant that helps prevent further clot formation. While important in MI management, combining it with streptokinase still relies on thrombolytic therapy as the primary intervention, which is less optimal than PCI.\n\n**In summary:** For patients experiencing an acute ST-elevation myocardial infarction (STEMI), timely reperfusion (restoring blood flow) is paramount. Early primary coronary intervention (PCI) is the most effective and preferred method for achieving this, leading to better outcomes compared to thrombolytic therapy alone or in combination with other medications.",
      "ground_truth": "Early primary coronary intervention || Ref : harrisons-manual-of-medicine-16th-edition pg no: 622-624 TREATMENT Initial Therapy Initial goals are to: (1) quickly identify if patient is candidate for reperfusion therapy, (2) relieve pain, and (3) prevent/treat arrhythmias and mechanical complications. * Aspirin should be administered immediately (162-325 mg chewed at presentation, then 162-325 mg PO qd), unless pt is aspirin-intolerant. * Perform targeted history, exam, and ECG to identify STEMI (\u00011 mmST elevation in two contiguous leads or new LBBB) and appropriateness of reperfusion therapy , which reduces infarct size, LV dysfunction, and moality. * Primary PCI is generally more effective than fibrinolysis and is preferred at experienced centers capable of performing procedure rapidly , especially when diagnosis is in doubt, cardiogenic shock is present, bleeding risk is increased, or if symptoms have been present for \u00013 h. * Proceed with IV fibrinolysis if PCI is not available or if logistics would delay PCI \u00011 h longer than fibrinolysis could be initiated (Fig. 123-1). Dooo- needle time should be \u0005 30 min for maximum benefit. Ensure absence of contraindications before administering fibrinolytic agent. Those treated within 1-3 h benefit most; can still be useful up to 12 h if chest pain is persistent or ST remains elevated in leads that have not developed new Q waves. Complications include bleeding, reperfusion arrhythmias, and, in case of streptokinase (SK), allergic reactions. Heparin should be initiated with fibrinolytic agents other than SK ; maintain aPTTT at 1.5-2.0 control (\u000150-70 s). * If chest pain or ST elevation persists \u000190 min after fibrinolysis, consider referral for rescue PCI. Later coronary angiography after fibrinolysis generally reserved for pts with recurrent angina or positive stress test. The initial management of NSTEMI (non-Q MI) is different . In paicular, fibrinolytic therapy should not be Additional Standard Treatment (Whether or not reperfusion therapy is undeaken): * Hospitalize in CCU with continuous ECG monitoring. * IV line for emergency arrhythmia treatment. * Pain control: (1) Morphine sulfate 2-4 mg IV q5-10min until pain is relieved or side effects develop ; (2) nitroglycerin 0.3 mg SL if systolic bp \u0001 100 mmHg; for refractory pain: IV nitroglycerin (begin at 10 g/min, titrate upward to maximum of 200 g/min, monitoring bp closely); do not administer nitrates within 24 h of sildenafil or within 48 h of tadalafil (used for erectile dysfunction); (3) -adrenergic antagonists * Oxygen 2-4 L/min by nasal cannula (maintain O2 saturation \u0001 90%). * Mild sedation (e.g., diazepam 5 mg PO qid). * Soft diet and stool softeners (e.g., docusate sodium 100-200 mg/d). * -Adrenergic blockers reduce myocardial O2 consumption, limit infarct size, and reduce moality. Especially useful in pts with hypeension, tachycardia, or persistent ischemic pain; contraindications include active CHF, systolic bp \u0005 95 mmHg, hea rate \u0005 50 beats/min, AV block,or history of bronchospasm. Administer IV (e.g., metoprolol 5 mg q5-10min to total dose of 15 mg), followed by PO regimen (e.g., metoprolol 25-100 mg bid). * Anticoagulation/antiplatelet agents: Pts who receive fibrinolytic therapy are begun on heparin and aspirin as indicated above. In absence of fibrinolytic therapy, administer aspirin, 160-325 mg qd, and low-dose heparin (5000 U SC q12h for DVT prevention). Full-dose IV heparin (PTT 2 control) or low-molecular-weight heparin (e.g., enoxaparin 1 mg/kg SC q12h) followed by oral anticoagulants is recommended for pts with severe CHF, presence of ventricular thrombus by echocardiogram, or large dyskinetic region in anterior MI. Oral anticoagulants are continued for 3 to 6 months, then replaced by aspirin. * ACE inhibitors reduce moality in pts following acute MI and should be prescribed within 24 h of hospitalization for pts with STEMI--e.g., captopril (6.25 mg PO test dose) advanced to 50 mg PO tid. ACE inhibitors should be continued indefinitely after discharge in pts with CHF or those with asymptomatic LV dysfunction ; if ACE inhibitor intolerant, use angiotensin receptor blocker (e.g., valsaan or candesaan). * Serum magnesium level should be measured and repleted if necessary to reduce risk of arrhythmias.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "In JVP y descent is absent and X wave is prominent? Thiscsuggests: A. Restictive cardiomyopathy | B. Cardiac tamponade | C. Constrictive pericarditis | D. Right Ventricular Failure",
      "answer": "The correct answer is **C. Constrictive pericarditis**.\n\nHere's why:\n\n*   **JVP (Jugular Venous Pressure) Waveforms:** The JVP reflects the pressure in the right atrium. It has characteristic 'a', 'x', 'v', and 'y' waves.\n    *   **'a' wave:** Represents atrial contraction.\n    *   **'x' descent:** Represents atrial relaxation and the downward movement of the base of the heart during ventricular systole.\n    *   **'v' wave:** Represents atrial filling during ventricular systole.\n    *   **'y' descent:** Represents the opening of the tricuspid valve and rapid ventricular filling.\n\n*   **Constrictive Pericarditis:** In constrictive pericarditis, the pericardium (the sac around the heart) becomes thickened and stiff. This restricts the ability of the ventricles to fill adequately during diastole.\n    *   **Absent 'y' descent:** The stiff pericardium prevents rapid filling of the ventricle after the tricuspid valve opens. This leads to a blunted or absent 'y' descent.\n    *   **Prominent 'x' descent:** As the ventricles contract, the stiff pericardium resists the normal downward movement of the heart's base. This exaggerated downward pull during atrial relaxation results in a prominent 'x' descent.\n\nLet's look at why the other options are less likely:\n\n*   **A. Restrictive Cardiomyopathy:** While restrictive cardiomyopathy also impairs ventricular filling, the JVP waveform typically shows a prominent 'a' wave and a rapid 'y' descent (due to the stiff ventricle allowing rapid filling once the valve opens, but then stopping abruptly).\n*   **B. Cardiac Tamponade:** In cardiac tamponade, there is fluid accumulation in the pericardial sac, compressing the heart. This leads to equalization of diastolic pressures and a pulsus paradoxus. The JVP in tamponade often shows a diminished or absent 'x' descent and a prominent 'v' wave, with a less distinct 'y' descent.\n*   **D. Right Ventricular Failure:** In isolated right ventricular failure, the 'v' wave in the JVP is typically very prominent due to the inability of the right ventricle to handle the venous return. The 'y' descent may be present but can be slowed.\n\nTherefore, the combination of an absent 'y' descent and a prominent 'x' wave in the JVP is a classic finding suggestive of **constrictive pericarditis**.",
      "ground_truth": "Cardiac tamponade || Ans. (b) Cardiac tamponadeRef.: Harrison 19th ed. /1573JVP FindingsJVP WavesFindingsConstrictive pericarditisFindingsCardiac tamponadeX waveProminentProminentY waveProminentAbsent",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Sudden cardiac death may occur in all of the following except A. Dilated cardiomyopathy | B. Hyperophic cardiomyopathy | C. Eisenmenger's syndrome | D. Ventricular septal defect",
      "answer": "The correct answer is **D. Ventricular septal defect**.\n\nHere's why:\n\n*   **Sudden cardiac death (SCD)** is the abrupt loss of heart function, breathing, and consciousness. It's often caused by a sudden, unexpected electrical disturbance in the heart.\n\nLet's look at the options:\n\n*   **A. Dilated cardiomyopathy:** In this condition, the heart's main pumping chamber (left ventricle) becomes enlarged and weakened, making it harder to pump blood. This can lead to arrhythmias (irregular heartbeats) and increase the risk of SCD.\n*   **B. Hypertrophic cardiomyopathy:** This is a condition where the heart muscle becomes abnormally thick. This thickening can obstruct blood flow and disrupt the heart's electrical system, leading to a higher risk of SCD, especially in young athletes.\n*   **C. Eisenmenger's syndrome:** This is a complication of a congenital heart defect (a problem present at birth) where there's a large hole between the heart's lower chambers (ventricles) or between the major arteries leaving the heart. This leads to blood flowing from the right side of the heart to the left, causing high blood pressure in the lungs and eventually irreversible lung damage. This severe condition can lead to heart failure and SCD.\n*   **D. Ventricular septal defect (VSD):** A VSD is a hole in the wall separating the two lower chambers of the heart. While large VSDs can cause significant problems and may require surgery, they are generally **not** a direct cause of sudden cardiac death in the same way as the other conditions listed. Smaller VSDs may even close on their own. The risk of SCD is significantly lower compared to the other conditions.\n\n**In summary:** Dilated cardiomyopathy, hypertrophic cardiomyopathy, and Eisenmenger's syndrome are all conditions that significantly increase the risk of sudden cardiac death due to their impact on heart structure, function, and electrical stability. A ventricular septal defect, while a heart abnormality, is less directly associated with SCD.",
      "ground_truth": "Ventricular septal defect || Sudden cardiac death (SCD) is defined as natural death due to cardiac causes in a person who may or may not have previously recognized hea disease but in whom the time and mode of death are unexpected. Ref Davidson edition23rd pg 436",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Heart failure cells are seen in - A. Kidney | B. Heart | C. Lungs | D. Brain",
      "answer": "The correct answer is **C. Lungs**.\n\n**Explanation:**\n\nHeart failure cells, also known as siderophages, are macrophages that have phagocytosed (engulfed) hemosiderin. Hemosiderin is an iron-storage complex that forms when red blood cells break down. In the context of heart failure, blood can back up into the lungs, leading to bleeding within the lung tissue. Macrophages in the lungs then clear this leaked blood, and the hemosiderin from the broken-down red blood cells accumulates within them, giving them the characteristic appearance of \"heart failure cells.\"",
      "ground_truth": "Lungs || Ans. is 'c' i.e., Lungs o Heart failure cells are hemosiderin containing macrophages in alveoli that are seen in left ventricular failure and denotes previous episodes of pulmonary edema.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Virchow's triad includes all of the following, EXCEPT- A. Venous stasis | B. Injury to veins | C. Blood hypercoagulability | D. Venous thrombosis",
      "answer": "The correct answer is **D. Venous thrombosis**.\n\n**Explanation:**\n\nVirchow's triad is a set of three broad categories of factors that are believed to contribute to the formation of venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). These three factors are:\n\n*   **A. Venous stasis:** This refers to the slowing or cessation of blood flow in the veins. This can happen due to immobility, prolonged sitting or standing, or conditions that impede blood flow.\n*   **B. Injury to veins:** This includes damage to the inner lining of the veins (endothelium). This can be caused by surgery, trauma, inflammation, or indwelling catheters.\n*   **C. Blood hypercoagulability:** This means the blood has an increased tendency to clot. This can be due to genetic factors, certain medical conditions (like cancer), medications (like oral contraceptives), or pregnancy.\n\n**D. Venous thrombosis** is the *result* or the *condition* that Virchow's triad helps to explain and predict, not one of the contributing factors itself. Venous thrombosis is the formation of a blood clot within a vein.",
      "ground_truth": "Venous thrombosis || Virchow's triad refers to three primary influences that predispose to thrombus formation. <NL> <NL> <NL> Endothelial injury (or vascular injury) <NL> Stasis or turbulence of blood flow <NL> Blood hypercoagulability <NL> <NL> <NL> Virchow's triad should be the cornerstone for assessment of risk factors for deep venous thrombosis. <NL> Stasis can occur with venous insufficiency, severe heart failure, or prolonged bed rest or immobility of an extremity following coma, pelvic or limb fracture, paralysis, extended aeroplane travel, or a lengthy operation. <NL> Endothelial injury can result from direct trauma (severed vein, venous cannulation, or transvenous pacing) or local irritation secondary to the infusion of chemotherapy, previous DVT, or phlebitis. <NL> <NL> Damaged endothelium leads to platelet aggregation, degranulation and formation of thrombosis as well as vasoconstriction ad activation of the coagulation cascade. <NL> The hypercoagulable state can be inherited or acquired. <NL> These are <NL> <NL> def. of antithrombin III, protein C or S <NL> increased homocysteine <NL> factor V Leiden mutation <NL> prothrombin gene mutation <NL> antiphospholipid syndrome <NL> paroxysmal nocturnal hemoglobinuria <NL> malignancy (lung cancer - most commonly pancreas, prostate, breast, ovary etc...) <NL> nephrotic syndrome <NL> pregnancy, high dose estrogen therapy or OCPs. <NL> <NL> Some important questions on deep vein thrombosis <NL> <NL> Homan's sign  Calf tenderness on forced ankle dorsiflexion. <NL> Phlegmasia alba dolens  Painful white leg <NL> Phlegmasia cerulea dolens  Painful blue leg <NL> Moses Sign  Calf tenderness on direct pressure on the calf <NL> Pratt's Sign  Calf tenderness on squeezing the calf from the sides. Duplex ultrasound is the diagnostic modality of choice in deep vein thrombosis.",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Thiazides false is A. Used in CCF | B. Causes hyperglycemia | C. Increases uric acid concentration in serum | D. Increases calcium excretion in urine",
      "answer": "The correct answer is **D. Increases calcium excretion in urine**.\n\nHere's why:\n\n*   **Thiazide diuretics** are a class of medications commonly used to treat hypertension and edema.\n*   **A. Used in CCF (Congestive Heart Failure):** Thiazides can be used in mild to moderate CCF to reduce fluid overload. So, this statement is **true**.\n*   **B. Causes hyperglycemia:** Thiazides can indeed cause an increase in blood glucose levels, particularly in individuals with diabetes or those at risk. So, this statement is **true**.\n*   **C. Increases uric acid concentration in serum:** Thiazides can impair the renal excretion of uric acid, leading to hyperuricemia, which can precipitate gout. So, this statement is **true**.\n*   **D. Increases calcium excretion in urine:** This is **false**. Thiazides paradoxically *decrease* calcium excretion in the urine by promoting its reabsorption in the distal convoluted tubules. This effect is beneficial in conditions like nephrolithiasis (kidney stones) where calcium stones are a concern.\n\nTherefore, the false statement about thiazides is that they increase calcium excretion in urine.",
      "ground_truth": "Increases calcium excretion in urine || Ans. is 'd' i.e. Increases calcium excretion in urine Thiazides are moderate efficacy diureticsThey inhibit NaCl reabsorption from the luminal side of epithelial cells in the DCT by blocking the Na+Cl- transporterThiazides increase calcium reabsorption in the kidney tubules thus, decreasing calcium excretion. But thiazides rarely cause hypercalcemia as a result of this enhanced reabsorption, they can unmask hypercalcemia due to other causes.This effect on calcium makes them useful in the t/t of kidney stones caused by idiopathic hypercalciuria.Major indications of thiazide diuretics:-HypertensionHeart failureNephrolithiasis due to idiopathic hypercalciuriaNephrogenic diabetes insipidusAdverse effect of thiazide diuretics Hypokalemic metabolic alkalosisDue to the action of thiazides, more salts are delivered to the collecting tubule. Increased delivery leads to increased secretion of K+ and H+ by the duct causing hypokalemic metabolic alkalosis.Impaired carbohydrate tolerance (Hyperglycemia)Hyperglycemia may occur in patients who are overtly diabetic or who have even mildly abnormal glucose tolerance tests.The effect is due to both impaired pancreatic release of insulin and diminished utilization of glucose. HyperlipidemiaThiazides cause a 5-15% increase in total serum cholesterol and low density lipoproteins (LDL) HyperuricemiaThiazides cause increased reabsorption of uric acid.HyponatremiaIt is due to combination of hypovolemia induced elevation of ADH, reduction in the diluting capacity of the kidney and increased thirst.Allergic reactionsThe thiazides are sulfonamides and they share cross-relativity with other members of this group. Photosensitivity or generalized dermatitis occurs rarely. Serious allergic reactions are extremely rare but do include hemolytic anemia, thrombocytopenia and acute necrotizing pancreatitis.Other toxicitiesWeakness, fatigability and paresthesiasContraindications of thiazide diureticsHepatic cirrhosisBorderline renal failure",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Which of the following drug is a renin inhibitor? A. Enalapril | B. Losartan | C. Clonidine | D. Aliskiren",
      "answer": "The correct answer is **D. Aliskiren**.\n\nHere's why:\n\n*   **Renin inhibitors** directly block the action of renin, an enzyme produced by the kidneys that initiates the renin-angiotensin-aldosterone system (RAAS). By inhibiting renin, these drugs reduce the production of angiotensin I and subsequently angiotensin II, leading to vasodilation and reduced blood pressure. Aliskiren is the only drug in the options that belongs to this class.\n\nLet's look at the other options:\n\n*   **A. Enalapril:** This is an **ACE inhibitor** (Angiotensin-Converting Enzyme inhibitor). ACE inhibitors block the enzyme that converts angiotensin I to angiotensin II, thus also impacting the RAAS but at a different step.\n*   **B. Losartan:** This is an **ARB** (Angiotensin II Receptor Blocker). ARBs block the receptors where angiotensin II would normally bind, preventing its effects. This is another way to interfere with the RAAS.\n*   **C. Clonidine:** This is a **centrally acting alpha-2 adrenergic agonist**. It works by stimulating alpha-2 receptors in the brainstem, which reduces sympathetic outflow from the central nervous system, leading to decreased heart rate, vasodilation, and lower blood pressure. It does not directly affect renin.",
      "ground_truth": "Aliskiren || ANSWER: (D) AliskirenREF: Goodman Gillman page 525, KDT 6th edition page 482, Katzung 12th ed page 190, 300Repeat from Pharmacology June 2010, December 2008RENIN INHIBITORSCleavage of angiotensinogen by renin is the rate-limiting step in the formation of ANG II and thus represents a logical target for inhibition of the renin-angiotensin system. Drugsthat inhibit renin have been available for many years but have been limited by low potency, poor bioavailability, and short duration of action. However, a new class of nonpeptide, low- molecularweight, orally active inhibitors has recently been developed. Aliskiren, a renin inhibitor recently approved for hypertension, is in clinical trials for heart failure. Preliminary results suggest an efficacy similar to that of ACE inhibitors. Aliskiren is contraindicated in pregnancy.INHIBITION OF RENIN-ANGIOTENSIN SYSTEMSympatheticblockersPlasma renin activity is increased by reflex increase in sympathetic discharge. Sympathetic blockers decreases renin release.Clonidine decreases central sympathetic outflow and thus will decrease plasma renin activity.B blockersadrenergic neurone blockers,central sympatholytics:* Clonidine (a2 agonist)* Guanfacine (a2 agonist)* Methyldopa (a2 agonist)* Moxonidine (imidazoline receptor agonist)* Prazosin (a1, antagonist)* Rescinnamine (ACE inhibitor)* Reserpine (VMAT inhibitor)* Rilmenidine (imidazoline receptor agonist)RenininhibitorsRenin inhibitory peptides and renin specific antibodies block renin action-interferes with generation of A-I from angiotensinogen. (rate limiting step}Aliskiren (Oral: 150, 300 mg tablets)Angiotensin converting enzyme (ACE) inhibitorsPrevent generation of the active principle A-IICaptopril and enaiaprilAngiotensinreceptor(ATI)antagonistsBlock the action of A-II on target cellsLosartan, valsartan, eprosartan, irbesartan, candesartan, olmesartan , and telmisartanAldosteroneantagonistsBlock mineralocorticoid receptorseplerenonespironolactone",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Drugs used in CCF are all except : A. Diuretics | B. Vasodilators | C. Dopamine/Dobutamine | D. Amiodarone",
      "answer": "The answer is **D. Amiodarone**.\n\nHere's why:\n\n*   **Congestive Heart Failure (CCF)**, also known as heart failure, is a condition where the heart can't pump blood effectively to meet the body's needs.\n*   **Diuretics** (A) are commonly used to reduce fluid buildup (edema) in patients with CCF by increasing urine output.\n*   **Vasodilators** (B) help to relax blood vessels, reducing the workload on the heart and improving blood flow.\n*   **Dopamine/Dobutamine** (C) are inotropic agents that increase the force of heart contractions, which can be beneficial in acute or severe CCF.\n*   **Amiodarone** (D) is an **antiarrhythmic drug**. While arrhythmias can sometimes occur in patients with CCF, amiodarone is primarily used to treat abnormal heart rhythms, not CCF itself. Its use in CCF is usually to manage a co-existing arrhythmia, not as a direct treatment for the heart failure.",
      "ground_truth": "Amiodarone || There is a significant evidencepractice gap in the treatment of CHF; particularly the underuse of ACE inhibitors and -blockers and aldosterone antagonists which have been shown to provide mortality benefit. <NL> Treatment of CHF aims to relieve symptoms, to maintain a euvolemic state (normal fluid level in the circulatory system), and to improve prognosis by delaying progression of heart failure and reducing cardiovascular risk. drugs used include: diuretic agents, vasodilator agents, positive inotropes, ACE inhibitors, beta blockers, and aldosterone antagonists (e.g.spironolactone). <NL> Some drugs which increase heart function, such as the positive inotrope Milrinone, lead to increased mortality, and are contraindicated",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    },
    {
      "question": "Current therapeutic status of milrinone in CHF is: A. First choice drug for a patient of mild CHF | B. As an add on drug to tide over the crisis in refractory CHF | C. Best drug for long-term maintenance therapy of CHF | D. Used only to suppress digitalis induced arrhythmias",
      "answer": "The correct answer is **B. As an add on drug to tide over the crisis in refractory CHF**.\n\nHere's why:\n\n*   **Milrinone** is a phosphodiesterase-3 inhibitor. It works by increasing cyclic AMP levels in cardiac and vascular smooth muscle cells, leading to positive inotropic (increased contractility) and vasodilatory effects.\n\nLet's break down why the other options are incorrect:\n\n*   **A. First choice drug for a patient of mild CHF:** Milrinone is a potent drug with significant side effects and is not indicated for mild heart failure. Standard therapies like ACE inhibitors, beta-blockers, and diuretics are the first-line treatments for mild CHF.\n*   **C. Best drug for long-term maintenance therapy of CHF:** Milrinone is generally not used for long-term maintenance therapy due to concerns about increased mortality with prolonged use. Its benefits are primarily seen in the short-term management of acute decompensated heart failure.\n*   **D. Used only to suppress digitalis induced arrhythmias:** Milrinone is not used to suppress digitalis-induced arrhythmias. In fact, it can sometimes exacerbate arrhythmias.\n\n**Explanation for B:**\n\nMilrinone is reserved for patients with **refractory congestive heart failure (CHF)**, meaning their condition is not adequately controlled by standard therapies. It is used as an **add-on drug** (often intravenously) to help stabilize these critically ill patients during an acute exacerbation or crisis. It can improve hemodynamics, reduce congestion, and bridge patients to more definitive therapies or recovery. However, its use is typically short-term due to potential adverse effects like arrhythmias and hypotension.",
      "ground_truth": "As an add on drug to tide over the crisis in refractory CHF ||",
      "model": "models/gemini-2.5-flash-lite",
      "method": "Direct LLM (No RAG)"
    }
  ]
}